这是一篇来自已证抗体库的有关人类 胱氨酸-天冬氨酸蛋白酶3 (caspase-3) 的综述,是根据1382篇发表使用所有方法的文章归纳的。这综述旨在帮助来邦网的访客找到最适合胱氨酸-天冬氨酸蛋白酶3 抗体。
胱氨酸-天冬氨酸蛋白酶3 同义词: CPP32; CPP32B; SCA-1; caspase-3; CASP-3; CPP-32; PARP cleavage protease; SREBP cleavage activity 1; apopain; caspase 3, apoptosis-related cysteine peptidase; caspase 3, apoptosis-related cysteine protease; cysteine protease CPP32; procaspase3; protein Yama

基因敲除验证
赛信通(上海)生物试剂有限公司兔 多克隆
  • 免疫印迹 (基因敲除); 小鼠; 图1
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫印迹 (基因敲除)在小鼠样品上 (图1). Oxid Med Cell Longev (2016) ncbi
赛信通(上海)生物试剂有限公司兔 多克隆
  • 免疫组化 (基因敲除); 小鼠
  • 免疫印迹 (基因敲除); 小鼠; 1:3000
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Tech, 9662)被用于免疫组化 (基因敲除)在小鼠样品上 和 免疫印迹 (基因敲除)在小鼠样品上浓度为1:3000. PLoS ONE (2015) ncbi
赛信通(上海)生物试剂有限公司兔 多克隆
  • 免疫印迹 (基因敲除); 小鼠; 图6
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9662)被用于免疫印迹 (基因敲除)在小鼠样品上 (图6). J Neurosci (2015) ncbi
碧迪BD小鼠 单克隆(19/Caspase-3/CPP32)
  • 免疫印迹 (基因敲除); 人类; 1:1000; 图4a
碧迪BD胱氨酸-天冬氨酸蛋白酶3抗体(BD Biosciences, 610323)被用于免疫印迹 (基因敲除)在人类样品上浓度为1:1000 (图4a). Cell Death Dis (2017) ncbi
艾博抗(上海)贸易有限公司
兔 单克隆(E83-77)
  • 免疫印迹; 人类; 图4c
艾博抗(上海)贸易有限公司胱氨酸-天冬氨酸蛋白酶3抗体(ab200342, ab32042)被用于免疫印迹在人类样品上 (图4c). Biomed Pharmacother (2017) ncbi
兔 多克隆
  • 细胞化学; 人类; 1:1000; 图5g
艾博抗(上海)贸易有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Abcam, ab4051)被用于免疫细胞化学在人类样品上浓度为1:1000 (图5g). Cell Death Differ (2017) ncbi
兔 单克隆(E87)
  • 免疫印迹; 人类; 图2c
艾博抗(上海)贸易有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Abcam, ab32351)被用于免疫印迹在人类样品上 (图2c). Neurochem Res (2017) ncbi
兔 多克隆
  • 免疫组化; 大鼠; 1:100; 图7a
艾博抗(上海)贸易有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Abcam, ab4051)被用于免疫组化在大鼠样品上浓度为1:100 (图7a). Pathophysiology (2017) ncbi
兔 单克隆(EPR16888)
  • 免疫印迹; 小鼠; 图6b
艾博抗(上海)贸易有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Abcam, ab179517)被用于免疫印迹在小鼠样品上 (图6b). Autophagy (2017) ncbi
兔 多克隆
  • 免疫印迹; 小鼠; 1:200; 图2e
艾博抗(上海)贸易有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Abcam, ab2302)被用于免疫印迹在小鼠样品上浓度为1:200 (图2e). J Mol Neurosci (2017) ncbi
兔 单克隆(E61)
  • 免疫印迹; 人类; 图4
艾博抗(上海)贸易有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Abcam, ab32150)被用于免疫印迹在人类样品上 (图4). Braz J Med Biol Res (2017) ncbi
兔 多克隆
  • 细胞化学; 大鼠; 图5c
艾博抗(上海)贸易有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Abcam, ab13847)被用于免疫细胞化学在大鼠样品上 (图5c). Oncotarget (2016) ncbi
兔 多克隆
  • 免疫组化; 小鼠; 图9e
艾博抗(上海)贸易有限公司胱氨酸-天冬氨酸蛋白酶3抗体(abcam, ab13847)被用于免疫组化在小鼠样品上 (图9e). Nature (2016) ncbi
兔 多克隆
  • 免疫组化-P; 小鼠; 1:50; 图S8A
艾博抗(上海)贸易有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Abcam, ab13847)被用于免疫组化-石蜡切片在小鼠样品上浓度为1:50 (图S8A). J Clin Invest (2016) ncbi
兔 多克隆
  • 免疫组化; 小鼠; 0.5 ug/ml; 图2
艾博抗(上海)贸易有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Abcam, ab4051)被用于免疫组化在小鼠样品上浓度为0.5 ug/ml (图2). Oncotarget (2016) ncbi
兔 单克隆(E87)
  • 免疫印迹; 人类; 图4c
艾博抗(上海)贸易有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Abcam, ab32351)被用于免疫印迹在人类样品上 (图4c). Oncotarget (2016) ncbi
兔 多克隆
  • 免疫组化-F; 大鼠; 1:500; 图2
艾博抗(上海)贸易有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Abcam, ab13847)被用于免疫组化-冰冻切片在大鼠样品上浓度为1:500 (图2). Acta Neuropathol Commun (2016) ncbi
兔 单克隆(E83-77)
  • 免疫印迹; 人类; 图8a
艾博抗(上海)贸易有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Abcam, E83-77)被用于免疫印迹在人类样品上 (图8a). PLoS ONE (2016) ncbi
兔 单克隆(E83-77)
  • 免疫印迹; 人类; 1:500; 图s3d
艾博抗(上海)贸易有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Abcam, ab32042)被用于免疫印迹在人类样品上浓度为1:500 (图s3d). EJNMMI Res (2016) ncbi
兔 单克隆(E87)
  • 免疫印迹; 人类; 1:5000; 图4c
艾博抗(上海)贸易有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Abcam, ab32351)被用于免疫印迹在人类样品上浓度为1:5000 (图4c). Oncotarget (2016) ncbi
兔 单克隆(E83-77)
  • 免疫印迹; 人类; 1:1000; 图4c
艾博抗(上海)贸易有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Abcam, ab32042)被用于免疫印迹在人类样品上浓度为1:1000 (图4c). Oncotarget (2016) ncbi
兔 多克隆
  • 免疫印迹; 小鼠; 1:1000
艾博抗(上海)贸易有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Abcam, ab-4051)被用于免疫印迹在小鼠样品上浓度为1:1000. Biochem Pharmacol (2016) ncbi
兔 多克隆
  • 免疫组化; 小鼠; 1:200; 图s5
艾博抗(上海)贸易有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Abcam, ab2302)被用于免疫组化在小鼠样品上浓度为1:200 (图s5). PLoS Genet (2016) ncbi
兔 多克隆
  • 免疫印迹; 人类; 1:1000; 图s9
  • 细胞化学; 人类; 1:100; 图s9
艾博抗(上海)贸易有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Abcam, ab13847)被用于免疫印迹在人类样品上浓度为1:1000 (图s9) 和 免疫细胞化学在人类样品上浓度为1:100 (图s9). Nat Commun (2016) ncbi
兔 多克隆
  • 免疫印迹; 大鼠; 图2
艾博抗(上海)贸易有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Abcam, ab2302)被用于免疫印迹在大鼠样品上 (图2). Mol Brain (2016) ncbi
兔 单克隆(E83-77)
  • 免疫印迹; 人类; 1:500; 图6
艾博抗(上海)贸易有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Abcam, ab32042)被用于免疫印迹在人类样品上浓度为1:500 (图6). Mol Med Rep (2016) ncbi
兔 多克隆
  • 免疫印迹; 人类; 1:1000; 图3b
艾博抗(上海)贸易有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Abcam, ab13847)被用于免疫印迹在人类样品上浓度为1:1000 (图3b). Mol Med Rep (2016) ncbi
兔 多克隆
  • 免疫印迹; 小鼠; 1:4000; 图4
艾博抗(上海)贸易有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Abcam, ab13847)被用于免疫印迹在小鼠样品上浓度为1:4000 (图4). Nat Commun (2016) ncbi
兔 多克隆
  • 免疫印迹; 人类; 图3
艾博抗(上海)贸易有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Abcam, ab2302)被用于免疫印迹在人类样品上 (图3). J Cancer (2016) ncbi
兔 多克隆
  • 免疫印迹; 人类; 图3
艾博抗(上海)贸易有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Abcam, ab13847)被用于免疫印迹在人类样品上 (图3). Oncol Lett (2016) ncbi
兔 多克隆
  • 免疫印迹; 人类; 图3
艾博抗(上海)贸易有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Abcam, ab2302)被用于免疫印迹在人类样品上 (图3). Oncol Lett (2016) ncbi
兔 多克隆
  • 免疫印迹; 人类; 图3
艾博抗(上海)贸易有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Abcam, 13847)被用于免疫印迹在人类样品上 (图3). Acta Neuropathol Commun (2016) ncbi
兔 多克隆
  • 免疫印迹; 人类; 图2c
艾博抗(上海)贸易有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Abcam, ab13847)被用于免疫印迹在人类样品上 (图2c). PLoS ONE (2016) ncbi
兔 单克隆(E87)
  • 免疫印迹; 人类; 图4
艾博抗(上海)贸易有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Abcam, ab32351)被用于免疫印迹在人类样品上 (图4). Oncotarget (2016) ncbi
兔 多克隆
  • 细胞化学; platanna; 1:200; 图8
艾博抗(上海)贸易有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Abcam, ab13847)被用于免疫细胞化学在platanna样品上浓度为1:200 (图8). Development (2016) ncbi
兔 多克隆
  • 免疫组化; 人类; 1:50; 图5
  • 细胞化学; 人类; 1:50; 图5
艾博抗(上海)贸易有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Abcam, ab2302)被用于免疫组化在人类样品上浓度为1:50 (图5) 和 免疫细胞化学在人类样品上浓度为1:50 (图5). Development (2016) ncbi
兔 多克隆
  • 细胞化学; 大鼠; 1:500; 图2
艾博抗(上海)贸易有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Abcam, 13847)被用于免疫细胞化学在大鼠样品上浓度为1:500 (图2). Cell Med (2015) ncbi
兔 单克隆(E83-77)
  • 细胞化学; 人类; 1:100; 图11
  • 免疫印迹; 人类; 1:1000; 图9
艾博抗(上海)贸易有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Abcam, ab32042)被用于免疫细胞化学在人类样品上浓度为1:100 (图11) 和 免疫印迹在人类样品上浓度为1:1000 (图9). Drug Des Devel Ther (2016) ncbi
兔 单克隆(E87)
  • 免疫印迹; 人类; 1:5000; 图4
艾博抗(上海)贸易有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Abcam, ab32351)被用于免疫印迹在人类样品上浓度为1:5000 (图4). Int J Mol Med (2016) ncbi
兔 多克隆
  • 免疫印迹; 人类; 图1
艾博抗(上海)贸易有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Abcam, ab13847)被用于免疫印迹在人类样品上 (图1). Nat Commun (2016) ncbi
兔 多克隆
  • 细胞化学; 小鼠; 1:200; 图2
艾博抗(上海)贸易有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Abcam, ab13847)被用于免疫细胞化学在小鼠样品上浓度为1:200 (图2). Biol Reprod (2016) ncbi
兔 多克隆
  • 细胞化学; 人类
艾博抗(上海)贸易有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Abcam, ab2302)被用于免疫细胞化学在人类样品上. J Neurosci (2016) ncbi
兔 多克隆
  • 免疫印迹; 人类; 1:300; 图3a
艾博抗(上海)贸易有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Abcam, ab44976)被用于免疫印迹在人类样品上浓度为1:300 (图3a). Sci Rep (2016) ncbi
兔 多克隆
  • 免疫组化-F; 小鼠; 1:200; 图s3
艾博抗(上海)贸易有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Abcam, ab13847)被用于免疫组化-冰冻切片在小鼠样品上浓度为1:200 (图s3). J Cell Biol (2016) ncbi
兔 多克隆
  • 免疫印迹; 小鼠; 1:800; 图4
艾博抗(上海)贸易有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Abcam, ab2302)被用于免疫印迹在小鼠样品上浓度为1:800 (图4). Mol Med Rep (2016) ncbi
兔 多克隆
  • 免疫组化; 小鼠; 1:100; 图5a
艾博抗(上海)贸易有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Abcam, ab4051)被用于免疫组化在小鼠样品上浓度为1:100 (图5a). Oncol Rep (2016) ncbi
兔 多克隆
  • 免疫印迹; 人类; 1:200; 图3
艾博抗(上海)贸易有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Abcam, ab2302)被用于免疫印迹在人类样品上浓度为1:200 (图3). Mol Med Rep (2016) ncbi
兔 多克隆
  • 免疫印迹; 人类; 1:500; 图3
艾博抗(上海)贸易有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Abcam, ab2302)被用于免疫印迹在人类样品上浓度为1:500 (图3). Oncol Lett (2015) ncbi
兔 单克隆(E87)
  • 免疫印迹; 人类; 1:500; 图3
艾博抗(上海)贸易有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Abcam, ab32351)被用于免疫印迹在人类样品上浓度为1:500 (图3). Oncol Lett (2015) ncbi
兔 多克隆
  • 免疫组化; tiger salamander; 1:800; 图s1
艾博抗(上海)贸易有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Abcam, ab13847)被用于免疫组化在tiger salamander样品上浓度为1:800 (图s1). elife (2015) ncbi
小鼠 单克隆(31A1067)
  • 免疫印迹; 人类; 图5
艾博抗(上海)贸易有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Abcam, 31A1067)被用于免疫印迹在人类样品上 (图5). Blood Cancer J (2015) ncbi
兔 单克隆(E83-77)
  • 免疫组化; 小鼠; 图2s1
艾博抗(上海)贸易有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Abcam, ab32042)被用于免疫组化在小鼠样品上 (图2s1). elife (2015) ncbi
兔 多克隆
  • 免疫组化-F; 斑马鱼
艾博抗(上海)贸易有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Abcam, 13847)被用于免疫组化-冰冻切片在斑马鱼样品上. J Neurosci (2015) ncbi
兔 多克隆
  • 免疫印迹; 小鼠; 图1
艾博抗(上海)贸易有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Abcam, ab4051)被用于免疫印迹在小鼠样品上 (图1). J Cell Mol Med (2016) ncbi
兔 多克隆
  • 免疫印迹; 小鼠; 图1
艾博抗(上海)贸易有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Abcam, ab2302)被用于免疫印迹在小鼠样品上 (图1). J Cell Mol Med (2016) ncbi
兔 多克隆
  • 细胞化学; 人类; 1:600; 图5
艾博抗(上海)贸易有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Abcam, ab13847)被用于免疫细胞化学在人类样品上浓度为1:600 (图5). BMC Cancer (2015) ncbi
兔 多克隆
  • 免疫印迹; 小鼠; 图6c
艾博抗(上海)贸易有限公司胱氨酸-天冬氨酸蛋白酶3抗体(abcam, ab2302)被用于免疫印迹在小鼠样品上 (图6c). Front Pharmacol (2015) ncbi
兔 多克隆
  • 免疫组化-P; 大鼠; 1:500; 图6a
艾博抗(上海)贸易有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Abcam, ab4051)被用于免疫组化-石蜡切片在大鼠样品上浓度为1:500 (图6a). Mol Cell Endocrinol (2016) ncbi
兔 多克隆
  • 免疫组化-F; 大鼠; 1:500; 图3a
艾博抗(上海)贸易有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Abcam, ab2302)被用于免疫组化-冰冻切片在大鼠样品上浓度为1:500 (图3a). PLoS ONE (2015) ncbi
兔 多克隆
  • 免疫组化-P; 小鼠; 1:300; 图5e
艾博抗(上海)贸易有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Abcam, Ab13847)被用于免疫组化-石蜡切片在小鼠样品上浓度为1:300 (图5e). Front Neuroanat (2015) ncbi
兔 多克隆
  • 细胞化学; 大鼠; 1:1000
艾博抗(上海)贸易有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Abcam, Ab13847)被用于免疫细胞化学在大鼠样品上浓度为1:1000. Biol Trace Elem Res (2016) ncbi
兔 多克隆
  • 免疫印迹; 小鼠; 1:1000; 图5a,b
艾博抗(上海)贸易有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Abcam, ab2302)被用于免疫印迹在小鼠样品上浓度为1:1000 (图5a,b). PLoS ONE (2015) ncbi
兔 单克隆(E83-77)
  • 免疫印迹; 人类; 图3
艾博抗(上海)贸易有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Abcam, ab32042)被用于免疫印迹在人类样品上 (图3). Nucleic Acids Res (2015) ncbi
兔 多克隆
  • 细胞化学; 人类; 1:500; 图s5
艾博抗(上海)贸易有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Abcam, ab2302)被用于免疫细胞化学在人类样品上浓度为1:500 (图s5). PLoS Biol (2015) ncbi
兔 多克隆
  • 免疫组化-F; 小鼠; 1:500; 图s8
艾博抗(上海)贸易有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Abcam, ab13847)被用于免疫组化-冰冻切片在小鼠样品上浓度为1:500 (图s8). Nat Commun (2015) ncbi
兔 多克隆
  • 免疫印迹; 人类; 1:1000; 图4
艾博抗(上海)贸易有限公司胱氨酸-天冬氨酸蛋白酶3抗体(abcam, ab2302)被用于免疫印迹在人类样品上浓度为1:1000 (图4). Sci Rep (2015) ncbi
兔 多克隆
  • 免疫组化-P; 小鼠; 1:1000; 图s2.
艾博抗(上海)贸易有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Abcam, AB2302)被用于免疫组化-石蜡切片在小鼠样品上浓度为1:1000 (图s2.). elife (2015) ncbi
兔 多克隆
  • 免疫组化; 小鼠; 1:300; 图3
艾博抗(上海)贸易有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Abcam, ab2302)被用于免疫组化在小鼠样品上浓度为1:300 (图3). Nat Commun (2015) ncbi
兔 单克隆(E87)
  • 免疫印迹; 人类; 图2f
艾博抗(上海)贸易有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Abcam, ab32351)被用于免疫印迹在人类样品上 (图2f). Oncogene (2016) ncbi
兔 单克隆(E83-77)
  • 免疫印迹; 人类; 图4
艾博抗(上海)贸易有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Abcam, ab32042)被用于免疫印迹在人类样品上 (图4). Int J Mol Sci (2015) ncbi
兔 多克隆
  • 免疫印迹; 大鼠; 1:500; 图4
艾博抗(上海)贸易有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Abcam, ab44976)被用于免疫印迹在大鼠样品上浓度为1:500 (图4). Am J Physiol Renal Physiol (2015) ncbi
兔 多克隆
  • 免疫组化; 人类; 表2
艾博抗(上海)贸易有限公司胱氨酸-天冬氨酸蛋白酶3抗体(abcam, ab4051)被用于免疫组化在人类样品上 (表2). PLoS ONE (2015) ncbi
兔 多克隆
  • 免疫组化-F; 小鼠; 1:500
艾博抗(上海)贸易有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Abcam, ab13847)被用于免疫组化-冰冻切片在小鼠样品上浓度为1:500. PLoS ONE (2015) ncbi
兔 单克隆(E83-77)
  • 免疫印迹; 人类; 1:1000; 图4b
艾博抗(上海)贸易有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Abcam, 32042)被用于免疫印迹在人类样品上浓度为1:1000 (图4b). Oncotarget (2015) ncbi
兔 单克隆(E87)
  • 免疫印迹; 人类; 图5
艾博抗(上海)贸易有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Abcam, ab32351)被用于免疫印迹在人类样品上 (图5). Biomaterials (2015) ncbi
兔 多克隆
  • 免疫组化-F; 小鼠; 1:300
艾博抗(上海)贸易有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Abcam, ab2302)被用于免疫组化-冰冻切片在小鼠样品上浓度为1:300. PLoS ONE (2015) ncbi
兔 单克隆(E83-77)
  • 细胞化学; 人类; 1:200; 图4c
艾博抗(上海)贸易有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Epitomics, ab32042)被用于免疫细胞化学在人类样品上浓度为1:200 (图4c). Mol Med Rep (2015) ncbi
兔 多克隆
  • 免疫组化; 小鼠; 1:500
艾博抗(上海)贸易有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Abcam, ab2302)被用于免疫组化在小鼠样品上浓度为1:500. Cell Death Differ (2015) ncbi
兔 多克隆
  • 免疫印迹; 人类
艾博抗(上海)贸易有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Abcam, 2302)被用于免疫印迹在人类样品上. Oncotarget (2015) ncbi
兔 多克隆
  • 免疫印迹; 大鼠
艾博抗(上海)贸易有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Abcam, ab2302)被用于免疫印迹在大鼠样品上. Exp Neurol (2015) ncbi
兔 多克隆
  • 细胞化学; 大鼠; 1:100
艾博抗(上海)贸易有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Abcam, ab13847)被用于免疫细胞化学在大鼠样品上浓度为1:100. Nat Neurosci (2015) ncbi
兔 多克隆
  • 免疫组化-P; marmosets; 1:100
艾博抗(上海)贸易有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Abcam, ab13847)被用于免疫组化-石蜡切片在marmosets样品上浓度为1:100. Dev Biol (2015) ncbi
兔 多克隆
  • 免疫组化-P; 人类; 1:200
艾博抗(上海)贸易有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Abcam, ab4051)被用于免疫组化-石蜡切片在人类样品上浓度为1:200. Oncol Lett (2015) ncbi
兔 多克隆
  • 细胞化学; 小鼠
艾博抗(上海)贸易有限公司胱氨酸-天冬氨酸蛋白酶3抗体(abcam, ab2302)被用于免疫细胞化学在小鼠样品上. Biomaterials (2015) ncbi
兔 多克隆
  • 免疫组化-P; 大鼠
艾博抗(上海)贸易有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Abcam, ab4051)被用于免疫组化-石蜡切片在大鼠样品上. Int J Stem Cells (2014) ncbi
兔 多克隆
  • 免疫组化; 小鼠; 1:10
艾博抗(上海)贸易有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Abcam, ab4051)被用于免疫组化在小鼠样品上浓度为1:10. J Neuroinflammation (2014) ncbi
兔 多克隆
  • 免疫组化-P; 小鼠
艾博抗(上海)贸易有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Abcam, ab2302)被用于免疫组化-石蜡切片在小鼠样品上. Arthritis Rheumatol (2015) ncbi
兔 单克隆(E87)
  • 免疫印迹; 人类; 图6a
艾博抗(上海)贸易有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Abcam, ab32351)被用于免疫印迹在人类样品上 (图6a). Int J Mol Med (2015) ncbi
兔 多克隆
  • 免疫组化; 人类; 1:100; 图1
艾博抗(上海)贸易有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Abcam, ab2302)被用于免疫组化在人类样品上浓度为1:100 (图1). Sci Rep (2014) ncbi
兔 多克隆
  • 免疫组化-P; 小鼠; 1:200
艾博抗(上海)贸易有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Abcam, ab13847)被用于免疫组化-石蜡切片在小鼠样品上浓度为1:200. Hum Reprod (2014) ncbi
兔 多克隆
  • 细胞化学; 人类
艾博抗(上海)贸易有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Abcam, ab13847)被用于免疫细胞化学在人类样品上. Mar Drugs (2014) ncbi
兔 单克隆(E83-77)
  • 免疫印迹; 人类; 1:1000
艾博抗(上海)贸易有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Abcam, ab32042)被用于免疫印迹在人类样品上浓度为1:1000. Brain Pathol (2015) ncbi
小鼠 单克隆(31A1067)
  • 免疫印迹; 人类; 1:500
艾博抗(上海)贸易有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Abcam, Ab13585)被用于免疫印迹在人类样品上浓度为1:500. Mol Oncol (2015) ncbi
兔 单克隆(E83-77)
  • 免疫印迹; 人类; 图1
艾博抗(上海)贸易有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Abcam, ab32042)被用于免疫印迹在人类样品上 (图1). Oncogene (2015) ncbi
兔 多克隆
  • 免疫组化-P; 人类
艾博抗(上海)贸易有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Abcam, ab4051)被用于免疫组化-石蜡切片在人类样品上. J Immunol (2014) ncbi
兔 多克隆
  • 免疫组化-F; 小鼠; 1:10
艾博抗(上海)贸易有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Abcam, ab4051)被用于免疫组化-冰冻切片在小鼠样品上浓度为1:10. Invest Ophthalmol Vis Sci (2014) ncbi
兔 多克隆
  • 免疫组化-F; 小鼠; 1:1000
艾博抗(上海)贸易有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Abcam, ab13847)被用于免疫组化-冰冻切片在小鼠样品上浓度为1:1000. Neurosci Lett (2014) ncbi
兔 多克隆
  • 免疫印迹; 人类
艾博抗(上海)贸易有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Abcam, ab13847)被用于免疫印迹在人类样品上. Curr Mol Med (2014) ncbi
兔 多克隆
  • 免疫印迹; 大鼠; 1:500
艾博抗(上海)贸易有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Abcam, ab2302)被用于免疫印迹在大鼠样品上浓度为1:500. Auton Neurosci (2014) ncbi
兔 多克隆
  • 免疫组化-P; 小鼠
艾博抗(上海)贸易有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Abcam, ab13847)被用于免疫组化-石蜡切片在小鼠样品上. Biol Reprod (2014) ncbi
兔 多克隆
  • 免疫印迹; 小鼠
艾博抗(上海)贸易有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Abcam, ab123114)被用于免疫印迹在小鼠样品上. Clin Sci (Lond) (2014) ncbi
兔 多克隆
  • 免疫组化-F; 小鼠; 1:50
艾博抗(上海)贸易有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Abcam, ab2302)被用于免疫组化-冰冻切片在小鼠样品上浓度为1:50. Mol Ther (2014) ncbi
兔 多克隆
  • 免疫组化-P; 小鼠
艾博抗(上海)贸易有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Abcam, ab13847)被用于免疫组化-石蜡切片在小鼠样品上. Am J Pathol (2014) ncbi
兔 多克隆
  • 免疫组化-P; 人类; 1:100
艾博抗(上海)贸易有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Abcam, ab4051)被用于免疫组化-石蜡切片在人类样品上浓度为1:100. Cancer Res (2014) ncbi
兔 单克隆(E87)
  • 免疫印迹; 大鼠
艾博抗(上海)贸易有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Abcam, ab32351)被用于免疫印迹在大鼠样品上. BMC Vet Res (2013) ncbi
兔 多克隆
  • 免疫组化-P; 大鼠; 1:400
艾博抗(上海)贸易有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Abcam, ab44976)被用于免疫组化-石蜡切片在大鼠样品上浓度为1:400. J Transl Med (2013) ncbi
兔 多克隆
  • 免疫组化-F; 大鼠
  • 细胞化学; 大鼠
艾博抗(上海)贸易有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Abcam, ab13847)被用于免疫组化-冰冻切片在大鼠样品上 和 免疫细胞化学在大鼠样品上. Stroke (2013) ncbi
兔 多克隆
  • 免疫组化-P; 小鼠; 1:250
艾博抗(上海)贸易有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Abcam, ab13847)被用于免疫组化-石蜡切片在小鼠样品上浓度为1:250. Cancer Gene Ther (2013) ncbi
兔 多克隆
  • 免疫组化; 小鼠; 1:200
艾博抗(上海)贸易有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Abcam, ab13847)被用于免疫组化在小鼠样品上浓度为1:200. Toxicol Appl Pharmacol (2013) ncbi
兔 多克隆
  • 免疫组化; 小鼠; 1:500
艾博抗(上海)贸易有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Abcam, ab13847)被用于免疫组化在小鼠样品上浓度为1:500. PLoS ONE (2013) ncbi
兔 多克隆
  • 免疫组化; platanna; 1:200
艾博抗(上海)贸易有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Abcam, ab13847)被用于免疫组化在platanna样品上浓度为1:200. Development (2013) ncbi
兔 多克隆
  • 免疫组化; 淡水涡虫;真涡虫; 1:1000
艾博抗(上海)贸易有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Abcam, ab13847)被用于免疫组化在淡水涡虫;真涡虫样品上浓度为1:1000. Development (2013) ncbi
兔 多克隆
  • 细胞化学; 猪
艾博抗(上海)贸易有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Abcam, ab13847)被用于免疫细胞化学在猪样品上. Stem Cells Transl Med (2012) ncbi
兔 多克隆
  • 免疫印迹; 小鼠; 1:200
艾博抗(上海)贸易有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Abcam, ab4051)被用于免疫印迹在小鼠样品上浓度为1:200. Dev Biol (2013) ncbi
圣克鲁斯生物技术
小鼠 单克隆(B-4)
  • 免疫印迹; 人类; 图2c
圣克鲁斯生物技术胱氨酸-天冬氨酸蛋白酶3抗体(Santa Cruz, sc-271028)被用于免疫印迹在人类样品上 (图2c). PLoS Pathog (2017) ncbi
小鼠 单克隆(E-8)
  • 免疫印迹; 人类; 图3e
圣克鲁斯生物技术胱氨酸-天冬氨酸蛋白酶3抗体(Santa Cruz Biotechnology, sc-7272)被用于免疫印迹在人类样品上 (图3e). Exp Ther Med (2017) ncbi
小鼠 单克隆(C-6)
  • 免疫印迹; 人类; 1:2500; 图4B
圣克鲁斯生物技术胱氨酸-天冬氨酸蛋白酶3抗体(Santa cruz, sc-271759)被用于免疫印迹在人类样品上浓度为1:2500 (图4B). Mol Med Rep (2017) ncbi
小鼠 单克隆(E-8)
  • 免疫印迹; 人类; 1:500; 图4c
圣克鲁斯生物技术胱氨酸-天冬氨酸蛋白酶3抗体(Santa Cruz, sc-7272)被用于免疫印迹在人类样品上浓度为1:500 (图4c). Oncol Lett (2017) ncbi
小鼠 单克隆(31A1067)
  • 免疫印迹; 人类; 1:1000; 图2d
圣克鲁斯生物技术胱氨酸-天冬氨酸蛋白酶3抗体(Santa Cruz, sc-56053)被用于免疫印迹在人类样品上浓度为1:1000 (图2d). Int J Mol Med (2017) ncbi
小鼠 单克隆(4.1.18)
  • 免疫印迹; 人类; 1:1000; 图6A
圣克鲁斯生物技术胱氨酸-天冬氨酸蛋白酶3抗体(Santa Cruz, sc-65497)被用于免疫印迹在人类样品上浓度为1:1000 (图6A). Int J Mol Med (2017) ncbi
小鼠 单克隆(3CSP01)
  • 免疫印迹 (基因敲减); 人类; 图2j
圣克鲁斯生物技术胱氨酸-天冬氨酸蛋白酶3抗体(Santa Cruz, sc-65496)被用于免疫印迹 (基因敲减)在人类样品上 (图2j). Biomed Res Int (2017) ncbi
小鼠 单克隆(E-8)
  • 免疫组化-P; 人类; 1:200; 图4G
圣克鲁斯生物技术胱氨酸-天冬氨酸蛋白酶3抗体(Santa Cruz, sc-7272)被用于免疫组化-石蜡切片在人类样品上浓度为1:200 (图4G). Oncotarget (2017) ncbi
小鼠 单克隆(E-8)
  • 免疫组化-F; gerbils; 1:500; 图4
圣克鲁斯生物技术胱氨酸-天冬氨酸蛋白酶3抗体(Santa Cruz, SC-7272)被用于免疫组化-冰冻切片在gerbils样品上浓度为1:500 (图4). Exp Ther Med (2017) ncbi
小鼠 单克隆(C-6)
  • 免疫印迹; 人类; 1:1000; 图4a
圣克鲁斯生物技术胱氨酸-天冬氨酸蛋白酶3抗体(Santa Cruz Biotechnology, sc-271759)被用于免疫印迹在人类样品上浓度为1:1000 (图4a). Exp Ther Med (2016) ncbi
小鼠 单克隆(E-8)
  • 免疫印迹; 人类; 图4e
圣克鲁斯生物技术胱氨酸-天冬氨酸蛋白酶3抗体(Santa Cruz, sc-7272)被用于免疫印迹在人类样品上 (图4e). Oncogene (2017) ncbi
小鼠 单克隆(E-8)
  • 免疫组化-P; 人类; 1:75; 图6a
圣克鲁斯生物技术胱氨酸-天冬氨酸蛋白酶3抗体(Santa Cruz, sc-7272)被用于免疫组化-石蜡切片在人类样品上浓度为1:75 (图6a). Cancer Lett (2017) ncbi
小鼠 单克隆(E-8)
  • 免疫印迹; 人类; 图5
圣克鲁斯生物技术胱氨酸-天冬氨酸蛋白酶3抗体(Santa Cruz, sc-7272)被用于免疫印迹在人类样品上 (图5). Mol Med Rep (2016) ncbi
小鼠 单克隆
  • 免疫印迹; 人类; 图3d
圣克鲁斯生物技术胱氨酸-天冬氨酸蛋白酶3抗体(Santa Cruz Biotechnology, C-6)被用于免疫印迹在人类样品上 (图3d). Oncol Rep (2016) ncbi
小鼠 单克隆(C-6)
  • 免疫印迹; 人类; 图3d
圣克鲁斯生物技术胱氨酸-天冬氨酸蛋白酶3抗体(Santa Cruz Biotechnology, C-6)被用于免疫印迹在人类样品上 (图3d). Oncol Rep (2016) ncbi
小鼠 单克隆(E-8)
  • 免疫印迹; 人类; 图8a
圣克鲁斯生物技术胱氨酸-天冬氨酸蛋白酶3抗体(Santa Cruz, E-8)被用于免疫印迹在人类样品上 (图8a). PLoS ONE (2016) ncbi
小鼠 单克隆(E-8)
  • 免疫印迹; 人类; 图8a
圣克鲁斯生物技术胱氨酸-天冬氨酸蛋白酶3抗体(Santa Cruz, E-8)被用于免疫印迹在人类样品上 (图8a). PLoS ONE (2016) ncbi
小鼠 单克隆(4.1.18)
  • 免疫组化-P; 人类; 1:200; 图4a
  • 免疫印迹; 人类; 1:1000; 图1g
圣克鲁斯生物技术胱氨酸-天冬氨酸蛋白酶3抗体(Santa Cruz, sc-65497)被用于免疫组化-石蜡切片在人类样品上浓度为1:200 (图4a) 和 免疫印迹在人类样品上浓度为1:1000 (图1g). Mol Med Rep (2016) ncbi
小鼠 单克隆(E-8)
  • 细胞化学; 小鼠; 图7
圣克鲁斯生物技术胱氨酸-天冬氨酸蛋白酶3抗体(Santa Cruz, SC-7272)被用于免疫细胞化学在小鼠样品上 (图7). Toxicology (2016) ncbi
小鼠 单克隆(31A1067)
  • 免疫印迹; 人类; 1:200; 图5
圣克鲁斯生物技术胱氨酸-天冬氨酸蛋白酶3抗体(Santa Cruz, sc-56053)被用于免疫印迹在人类样品上浓度为1:200 (图5). Oncol Lett (2016) ncbi
小鼠 单克隆(E-8)
  • 免疫印迹; 人类; 1:4000; 图3a
圣克鲁斯生物技术胱氨酸-天冬氨酸蛋白酶3抗体(Santa Cruz, sc7272)被用于免疫印迹在人类样品上浓度为1:4000 (图3a). FEBS Lett (2016) ncbi
小鼠 单克隆(3CSP01)
  • 免疫印迹; 人类; 1:800; 图6
圣克鲁斯生物技术胱氨酸-天冬氨酸蛋白酶3抗体(Santa Cruz, sc-65496)被用于免疫印迹在人类样品上浓度为1:800 (图6). Int J Biochem Cell Biol (2016) ncbi
小鼠 单克隆(E-8)
  • 免疫印迹; 人类; 1:1000; 表2
圣克鲁斯生物技术胱氨酸-天冬氨酸蛋白酶3抗体(santa Cruz, sc-7272)被用于免疫印迹在人类样品上浓度为1:1000 (表2). Oncol Lett (2015) ncbi
小鼠 单克隆(46)
  • 免疫印迹; 小鼠; 图2c
圣克鲁斯生物技术胱氨酸-天冬氨酸蛋白酶3抗体(Santa Cruz, 46)被用于免疫印迹在小鼠样品上 (图2c). J Biol Chem (2016) ncbi
小鼠 单克隆(C-6)
  • 免疫组化; 小鼠; 图6
圣克鲁斯生物技术胱氨酸-天冬氨酸蛋白酶3抗体(Santa Cruz, 271759)被用于免疫组化在小鼠样品上 (图6). Sci Rep (2015) ncbi
小鼠 单克隆(E-8)
  • 免疫印迹; 大鼠; 1:500; 图4
圣克鲁斯生物技术胱氨酸-天冬氨酸蛋白酶3抗体(SantaCruz, sc-7272)被用于免疫印迹在大鼠样品上浓度为1:500 (图4). Mol Med Rep (2015) ncbi
小鼠 单克隆(31A1067)
  • 免疫印迹; 人类; 1:1000; 图1
圣克鲁斯生物技术胱氨酸-天冬氨酸蛋白酶3抗体(santa Cruz, sc-56053)被用于免疫印迹在人类样品上浓度为1:1000 (图1). Cell Death Dis (2015) ncbi
小鼠 单克隆(E-8)
  • 免疫印迹; 人类; 1:500; 图 4
圣克鲁斯生物技术胱氨酸-天冬氨酸蛋白酶3抗体(Santa Cruz Biotechnology, sc-7272)被用于免疫印迹在人类样品上浓度为1:500 (图 4). Reproduction (2015) ncbi
小鼠 单克隆(E-8)
  • 免疫印迹; 大鼠
圣克鲁斯生物技术胱氨酸-天冬氨酸蛋白酶3抗体(Santa Cruz, sc-7272)被用于免疫印迹在大鼠样品上. Mol Cell Endocrinol (2015) ncbi
小鼠 单克隆(E-8)
  • 免疫印迹; 人类; 图f4
圣克鲁斯生物技术胱氨酸-天冬氨酸蛋白酶3抗体(santa cruz, sc-7272)被用于免疫印迹在人类样品上 (图f4). Oncotarget (2015) ncbi
小鼠 单克隆(B-4)
  • 免疫印迹; 人类; 图6
圣克鲁斯生物技术胱氨酸-天冬氨酸蛋白酶3抗体(Santa Cruz, sc-271028)被用于免疫印迹在人类样品上 (图6). Cell Death Dis (2015) ncbi
小鼠 单克隆(CPP324-1-18)
  • 免疫印迹; 人类; 1:200; 图6
圣克鲁斯生物技术胱氨酸-天冬氨酸蛋白酶3抗体(Santa Cruz, sc-56052)被用于免疫印迹在人类样品上浓度为1:200 (图6). Oncol Lett (2015) ncbi
小鼠 单克隆(E-8)
  • 免疫印迹; 人类; 图3
圣克鲁斯生物技术胱氨酸-天冬氨酸蛋白酶3抗体(Santa Cruz, sc-7272)被用于免疫印迹在人类样品上 (图3). Cancer Biol Ther (2015) ncbi
小鼠 单克隆(46)
  • 免疫印迹; 大鼠; 1:200
圣克鲁斯生物技术胱氨酸-天冬氨酸蛋白酶3抗体(Santa Cruz Biotechnology, SC136219)被用于免疫印迹在大鼠样品上浓度为1:200. J Pineal Res (2015) ncbi
小鼠 单克隆(3C119)
  • 免疫组化; 小鼠; 1:400
圣克鲁斯生物技术胱氨酸-天冬氨酸蛋白酶3抗体(Santa Cruz Biotechnology, sc-70497)被用于免疫组化在小鼠样品上浓度为1:400. PLoS ONE (2014) ncbi
小鼠 单克隆(C-6)
  • 免疫印迹; 人类
圣克鲁斯生物技术胱氨酸-天冬氨酸蛋白酶3抗体(Santa Cruz, sc-271759)被用于免疫印迹在人类样品上. Gene (2014) ncbi
小鼠 单克隆(31A1067)
  • 免疫印迹; 人类; 图2
圣克鲁斯生物技术胱氨酸-天冬氨酸蛋白酶3抗体(Santa Cruz, sc-56053)被用于免疫印迹在人类样品上 (图2). Autophagy (2014) ncbi
小鼠 单克隆(E-8)
  • 免疫印迹; 人类
圣克鲁斯生物技术胱氨酸-天冬氨酸蛋白酶3抗体(Santa Cruz Biotechnology, sc-7272)被用于免疫印迹在人类样品上. Oncotarget (2014) ncbi
小鼠 单克隆(E-8)
  • 免疫印迹; 人类; 1:100
圣克鲁斯生物技术胱氨酸-天冬氨酸蛋白酶3抗体(Santa Cruz Biotechnology, sc-7272)被用于免疫印迹在人类样品上浓度为1:100. Biomed Res Int (2014) ncbi
小鼠 单克隆(46)
  • 免疫印迹; 小鼠
圣克鲁斯生物技术胱氨酸-天冬氨酸蛋白酶3抗体(Santa Cruz, sc-136219)被用于免疫印迹在小鼠样品上. Eur J Pharmacol (2014) ncbi
小鼠 单克隆(31A1067)
  • 免疫印迹; 兔; 1:1000
圣克鲁斯生物技术胱氨酸-天冬氨酸蛋白酶3抗体(Santa Cruz, sc-56053)被用于免疫印迹在兔样品上浓度为1:1000. Eur J Nutr (2014) ncbi
安迪生物R&D
兔 单克隆(269518)
  • 免疫组化-P; 人类; 1:100; 图2;
安迪生物R&D胱氨酸-天冬氨酸蛋白酶3抗体(R&D, MAB835)被用于免疫组化-石蜡切片在人类样品上浓度为1:100 (图2;). Oncol Lett (2017) ncbi
兔 单克隆(269518)
  • 免疫组化; 人类; 图3c
  • 免疫印迹; 人类; 1:1000; 图2c
安迪生物R&D胱氨酸-天冬氨酸蛋白酶3抗体(R&D, MAB835)被用于免疫组化在人类样品上 (图3c) 和 免疫印迹在人类样品上浓度为1:1000 (图2c). Mol Ther Nucleic Acids (2017) ncbi
兔 多克隆
  • 免疫印迹; 小鼠; 1:1000; 图s1c
安迪生物R&D胱氨酸-天冬氨酸蛋白酶3抗体(R&D, AF835)被用于免疫印迹在小鼠样品上浓度为1:1000 (图s1c). Redox Biol (2016) ncbi
兔 多克隆
  • 免疫组化-P; 小鼠; 1:800; 图5
安迪生物R&D胱氨酸-天冬氨酸蛋白酶3抗体(R&D Systems, AF835)被用于免疫组化-石蜡切片在小鼠样品上浓度为1:800 (图5). BMC Cancer (2016) ncbi
兔 多克隆
  • 免疫组化-F; 小鼠; 1:250; 图s1
安迪生物R&D胱氨酸-天冬氨酸蛋白酶3抗体(R&D systems, AF835)被用于免疫组化-冰冻切片在小鼠样品上浓度为1:250 (图s1). PLoS Genet (2016) ncbi
兔 多克隆
  • 免疫组化-F; 小鼠; 1:200; 图s2
安迪生物R&D胱氨酸-天冬氨酸蛋白酶3抗体(R&D Systems, AF835)被用于免疫组化-冰冻切片在小鼠样品上浓度为1:200 (图s2). Oncogene (2017) ncbi
兔 多克隆
  • 免疫组化-F; 小鼠; 1:500
安迪生物R&D胱氨酸-天冬氨酸蛋白酶3抗体(R&D Systems, AF835)被用于免疫组化-冰冻切片在小鼠样品上浓度为1:500. J Cell Sci (2016) ncbi
兔 多克隆
  • 免疫组化-P; 小鼠; 1:100; 图3a
安迪生物R&D胱氨酸-天冬氨酸蛋白酶3抗体(R&D, AF835)被用于免疫组化-石蜡切片在小鼠样品上浓度为1:100 (图3a). Nat Commun (2016) ncbi
兔 多克隆
  • 免疫组化; 小鼠; 1:200
安迪生物R&D胱氨酸-天冬氨酸蛋白酶3抗体(R&D, AF835)被用于免疫组化在小鼠样品上浓度为1:200. Science (2016) ncbi
兔 多克隆
  • 免疫组化-P; 大鼠; 1:100; 图6
安迪生物R&D胱氨酸-天冬氨酸蛋白酶3抗体(R&D Systems, AF835)被用于免疫组化-石蜡切片在大鼠样品上浓度为1:100 (图6). PLoS ONE (2016) ncbi
兔 多克隆
  • 免疫组化; 小鼠; 1:2000; 图1
安迪生物R&D胱氨酸-天冬氨酸蛋白酶3抗体(R&D systems, AF835)被用于免疫组化在小鼠样品上浓度为1:2000 (图1). Front Mol Neurosci (2015) ncbi
兔 多克隆
  • IHC-Free; 鸡; 1:500; 图4
安迪生物R&D胱氨酸-天冬氨酸蛋白酶3抗体(R&D Systems, AF835)被用于immunohistochemistry - free floating section在鸡样品上浓度为1:500 (图4). J Cell Biol (2015) ncbi
兔 多克隆
  • 免疫组化-P; 人类; 1:1500; 图5b
安迪生物R&D胱氨酸-天冬氨酸蛋白酶3抗体(R&D Systems, AF835)被用于免疫组化-石蜡切片在人类样品上浓度为1:1500 (图5b). Oncotarget (2015) ncbi
兔 多克隆
  • 免疫组化-P; 小鼠
安迪生物R&D胱氨酸-天冬氨酸蛋白酶3抗体(R&D Systems, AF835)被用于免疫组化-石蜡切片在小鼠样品上. Mol Cell Biol (2015) ncbi
小鼠 单克隆(84803)
  • 免疫组化; 小鼠; 图5
安迪生物R&D胱氨酸-天冬氨酸蛋白酶3抗体(R&D Systems, 84803)被用于免疫组化在小鼠样品上 (图5). Cell Death Dis (2015) ncbi
兔 多克隆
  • 细胞化学; 小鼠; 1:500; 图2
安迪生物R&D胱氨酸-天冬氨酸蛋白酶3抗体(R&D Systems, AF835)被用于免疫细胞化学在小鼠样品上浓度为1:500 (图2). Development (2015) ncbi
兔 多克隆
  • 免疫组化; 小鼠; 图5c
安迪生物R&D胱氨酸-天冬氨酸蛋白酶3抗体(R&D Systems, AF 835)被用于免疫组化在小鼠样品上 (图5c). PLoS ONE (2015) ncbi
兔 多克隆
  • 免疫组化-F; 小鼠
安迪生物R&D胱氨酸-天冬氨酸蛋白酶3抗体(R&D Systems, AF835)被用于免疫组化-冰冻切片在小鼠样品上. Glia (2015) ncbi
兔 多克隆
  • 免疫组化-P; 小鼠; 1:1000; 图3
安迪生物R&D胱氨酸-天冬氨酸蛋白酶3抗体(R&D Systems, AF835)被用于免疫组化-石蜡切片在小鼠样品上浓度为1:1000 (图3). PLoS ONE (2015) ncbi
兔 多克隆
  • 细胞化学; 小鼠; 1:500; 图4
安迪生物R&D胱氨酸-天冬氨酸蛋白酶3抗体(R&D systems, AF835)被用于免疫细胞化学在小鼠样品上浓度为1:500 (图4). J Neurosci (2015) ncbi
兔 多克隆
  • 免疫组化-P; 小鼠
安迪生物R&D胱氨酸-天冬氨酸蛋白酶3抗体(R和D, AF835)被用于免疫组化-石蜡切片在小鼠样品上. Nat Med (2015) ncbi
兔 多克隆
  • 免疫组化-P; 小鼠; 1:100; 图1
安迪生物R&D胱氨酸-天冬氨酸蛋白酶3抗体(R&D Systems, AF835)被用于免疫组化-石蜡切片在小鼠样品上浓度为1:100 (图1). J Cell Mol Med (2015) ncbi
兔 多克隆
  • 免疫组化; 羊; 1:1000
安迪生物R&D胱氨酸-天冬氨酸蛋白酶3抗体(R&D Systems, AF835)被用于免疫组化在羊样品上浓度为1:1000. Reprod Sci (2015) ncbi
兔 多克隆
  • 免疫组化; 人类; 1:100
安迪生物R&D胱氨酸-天冬氨酸蛋白酶3抗体(R&D Systems, AF835)被用于免疫组化在人类样品上浓度为1:100. Brain Pathol (2015) ncbi
兔 多克隆
  • 免疫组化-P; 小鼠; 图1
安迪生物R&D胱氨酸-天冬氨酸蛋白酶3抗体(R&D Systems, AF835)被用于免疫组化-石蜡切片在小鼠样品上 (图1). Cell Death Differ (2014) ncbi
兔 多克隆
  • 免疫组化-F; 小鼠; 1:1000
安迪生物R&D胱氨酸-天冬氨酸蛋白酶3抗体(RD, AF835)被用于免疫组化-冰冻切片在小鼠样品上浓度为1:1000. Neurobiol Dis (2014) ncbi
兔 多克隆
  • 免疫组化-F; 小鼠; 1:1000
安迪生物R&D胱氨酸-天冬氨酸蛋白酶3抗体(R&D Systems, AF835)被用于免疫组化-冰冻切片在小鼠样品上浓度为1:1000. Hum Mol Genet (2014) ncbi
兔 多克隆
  • 免疫印迹; 人类; 0.5 ug/ml
安迪生物R&D胱氨酸-天冬氨酸蛋白酶3抗体(R&D Systems, AF835)被用于免疫印迹在人类样品上浓度为0.5 ug/ml. J Immunol (2014) ncbi
兔 多克隆
  • 免疫组化; 小鼠; 1:200
安迪生物R&D胱氨酸-天冬氨酸蛋白酶3抗体(R&D Systems, AF835)被用于免疫组化在小鼠样品上浓度为1:200. J Pathol (2014) ncbi
兔 多克隆
  • 免疫组化-P; 人类; 1:800
安迪生物R&D胱氨酸-天冬氨酸蛋白酶3抗体(R&D Systems, AF835)被用于免疫组化-石蜡切片在人类样品上浓度为1:800. BMC Nephrol (2014) ncbi
兔 多克隆
  • 免疫组化-F; 小鼠; 1:500
安迪生物R&D胱氨酸-天冬氨酸蛋白酶3抗体(R&D System, AF835)被用于免疫组化-冰冻切片在小鼠样品上浓度为1:500. PLoS ONE (2013) ncbi
兔 多克隆
  • 细胞化学; 人类; 1:1000
  • 细胞化学; 小鼠
安迪生物R&D胱氨酸-天冬氨酸蛋白酶3抗体(R&D Systems, AF835)被用于免疫细胞化学在人类样品上浓度为1:1000 和 在小鼠样品上. Acta Histochem (2014) ncbi
兔 多克隆
  • 免疫组化; 小鼠
安迪生物R&D胱氨酸-天冬氨酸蛋白酶3抗体(R&D, AF835)被用于免疫组化在小鼠样品上. Cell Rep (2012) ncbi
兔 多克隆
  • 免疫组化; 小鼠; 1:500
安迪生物R&D胱氨酸-天冬氨酸蛋白酶3抗体(R&D Systems, AF835)被用于免疫组化在小鼠样品上浓度为1:500. J Biol Chem (2012) ncbi
兔 多克隆
  • 免疫组化; 小鼠; 1:500
安迪生物R&D胱氨酸-天冬氨酸蛋白酶3抗体(R&D Systems, AF835)被用于免疫组化在小鼠样品上浓度为1:500. Dev Biol (2012) ncbi
兔 多克隆
  • 免疫组化-F; 小鼠
安迪生物R&D胱氨酸-天冬氨酸蛋白酶3抗体(R&D Systems, AF835)被用于免疫组化-冰冻切片在小鼠样品上. Neuro Oncol (2011) ncbi
兔 多克隆
  • 免疫组化; 小鼠; 1:2000
安迪生物R&D胱氨酸-天冬氨酸蛋白酶3抗体(R&D Systems, AF835)被用于免疫组化在小鼠样品上浓度为1:2000. J Comp Neurol (2009) ncbi
山羊 多克隆
  • 免疫印迹; 人类
安迪生物R&D胱氨酸-天冬氨酸蛋白酶3抗体(R&D Systems, AF-605-NA)被用于免疫印迹在人类样品上. Hepatology (2007) ncbi
兔 多克隆
  • IHC-Free; 小鼠; 0.3 ug/ml
安迪生物R&D胱氨酸-天冬氨酸蛋白酶3抗体(R&D Systems, AF835)被用于immunohistochemistry - free floating section在小鼠样品上浓度为0.3 ug/ml. J Comp Neurol (2006) ncbi
赛默飞世尔
小鼠 单克隆(74T2)
  • 细胞化学; 大鼠; 1:100; 图3
赛默飞世尔胱氨酸-天冬氨酸蛋白酶3抗体(Thermo Scientific, 437,800)被用于免疫细胞化学在大鼠样品上浓度为1:100 (图3). Cell Biosci (2017) ncbi
小鼠 单克隆(CPP32 4-1-18)
  • 免疫组化; 大鼠; 1:500; 图4a
赛默飞世尔胱氨酸-天冬氨酸蛋白酶3抗体(Pierce, CPP324-1-18)被用于免疫组化在大鼠样品上浓度为1:500 (图4a). Rom J Morphol Embryol (2016) ncbi
兔 多克隆
  • 免疫组化-P; 大鼠; 图3a
赛默飞世尔胱氨酸-天冬氨酸蛋白酶3抗体(Thermo Fisher, PAI-29157)被用于免疫组化-石蜡切片在大鼠样品上 (图3a). Reprod Biol (2016) ncbi
小鼠 单克隆(31A1067)
  • 免疫印迹; 人类; 图2
赛默飞世尔胱氨酸-天冬氨酸蛋白酶3抗体(Thermo Scientific, MA191637)被用于免疫印迹在人类样品上 (图2). Mol Cancer (2016) ncbi
兔 单克隆(9H19L2)
  • 细胞化学; 人类; 图5
赛默飞世尔胱氨酸-天冬氨酸蛋白酶3抗体(Invitrogen, 700182)被用于免疫细胞化学在人类样品上 (图5). Radiat Oncol (2016) ncbi
兔 单克隆(9H19L2)
  • 免疫印迹; 人类; 1:500; 图3h
赛默飞世尔胱氨酸-天冬氨酸蛋白酶3抗体(Invitrogen, 9H19L2)被用于免疫印迹在人类样品上浓度为1:500 (图3h). Mol Cell Biochem (2016) ncbi
小鼠 单克隆(CPP32 4-1-18)
  • 免疫组化-P; 大鼠; 1:500; 图3g
赛默飞世尔胱氨酸-天冬氨酸蛋白酶3抗体(LabVision, MA1-16843)被用于免疫组化-石蜡切片在大鼠样品上浓度为1:500 (图3g). Acta Histochem (2016) ncbi
小鼠 单克隆(4-1-18)
  • 免疫组化-P; 人类; 1:100; 表3
赛默飞世尔胱氨酸-天冬氨酸蛋白酶3抗体(Invitrogen, 35-1600Z)被用于免疫组化-石蜡切片在人类样品上浓度为1:100 (表3). Oncol Lett (2016) ncbi
兔 单克隆(9H19L2)
  • 免疫印迹; 人类; 图4
赛默飞世尔胱氨酸-天冬氨酸蛋白酶3抗体(Thermo Scientific, 9H19L2)被用于免疫印迹在人类样品上 (图4). Int J Mol Sci (2016) ncbi
兔 单克隆(9H19L2)
  • 细胞化学; 人类; 1:50; 图2
赛默飞世尔胱氨酸-天冬氨酸蛋白酶3抗体(分子探针, 700182)被用于免疫细胞化学在人类样品上浓度为1:50 (图2). J Assist Reprod Genet (2016) ncbi
兔 单克隆(9H19L2)
  • 免疫组化-P; 大鼠; 图4
赛默飞世尔胱氨酸-天冬氨酸蛋白酶3抗体(Thermo Fisher, 700182)被用于免疫组化-石蜡切片在大鼠样品上 (图4). Ann Anat (2016) ncbi
小鼠 单克隆(CPP32 4-1-18)
  • 免疫印迹; 人类; 1:250; 图2
赛默飞世尔胱氨酸-天冬氨酸蛋白酶3抗体(Zymed Laboratories, MA1-16843)被用于免疫印迹在人类样品上浓度为1:250 (图2). Exp Ther Med (2015) ncbi
兔 单克隆(22HCLC)
  • 免疫印迹; 人类; 1:500; 图5a
赛默飞世尔胱氨酸-天冬氨酸蛋白酶3抗体(Thermo Fisher Scientific, 710431)被用于免疫印迹在人类样品上浓度为1:500 (图5a). Int J Oncol (2015) ncbi
兔 单克隆(9H19L2)
  • 免疫印迹; 人类
赛默飞世尔胱氨酸-天冬氨酸蛋白酶3抗体(Invitrogen, 700182)被用于免疫印迹在人类样品上. Nanomedicine (Lond) (2015) ncbi
小鼠 单克隆(4-1-18)
  • 免疫印迹; 人类; 2 ug/ml
赛默飞世尔胱氨酸-天冬氨酸蛋白酶3抗体(生活技术, 35-1600Z)被用于免疫印迹在人类样品上浓度为2 ug/ml. Oncol Rep (2015) ncbi
兔 单克隆(9H19L2)
  • 免疫组化-P; 人类; 1:500
赛默飞世尔胱氨酸-天冬氨酸蛋白酶3抗体(Invitrogen, 9H19L2)被用于免疫组化-石蜡切片在人类样品上浓度为1:500. BMC Cancer (2014) ncbi
小鼠 单克隆(CPP32 4-1-18)
  • 免疫组化-P; 蜜蜂
赛默飞世尔胱氨酸-天冬氨酸蛋白酶3抗体(Neomarkers, CPP32)被用于免疫组化-石蜡切片在蜜蜂样品上. Environ Microbiol Rep (2013) ncbi
小鼠 单克隆(4-1-18)
  • 免疫组化-P; 小鼠; 1:20; 图4
赛默飞世尔胱氨酸-天冬氨酸蛋白酶3抗体(Zymed, 35-1600)被用于免疫组化-石蜡切片在小鼠样品上浓度为1:20 (图4). Autoimmune Dis (2011) ncbi
小鼠 单克隆(3CSP03 (4.1.18))
  • 免疫组化-P; 人类
赛默飞世尔胱氨酸-天冬氨酸蛋白酶3抗体(NeoMarkers, 3CSP03)被用于免疫组化-石蜡切片在人类样品上. J Korean Med Sci (2007) ncbi
小鼠 单克隆(3CSP03)
  • 免疫组化-P; 人类
赛默飞世尔胱氨酸-天冬氨酸蛋白酶3抗体(NeoMarkers, 3CSP03)被用于免疫组化-石蜡切片在人类样品上. J Korean Med Sci (2007) ncbi
小鼠 单克隆(CPP32 4-1-18)
  • 免疫组化; 大鼠; 图5
赛默飞世尔胱氨酸-天冬氨酸蛋白酶3抗体(Neomarkers, CPP32)被用于免疫组化在大鼠样品上 (图5). Clin Orthop Relat Res (2004) ncbi
兔 单克隆(9H19L2)
  • 免疫组化-P; 大鼠; 图4B
赛默飞世尔胱氨酸-天冬氨酸蛋白酶3抗体(noco, noca)被用于免疫组化-石蜡切片在大鼠样品上 (图4B). Exp Physiol (2003) ncbi
Novus Biologicals
兔 多克隆
  • 免疫印迹; 人类; 图1c
Novus Biologicals胱氨酸-天冬氨酸蛋白酶3抗体(Novus Biologicals, NB100-56113)被用于免疫印迹在人类样品上 (图1c). Toxicol In Vitro (2017) ncbi
兔 多克隆
  • 免疫印迹; 人类; 图7i
Novus Biologicals胱氨酸-天冬氨酸蛋白酶3抗体(Novus, NB100-56113)被用于免疫印迹在人类样品上 (图7i). J Cell Biochem (2017) ncbi
兔 多克隆
  • 免疫印迹; 人类; 图3e
Novus Biologicals胱氨酸-天冬氨酸蛋白酶3抗体(Novus Biologicals, NB100-56113)被用于免疫印迹在人类样品上 (图3e). Exp Cell Res (2016) ncbi
小鼠 单克隆(CPP32 4-1-18)
  • 免疫组化; 小鼠; 图3
Novus Biologicals胱氨酸-天冬氨酸蛋白酶3抗体(Novus Biologicals, NB500-210)被用于免疫组化在小鼠样品上 (图3). Mol Cell Endocrinol (2017) ncbi
小鼠 单克隆(31A1067)
  • 免疫印迹; 人类; 图4
Novus Biologicals胱氨酸-天冬氨酸蛋白酶3抗体(Novus Biologicals, NB100-56708)被用于免疫印迹在人类样品上 (图4). Sci Rep (2016) ncbi
兔 多克隆
  • 免疫印迹; 大鼠; 1:1500; 图10
Novus Biologicals胱氨酸-天冬氨酸蛋白酶3抗体(Novus Biological, NB100-56113)被用于免疫印迹在大鼠样品上浓度为1:1500 (图10). Pain (2014) ncbi
小鼠 单克隆(31A1067)
  • 免疫印迹; 人类; 图1c
Novus Biologicals胱氨酸-天冬氨酸蛋白酶3抗体(Imgenex, 31A1067)被用于免疫印迹在人类样品上 (图1c). Cell Death Dis (2014) ncbi
小鼠 单克隆(31A1067)
  • 免疫印迹; 人类; 图1c
Novus Biologicals胱氨酸-天冬氨酸蛋白酶3抗体(Imgenex, 31A1067)被用于免疫印迹在人类样品上 (图1c). Cell Death Dis (2014) ncbi
小鼠 单克隆(31A1067)
  • 免疫印迹; 人类; 图1c
Novus Biologicals胱氨酸-天冬氨酸蛋白酶3抗体(Imgenex, 31A1067)被用于免疫印迹在人类样品上 (图1c). Cell Death Dis (2014) ncbi
小鼠 单克隆(31A1067)
  • 免疫印迹; 小鼠; 1:1000
Novus Biologicals胱氨酸-天冬氨酸蛋白酶3抗体(Imgenex, 31A1067)被用于免疫印迹在小鼠样品上浓度为1:1000. J Neural Transm (Vienna) (2015) ncbi
小鼠 单克隆(31A1067)
  • 免疫印迹; 小鼠; 1:1000
Novus Biologicals胱氨酸-天冬氨酸蛋白酶3抗体(Imgenex, 31A1067)被用于免疫印迹在小鼠样品上浓度为1:1000. J Neural Transm (Vienna) (2015) ncbi
小鼠 单克隆(31A1067)
  • 免疫印迹; 小鼠; 1:1000
Novus Biologicals胱氨酸-天冬氨酸蛋白酶3抗体(Imgenex, 31A1067)被用于免疫印迹在小鼠样品上浓度为1:1000. J Neural Transm (Vienna) (2015) ncbi
小鼠 单克隆(31A1067)
  • 免疫印迹; 小鼠; 1:1000
Novus Biologicals胱氨酸-天冬氨酸蛋白酶3抗体(Imgenex, 31A1067)被用于免疫印迹在小鼠样品上浓度为1:1000. J Neural Transm (Vienna) (2015) ncbi
小鼠 单克隆(31A1067)
  • 免疫印迹; 小鼠; 1:1000
Novus Biologicals胱氨酸-天冬氨酸蛋白酶3抗体(Imgenex, 31A1067)被用于免疫印迹在小鼠样品上浓度为1:1000. J Neural Transm (Vienna) (2015) ncbi
小鼠 单克隆(31A1067)
  • 免疫印迹; 小鼠; 1:1000
Novus Biologicals胱氨酸-天冬氨酸蛋白酶3抗体(Imgenex, 31A1067)被用于免疫印迹在小鼠样品上浓度为1:1000. J Neural Transm (Vienna) (2015) ncbi
小鼠 单克隆(31A1067)
  • 免疫印迹; 小鼠; 1:1000
Novus Biologicals胱氨酸-天冬氨酸蛋白酶3抗体(Imgenex, 31A1067)被用于免疫印迹在小鼠样品上浓度为1:1000. J Neural Transm (Vienna) (2015) ncbi
小鼠 单克隆(31A1067)
  • 免疫组化; 小鼠
Novus Biologicals胱氨酸-天冬氨酸蛋白酶3抗体(Novus, NB100-56708)被用于免疫组化在小鼠样品上. Neuroscience (2014) ncbi
小鼠 单克隆(31A1067)
  • 免疫组化; 小鼠; 1:100; 图8
Novus Biologicals胱氨酸-天冬氨酸蛋白酶3抗体(Novus Biologicals, NB100-56708)被用于免疫组化在小鼠样品上浓度为1:100 (图8). PLoS ONE (2013) ncbi
Enzo Life Sciences
兔 多克隆
  • 免疫印迹; 人类; 图1g
Enzo Life Sciences胱氨酸-天冬氨酸蛋白酶3抗体(ALEXIS Corporation, ADI-AAP-113)被用于免疫印迹在人类样品上 (图1g). Antioxid Redox Signal (2017) ncbi
兔 多克隆
  • 免疫印迹; 人类; 图1g
Enzo Life Sciences胱氨酸-天冬氨酸蛋白酶3抗体(ALEXIS Corporation, ADI-AAP-113)被用于免疫印迹在人类样品上 (图1g). Antioxid Redox Signal (2017) ncbi
兔 多克隆
  • 免疫印迹; 人类; 图1b
Enzo Life Sciences胱氨酸-天冬氨酸蛋白酶3抗体(Enzo, AAP-113)被用于免疫印迹在人类样品上 (图1b). Oncotarget (2016) ncbi
兔 多克隆
  • 免疫印迹; 人类; 图1b
Enzo Life Sciences胱氨酸-天冬氨酸蛋白酶3抗体(Enzo, AAP-113)被用于免疫印迹在人类样品上 (图1b). Oncotarget (2016) ncbi
兔 多克隆
  • 免疫印迹; 人类; 图3
Enzo Life Sciences胱氨酸-天冬氨酸蛋白酶3抗体(Enzo Life Sciences, ADI-AAS-103)被用于免疫印迹在人类样品上 (图3). EBioMedicine (2015) ncbi
小鼠 单克隆(31A1067)
  • 免疫印迹; 人类; 图2g
Enzo Life Sciences胱氨酸-天冬氨酸蛋白酶3抗体(Enzo Life Science, 31A1067)被用于免疫印迹在人类样品上 (图2g). Oncotarget (2015) ncbi
兔 多克隆
  • 免疫印迹; 人类
Enzo Life Sciences胱氨酸-天冬氨酸蛋白酶3抗体(Enzo Life Sciences, SA-320)被用于免疫印迹在人类样品上. Genetics (2014) ncbi
小鼠 单克隆(31A1067)
  • 免疫印迹; 人类
Enzo Life Sciences胱氨酸-天冬氨酸蛋白酶3抗体(Enzo Life Sciences, 31A1067)被用于免疫印迹在人类样品上. Oncol Rep (2012) ncbi
小鼠 单克隆(31A1067)
  • 免疫印迹; 人类; 1:2000
Enzo Life Sciences胱氨酸-天冬氨酸蛋白酶3抗体(Alexis, ALX-804-305-C100)被用于免疫印迹在人类样品上浓度为1:2000. Cancer Gene Ther (2007) ncbi
武汉三鹰
兔 多克隆
  • 免疫印迹; 小鼠; 图5c
武汉三鹰胱氨酸-天冬氨酸蛋白酶3抗体(Proteintech, 19677)被用于免疫印迹在小鼠样品上 (图5c). Sci Rep (2017) ncbi
兔 多克隆
  • 免疫印迹; 小鼠; 图3a
武汉三鹰胱氨酸-天冬氨酸蛋白酶3抗体(Proteintech, 19677-1-AP)被用于免疫印迹在小鼠样品上 (图3a). PLoS ONE (2016) ncbi
兔 多克隆
  • 免疫印迹; 小鼠; 1:1000; 图3c
武汉三鹰胱氨酸-天冬氨酸蛋白酶3抗体(Proteintech, 19677-1-AP)被用于免疫印迹在小鼠样品上浓度为1:1000 (图3c). Reprod Domest Anim (2016) ncbi
兔 多克隆
  • 免疫印迹; 人类; 1:500
武汉三鹰胱氨酸-天冬氨酸蛋白酶3抗体(Proteintech, 19677-1-AP)被用于免疫印迹在人类样品上浓度为1:500. Mol Carcinog (2016) ncbi
Bioss
兔 多克隆
  • 免疫印迹; 羊; 图6e
Bioss胱氨酸-天冬氨酸蛋白酶3抗体(Beijing Biosynthesis Biotechnology, bs-0081R)被用于免疫印迹在羊样品上 (图6e). Toxicol Appl Pharmacol (2016) ncbi
兔 多克隆
  • 免疫印迹; 小鼠; 1:200; 图3
Bioss胱氨酸-天冬氨酸蛋白酶3抗体(BIOSS, bs-0081R)被用于免疫印迹在小鼠样品上浓度为1:200 (图3). Int J Mol Sci (2016) ncbi
兔 多克隆
  • 免疫印迹; 人类; 1:1000; 图3
Bioss胱氨酸-天冬氨酸蛋白酶3抗体(BIOSS, bs-0081R)被用于免疫印迹在人类样品上浓度为1:1000 (图3). Mol Med Rep (2015) ncbi
LifeSpan Biosciences
兔 多克隆
  • 免疫组化; 小鼠; 1:50; 图2
LifeSpan Biosciences胱氨酸-天冬氨酸蛋白酶3抗体(LSBio, #LS-B2845)被用于免疫组化在小鼠样品上浓度为1:50 (图2). Reprod Sci (2016) ncbi
亚诺法生技股份有限公司
兔 多克隆
  • 免疫印迹; 人类
亚诺法生技股份有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Abnova Corporation, H00000836-D01P)被用于免疫印迹在人类样品上. Cell Death Differ (2011) ncbi
赛信通(上海)生物试剂有限公司
兔 多克隆
  • 免疫印迹; 小鼠; 图3a
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signalling, 9662)被用于免疫印迹在小鼠样品上 (图3a). J Mol Biol (2017) ncbi
兔 多克隆
  • 免疫印迹; 小鼠; 图3a
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signalling, 9661)被用于免疫印迹在小鼠样品上 (图3a). J Mol Biol (2017) ncbi
兔 单克隆(5A1E)
  • 免疫组化-F; 小鼠; 1:400; 图4a
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 5A1E)被用于免疫组化-冰冻切片在小鼠样品上浓度为1:400 (图4a). PLoS ONE (2017) ncbi
兔 单克隆(5A1E)
  • 免疫印迹; 人类; 图5b
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9664)被用于免疫印迹在人类样品上 (图5b). Am J Physiol Heart Circ Physiol (2017) ncbi
兔 单克隆(5A1E)
  • 免疫印迹; 小鼠; 1:1000; 图1h
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signalling, 9664)被用于免疫印迹在小鼠样品上浓度为1:1000 (图1h). Sci Rep (2017) ncbi
兔 单克隆(8G10)
  • 免疫印迹; 小鼠; 1:1000; 图1h
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signalling, 9665)被用于免疫印迹在小鼠样品上浓度为1:1000 (图1h). Sci Rep (2017) ncbi
兔 单克隆(5A1E)
  • 免疫组化; 小鼠; 1:200; 图3g
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9664S)被用于免疫组化在小鼠样品上浓度为1:200 (图3g). Genes Dev (2017) ncbi
兔 多克隆
  • 免疫印迹; 人类; 图7f
  • 免疫组化; 人类; 图7g
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫印迹在人类样品上 (图7f) 和 免疫组化在人类样品上 (图7g). J Cell Biol (2017) ncbi
兔 单克隆(5A1E)
  • 细胞化学; 人类; 图9e
  • 免疫印迹; 人类; 图9a
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9664)被用于免疫细胞化学在人类样品上 (图9e) 和 免疫印迹在人类样品上 (图9a). J Cell Biol (2017) ncbi
兔 单克隆(5A1E)
  • 免疫印迹; 大鼠; 图6p
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9664)被用于免疫印迹在大鼠样品上 (图6p). Brain Behav Immun (2017) ncbi
兔 多克隆
  • 免疫印迹; 人类; 图4i
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell signaling, 9661)被用于免疫印迹在人类样品上 (图4i). Leuk Lymphoma (2017) ncbi
兔 单克隆(5A1E)
  • 免疫印迹; 人类; 图2b
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 96645)被用于免疫印迹在人类样品上 (图2b). Cancer Cell (2017) ncbi
兔 单克隆(5A1E)
  • 免疫组化-F; 小鼠; 图s2g
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 5A1E)被用于免疫组化-冰冻切片在小鼠样品上 (图s2g). Science (2017) ncbi
兔 单克隆(8G10)
  • 免疫印迹; 人类; 1:1000; 图5a
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 8G10)被用于免疫印迹在人类样品上浓度为1:1000 (图5a). Immun Inflamm Dis (2017) ncbi
兔 多克隆
  • 免疫印迹; 人类; 1:1000; 图3c
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9662S)被用于免疫印迹在人类样品上浓度为1:1000 (图3c). J Biol Chem (2017) ncbi
兔 多克隆
  • 免疫印迹; 小鼠; 图e4c
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫印迹在小鼠样品上 (图e4c). Nature (2017) ncbi
兔 多克隆
  • 免疫印迹; 人类; 图1d
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9662)被用于免疫印迹在人类样品上 (图1d). Nature (2017) ncbi
兔 多克隆
  • 免疫印迹; 人类; 图1c
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661S)被用于免疫印迹在人类样品上 (图1c). Nature (2017) ncbi
兔 多克隆
  • 免疫印迹; 人类; 图s1d
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell signal, 9662)被用于免疫印迹在人类样品上 (图s1d). Nature (2017) ncbi
兔 单克隆(D3E9)
  • 免疫印迹; 人类; 图6c
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9579)被用于免疫印迹在人类样品上 (图6c). Transl Neurodegener (2017) ncbi
兔 多克隆
  • 免疫印迹; 人类; 图s6
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell signaling, 9661)被用于免疫印迹在人类样品上 (图s6). Proc Natl Acad Sci U S A (2017) ncbi
兔 多克隆
  • 免疫组化-P; 小鼠; 1:100; 图4c
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫组化-石蜡切片在小鼠样品上浓度为1:100 (图4c). EMBO Mol Med (2017) ncbi
兔 单克隆(D3E9)
  • 免疫组化; 小鼠; 1:200; 图2e
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9579S)被用于免疫组化在小鼠样品上浓度为1:200 (图2e). PLoS Biol (2017) ncbi
兔 单克隆(5A1E)
  • 免疫组化-P; 小鼠; 1:100; 图s2g
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell signaling, 9664)被用于免疫组化-石蜡切片在小鼠样品上浓度为1:100 (图s2g). Nature (2017) ncbi
兔 单克隆(5A1E)
  • 免疫印迹; 人类; 1:1000; 图5e
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell signaling, 9664)被用于免疫印迹在人类样品上浓度为1:1000 (图5e). Biochem Pharmacol (2017) ncbi
兔 单克隆(5A1E)
  • 免疫组化; 人类; 1:400; 图s1d
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(CST, 9664)被用于免疫组化在人类样品上浓度为1:400 (图s1d). J Cell Sci (2017) ncbi
兔 单克隆(D3E9)
  • 免疫组化-F; 小鼠; 图s10a
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9604)被用于免疫组化-冰冻切片在小鼠样品上 (图s10a). Nature (2017) ncbi
兔 单克隆(8G10)
  • FC; 小鼠; 图2c
  • 免疫印迹; 小鼠; 图2
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(cell signalling, 8G10)被用于流式细胞仪在小鼠样品上 (图2c) 和 免疫印迹在小鼠样品上 (图2). J Clin Invest (2017) ncbi
兔 单克隆(5A1E)
  • 免疫印迹; 小鼠; 1:1000; 图4
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell signaling, 9664S)被用于免疫印迹在小鼠样品上浓度为1:1000 (图4). Biomed Rep (2017) ncbi
兔 多克隆
  • 免疫印迹; 小鼠; 图7f
  • 免疫印迹; 大鼠; 图1d
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫印迹在小鼠样品上 (图7f) 和 在大鼠样品上 (图1d). Clin Exp Pharmacol Physiol (2017) ncbi
兔 单克隆(5A1E)
  • 免疫印迹; 人类; 图4c
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9664)被用于免疫印迹在人类样品上 (图4c). J Pathol (2017) ncbi
兔 多克隆
  • 免疫印迹; 人类; 图3
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(cell signalling, 9662)被用于免疫印迹在人类样品上 (图3). Neoplasia (2017) ncbi
兔 多克隆
  • 免疫印迹; 大鼠; 1:1000; 图6a
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(cell signalling, 9662)被用于免疫印迹在大鼠样品上浓度为1:1000 (图6a). Am J Transl Res (2017) ncbi
兔 多克隆
  • 免疫印迹; 小鼠; 图s1
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(cell signalling, 9661)被用于免疫印迹在小鼠样品上 (图s1). Cell Death Dis (2017) ncbi
兔 多克隆
  • 免疫印迹 (基因敲减); 人类; 图4a
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell signaling, 9661)被用于免疫印迹 (基因敲减)在人类样品上 (图4a). Front Cell Infect Microbiol (2017) ncbi
小鼠 单克隆(3G2)
  • 免疫印迹; 人类; 图3
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9668)被用于免疫印迹在人类样品上 (图3). Oncol Lett (2017) ncbi
兔 多克隆
  • 免疫组化-P; 人类; 1:100; 图s7b
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫组化-石蜡切片在人类样品上浓度为1:100 (图s7b). Nature (2017) ncbi
兔 单克隆(8G10)
  • 免疫印迹; 人类; 图7a
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9665)被用于免疫印迹在人类样品上 (图7a). Cancer Immunol Res (2017) ncbi
兔 多克隆
  • 免疫组化; 大鼠; 1:5000; 图1e
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661S)被用于免疫组化在大鼠样品上浓度为1:5000 (图1e). J Neurosci (2017) ncbi
兔 多克隆
  • 细胞化学; 小鼠; 图3e
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(cell signalling, 9661)被用于免疫细胞化学在小鼠样品上 (图3e). FASEB J (2017) ncbi
兔 单克隆(8G10)
  • 免疫印迹; 人类; 图2c
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9665)被用于免疫印迹在人类样品上 (图2c). Nucleic Acids Res (2017) ncbi
兔 单克隆(5A1E)
  • 免疫印迹; 小鼠; 1:500; 图6a
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell signaling, 9664)被用于免疫印迹在小鼠样品上浓度为1:500 (图6a). elife (2017) ncbi
兔 多克隆
  • 细胞化学; 人类; 1:250; 图s3e
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661S)被用于免疫细胞化学在人类样品上浓度为1:250 (图s3e). Nature (2017) ncbi
兔 多克隆
  • 免疫组化; 果蝇; 1:500; 图1e
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫组化在果蝇样品上浓度为1:500 (图1e). EMBO J (2017) ncbi
兔 单克隆(8G10)
  • 免疫印迹; 人类; 图3f
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, Inc., 9665)被用于免疫印迹在人类样品上 (图3f). Sci Rep (2017) ncbi
兔 单克隆(5A1E)
  • 免疫印迹; 人类; 图3f
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, Inc., 9664)被用于免疫印迹在人类样品上 (图3f). Sci Rep (2017) ncbi
兔 多克隆
  • 免疫组化-P; 小鼠; 1:200; 图3d
  • 免疫印迹; 小鼠; 1:200; 图3e
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫组化-石蜡切片在小鼠样品上浓度为1:200 (图3d) 和 免疫印迹在小鼠样品上浓度为1:200 (图3e). Nat Commun (2017) ncbi
兔 单克隆(5A1E)
  • 免疫印迹; 大鼠; 1:200; 图2d
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9664)被用于免疫印迹在大鼠样品上浓度为1:200 (图2d). Toxicology (2017) ncbi
兔 多克隆
  • 免疫组化-P; 小鼠; 1:50; 图4b
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell signaling, 9661)被用于免疫组化-石蜡切片在小鼠样品上浓度为1:50 (图4b). Arterioscler Thromb Vasc Biol (2017) ncbi
兔 多克隆
  • 免疫组化-F; 大鼠; 1:500; 图8
  • 免疫印迹; 大鼠; 1:1000; 图1f
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫组化-冰冻切片在大鼠样品上浓度为1:500 (图8) 和 免疫印迹在大鼠样品上浓度为1:1000 (图1f). Brain Behav Immun (2017) ncbi
兔 多克隆
  • 免疫印迹; 人类; 图1a
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(cell signalling, 9662)被用于免疫印迹在人类样品上 (图1a). Cell Death Dis (2017) ncbi
兔 单克隆(8G10)
  • 免疫印迹; 小鼠; 1:1000; 图4h
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9,665)被用于免疫印迹在小鼠样品上浓度为1:1000 (图4h). Nat Commun (2017) ncbi
兔 多克隆
  • 免疫组化-P; 小鼠; 图3g
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(CST, 9661)被用于免疫组化-石蜡切片在小鼠样品上 (图3g). Genes Dev (2017) ncbi
兔 单克隆(5A1E)
  • 免疫组化-F; 小鼠; 图7e
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(cst, 9664)被用于免疫组化-冰冻切片在小鼠样品上 (图7e). PLoS ONE (2017) ncbi
兔 单克隆(5A1E)
  • 免疫印迹; 小鼠; 图4b
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9664)被用于免疫印迹在小鼠样品上 (图4b). Biochem Pharmacol (2017) ncbi
兔 单克隆(8G10)
  • 免疫印迹; 小鼠; 图4b
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9665)被用于免疫印迹在小鼠样品上 (图4b). Biochem Pharmacol (2017) ncbi
兔 单克隆(5A1E)
  • 免疫组化; 小鼠; 1:200; 图7a
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signalling, Asp175 5A1E)被用于免疫组化在小鼠样品上浓度为1:200 (图7a). PLoS Pathog (2017) ncbi
兔 单克隆(5A1E)
  • 细胞化学; 人类; 图1b
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9664)被用于免疫细胞化学在人类样品上 (图1b). Sci Rep (2017) ncbi
兔 多克隆
  • 免疫印迹; 小鼠; 1:1000
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫印迹在小鼠样品上浓度为1:1000. Sci Rep (2017) ncbi
兔 多克隆
  • 免疫组化; 小鼠; 1:1000; 表1
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫组化在小鼠样品上浓度为1:1000 (表1). elife (2017) ncbi
兔 单克隆(5A1E)
  • 免疫印迹; 人类; 图1f
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell signalling, 9664)被用于免疫印迹在人类样品上 (图1f). Cancer Lett (2017) ncbi
小鼠 单克隆(3G2)
  • 免疫印迹 (基因敲减); 人类; 图3c
  • 免疫印迹; 小鼠; 图1c
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(cell signalling, 9668)被用于免疫印迹 (基因敲减)在人类样品上 (图3c). EMBO J (2017) ncbi
兔 单克隆(5A1E)
  • 免疫印迹; 人类; 图1f
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(cell signalling, 9664)被用于免疫印迹在人类样品上 (图1f). EMBO J (2017) ncbi
兔 多克隆
  • 免疫印迹; 人类; 1:2000; 图4e
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(cell signalling, 9662)被用于免疫印迹在人类样品上浓度为1:2000 (图4e). Sci Rep (2017) ncbi
兔 多克隆
  • 免疫印迹; 人类; 1:2000; 图4e
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(cell signalling, 9661)被用于免疫印迹在人类样品上浓度为1:2000 (图4e). Sci Rep (2017) ncbi
兔 多克隆
  • 免疫印迹; 小鼠; 1:1000; 图7d
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫印迹在小鼠样品上浓度为1:1000 (图7d). Theranostics (2017) ncbi
兔 多克隆
  • 免疫印迹; 人类
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(CST, 9662)被用于免疫印迹在人类样品上. Mol Ther (2017) ncbi
兔 多克隆
  • 免疫印迹; 人类; 1:1000; 图1a
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9662S)被用于免疫印迹在人类样品上浓度为1:1000 (图1a). Mol Cell Biol (2017) ncbi
兔 多克隆
  • 细胞化学; 小鼠; 图2b
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9669)被用于免疫细胞化学在小鼠样品上 (图2b). Cell Death Dis (2017) ncbi
兔 多克隆
  • FC; 人类; 1:500; 图10b
  • 细胞化学; 人类; 1:500; 图8b
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9661)被用于流式细胞仪在人类样品上浓度为1:500 (图10b) 和 免疫细胞化学在人类样品上浓度为1:500 (图8b). Sci Rep (2017) ncbi
兔 多克隆
  • 免疫印迹; 人类; 1:250; 图6A
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫印迹在人类样品上浓度为1:250 (图6A). Int J Mol Med (2017) ncbi
兔 单克隆(5A1E)
  • 免疫印迹; 小鼠; 1:500; 图4d
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9664)被用于免疫印迹在小鼠样品上浓度为1:500 (图4d). Int J Mol Med (2017) ncbi
兔 单克隆(5A1E)
  • 免疫组化-P; African green monkey; 1:800; 图st5
  • 免疫组化-P; 人类; 1:800; 图st5
  • 免疫组化-P; 小鼠; 1:800; 图st5
  • 免疫组化-P; 大鼠; 1:800; 图st5
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9664)被用于免疫组化-石蜡切片在African green monkey样品上浓度为1:800 (图st5), 在人类样品上浓度为1:800 (图st5), 在小鼠样品上浓度为1:800 (图st5), 和 在大鼠样品上浓度为1:800 (图st5). J Toxicol Pathol (2017) ncbi
兔 多克隆
  • 免疫组化-P; 小鼠; 图3b
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9661)被用于免疫组化-石蜡切片在小鼠样品上 (图3b). J Cell Biol (2017) ncbi
兔 单克隆(5A1E)
  • 免疫组化; 小鼠; 图8d
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9664S)被用于免疫组化在小鼠样品上 (图8d). J Exp Med (2017) ncbi
兔 多克隆
  • 免疫组化-P; 小鼠; 图s7h
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫组化-石蜡切片在小鼠样品上 (图s7h). Nature (2017) ncbi
兔 多克隆
  • 免疫印迹; 猪; 图1c
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9662)被用于免疫印迹在猪样品上 (图1c). Sci Rep (2017) ncbi
兔 多克隆
  • 免疫组化; 大鼠; 图2b
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫组化在大鼠样品上 (图2b). Sci Rep (2017) ncbi
兔 多克隆
  • 免疫组化-P; 小鼠; 1:150
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫组化-石蜡切片在小鼠样品上浓度为1:150. J Clin Invest (2017) ncbi
兔 多克隆
  • 免疫组化; 小鼠; 1:100; 图4e
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(cell signalling, 9661)被用于免疫组化在小鼠样品上浓度为1:100 (图4e). J Clin Invest (2017) ncbi
兔 单克隆(5A1E)
  • 免疫印迹; 小鼠; 图12A
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell signaling, 9664)被用于免疫印迹在小鼠样品上 (图12A). EBioMedicine (2017) ncbi
兔 多克隆
  • 免疫印迹; 人类; 图s2c
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(CST, 9662)被用于免疫印迹在人类样品上 (图s2c). Sci Rep (2017) ncbi
兔 单克隆(5A1E)
  • 免疫印迹; 人类; 图4c
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 5A1E)被用于免疫印迹在人类样品上 (图4c). Neoplasia (2017) ncbi
兔 单克隆(8G10)
  • 免疫印迹; 人类; 图4c
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 8G10)被用于免疫印迹在人类样品上 (图4c). Neoplasia (2017) ncbi
小鼠 单克隆(3G2)
  • 免疫印迹; 人类; 图2a
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9668)被用于免疫印迹在人类样品上 (图2a). Oncotarget (2017) ncbi
兔 单克隆(5A1E)
  • 免疫组化-P; 小鼠; 1:500; 图4a
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9664)被用于免疫组化-石蜡切片在小鼠样品上浓度为1:500 (图4a). Sci Rep (2017) ncbi
兔 多克隆
  • 细胞化学; 斑马鱼; 1:100; 图s6
  • 细胞化学; 小鼠; 1:100; 图s6
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(cell signalling, 9661)被用于免疫细胞化学在斑马鱼样品上浓度为1:100 (图s6) 和 在小鼠样品上浓度为1:100 (图s6). Sci Adv (2016) ncbi
兔 单克隆(5A1E)
  • 免疫组化; 小鼠; 1:100; 图s4
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(New England Biolabs, 9664)被用于免疫组化在小鼠样品上浓度为1:100 (图s4). Proc Natl Acad Sci U S A (2017) ncbi
兔 多克隆
  • 免疫印迹; 人类; 图4a
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫印迹在人类样品上 (图4a). Peerj (2017) ncbi
兔 多克隆
  • 免疫组化-P; 小鼠; 1:200; 图4e
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫组化-石蜡切片在小鼠样品上浓度为1:200 (图4e). Nat Commun (2017) ncbi
兔 多克隆
  • 免疫印迹; 人类; 1:1000; 图1b
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661S)被用于免疫印迹在人类样品上浓度为1:1000 (图1b). Nat Commun (2017) ncbi
兔 单克隆(5A1E)
  • 免疫组化-P; 小鼠; 图s4e
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell signaling, 5A1E)被用于免疫组化-石蜡切片在小鼠样品上 (图s4e). PLoS Biol (2017) ncbi
兔 单克隆(8G10)
  • 免疫印迹; 人类; 1:1000; 图3b
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9665)被用于免疫印迹在人类样品上浓度为1:1000 (图3b). Oncol Lett (2017) ncbi
兔 单克隆(5A1E)
  • 免疫印迹; 人类; 1:1000; 图3b
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9664)被用于免疫印迹在人类样品上浓度为1:1000 (图3b). Oncol Lett (2017) ncbi
兔 单克隆(5A1E)
  • 免疫印迹; 人类; 图7e
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signalling, 9654s)被用于免疫印迹在人类样品上 (图7e). Autophagy (2017) ncbi
兔 多克隆
  • 细胞化学; 人类; 1:100; 图st4
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫细胞化学在人类样品上浓度为1:100 (图st4). Nat Biotechnol (2017) ncbi
兔 单克隆(5A1E)
  • 免疫印迹; 人类; 1:1000; 图6b
  • 细胞化学; 人类; 1:1000; 图2c
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9664)被用于免疫印迹在人类样品上浓度为1:1000 (图6b) 和 免疫细胞化学在人类样品上浓度为1:1000 (图2c). Nat Commun (2017) ncbi
兔 多克隆
  • 细胞化学; 人类; 图1f
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9661S)被用于免疫细胞化学在人类样品上 (图1f). Cell Stem Cell (2017) ncbi
兔 多克隆
  • 免疫印迹; 人类; 1:1000
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9662)被用于免疫印迹在人类样品上浓度为1:1000. Oncol Lett (2016) ncbi
兔 多克隆
  • 免疫印迹; 人类; 1:600; 图2e
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫印迹在人类样品上浓度为1:600 (图2e). Oncol Lett (2016) ncbi
兔 多克隆
  • 免疫印迹; 人类; 1:1000; 图2a
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9662)被用于免疫印迹在人类样品上浓度为1:1000 (图2a). Radiother Oncol (2017) ncbi
兔 单克隆(5A1E)
  • 免疫印迹; 小鼠; 1:1000; 图5e
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell signaling, 9664)被用于免疫印迹在小鼠样品上浓度为1:1000 (图5e). PLoS ONE (2017) ncbi
小鼠 单克隆(3G2)
  • 免疫印迹; 人类; 图s2
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9668)被用于免疫印迹在人类样品上 (图s2). PLoS ONE (2017) ncbi
兔 单克隆(8G10)
  • 免疫印迹; 人类; 图2d
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9665)被用于免疫印迹在人类样品上 (图2d). FEBS Open Bio (2017) ncbi
兔 单克隆(5A1E)
  • 免疫印迹; 人类; 图2d
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9664)被用于免疫印迹在人类样品上 (图2d). FEBS Open Bio (2017) ncbi
兔 多克隆
  • 免疫印迹; 小鼠; 1:500; 图6c
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell signaling, 9662)被用于免疫印迹在小鼠样品上浓度为1:500 (图6c). Clin Sci (Lond) (2017) ncbi
兔 多克隆
  • 免疫组化-P; 小鼠; 图2m
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫组化-石蜡切片在小鼠样品上 (图2m). J Exp Med (2017) ncbi
兔 单克隆(5A1E)
  • 免疫印迹 (基因敲减); 人类; 1:1000; 图8a
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9664)被用于免疫印迹 (基因敲减)在人类样品上浓度为1:1000 (图8a). PLoS ONE (2017) ncbi
兔 多克隆
  • 免疫印迹 (基因敲减); 人类; 1:1000; 图8a
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9662)被用于免疫印迹 (基因敲减)在人类样品上浓度为1:1000 (图8a). PLoS ONE (2017) ncbi
兔 多克隆
  • 免疫印迹; 人类; 图7a
  • 免疫印迹; 小鼠; 图2e
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫印迹在人类样品上 (图7a) 和 在小鼠样品上 (图2e). J Clin Invest (2017) ncbi
兔 单克隆(5A1E)
  • FC; 人类; 图s1
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9664 S)被用于流式细胞仪在人类样品上 (图s1). Sci Rep (2017) ncbi
兔 多克隆
  • 免疫印迹; 人类; 图1f
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(cell signalling, 9661)被用于免疫印迹在人类样品上 (图1f). elife (2017) ncbi
兔 多克隆
  • 免疫组化; 小鼠; 1:500; 图7h
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(cell signalling, 9661)被用于免疫组化在小鼠样品上浓度为1:500 (图7h). Nat Commun (2017) ncbi
兔 单克隆(8G10)
  • 免疫印迹; 大鼠; 1:1000; 图6e
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9665)被用于免疫印迹在大鼠样品上浓度为1:1000 (图6e). Nat Commun (2017) ncbi
兔 单克隆(5A1E)
  • 免疫印迹; 大鼠; 1:1000; 图6e
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9664)被用于免疫印迹在大鼠样品上浓度为1:1000 (图6e). Nat Commun (2017) ncbi
兔 多克隆
  • FC; 小鼠; 1:800; 图1a
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9661S)被用于流式细胞仪在小鼠样品上浓度为1:800 (图1a). PLoS ONE (2017) ncbi
兔 单克隆(8G10)
  • 免疫印迹; 人类; 1:1000; 图3e
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9665)被用于免疫印迹在人类样品上浓度为1:1000 (图3e). Nat Commun (2017) ncbi
兔 多克隆
  • 免疫组化-P; 大鼠; 1:50; 图2a
  • 免疫印迹; 大鼠; 1:1000; 图4d
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫组化-石蜡切片在大鼠样品上浓度为1:50 (图2a) 和 免疫印迹在大鼠样品上浓度为1:1000 (图4d). Sci Rep (2017) ncbi
兔 多克隆
  • 免疫组化-P; 小鼠; 图2a
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9661)被用于免疫组化-石蜡切片在小鼠样品上 (图2a). Mol Cell Biol (2017) ncbi
兔 单克隆(5A1E)
  • 免疫印迹; 大鼠; 图6a
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9664)被用于免疫印迹在大鼠样品上 (图6a). PLoS ONE (2017) ncbi
兔 多克隆
  • 免疫印迹; 人类; 图1c
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫印迹在人类样品上 (图1c). Oncotarget (2017) ncbi
兔 多克隆
  • 细胞化学; 小鼠; 1:50; 图3f
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell signaling, 9661)被用于免疫细胞化学在小鼠样品上浓度为1:50 (图3f). EMBO Mol Med (2017) ncbi
兔 多克隆
  • 免疫组化-P; 小鼠; 1:1600; 图5b
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫组化-石蜡切片在小鼠样品上浓度为1:1600 (图5b). PLoS ONE (2017) ncbi
兔 单克隆(5A1E)
  • 免疫组化-P; 小鼠; 图3d
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9664)被用于免疫组化-石蜡切片在小鼠样品上 (图3d). Nat Commun (2017) ncbi
兔 单克隆(5A1E)
  • 免疫组化-F; 大鼠
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell signaling, 9664S)被用于免疫组化-冰冻切片在大鼠样品上. Tissue Cell (2016) ncbi
兔 单克隆(5A1E)
  • 免疫组化-P; 大鼠; 1:100
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9664)被用于免疫组化-石蜡切片在大鼠样品上浓度为1:100. Brain Res (2016) ncbi
兔 多克隆
  • 免疫印迹; 人类; 图2c
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫印迹在人类样品上 (图2c). Oncotarget (2016) ncbi
兔 单克隆(5A1E)
  • 免疫印迹; 小鼠; 1:500
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell signaling, 9664)被用于免疫印迹在小鼠样品上浓度为1:500. Brain Res (2016) ncbi
兔 单克隆(5A1E)
  • 免疫印迹; 人类; 图7c
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell signaling, 9664)被用于免疫印迹在人类样品上 (图7c). Oncotarget (2016) ncbi
兔 多克隆
  • 免疫印迹; 小鼠; 图5e
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(CST, 9662)被用于免疫印迹在小鼠样品上 (图5e). J Am Heart Assoc (2016) ncbi
兔 多克隆
  • 免疫印迹; 小鼠; 图5e
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(CST, 9661)被用于免疫印迹在小鼠样品上 (图5e). J Am Heart Assoc (2016) ncbi
兔 多克隆
  • 免疫印迹; 人类; 图5
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9662)被用于免疫印迹在人类样品上 (图5). Cell Death Dis (2016) ncbi
兔 单克隆(5A1E)
  • FC; 人类; 图s7e
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(cell signalling, 9664)被用于流式细胞仪在人类样品上 (图s7e). Nat Commun (2016) ncbi
兔 多克隆
  • 免疫印迹; 小鼠; 图2g
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9662)被用于免疫印迹在小鼠样品上 (图2g). Sci Transl Med (2016) ncbi
兔 多克隆
  • 免疫印迹; 人类; 图5f
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661s)被用于免疫印迹在人类样品上 (图5f). J Biol Chem (2016) ncbi
兔 多克隆
  • 免疫印迹 (基因敲减); 大鼠; 图s8
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signalling, 9662)被用于免疫印迹 (基因敲减)在大鼠样品上 (图s8). Oncotarget (2016) ncbi
兔 单克隆(5A1E)
  • 免疫印迹; 大鼠; 图5a
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signalling, 9664)被用于免疫印迹在大鼠样品上 (图5a). Oncotarget (2016) ncbi
兔 多克隆
  • 细胞化学; 人类; 图s2
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫细胞化学在人类样品上 (图s2). Oncotarget (2016) ncbi
兔 多克隆
  • 免疫印迹; 大鼠; 图9a
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell signaling, 9661)被用于免疫印迹在大鼠样品上 (图9a). PLoS ONE (2016) ncbi
兔 多克隆
  • 免疫印迹; 大鼠; 图7b
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell signaling, 9662)被用于免疫印迹在大鼠样品上 (图7b). Cardiovasc Res (2016) ncbi
兔 单克隆(5A1E)
  • 免疫印迹; 大鼠; 图7b
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell signaling, 9664)被用于免疫印迹在大鼠样品上 (图7b). Cardiovasc Res (2016) ncbi
兔 多克隆
  • 免疫组化-P; 小鼠; 1:200; 图s13
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661S)被用于免疫组化-石蜡切片在小鼠样品上浓度为1:200 (图s13). Breast Cancer Res (2016) ncbi
兔 多克隆
  • 免疫组化-P; 小鼠; 图1h
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9661S)被用于免疫组化-石蜡切片在小鼠样品上 (图1h). Mol Cell Biol (2016) ncbi
兔 单克隆(5A1E)
  • 免疫印迹; 人类; 图2a
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 5A1E)被用于免疫印迹在人类样品上 (图2a). Biochem Biophys Res Commun (2017) ncbi
小鼠 单克隆(3G2)
  • 免疫印迹; 人类; 图4c
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9668)被用于免疫印迹在人类样品上 (图4c). Expert Opin Ther Targets (2016) ncbi
兔 多克隆
  • 细胞化学; 小鼠; 图2c
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫细胞化学在小鼠样品上 (图2c). Proc Natl Acad Sci U S A (2016) ncbi
兔 多克隆
  • 免疫印迹; 人类; 图3c
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9662)被用于免疫印迹在人类样品上 (图3c). Mol Nutr Food Res (2016) ncbi
兔 多克隆
  • 免疫印迹; 人类; 图1g
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661S)被用于免疫印迹在人类样品上 (图1g). Antioxid Redox Signal (2017) ncbi
兔 多克隆
  • 免疫印迹; 人类; 图1c
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫印迹在人类样品上 (图1c). Int J Biochem Cell Biol (2016) ncbi
兔 多克隆
  • 免疫组化; 人类; 1:100; 图s3a
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technologies, 9661)被用于免疫组化在人类样品上浓度为1:100 (图s3a). Proc Natl Acad Sci U S A (2016) ncbi
兔 多克隆
  • 免疫组化-P; 小鼠; 1:250; 图6a
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫组化-石蜡切片在小鼠样品上浓度为1:250 (图6a). J Exp Med (2016) ncbi
兔 多克隆
  • 免疫组化; 果蝇; 1:100; 图5b
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661S)被用于免疫组化在果蝇样品上浓度为1:100 (图5b). Nat Commun (2016) ncbi
兔 多克隆
  • 免疫印迹; 人类; 图7g
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫印迹在人类样品上 (图7g). Oncotarget (2016) ncbi
兔 多克隆
  • 免疫组化-P; 小鼠; 图2a
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signalling, 9661)被用于免疫组化-石蜡切片在小鼠样品上 (图2a). Science (2016) ncbi
兔 多克隆
  • 免疫印迹; 小鼠; 1:1000; 图8c
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫印迹在小鼠样品上浓度为1:1000 (图8c). Cell Death Dis (2016) ncbi
兔 多克隆
  • 免疫印迹; 小鼠; 图1a
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell signaling, 9661)被用于免疫印迹在小鼠样品上 (图1a). JCI Insight (2016) ncbi
兔 多克隆
  • 免疫印迹; 人类; 1:500; 图6b
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9662)被用于免疫印迹在人类样品上浓度为1:500 (图6b). Int J Mol Sci (2016) ncbi
小鼠 单克隆(3G2)
  • 免疫印迹; 人类; 1:1000; 图2c
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9668S)被用于免疫印迹在人类样品上浓度为1:1000 (图2c). Int J Oncol (2017) ncbi
兔 单克隆(5A1E)
  • 免疫印迹; 人类; 1:1000; 图2c
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9664S)被用于免疫印迹在人类样品上浓度为1:1000 (图2c). Int J Oncol (2017) ncbi
兔 多克隆
  • 免疫组化-F; 小鼠; 1:200; 图4a
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫组化-冰冻切片在小鼠样品上浓度为1:200 (图4a). Neural Dev (2016) ncbi
兔 多克隆
  • 免疫印迹; 小鼠; 1:1000; 图1g
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫印迹在小鼠样品上浓度为1:1000 (图1g). EMBO Mol Med (2017) ncbi
兔 多克隆
  • 免疫组化-P; 小鼠; 1:200; 图3d
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫组化-石蜡切片在小鼠样品上浓度为1:200 (图3d). Hepatology (2016) ncbi
兔 单克隆(5A1E)
  • 免疫组化-F; 小鼠; 1:400; 图6a
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9664)被用于免疫组化-冰冻切片在小鼠样品上浓度为1:400 (图6a). elife (2016) ncbi
兔 单克隆(8G10)
  • 免疫印迹; 人类; 图2b
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9665)被用于免疫印迹在人类样品上 (图2b). Int J Nanomedicine (2016) ncbi
兔 多克隆
  • 免疫印迹 (基因敲除); 小鼠; 图1
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫印迹 (基因敲除)在小鼠样品上 (图1). Oxid Med Cell Longev (2016) ncbi
兔 多克隆
  • 细胞化学; 人类; 1:100; 图s10a
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661S)被用于免疫细胞化学在人类样品上浓度为1:100 (图s10a). Nat Med (2016) ncbi
兔 多克隆
  • 免疫印迹; 人类; 图s10a
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫印迹在人类样品上 (图s10a). Oncogene (2016) ncbi
兔 单克隆(5A1E)
  • 细胞化学; 人类; 图2i
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9664)被用于免疫细胞化学在人类样品上 (图2i). Biochim Biophys Acta (2017) ncbi
兔 多克隆
  • 免疫印迹; 人类; 图4d
  • 细胞化学; 人类; 图4c
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9662)被用于免疫印迹在人类样品上 (图4d) 和 免疫细胞化学在人类样品上 (图4c). PLoS ONE (2016) ncbi
兔 多克隆
  • 免疫组化-P; 小鼠; 图2c
  • 免疫印迹; 小鼠; 图2d
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661S)被用于免疫组化-石蜡切片在小鼠样品上 (图2c) 和 免疫印迹在小鼠样品上 (图2d). Cell Death Dis (2016) ncbi
兔 多克隆
  • 免疫印迹; 人类; 图3c
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫印迹在人类样品上 (图3c). Oncotarget (2016) ncbi
兔 单克隆(8G10)
  • 免疫印迹; 人类; 图3c
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9665)被用于免疫印迹在人类样品上 (图3c). Oncotarget (2016) ncbi
兔 多克隆
  • 免疫组化; 小鼠; 1:200; 图st1
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signalling, 9661S)被用于免疫组化在小鼠样品上浓度为1:200 (图st1). Sci Rep (2016) ncbi
兔 单克隆(8G10)
  • 免疫印迹; 人类; 图5a
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 8G10)被用于免疫印迹在人类样品上 (图5a). Nat Chem Biol (2017) ncbi
兔 单克隆(5A1E)
  • 免疫组化-P; 人类
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9664)被用于免疫组化-石蜡切片在人类样品上. J Clin Invest (2016) ncbi
兔 多克隆
  • 免疫组化; 小鼠; 图2
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell signalling, 9661)被用于免疫组化在小鼠样品上 (图2). Nature (2016) ncbi
兔 单克隆(D3E9)
  • 免疫组化-P; 大鼠; 1:400; 图11
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9579)被用于免疫组化-石蜡切片在大鼠样品上浓度为1:400 (图11). Oncotarget (2016) ncbi
兔 单克隆(5A1E)
  • 免疫印迹; 人类; 图4a
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell signaling, 9664)被用于免疫印迹在人类样品上 (图4a). Redox Biol (2016) ncbi
兔 多克隆
  • 免疫印迹; 人类; 图1a
  • 免疫组化; 人类; 1:100; 图2a
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signalling, 9662)被用于免疫印迹在人类样品上 (图1a) 和 免疫组化在人类样品上浓度为1:100 (图2a). Apoptosis (2016) ncbi
兔 多克隆
  • 免疫组化-F; 小鼠; 1:1000; 图10
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell signaling, 9661)被用于免疫组化-冰冻切片在小鼠样品上浓度为1:1000 (图10). J Neurosci (2016) ncbi
兔 单克隆(8G10)
  • 免疫印迹; 小鼠; 图s3c
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9665)被用于免疫印迹在小鼠样品上 (图s3c). Proc Natl Acad Sci U S A (2016) ncbi
兔 多克隆
  • 免疫组化; 小鼠; 1:100; 图s3a
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell signaling, 9661)被用于免疫组化在小鼠样品上浓度为1:100 (图s3a). Development (2016) ncbi
兔 单克隆(D3E9)
  • 免疫组化-P; 小鼠; 图3b
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, D3E9)被用于免疫组化-石蜡切片在小鼠样品上 (图3b). Acta Neuropathol (2016) ncbi
兔 多克隆
  • 免疫印迹; 大鼠; 图2k
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(CST, 9662S)被用于免疫印迹在大鼠样品上 (图2k). Oncotarget (2016) ncbi
兔 单克隆(D3E9)
  • 免疫组化; 人类; 1:500; 图4e
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9579)被用于免疫组化在人类样品上浓度为1:500 (图4e). Nat Cell Biol (2016) ncbi
兔 多克隆
  • 免疫印迹; 人类; 1:1000; 图s5c
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫印迹在人类样品上浓度为1:1000 (图s5c). Nat Commun (2016) ncbi
兔 单克隆(8G10)
  • 免疫印迹; 人类; 1:1000; 图s5c
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9665)被用于免疫印迹在人类样品上浓度为1:1000 (图s5c). Nat Commun (2016) ncbi
兔 单克隆(5A1E)
  • FC; 人类; 1:800; 图3b
  • 细胞化学; 人类; 1:800; 图4d
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9664)被用于流式细胞仪在人类样品上浓度为1:800 (图3b) 和 免疫细胞化学在人类样品上浓度为1:800 (图4d). Mol Neurobiol (2016) ncbi
兔 单克隆(5A1E)
  • 免疫组化-P; 小鼠; 1:100; 图5f
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell signaling, 9664S)被用于免疫组化-石蜡切片在小鼠样品上浓度为1:100 (图5f). Oncotarget (2016) ncbi
兔 单克隆(8G10)
  • 免疫印迹; 大鼠; 图5b
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9665)被用于免疫印迹在大鼠样品上 (图5b). PLoS ONE (2016) ncbi
兔 单克隆(5A1E)
  • 免疫印迹; 大鼠; 图5b
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9664)被用于免疫印迹在大鼠样品上 (图5b). PLoS ONE (2016) ncbi
兔 多克隆
  • 免疫组化-P; 人类; 1:200; 图4b
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫组化-石蜡切片在人类样品上浓度为1:200 (图4b). Oncotarget (2016) ncbi
兔 单克隆(8G10)
  • 免疫印迹; 人类; 图2d
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9665)被用于免疫印迹在人类样品上 (图2d). Mol Med Rep (2016) ncbi
兔 单克隆(5A1E)
  • 免疫组化; 小鼠; 1:100
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9664S)被用于免疫组化在小鼠样品上浓度为1:100. elife (2016) ncbi
兔 单克隆(5A1E)
  • 免疫组化; 大鼠; 图3h
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9664)被用于免疫组化在大鼠样品上 (图3h). PLoS ONE (2016) ncbi
兔 多克隆
  • 免疫印迹; 人类; 图3
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫印迹在人类样品上 (图3). BMC Cancer (2016) ncbi
兔 多克隆
  • 免疫组化-P; 小鼠; 1:600; 图7c
  • 免疫印迹; 小鼠; 1:1000; 图7b
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9661)被用于免疫组化-石蜡切片在小鼠样品上浓度为1:600 (图7c) 和 免疫印迹在小鼠样品上浓度为1:1000 (图7b). J Biomed Sci (2016) ncbi
兔 多克隆
  • 免疫组化-P; 小鼠; 1:500; 图s4a
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9661)被用于免疫组化-石蜡切片在小鼠样品上浓度为1:500 (图s4a). Sci Rep (2016) ncbi
兔 多克隆
  • 免疫印迹; 人类; 图3
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signalling, 9662)被用于免疫印迹在人类样品上 (图3). Oncotarget (2016) ncbi
兔 单克隆(5A1E)
  • 免疫印迹; 人类; 图1c
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 5A1E)被用于免疫印迹在人类样品上 (图1c). Cancer Sci (2016) ncbi
兔 单克隆(8G10)
  • 免疫印迹; 小鼠; 1:1000; 图5a
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9665)被用于免疫印迹在小鼠样品上浓度为1:1000 (图5a). J Huntingtons Dis (2016) ncbi
兔 多克隆
  • 免疫印迹; 人类; 图2c
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9662S)被用于免疫印迹在人类样品上 (图2c). Sci Rep (2016) ncbi
兔 多克隆
  • 免疫印迹; 人类; 图2c
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫印迹在人类样品上 (图2c). Sci Rep (2016) ncbi
兔 多克隆
  • 免疫印迹; 人类; 1:1000; 图5a
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(cell signalling, 9662)被用于免疫印迹在人类样品上浓度为1:1000 (图5a). Toxicol Appl Pharmacol (2016) ncbi
兔 单克隆(8G10)
  • 免疫印迹; 人类; 图1a
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(CST, 9665)被用于免疫印迹在人类样品上 (图1a). Mol Cell Biol (2016) ncbi
兔 多克隆
  • 免疫印迹; 人类; 图3c
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(CST, 9661)被用于免疫印迹在人类样品上 (图3c). Mol Cell Biol (2016) ncbi
兔 单克隆(5A1E)
  • 免疫印迹; 人类; 图3F
  • 细胞化学; 人类; 图3C
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9664)被用于免疫印迹在人类样品上 (图3F) 和 免疫细胞化学在人类样品上 (图3C). Genes Dev (2016) ncbi
兔 单克隆(8G10)
  • 免疫印迹; 人类; 1:2000; 图6c
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9665)被用于免疫印迹在人类样品上浓度为1:2000 (图6c). Oncotarget (2016) ncbi
兔 单克隆(5A1E)
  • 免疫印迹; 人类; 1:500; 图6c
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9664)被用于免疫印迹在人类样品上浓度为1:500 (图6c). Oncotarget (2016) ncbi
兔 多克隆
  • 细胞化学; 人类; 1:400; 图5c
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫细胞化学在人类样品上浓度为1:400 (图5c). Oncotarget (2016) ncbi
兔 多克隆
  • 免疫印迹; 人类; 1:200; 图st1
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9662)被用于免疫印迹在人类样品上浓度为1:200 (图st1). Nat Commun (2016) ncbi
兔 单克隆(5A1E)
  • 免疫组化; 小鼠; 图4
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9664)被用于免疫组化在小鼠样品上 (图4). Sci Rep (2016) ncbi
兔 多克隆
  • 免疫印迹; 人类; 1:1000; 图3a
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(cell signalling, 9662)被用于免疫印迹在人类样品上浓度为1:1000 (图3a). Oncotarget (2016) ncbi
兔 单克隆(5A1E)
  • 免疫印迹; 人类; 1:1000; 图3a
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(cell signalling, 9664)被用于免疫印迹在人类样品上浓度为1:1000 (图3a). Oncotarget (2016) ncbi
兔 多克隆
  • 免疫印迹; 人类; 图3b
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9662)被用于免疫印迹在人类样品上 (图3b). Oncotarget (2016) ncbi
兔 多克隆
  • 免疫组化; 小鼠; 1:200; 图6d
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫组化在小鼠样品上浓度为1:200 (图6d). Oncotarget (2016) ncbi
兔 多克隆
  • 免疫组化-P; 小鼠; 1:200
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫组化-石蜡切片在小鼠样品上浓度为1:200. Development (2016) ncbi
兔 多克隆
  • 免疫组化-P; 人类; 图4c
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(CST, 9661)被用于免疫组化-石蜡切片在人类样品上 (图4c). Nature (2016) ncbi
兔 多克隆
  • 免疫印迹; 人类; 1:1000; 图2
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell signaling, 9662)被用于免疫印迹在人类样品上浓度为1:1000 (图2). Nat Commun (2016) ncbi
兔 单克隆(5A1E)
  • 细胞化学; 大鼠; 图9d
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9664)被用于免疫细胞化学在大鼠样品上 (图9d). Mol Cell Biol (2016) ncbi
兔 多克隆
  • 免疫印迹; 小鼠; 图s7
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell signaling, 9661)被用于免疫印迹在小鼠样品上 (图s7). Mol Psychiatry (2016) ncbi
兔 多克隆
  • 免疫组化-P; 小鼠; 1:200; 图3
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661S)被用于免疫组化-石蜡切片在小鼠样品上浓度为1:200 (图3). Sci Rep (2016) ncbi
兔 单克隆(5A1E)
  • 细胞化学; 大鼠; 1:200
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9664)被用于免疫细胞化学在大鼠样品上浓度为1:200. J Pharmacol Exp Ther (2016) ncbi
兔 多克隆
  • 免疫组化; 小鼠; 1:200; 图s7b
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signalling Technologies, 9661)被用于免疫组化在小鼠样品上浓度为1:200 (图s7b). Open Biol (2016) ncbi
兔 单克隆(5A1E)
  • 免疫印迹; 人类; 图2
  • 免疫印迹; 大鼠; 图6
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Tech, 9664)被用于免疫印迹在人类样品上 (图2) 和 在大鼠样品上 (图6). Carcinogenesis (2016) ncbi
兔 多克隆
  • 免疫印迹; 人类; 图4a
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9662)被用于免疫印迹在人类样品上 (图4a). Oncotarget (2016) ncbi
兔 单克隆(5A1E)
  • 免疫印迹; 大鼠; 1:1000; 图7d
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9664)被用于免疫印迹在大鼠样品上浓度为1:1000 (图7d). Oncotarget (2016) ncbi
兔 单克隆(8G10)
  • 免疫印迹; 大鼠; 1:1000; 图7d
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9665)被用于免疫印迹在大鼠样品上浓度为1:1000 (图7d). Oncotarget (2016) ncbi
兔 多克隆
  • 免疫印迹; 人类; 图4f
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9661)被用于免疫印迹在人类样品上 (图4f). Oncotarget (2016) ncbi
兔 多克隆
  • 免疫组化-F; 大鼠; 1:1000; 图8a
  • 免疫印迹; 大鼠; 1:1000; 图8c
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫组化-冰冻切片在大鼠样品上浓度为1:1000 (图8a) 和 免疫印迹在大鼠样品上浓度为1:1000 (图8c). Mol Genet Metab (2016) ncbi
兔 多克隆
  • 免疫印迹; 人类; 1:1000; 图5B
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫印迹在人类样品上浓度为1:1000 (图5B). PLoS ONE (2016) ncbi
兔 多克隆
  • 免疫组化-F; 小鼠; 1:1000; 图s3i
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell signaling, 9661)被用于免疫组化-冰冻切片在小鼠样品上浓度为1:1000 (图s3i). Nat Neurosci (2016) ncbi
兔 多克隆
  • 免疫印迹; 人类; 图2
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9662)被用于免疫印迹在人类样品上 (图2). PLoS ONE (2016) ncbi
兔 单克隆(5A1E)
  • 免疫组化; 小鼠; 1:100; 图s3b
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technologies, 9664)被用于免疫组化在小鼠样品上浓度为1:100 (图s3b). Nat Commun (2016) ncbi
兔 多克隆
  • 免疫组化-P; 小鼠; 1:50; 图4j
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫组化-石蜡切片在小鼠样品上浓度为1:50 (图4j). Front Cell Neurosci (2016) ncbi
兔 多克隆
  • 免疫组化; 人类
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫组化在人类样品上. J Clin Invest (2016) ncbi
兔 多克隆
  • 免疫组化-P; 小鼠; 1:1000; 图3
  • FC; 小鼠; 1:50; 图4
  • 免疫印迹; 小鼠; 1:1000; 图3
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signalling, 9661)被用于免疫组化-石蜡切片在小鼠样品上浓度为1:1000 (图3), 流式细胞仪在小鼠样品上浓度为1:50 (图4), 和 免疫印迹在小鼠样品上浓度为1:1000 (图3). Nat Commun (2016) ncbi
兔 单克隆(5A1E)
  • 细胞化学; 人类; 图7e
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9664)被用于免疫细胞化学在人类样品上 (图7e). Autophagy (2016) ncbi
兔 多克隆
  • 免疫组化; 斑马鱼; 1:500; 图2d
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫组化在斑马鱼样品上浓度为1:500 (图2d). Neurotox Res (2016) ncbi
兔 多克隆
  • 免疫印迹; 人类; 图3f
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫印迹在人类样品上 (图3f). Oncotarget (2016) ncbi
兔 单克隆(D3E9)
  • 细胞化学; 人类; 图e2a
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, D3E9)被用于免疫细胞化学在人类样品上 (图e2a). Nature (2016) ncbi
兔 单克隆(D3E9)
  • 细胞化学; 人类; 图e2a
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, D3E9)被用于免疫细胞化学在人类样品上 (图e2a). Nature (2016) ncbi
兔 多克隆
  • 免疫印迹; 人类; 1:1000; 图s15
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9662)被用于免疫印迹在人类样品上浓度为1:1000 (图s15). Nat Commun (2016) ncbi
兔 多克隆
  • 免疫组化-P; 人类; 1:100; 图7
  • 免疫印迹; 人类; 1:1000; 图s15
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫组化-石蜡切片在人类样品上浓度为1:100 (图7) 和 免疫印迹在人类样品上浓度为1:1000 (图s15). Nat Commun (2016) ncbi
兔 单克隆(5A1E)
  • 免疫印迹; 人类; 1:1000; 图4b
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9664S)被用于免疫印迹在人类样品上浓度为1:1000 (图4b). Redox Biol (2016) ncbi
兔 多克隆
  • 免疫印迹; 人类; 图1d
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9662)被用于免疫印迹在人类样品上 (图1d). Sci Rep (2016) ncbi
兔 多克隆
  • 免疫印迹; 人类
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫印迹在人类样品上. Oncotarget (2016) ncbi
兔 单克隆(D3E9)
  • FC; 小鼠; 图5
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9602S)被用于流式细胞仪在小鼠样品上 (图5). PLoS Pathog (2016) ncbi
兔 多克隆
  • 免疫印迹; 小鼠; 1:1000; 图s1
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signalling, 9662S)被用于免疫印迹在小鼠样品上浓度为1:1000 (图s1). Nat Commun (2016) ncbi
兔 单克隆(5A1E)
  • 免疫组化-P; 小鼠; 1:1000; 图7b
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell signaling, 9664)被用于免疫组化-石蜡切片在小鼠样品上浓度为1:1000 (图7b). Nat Cell Biol (2016) ncbi
兔 多克隆
  • 细胞化学; 小鼠; 图2e
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell signaling, 9661S)被用于免疫细胞化学在小鼠样品上 (图2e). J Biol Chem (2016) ncbi
兔 多克隆
  • 免疫印迹; 人类; 1:1000; 图5F
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9662)被用于免疫印迹在人类样品上浓度为1:1000 (图5F). PLoS ONE (2016) ncbi
兔 单克隆(5A1E)
  • 免疫印迹; 人类; 图2a
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9664)被用于免疫印迹在人类样品上 (图2a). Oncotarget (2016) ncbi
兔 多克隆
  • 免疫印迹; 大鼠; 1:1000; 图4a
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell signaling, 9661)被用于免疫印迹在大鼠样品上浓度为1:1000 (图4a). J Med Chem (2016) ncbi
兔 多克隆
  • 细胞化学; 大鼠; 1:500; 图s1
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell signaling, 9661)被用于免疫细胞化学在大鼠样品上浓度为1:500 (图s1). EMBO J (2016) ncbi
兔 多克隆
  • 免疫印迹; 狗; 1:500; 图3a
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫印迹在狗样品上浓度为1:500 (图3a). Am J Physiol Gastrointest Liver Physiol (2016) ncbi
兔 多克隆
  • 免疫组化-P; 小鼠; 1:200; 图6e
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signalling, 9661S)被用于免疫组化-石蜡切片在小鼠样品上浓度为1:200 (图6e). Nat Commun (2016) ncbi
兔 单克隆(5A1E)
  • 免疫印迹; 大鼠; 图2a
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9664)被用于免疫印迹在大鼠样品上 (图2a). Biochem J (2016) ncbi
兔 多克隆
  • 免疫组化; 小鼠; 图2a
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661S)被用于免疫组化在小鼠样品上 (图2a). Nature (2016) ncbi
兔 多克隆
  • 免疫印迹; 人类; 1:1000; 图4
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9662)被用于免疫印迹在人类样品上浓度为1:1000 (图4). Mol Med Rep (2016) ncbi
兔 单克隆(5A1E)
  • 免疫印迹; 小鼠; 1:500; 图2d
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9664)被用于免疫印迹在小鼠样品上浓度为1:500 (图2d). Dis Model Mech (2016) ncbi
兔 多克隆
  • 免疫印迹; 小鼠; 1:500; 图2d
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9662)被用于免疫印迹在小鼠样品上浓度为1:500 (图2d). Dis Model Mech (2016) ncbi
兔 多克隆
  • 免疫组化; 小鼠; 1:300
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫组化在小鼠样品上浓度为1:300. Nat Commun (2016) ncbi
兔 单克隆(5A1E)
  • 免疫组化-P; 小鼠; 1:150; 图s1
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9664)被用于免疫组化-石蜡切片在小鼠样品上浓度为1:150 (图s1). Integr Biol (Camb) (2016) ncbi
兔 单克隆(5A1E)
  • 免疫组化; purple urchin; 1:250; 图4
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9664L)被用于免疫组化在purple urchin样品上浓度为1:250 (图4). elife (2016) ncbi
兔 多克隆
  • 免疫印迹; 人类; 图2
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫印迹在人类样品上 (图2). BMC Cancer (2016) ncbi
兔 单克隆(5A1E)
  • 免疫印迹; 人类
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9664)被用于免疫印迹在人类样品上. Oncotarget (2016) ncbi
兔 多克隆
  • 免疫印迹; 人类; 图7a
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9662)被用于免疫印迹在人类样品上 (图7a). Oncotarget (2016) ncbi
兔 单克隆(8G10)
  • 免疫印迹; 人类; 1:1000; 图1
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(CST, 8G10)被用于免疫印迹在人类样品上浓度为1:1000 (图1). Cell Death Dis (2016) ncbi
兔 单克隆(5A1E)
  • 免疫组化-F; 小鼠; 1:500; 图2
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell signaling, 9664S)被用于免疫组化-冰冻切片在小鼠样品上浓度为1:500 (图2). Mol Neurodegener (2016) ncbi
兔 单克隆(5A1E)
  • 免疫印迹; 小鼠; 图7
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9664)被用于免疫印迹在小鼠样品上 (图7). Oncotarget (2016) ncbi
兔 单克隆(5A1E)
  • 免疫印迹; 人类; 图s1c
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9664)被用于免疫印迹在人类样品上 (图s1c). Oncotarget (2016) ncbi
兔 多克隆
  • 免疫印迹; 人类; 1:800; 图6
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell signaling, 9662S)被用于免疫印迹在人类样品上浓度为1:800 (图6). PLoS ONE (2016) ncbi
兔 多克隆
  • 免疫印迹; 人类; 图7
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell signaling, 9661)被用于免疫印迹在人类样品上 (图7). BMC Complement Altern Med (2016) ncbi
兔 单克隆(8G10)
  • 免疫印迹; 人类; 图7
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell signaling, 9665)被用于免疫印迹在人类样品上 (图7). BMC Complement Altern Med (2016) ncbi
兔 多克隆
  • 免疫组化; 斑马鱼; 图6i
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫组化在斑马鱼样品上 (图6i). Nat Commun (2016) ncbi
兔 多克隆
  • 免疫印迹; 人类; 图5g
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(cell signalling, 9661)被用于免疫印迹在人类样品上 (图5g). Oncotarget (2016) ncbi
兔 多克隆
  • 免疫组化-P; 小鼠; 1:400; 图s2
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫组化-石蜡切片在小鼠样品上浓度为1:400 (图s2). Nat Commun (2016) ncbi
兔 多克隆
  • 免疫印迹; 人类; 1:1000; 图2
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Tech, 9662S)被用于免疫印迹在人类样品上浓度为1:1000 (图2). Oncol Lett (2016) ncbi
兔 多克隆
  • 免疫印迹; 人类; 1:1000; 图3
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9662S)被用于免疫印迹在人类样品上浓度为1:1000 (图3). Sci Rep (2016) ncbi
兔 单克隆(5A1E)
  • 免疫印迹; 小鼠; 图3c
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9664)被用于免疫印迹在小鼠样品上 (图3c). Cell Death Dis (2016) ncbi
兔 单克隆(D3E9)
  • 细胞化学; 人类; 图4a
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell signaling, 9603)被用于免疫细胞化学在人类样品上 (图4a). Oncotarget (2016) ncbi
兔 多克隆
  • 免疫组化-F; 小鼠; 1:200; 图s6a
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫组化-冰冻切片在小鼠样品上浓度为1:200 (图s6a). Nature (2016) ncbi
兔 单克隆(8G10)
  • 免疫印迹; 人类; 1:1000; 图2
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9665)被用于免疫印迹在人类样品上浓度为1:1000 (图2). Mol Med Rep (2016) ncbi
兔 单克隆(5A1E)
  • 免疫组化; 猕猴; 图6e
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 5A1E)被用于免疫组化在猕猴样品上 (图6e). J Immunol (2016) ncbi
兔 多克隆
  • 免疫组化; 小鼠; 1:400; 图5h
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫组化在小鼠样品上浓度为1:400 (图5h). J Clin Invest (2016) ncbi
兔 单克隆(5A1E)
  • 免疫组化; 小鼠; 1:100
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9664S)被用于免疫组化在小鼠样品上浓度为1:100. Aging (Albany NY) (2016) ncbi
兔 多克隆
  • 免疫印迹; 人类; 1:1000; 图4
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9662)被用于免疫印迹在人类样品上浓度为1:1000 (图4). Sci Rep (2016) ncbi
兔 单克隆(5A1E)
  • 免疫印迹; 人类; 1:1000; 图4
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9664)被用于免疫印迹在人类样品上浓度为1:1000 (图4). Sci Rep (2016) ncbi
兔 单克隆(5A1E)
  • 免疫组化-P; 小鼠; 图5
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 5A1E)被用于免疫组化-石蜡切片在小鼠样品上 (图5). Sci Rep (2016) ncbi
兔 多克隆
  • 免疫组化; 小鼠; 1:400; 图3b
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(cell signalling, 9661)被用于免疫组化在小鼠样品上浓度为1:400 (图3b). Gut (2017) ncbi
兔 多克隆
  • 免疫印迹; 大鼠; 1:1000; 图7B
  • 免疫组化; 大鼠; 1:400; 图7A
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9662)被用于免疫印迹在大鼠样品上浓度为1:1000 (图7B) 和 免疫组化在大鼠样品上浓度为1:400 (图7A). Am J Transl Res (2016) ncbi
兔 多克隆
  • 免疫组化-F; 小鼠; 1:100; 图6h
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(CST, 9661)被用于免疫组化-冰冻切片在小鼠样品上浓度为1:100 (图6h). Development (2016) ncbi
兔 多克隆
  • 免疫印迹; 人类; 图4
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Tech, 9662S)被用于免疫印迹在人类样品上 (图4). Sci Rep (2016) ncbi
兔 多克隆
  • 免疫组化; 小鼠
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫组化在小鼠样品上. elife (2016) ncbi
兔 单克隆(5A1E)
  • 细胞化学; 小鼠; 1:400; 图s1f
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 5A1E)被用于免疫细胞化学在小鼠样品上浓度为1:400 (图s1f). Nat Med (2016) ncbi
兔 多克隆
  • 免疫印迹; 人类; 图2
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9662)被用于免疫印迹在人类样品上 (图2). PLoS ONE (2016) ncbi
兔 多克隆
  • 免疫组化-P; 人类; 1:300; 图s11a
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫组化-石蜡切片在人类样品上浓度为1:300 (图s11a). Sci Rep (2016) ncbi
兔 多克隆
  • 免疫印迹; 大鼠; 1:1000; 表3
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9662)被用于免疫印迹在大鼠样品上浓度为1:1000 (表3). Oncotarget (2016) ncbi
兔 多克隆
  • 免疫组化-P; 大鼠; 1:50; 图3
  • 免疫印迹; 大鼠; 1:1000; 图3
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫组化-石蜡切片在大鼠样品上浓度为1:50 (图3) 和 免疫印迹在大鼠样品上浓度为1:1000 (图3). Physiol Rep (2016) ncbi
兔 多克隆
  • 免疫组化; 小鼠; 1:1000; 表1
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9662)被用于免疫组化在小鼠样品上浓度为1:1000 (表1). J Comp Neurol (2017) ncbi
兔 单克隆(5A1E)
  • 免疫组化-F; 小鼠; 1:200; 图s2b
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell signaling, 9664)被用于免疫组化-冰冻切片在小鼠样品上浓度为1:200 (图s2b). J Clin Invest (2016) ncbi
兔 单克隆(5A1E)
  • 免疫印迹; 人类; 图4e
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9664)被用于免疫印迹在人类样品上 (图4e). Cancer Sci (2016) ncbi
兔 单克隆(5A1E)
  • 免疫印迹; 人类; 1:500; 图s6a
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Siganling, 9664S)被用于免疫印迹在人类样品上浓度为1:500 (图s6a). Nat Cell Biol (2016) ncbi
兔 单克隆(8G10)
  • 免疫印迹; 人类; 1:1000; 图3
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9665)被用于免疫印迹在人类样品上浓度为1:1000 (图3). Exp Ther Med (2016) ncbi
兔 单克隆(5A1E)
  • 免疫印迹; 人类; 1:1000; 图3
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9664)被用于免疫印迹在人类样品上浓度为1:1000 (图3). Exp Ther Med (2016) ncbi
兔 多克隆
  • 免疫组化-P; 小鼠; 1:1000; 图3d
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661S)被用于免疫组化-石蜡切片在小鼠样品上浓度为1:1000 (图3d). Oncogene (2016) ncbi
兔 多克隆
  • 免疫印迹; 小鼠; 图5c
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9662)被用于免疫印迹在小鼠样品上 (图5c). J Transl Med (2016) ncbi
兔 多克隆
  • 免疫组化; 小鼠; 1:400; 图s6a
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫组化在小鼠样品上浓度为1:400 (图s6a). Nat Commun (2016) ncbi
兔 单克隆(5A1E)
  • 免疫组化-P; 小鼠; 1:2000; 图6d
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 5A1E)被用于免疫组化-石蜡切片在小鼠样品上浓度为1:2000 (图6d). Cancer Res (2016) ncbi
兔 单克隆(5A1E)
  • 免疫印迹; 人类; 1:1000; 图s5
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9664)被用于免疫印迹在人类样品上浓度为1:1000 (图s5). Nat Commun (2016) ncbi
兔 单克隆(5A1E)
  • 免疫印迹; 人类; 图3c
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9664)被用于免疫印迹在人类样品上 (图3c). Oncotarget (2016) ncbi
兔 多克隆
  • 免疫印迹; 人类; 图3c
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9662)被用于免疫印迹在人类样品上 (图3c). Oncotarget (2016) ncbi
兔 单克隆(5A1E)
  • 免疫印迹; 人类; 1:1000; 图5
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 5A1E)被用于免疫印迹在人类样品上浓度为1:1000 (图5). Sci Rep (2016) ncbi
兔 多克隆
  • 免疫印迹; 人类; 图3c
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫印迹在人类样品上 (图3c). J Biol Chem (2016) ncbi
兔 单克隆(8G10)
  • 免疫印迹; 小鼠; 图7
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9665)被用于免疫印迹在小鼠样品上 (图7). Hepatology (2016) ncbi
兔 多克隆
  • 细胞化学; 小鼠; 1:200; 图3a
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(CST, 9661S)被用于免疫细胞化学在小鼠样品上浓度为1:200 (图3a). Cell Rep (2016) ncbi
兔 多克隆
  • 免疫印迹; 小鼠; 1:400; 图1c
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9662)被用于免疫印迹在小鼠样品上浓度为1:400 (图1c). Exp Ther Med (2016) ncbi
兔 单克隆(D3E9)
  • 免疫组化 (基因敲减); 人类; 1:100; 图4b
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9579)被用于免疫组化 (基因敲减)在人类样品上浓度为1:100 (图4b). Oncotarget (2016) ncbi
兔 单克隆(5A1E)
  • 免疫印迹; 人类; 图7b
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell signaling, 9664)被用于免疫印迹在人类样品上 (图7b). Oncotarget (2016) ncbi
兔 单克隆(5A1E)
  • 免疫印迹; 小鼠; 图5
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9664)被用于免疫印迹在小鼠样品上 (图5). PLoS Pathog (2016) ncbi
兔 多克隆
  • 免疫印迹; 大鼠; 1:1000; 图1
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫印迹在大鼠样品上浓度为1:1000 (图1). Sci Rep (2016) ncbi
兔 多克隆
  • 免疫印迹; 大鼠; 1:1000; 图3
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9662)被用于免疫印迹在大鼠样品上浓度为1:1000 (图3). Sci Rep (2016) ncbi
兔 多克隆
  • 免疫印迹; 小鼠; 1:1000; 图s3
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫印迹在小鼠样品上浓度为1:1000 (图s3). Nat Commun (2016) ncbi
兔 多克隆
  • 免疫组化-P; 大鼠; 图7
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9661S)被用于免疫组化-石蜡切片在大鼠样品上 (图7). J Nutr Biochem (2016) ncbi
兔 多克隆
  • 细胞化学; 小鼠; 图s5c
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9669)被用于免疫细胞化学在小鼠样品上 (图s5c). Nat Biotechnol (2016) ncbi
小鼠 单克隆(3G2)
  • 免疫印迹; 人类; 图4d
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9668)被用于免疫印迹在人类样品上 (图4d). FEBS Open Bio (2016) ncbi
兔 多克隆
  • 免疫印迹; 小鼠; 图s2
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Tech, 9661S)被用于免疫印迹在小鼠样品上 (图s2). PLoS ONE (2016) ncbi
兔 多克隆
  • 免疫印迹; 人类; 图6c
  • 免疫印迹; 小鼠; 图1e
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫印迹在人类样品上 (图6c) 和 在小鼠样品上 (图1e). Proc Natl Acad Sci U S A (2016) ncbi
兔 多克隆
  • 免疫组化; 小鼠; 图2
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell signaling, 9661)被用于免疫组化在小鼠样品上 (图2). PLoS ONE (2016) ncbi
兔 单克隆(8G10)
  • 免疫印迹; 人类; 1:1000; 图1
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell signaling, 9665)被用于免疫印迹在人类样品上浓度为1:1000 (图1). Mol Med Rep (2016) ncbi
兔 多克隆
  • 免疫组化-P; 人类; 1:200; 图EV1
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫组化-石蜡切片在人类样品上浓度为1:200 (图EV1). EMBO Mol Med (2016) ncbi
兔 单克隆(5A1E)
  • 免疫印迹; 人类; 图3
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9664)被用于免疫印迹在人类样品上 (图3). Onco Targets Ther (2016) ncbi
小鼠 单克隆(3G2)
  • 免疫印迹; 人类; 图1
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9668)被用于免疫印迹在人类样品上 (图1). Int J Oncol (2016) ncbi
兔 多克隆
  • 免疫组化-P; 小鼠; 1:200; 图1
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫组化-石蜡切片在小鼠样品上浓度为1:200 (图1). Sci Rep (2016) ncbi
兔 多克隆
  • 免疫组化-P; 人类; 1:300; 图6d
  • 免疫印迹; 人类; 图6c
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661S)被用于免疫组化-石蜡切片在人类样品上浓度为1:300 (图6d) 和 免疫印迹在人类样品上 (图6c). Sci Rep (2016) ncbi
兔 多克隆
  • 免疫组化; 小鼠; 图s6a
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661S)被用于免疫组化在小鼠样品上 (图s6a). Nat Med (2016) ncbi
兔 单克隆(5A1E)
  • 免疫印迹; 大鼠; 1:1000; 图4
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9664)被用于免疫印迹在大鼠样品上浓度为1:1000 (图4). Mol Med Rep (2016) ncbi
兔 多克隆
  • 免疫印迹; 人类; 1:1000; 图5d
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫印迹在人类样品上浓度为1:1000 (图5d). Nat Commun (2016) ncbi
兔 单克隆(5A1E)
  • 免疫组化-P; 小鼠; 图2b
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9664)被用于免疫组化-石蜡切片在小鼠样品上 (图2b). Am J Pathol (2016) ncbi
兔 多克隆
  • 免疫印迹; 人类; 图5c
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫印迹在人类样品上 (图5c). Oncotarget (2016) ncbi
兔 单克隆(5A1E)
  • 免疫组化-P; 人类; 1:300; 图10
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9664)被用于免疫组化-石蜡切片在人类样品上浓度为1:300 (图10). Autophagy (2016) ncbi
小鼠 单克隆(3G2)
  • 免疫印迹; 人类; 图9
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9668T)被用于免疫印迹在人类样品上 (图9). Autophagy (2016) ncbi
兔 多克隆
  • 免疫印迹; 小鼠; 图2
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫印迹在小鼠样品上 (图2). Cell Rep (2016) ncbi
兔 多克隆
  • 免疫印迹; 人类; 1:500; 图1
  • 细胞化学; 人类; 1:500; 图1
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫印迹在人类样品上浓度为1:500 (图1) 和 免疫细胞化学在人类样品上浓度为1:500 (图1). Mol Brain (2016) ncbi
兔 多克隆
  • 细胞化学; 果蝇; 1:300; 图5
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9661)被用于免疫细胞化学在果蝇样品上浓度为1:300 (图5). Nat Commun (2016) ncbi
小鼠 单克隆(3G2)
  • 免疫印迹; 兔; 1:1000; 图6
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(cell Signaling Tech, 9668)被用于免疫印迹在兔样品上浓度为1:1000 (图6). Mol Med Rep (2016) ncbi
兔 多克隆
  • 细胞化学; 人类; 图3g
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫细胞化学在人类样品上 (图3g). Cell Transplant (2016) ncbi
兔 多克隆
  • 免疫印迹; 人类; 1:1000; 图4
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(cell Signaling Tech, 9662)被用于免疫印迹在人类样品上浓度为1:1000 (图4). Acta Neuropathol Commun (2016) ncbi
兔 单克隆(8G10)
  • 免疫印迹; 人类; 1:1000; 图2
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell signaling, 9665)被用于免疫印迹在人类样品上浓度为1:1000 (图2). Front Microbiol (2016) ncbi
兔 多克隆
  • 细胞化学; 人类; 1:400; 图4
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell signaling, 9661)被用于免疫细胞化学在人类样品上浓度为1:400 (图4). Sci Rep (2016) ncbi
兔 多克隆
  • 细胞化学; 人类; 1:500; 图2
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell signaling, 9661)被用于免疫细胞化学在人类样品上浓度为1:500 (图2). Sci Rep (2016) ncbi
兔 多克隆
  • 免疫组化; 小鼠; 1:400; 图7
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661S)被用于免疫组化在小鼠样品上浓度为1:400 (图7). EMBO Mol Med (2016) ncbi
兔 单克隆(5A1E)
  • 细胞化学; 人类; 1:500; 图3
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9664)被用于免疫细胞化学在人类样品上浓度为1:500 (图3). J Steroid Biochem Mol Biol (2016) ncbi
兔 多克隆
  • 免疫印迹; 人类; 1:1000; 图3
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫印迹在人类样品上浓度为1:1000 (图3). J Steroid Biochem Mol Biol (2016) ncbi
兔 单克隆(5A1E)
  • 免疫组化-P; 斑马鱼; 1:250; 图5
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9664)被用于免疫组化-石蜡切片在斑马鱼样品上浓度为1:250 (图5). elife (2016) ncbi
兔 单克隆(5A1E)
  • 免疫印迹; 人类; 图2c
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9664)被用于免疫印迹在人类样品上 (图2c). Oncotarget (2016) ncbi
兔 单克隆(8G10)
  • 免疫印迹; 人类; 图2c
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9665)被用于免疫印迹在人类样品上 (图2c). Oncotarget (2016) ncbi
兔 多克隆
  • 免疫组化; 小鼠; 图4h
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫组化在小鼠样品上 (图4h). J Pathol (2016) ncbi
兔 单克隆(5A1E)
  • 免疫组化-P; 小鼠; 图s3
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell signaling, 9664)被用于免疫组化-石蜡切片在小鼠样品上 (图s3). Cardiovasc Res (2016) ncbi
兔 单克隆(5A1E)
  • 免疫组化-P; 鸡; 1:400; 图s5
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9664S)被用于免疫组化-石蜡切片在鸡样品上浓度为1:400 (图s5). BMC Biol (2016) ncbi
兔 多克隆
  • 免疫印迹; 人类; 图2
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫印迹在人类样品上 (图2). BMC Complement Altern Med (2016) ncbi
兔 单克隆(5A1E)
  • 免疫印迹; 小鼠; 1:1000; 图7a
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9664)被用于免疫印迹在小鼠样品上浓度为1:1000 (图7a). JCI Insight (2016) ncbi
兔 多克隆
  • 细胞化学; 狗; 1:200; 图1
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661s)被用于免疫细胞化学在狗样品上浓度为1:200 (图1). Nat Commun (2016) ncbi
兔 多克隆
  • 免疫印迹; 人类; 1:1000; 图5d
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫印迹在人类样品上浓度为1:1000 (图5d). J Exp Clin Cancer Res (2016) ncbi
兔 单克隆(D3E9)
  • 免疫组化; 小鼠; 1:100; 图s3
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, D3E9)被用于免疫组化在小鼠样品上浓度为1:100 (图s3). Nat Commun (2016) ncbi
兔 单克隆(8G10)
  • 免疫印迹; 人类; 图2d
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(cell signalling, 9665)被用于免疫印迹在人类样品上 (图2d). Oncotarget (2016) ncbi
兔 单克隆(5A1E)
  • 免疫组化-F; 大鼠; 1:100; 图3
  • 免疫印迹; 大鼠; 1:1000; 图3
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell signaling, 9664)被用于免疫组化-冰冻切片在大鼠样品上浓度为1:100 (图3) 和 免疫印迹在大鼠样品上浓度为1:1000 (图3). Brain (2016) ncbi
兔 多克隆
  • 免疫印迹; 大鼠; 1:1000; 图4
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9662)被用于免疫印迹在大鼠样品上浓度为1:1000 (图4). Exp Ther Med (2016) ncbi
兔 多克隆
  • 免疫印迹; 人类; 图4
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫印迹在人类样品上 (图4). Onco Targets Ther (2016) ncbi
兔 多克隆
  • 免疫印迹; 人类; 1:500; 图6
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫印迹在人类样品上浓度为1:500 (图6). Cell Rep (2016) ncbi
兔 多克隆
  • 免疫组化-F; 大鼠; 1:300
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661S)被用于免疫组化-冰冻切片在大鼠样品上浓度为1:300. Fertil Steril (2016) ncbi
兔 多克隆
  • 免疫组化; 果蝇; 1:50; 图s3
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫组化在果蝇样品上浓度为1:50 (图s3). Development (2016) ncbi
兔 多克隆
  • 免疫印迹; 人类; 图1b
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9662)被用于免疫印迹在人类样品上 (图1b). J Mol Med (Berl) (2016) ncbi
兔 多克隆
  • 免疫印迹; 人类; 图4
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9662)被用于免疫印迹在人类样品上 (图4). Cell Death Dis (2016) ncbi
兔 多克隆
  • 免疫组化; 小鼠; 1:300; 图5b
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫组化在小鼠样品上浓度为1:300 (图5b). Diabetologia (2016) ncbi
兔 多克隆
  • 免疫印迹; 小鼠; 图1
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9662)被用于免疫印迹在小鼠样品上 (图1). Cell Rep (2016) ncbi
兔 单克隆(5A1E)
  • 免疫印迹; 人类; 图4
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9664)被用于免疫印迹在人类样品上 (图4). Autophagy (2016) ncbi
兔 多克隆
  • 免疫组化-P; 小鼠; 图5
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫组化-石蜡切片在小鼠样品上 (图5). Nat Commun (2016) ncbi
兔 单克隆(D3E9)
  • 免疫印迹; 小鼠; 图6g
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9579)被用于免疫印迹在小鼠样品上 (图6g). Nat Cell Biol (2016) ncbi
兔 单克隆(8G10)
  • 免疫印迹; 大鼠; 1:500; 图3
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9665S)被用于免疫印迹在大鼠样品上浓度为1:500 (图3). Biofactors (2016) ncbi
兔 多克隆
  • 免疫印迹; 人类; 图5e
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9662)被用于免疫印迹在人类样品上 (图5e). Oncotarget (2016) ncbi
兔 单克隆(5A1E)
  • 免疫印迹; 人类; 图5e
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9664)被用于免疫印迹在人类样品上 (图5e). Oncotarget (2016) ncbi
兔 单克隆(5A1E)
  • 免疫印迹; 人类; 1:1000; 图4
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Tech, 9664)被用于免疫印迹在人类样品上浓度为1:1000 (图4). Mol Med Rep (2016) ncbi
兔 单克隆(5A1E)
  • 免疫印迹; 人类; 图7a
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9664)被用于免疫印迹在人类样品上 (图7a). Oncol Rep (2016) ncbi
兔 单克隆(5A1E)
  • 免疫组化-P; 人类; 图5
  • 免疫印迹; 人类; 图5
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9664)被用于免疫组化-石蜡切片在人类样品上 (图5) 和 免疫印迹在人类样品上 (图5). PLoS ONE (2016) ncbi
兔 多克隆
  • 免疫组化; 果蝇; 1:300; 图s4
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 96615)被用于免疫组化在果蝇样品上浓度为1:300 (图s4). PLoS Genet (2016) ncbi
兔 多克隆
  • 免疫印迹; 小鼠; 图5c
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫印迹在小鼠样品上 (图5c). Genes Dev (2016) ncbi
兔 单克隆(5A1E)
  • 免疫印迹; 人类; 图4
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9664)被用于免疫印迹在人类样品上 (图4). BMC Cancer (2016) ncbi
兔 单克隆(5A1E)
  • 免疫组化; 人类; 1:500; 图4
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 5A1E)被用于免疫组化在人类样品上浓度为1:500 (图4). Nat Commun (2016) ncbi
兔 多克隆
  • 免疫组化; 大鼠; 1:200; 图1
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signalling, 9661s)被用于免疫组化在大鼠样品上浓度为1:200 (图1). Hum Mol Genet (2016) ncbi
兔 多克隆
  • 免疫组化; 人类; 1:150; 图5h
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling technology, 9661)被用于免疫组化在人类样品上浓度为1:150 (图5h). EMBO Mol Med (2016) ncbi
兔 多克隆
  • 细胞化学; 小鼠; 1:1000; 图s4c
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9661)被用于免疫细胞化学在小鼠样品上浓度为1:1000 (图s4c). Nat Commun (2016) ncbi
兔 单克隆(5A1E)
  • 免疫印迹; 人类; 1:500; 图3
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9664S)被用于免疫印迹在人类样品上浓度为1:500 (图3). Nat Cell Biol (2016) ncbi
兔 单克隆(5A1E)
  • 免疫印迹; African green monkey; 图s4
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Tech, 9664)被用于免疫印迹在African green monkey样品上 (图s4). Cancer Sci (2016) ncbi
兔 单克隆(5A1E)
  • 免疫印迹; 人类; 图1a
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 5A1E)被用于免疫印迹在人类样品上 (图1a). Biochem Biophys Res Commun (2016) ncbi
兔 多克隆
  • 免疫组化; 人类; 1:100
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫组化在人类样品上浓度为1:100. Dis Model Mech (2016) ncbi
兔 多克隆
  • 免疫印迹; 人类; 1:1000; 图4c
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9662)被用于免疫印迹在人类样品上浓度为1:1000 (图4c). PLoS ONE (2016) ncbi
兔 单克隆(5A1E)
  • 免疫印迹; 人类; 1:1000; 图4c
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9664)被用于免疫印迹在人类样品上浓度为1:1000 (图4c). PLoS ONE (2016) ncbi
兔 多克隆
  • 免疫印迹; 小鼠; 图s2i
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9662)被用于免疫印迹在小鼠样品上 (图s2i). Immunity (2016) ncbi
兔 多克隆
  • 免疫组化-P; 小鼠; 图1a
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫组化-石蜡切片在小鼠样品上 (图1a). Immunity (2016) ncbi
兔 多克隆
  • 免疫印迹; 大鼠; 图3
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫印迹在大鼠样品上 (图3). Int J Mol Sci (2016) ncbi
兔 单克隆(5A1E)
  • 免疫印迹; 人类; 1:1000; 图4f
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9664P)被用于免疫印迹在人类样品上浓度为1:1000 (图4f). Sci Rep (2016) ncbi
兔 单克隆(5A1E)
  • 免疫印迹; 人类; 图2
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9664)被用于免疫印迹在人类样品上 (图2). Sci Rep (2016) ncbi
兔 单克隆(5A1E)
  • 免疫组化-P; 小鼠; 1:100; 图5g
  • 免疫印迹; 小鼠; 1:1000; 图5d
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9664S)被用于免疫组化-石蜡切片在小鼠样品上浓度为1:100 (图5g) 和 免疫印迹在小鼠样品上浓度为1:1000 (图5d). J Biol Chem (2016) ncbi
兔 多克隆
  • 免疫印迹; 大鼠; 1:500; 图4
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫印迹在大鼠样品上浓度为1:500 (图4). J Diabetes Res (2016) ncbi
兔 多克隆
  • 免疫印迹; 人类; 图1f
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫印迹在人类样品上 (图1f). Oncotarget (2016) ncbi
兔 多克隆
  • 免疫组化-F; 小鼠; 图9
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell signaling, 9661)被用于免疫组化-冰冻切片在小鼠样品上 (图9). BMC Cancer (2016) ncbi
兔 单克隆(5A1E)
  • 免疫印迹; 小鼠; 图3c-d
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 5A1E)被用于免疫印迹在小鼠样品上 (图3c-d). Proc Natl Acad Sci U S A (2016) ncbi
兔 单克隆(5A1E)
  • 免疫印迹; 小鼠; 图1
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technolog, 9664)被用于免疫印迹在小鼠样品上 (图1). Cell Death Differ (2016) ncbi
兔 单克隆(5A1E)
  • 免疫组化-P; 小鼠; 1:100; 图7
  • 免疫印迹; 小鼠; 1:1000; 图7
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell signaling, 9664)被用于免疫组化-石蜡切片在小鼠样品上浓度为1:100 (图7) 和 免疫印迹在小鼠样品上浓度为1:1000 (图7). Oncotarget (2016) ncbi
兔 多克隆
  • 免疫印迹; 人类; 图6b
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(cell signalling, 9661)被用于免疫印迹在人类样品上 (图6b). J Biol Chem (2016) ncbi
兔 多克隆
  • 免疫印迹; 人类; 图2
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell signaling, 9662)被用于免疫印迹在人类样品上 (图2). Mol Cancer Ther (2016) ncbi
兔 多克隆
  • 免疫印迹; 人类; 图2
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell signaling, 9661)被用于免疫印迹在人类样品上 (图2). Mol Cancer Ther (2016) ncbi
兔 多克隆
  • 免疫组化-F; 小鼠; 1:200
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell signaling, 9661)被用于免疫组化-冰冻切片在小鼠样品上浓度为1:200. Nat Commun (2016) ncbi
兔 多克隆
  • 免疫组化-P; 小鼠; 1:330; 图7
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫组化-石蜡切片在小鼠样品上浓度为1:330 (图7). Int J Mol Sci (2016) ncbi
兔 多克隆
  • 免疫印迹; 人类; 1:1000; 图5
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Tech, 9662)被用于免疫印迹在人类样品上浓度为1:1000 (图5). Mol Med Rep (2016) ncbi
兔 多克隆
  • 免疫印迹; 人类; 1:1000; 图2f
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫印迹在人类样品上浓度为1:1000 (图2f). Mol Med Rep (2016) ncbi
兔 多克隆
  • 免疫印迹; 人类; 图4
  • 免疫印迹; 小鼠; 图4
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9661)被用于免疫印迹在人类样品上 (图4) 和 在小鼠样品上 (图4). Sci Rep (2016) ncbi
兔 多克隆
  • 免疫印迹; 人类; 图3
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Tech, 9662)被用于免疫印迹在人类样品上 (图3). Oncotarget (2016) ncbi
兔 单克隆(D3E9)
  • 细胞化学; 小鼠; 图1e
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell signaling, 9602)被用于免疫细胞化学在小鼠样品上 (图1e). Oncogenesis (2016) ncbi
兔 单克隆(5A1E)
  • 免疫组化-F; 小鼠; 图3b
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell signaling, 9664)被用于免疫组化-冰冻切片在小鼠样品上 (图3b). Oncogenesis (2016) ncbi
兔 多克隆
  • 免疫印迹; 人类; 图1
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9661)被用于免疫印迹在人类样品上 (图1). Cell Cycle (2016) ncbi
兔 单克隆(5A1E)
  • 免疫组化-P; 人类; 1:200; 图s8
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell signaling, 5A1E)被用于免疫组化-石蜡切片在人类样品上浓度为1:200 (图s8). Oncotarget (2016) ncbi
兔 单克隆(5A1E)
  • 免疫组化; 小鼠; 1:250
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9664)被用于免疫组化在小鼠样品上浓度为1:250. Int J Cancer (2016) ncbi
兔 多克隆
  • 免疫印迹; 小鼠; 1:1000; 图1c
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9662)被用于免疫印迹在小鼠样品上浓度为1:1000 (图1c). Int J Cancer (2016) ncbi
兔 单克隆(5A1E)
  • 免疫组化-P; 小鼠; 1:200; 图2
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell signaling, 9664)被用于免疫组化-石蜡切片在小鼠样品上浓度为1:200 (图2). J Pathol (2016) ncbi
兔 多克隆
  • 免疫印迹; 人类; 图8d
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫印迹在人类样品上 (图8d). J Cell Sci (2016) ncbi
兔 多克隆
  • 免疫组化-P; 小鼠; 图5a
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫组化-石蜡切片在小鼠样品上 (图5a). Sci Rep (2016) ncbi
兔 多克隆
  • 免疫组化; 小鼠; 1:100; 表4
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9669)被用于免疫组化在小鼠样品上浓度为1:100 (表4). Differentiation (2016) ncbi
兔 多克隆
  • 免疫组化; 小鼠; 1:1000; 图8
  • 免疫印迹; 小鼠; 1:1000; 图9
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫组化在小鼠样品上浓度为1:1000 (图8) 和 免疫印迹在小鼠样品上浓度为1:1000 (图9). Sci Rep (2016) ncbi
兔 多克隆
  • 免疫印迹; 小鼠; 1:1000; 图9
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9662)被用于免疫印迹在小鼠样品上浓度为1:1000 (图9). Sci Rep (2016) ncbi
兔 多克隆
  • 免疫印迹; 人类; 图5
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫印迹在人类样品上 (图5). Oncotarget (2016) ncbi
兔 单克隆(5A1E)
  • 免疫印迹; 人类; 图3a
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9664)被用于免疫印迹在人类样品上 (图3a). Mol Endocrinol (2016) ncbi
兔 多克隆
  • 细胞化学; 小鼠; 图s2
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9661)被用于免疫细胞化学在小鼠样品上 (图s2). elife (2016) ncbi
兔 多克隆
  • 免疫印迹; 人类; 1:1000; 图6a
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9662)被用于免疫印迹在人类样品上浓度为1:1000 (图6a). Int J Biochem Cell Biol (2016) ncbi
兔 多克隆
  • 免疫印迹; 人类; 1:1000; 图6a
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫印迹在人类样品上浓度为1:1000 (图6a). Int J Biochem Cell Biol (2016) ncbi
兔 多克隆
  • 免疫印迹; 人类; 图2
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(cell signaling, 9661)被用于免疫印迹在人类样品上 (图2). Nat Genet (2016) ncbi
兔 单克隆(8G10)
  • 免疫印迹; 大鼠; 图1
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell signaling, 9665)被用于免疫印迹在大鼠样品上 (图1). Cell Stress Chaperones (2016) ncbi
兔 单克隆(5A1E)
  • 免疫印迹; 人类; 1:400; 图4
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9664)被用于免疫印迹在人类样品上浓度为1:400 (图4). Mol Cell Endocrinol (2016) ncbi
兔 多克隆
  • 免疫印迹; 小鼠; 1:500; 图4e
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9662)被用于免疫印迹在小鼠样品上浓度为1:500 (图4e). Stem Cells (2016) ncbi
兔 多克隆
  • 免疫组化-F; 小鼠; 1:250; 图3
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9661)被用于免疫组化-冰冻切片在小鼠样品上浓度为1:250 (图3). elife (2016) ncbi
兔 单克隆(D3E9)
  • 免疫组化-P; 小鼠; 图5
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technologies, 9579S)被用于免疫组化-石蜡切片在小鼠样品上 (图5). Sci Rep (2016) ncbi
兔 多克隆
  • 免疫组化-P; 小鼠; 图5e
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫组化-石蜡切片在小鼠样品上 (图5e). Cell Metab (2016) ncbi
兔 多克隆
  • 免疫印迹 (基因敲减); 人类; 1:2000; 图5
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9669)被用于免疫印迹 (基因敲减)在人类样品上浓度为1:2000 (图5). Int J Mol Med (2016) ncbi
兔 多克隆
  • 免疫组化; 小鼠; 1:400; 图s1b
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9661)被用于免疫组化在小鼠样品上浓度为1:400 (图s1b). elife (2016) ncbi
兔 多克隆
  • 免疫印迹; 人类; 图1
  • 免疫组化; 人类; 1:750; 图1
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫印迹在人类样品上 (图1) 和 免疫组化在人类样品上浓度为1:750 (图1). Cell Death Dis (2016) ncbi
兔 多克隆
  • 免疫印迹; 人类; 图4
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9662)被用于免疫印迹在人类样品上 (图4). Oncotarget (2016) ncbi
兔 多克隆
  • 免疫印迹; 人类; 图3
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signalling, 9662)被用于免疫印迹在人类样品上 (图3). Mol Cancer (2016) ncbi
兔 多克隆
  • 免疫印迹; 人类; 图3
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signalling, 9661)被用于免疫印迹在人类样品上 (图3). Mol Cancer (2016) ncbi
兔 多克隆
  • 免疫组化-P; 羊; 1:1000; 图7
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(cell signaling, 9661)被用于免疫组化-石蜡切片在羊样品上浓度为1:1000 (图7). J Neuroinflammation (2016) ncbi
兔 单克隆(5A1E)
  • 免疫组化; 人类; 1:1000; 图5
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9664)被用于免疫组化在人类样品上浓度为1:1000 (图5). Nat Commun (2016) ncbi
兔 多克隆
  • 免疫印迹; 人类; 图1b
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫印迹在人类样品上 (图1b). Acta Neuropathol (2016) ncbi
兔 多克隆
  • 免疫印迹; 小鼠; 1:1000; 图s1d
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9662)被用于免疫印迹在小鼠样品上浓度为1:1000 (图s1d). Nat Commun (2016) ncbi
兔 多克隆
  • 免疫组化; 小鼠; 1:300; 图s1d
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫组化在小鼠样品上浓度为1:300 (图s1d). Nat Commun (2016) ncbi
兔 多克隆
  • 免疫组化-P; 小鼠; 1:100; 图5
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫组化-石蜡切片在小鼠样品上浓度为1:100 (图5). Sci Rep (2016) ncbi
兔 单克隆(5A1E)
  • 免疫印迹; 人类; 图2
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9664)被用于免疫印迹在人类样品上 (图2). Oncogene (2016) ncbi
兔 多克隆
  • 免疫组化; 果蝇; 1:1000; 图3
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661S)被用于免疫组化在果蝇样品上浓度为1:1000 (图3). Dis Model Mech (2016) ncbi
兔 多克隆
  • 免疫印迹; 小鼠; 图7
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9662)被用于免疫印迹在小鼠样品上 (图7). Nat Commun (2016) ncbi
兔 单克隆(5A1E)
  • 免疫印迹; 人类; 1:1000; 图3
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9664)被用于免疫印迹在人类样品上浓度为1:1000 (图3). Int J Oncol (2016) ncbi
小鼠 单克隆(3G2)
  • 免疫印迹; 人类; 1:1000; 图3
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9668)被用于免疫印迹在人类样品上浓度为1:1000 (图3). Int J Oncol (2016) ncbi
兔 多克隆
  • 免疫组化-P; 小鼠; 1:200; 图1
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫组化-石蜡切片在小鼠样品上浓度为1:200 (图1). Breast Cancer Res (2016) ncbi
兔 多克隆
  • 免疫印迹 (基因敲减); 人类; 1:1000; 图7
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9662)被用于免疫印迹 (基因敲减)在人类样品上浓度为1:1000 (图7). Oncotarget (2016) ncbi
兔 多克隆
  • 免疫组化-P; 人类; 图s6
  • 免疫印迹; 人类; 图s6
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫组化-石蜡切片在人类样品上 (图s6) 和 免疫印迹在人类样品上 (图s6). Neoplasia (2016) ncbi
兔 单克隆(8G10)
  • 免疫印迹; 人类; 1:1000; 图s8
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9665)被用于免疫印迹在人类样品上浓度为1:1000 (图s8). J Allergy Clin Immunol (2016) ncbi
兔 多克隆
  • 免疫印迹; 人类; 图5
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9662)被用于免疫印迹在人类样品上 (图5). Cell Rep (2016) ncbi
兔 多克隆
  • 免疫印迹; 人类; 图2d
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(CST, 9661)被用于免疫印迹在人类样品上 (图2d). Oncotarget (2016) ncbi
兔 多克隆
  • 免疫印迹; 人类; 图5
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signalling, 9661)被用于免疫印迹在人类样品上 (图5). Oncotarget (2016) ncbi
兔 多克隆
  • 免疫印迹; 人类; 图5
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signalling, 9662)被用于免疫印迹在人类样品上 (图5). Oncotarget (2016) ncbi
兔 多克隆
  • 免疫印迹; 人类; 1:1000; 图6
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9662)被用于免疫印迹在人类样品上浓度为1:1000 (图6). Biochem Pharmacol (2016) ncbi
兔 多克隆
  • 免疫印迹; 小鼠; 图8a
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫印迹在小鼠样品上 (图8a). J Virol (2016) ncbi
兔 多克隆
  • 免疫印迹; 小鼠; 图3b
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9662)被用于免疫印迹在小鼠样品上 (图3b). Aging Cell (2016) ncbi
兔 多克隆
  • 免疫印迹; 小鼠; 图5
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, S9661)被用于免疫印迹在小鼠样品上 (图5). J Cell Physiol (2016) ncbi
兔 多克隆
  • 免疫印迹; 小鼠
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, S9662)被用于免疫印迹在小鼠样品上. J Cell Physiol (2016) ncbi
兔 单克隆(8G10)
  • 免疫印迹; 人类; 图5b
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9665)被用于免疫印迹在人类样品上 (图5b). J Diabetes Res (2016) ncbi
兔 多克隆
  • 免疫组化-P; 人类; 1:400; 图1
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9661S)被用于免疫组化-石蜡切片在人类样品上浓度为1:400 (图1). Oncol Lett (2015) ncbi
兔 单克隆(8G10)
  • 免疫印迹; 人类; 图6c
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9665)被用于免疫印迹在人类样品上 (图6c). Stem Cells Int (2016) ncbi
兔 多克隆
  • 免疫印迹; 小鼠; 图s1
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell signaling, 9661)被用于免疫印迹在小鼠样品上 (图s1). J Cell Biol (2016) ncbi
兔 多克隆
  • 免疫印迹; 人类; 图3
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9662)被用于免疫印迹在人类样品上 (图3). Cell Death Dis (2016) ncbi
兔 单克隆(5A1E)
  • 免疫印迹; 人类; 图3a
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9664)被用于免疫印迹在人类样品上 (图3a). Redox Biol (2016) ncbi
兔 多克隆
  • 免疫组化; 小鼠; 1:800; 图s3
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫组化在小鼠样品上浓度为1:800 (图s3). Biol Open (2016) ncbi
兔 多克隆
  • 免疫印迹; 人类; 1:1000; 图s1
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 96625)被用于免疫印迹在人类样品上浓度为1:1000 (图s1). PLoS ONE (2016) ncbi
兔 多克隆
  • 免疫印迹; 小鼠; 图6
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661L)被用于免疫印迹在小鼠样品上 (图6). Oncotarget (2016) ncbi
兔 多克隆
  • 免疫组化; 小鼠; 1:200; 图6
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9661)被用于免疫组化在小鼠样品上浓度为1:200 (图6). Nat Commun (2016) ncbi
兔 单克隆(5A1E)
  • 免疫印迹; 人类; 图3, 4
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9664)被用于免疫印迹在人类样品上 (图3, 4). J Biol Chem (2016) ncbi
兔 多克隆
  • 细胞化学; 小鼠; 图1
  • 免疫印迹; 小鼠; 图1
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell signaling, 9662)被用于免疫细胞化学在小鼠样品上 (图1) 和 免疫印迹在小鼠样品上 (图1). Sci Rep (2016) ncbi
兔 多克隆
  • 免疫印迹; 小鼠; 1:1000; 图7
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫印迹在小鼠样品上浓度为1:1000 (图7). J Biol Chem (2016) ncbi
兔 单克隆(8G10)
  • 免疫印迹; 人类; 1:1000; 图3a
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9665)被用于免疫印迹在人类样品上浓度为1:1000 (图3a). Oncotarget (2016) ncbi
兔 单克隆(8G10)
  • 免疫印迹; 人类; 1:500; 图5
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9665)被用于免疫印迹在人类样品上浓度为1:500 (图5). Cancer Res (2016) ncbi
兔 单克隆(5A1E)
  • 免疫印迹; 人类; 1:500; 图5
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9664)被用于免疫印迹在人类样品上浓度为1:500 (图5). Cancer Res (2016) ncbi
兔 多克隆
  • 免疫印迹; 人类; 1:1000; 图3a
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9662S)被用于免疫印迹在人类样品上浓度为1:1000 (图3a). Biosci Rep (2016) ncbi
兔 多克隆
  • 免疫印迹; 人类; 图3
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫印迹在人类样品上 (图3). Oncotarget (2016) ncbi
兔 单克隆(5A1E)
  • 免疫组化-F; 小鼠; 1:100; 图2
  • 免疫印迹; 人类; 1:1000; 图s5
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9664)被用于免疫组化-冰冻切片在小鼠样品上浓度为1:100 (图2) 和 免疫印迹在人类样品上浓度为1:1000 (图s5). Nature (2016) ncbi
兔 多克隆
  • 免疫印迹; 人类; 1:1000; 图s5
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9662)被用于免疫印迹在人类样品上浓度为1:1000 (图s5). Nature (2016) ncbi
兔 多克隆
  • 免疫组化; 人类; 图7
  • 免疫印迹; 人类; 图7
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell signaling, 9661)被用于免疫组化在人类样品上 (图7) 和 免疫印迹在人类样品上 (图7). Oncotarget (2016) ncbi
兔 多克隆
  • 免疫印迹; 人类; 1:200; 图3a
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫印迹在人类样品上浓度为1:200 (图3a). Sci Rep (2016) ncbi
兔 多克隆
  • 免疫印迹; 人类; 图5g
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫印迹在人类样品上 (图5g). PLoS ONE (2016) ncbi
兔 单克隆(5A1E)
  • 免疫印迹; 小鼠; 图3c
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9664S)被用于免疫印迹在小鼠样品上 (图3c). Oncogene (2016) ncbi
兔 多克隆
  • 免疫印迹; 大鼠; 1:1000; 图4
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technologies, CST9662)被用于免疫印迹在大鼠样品上浓度为1:1000 (图4). Mol Med Rep (2016) ncbi
兔 多克隆
  • 免疫印迹; 人类; 图1
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell signaling, 9662)被用于免疫印迹在人类样品上 (图1). PLoS Pathog (2015) ncbi
兔 单克隆(8G10)
  • 免疫印迹; 人类; 图5
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9665)被用于免疫印迹在人类样品上 (图5). Oncotarget (2016) ncbi
兔 多克隆
  • 免疫组化-P; 小鼠; 1:500; 图1
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9661)被用于免疫组化-石蜡切片在小鼠样品上浓度为1:500 (图1). Dis Model Mech (2016) ncbi
兔 多克隆
  • 免疫印迹; 人类; 图5
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell signaling, 9662)被用于免疫印迹在人类样品上 (图5). Oncotarget (2016) ncbi
兔 单克隆(5A1E)
  • 免疫印迹; 小鼠; 图1
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 5A1)被用于免疫印迹在小鼠样品上 (图1). Data Brief (2015) ncbi
兔 单克隆(5A1E)
  • 免疫印迹; 小鼠; 1:1000; 图3c
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signalling, 9654)被用于免疫印迹在小鼠样品上浓度为1:1000 (图3c). Reprod Domest Anim (2016) ncbi
兔 单克隆(8G10)
  • 免疫印迹; 人类; 图2a
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9665)被用于免疫印迹在人类样品上 (图2a). Oncotarget (2016) ncbi
兔 单克隆(D3E9)
  • 免疫印迹; 小鼠; 图7
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9579)被用于免疫印迹在小鼠样品上 (图7). Mol Med Rep (2016) ncbi
兔 单克隆(8G10)
  • 免疫印迹; 小鼠; 图3
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9665)被用于免疫印迹在小鼠样品上 (图3). Oncotarget (2016) ncbi
兔 多克隆
  • 免疫印迹; 人类; 图2
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9662)被用于免疫印迹在人类样品上 (图2). J Biol Chem (2016) ncbi
兔 多克隆
  • 免疫组化; 小鼠; 1:200; 图1m
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫组化在小鼠样品上浓度为1:200 (图1m). Nat Commun (2015) ncbi
兔 多克隆
  • 免疫组化-P; 小鼠; 1:300; 图8
  • 免疫印迹; 人类; 1:500; 图1
  • 免疫印迹; 小鼠; 1:500; 图7
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫组化-石蜡切片在小鼠样品上浓度为1:300 (图8) 和 免疫印迹在人类样品上浓度为1:500 (图1) 和 在小鼠样品上浓度为1:500 (图7). Nat Commun (2015) ncbi
兔 单克隆(5A1E)
  • 免疫印迹; 小鼠; 1:1000; 图6
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9664)被用于免疫印迹在小鼠样品上浓度为1:1000 (图6). Nat Commun (2015) ncbi
兔 单克隆(5A1E)
  • 免疫印迹; 小鼠; 图5
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9664)被用于免疫印迹在小鼠样品上 (图5). Mol Cell Biol (2015) ncbi
兔 多克隆
  • 免疫印迹; 人类; 图6
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signalling, 9662)被用于免疫印迹在人类样品上 (图6). Oncotarget (2016) ncbi
兔 多克隆
  • 细胞化学; 人类; 1:100; 图2
  • 免疫组化; 人类; 1:100; 图4
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫细胞化学在人类样品上浓度为1:100 (图2) 和 免疫组化在人类样品上浓度为1:100 (图4). Mol Cancer (2015) ncbi
兔 多克隆
  • 免疫印迹; 人类; 图6
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9662)被用于免疫印迹在人类样品上 (图6). Oncotarget (2016) ncbi
兔 单克隆(D3E9)
  • 免疫组化; 小鼠; 1:400; 图2c
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9579)被用于免疫组化在小鼠样品上浓度为1:400 (图2c). Reprod Sci (2016) ncbi
兔 多克隆
  • 免疫组化-P; 小鼠; 1:100; 图2
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9661)被用于免疫组化-石蜡切片在小鼠样品上浓度为1:100 (图2). BMC Biol (2015) ncbi
兔 单克隆(5A1E)
  • 免疫印迹; 人类; 图6
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9664)被用于免疫印迹在人类样品上 (图6). Oncotarget (2015) ncbi
兔 单克隆(5A1E)
  • 免疫印迹; 人类; 图4
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9664)被用于免疫印迹在人类样品上 (图4). J Cell Biol (2015) ncbi
兔 单克隆(8G10)
  • 免疫组化-F; 小鼠; 1:100; 图3h
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signalling, 966515)被用于免疫组化-冰冻切片在小鼠样品上浓度为1:100 (图3h). J Neuroinflammation (2015) ncbi
兔 单克隆(5A1E)
  • 免疫组化-P; 小鼠; 图5
  • 免疫印迹; 小鼠; 图1
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9664)被用于免疫组化-石蜡切片在小鼠样品上 (图5) 和 免疫印迹在小鼠样品上 (图1). Am J Transplant (2016) ncbi
兔 多克隆
  • 免疫组化-P; 小鼠
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫组化-石蜡切片在小鼠样品上. Cancer Discov (2016) ncbi
兔 多克隆
  • 免疫组化; 小鼠; 1:100; 图2
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9661)被用于免疫组化在小鼠样品上浓度为1:100 (图2). Development (2016) ncbi
兔 多克隆
  • 免疫组化; 小鼠; 1:100; 图3e
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫组化在小鼠样品上浓度为1:100 (图3e). Dev Biol (2016) ncbi
兔 多克隆
  • 免疫印迹; 人类; 图7
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9662)被用于免疫印迹在人类样品上 (图7). Nucleic Acids Res (2016) ncbi
兔 多克隆
  • 免疫印迹; 人类; 图2a
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9662)被用于免疫印迹在人类样品上 (图2a). Oncotarget (2016) ncbi
兔 多克隆
  • 免疫印迹; 人类; 1:1000; 图2c
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell signaling, 9661)被用于免疫印迹在人类样品上浓度为1:1000 (图2c). Cancer Res (2015) ncbi
兔 多克隆
  • 免疫印迹; 人类; 图4
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫印迹在人类样品上 (图4). Int J Mol Med (2016) ncbi
兔 多克隆
  • 免疫印迹; 人类; 1:500; 图2c
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9661)被用于免疫印迹在人类样品上浓度为1:500 (图2c). Nat Commun (2015) ncbi
兔 多克隆
  • 免疫印迹; 小鼠; 1:1000; 图S5A
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫印迹在小鼠样品上浓度为1:1000 (图S5A). Autophagy (2016) ncbi
兔 单克隆(5A1E)
  • 免疫组化-P; 小鼠; 图7A
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9664)被用于免疫组化-石蜡切片在小鼠样品上 (图7A). Autophagy (2015) ncbi
兔 多克隆
  • 免疫印迹; 小鼠; 1:1000; 图3
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9661)被用于免疫印迹在小鼠样品上浓度为1:1000 (图3). J Biol Chem (2015) ncbi
兔 多克隆
  • 免疫组化-F; 小鼠; 1:400; 图s6
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫组化-冰冻切片在小鼠样品上浓度为1:400 (图s6). Sci Rep (2015) ncbi
兔 多克隆
  • FC; 人类; 图5
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于流式细胞仪在人类样品上 (图5). BMC Cancer (2015) ncbi
兔 单克隆(8G10)
  • 免疫印迹; 人类; 图1
  • 免疫印迹; 小鼠; 图1
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9665)被用于免疫印迹在人类样品上 (图1) 和 在小鼠样品上 (图1). Sci Rep (2015) ncbi
兔 单克隆(8G10)
  • 免疫印迹; 小鼠; 1:1000; 图7
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9665)被用于免疫印迹在小鼠样品上浓度为1:1000 (图7). Nat Cell Biol (2015) ncbi
兔 单克隆(5A1E)
  • 免疫组化; 人类; 1:50; 图4c
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(cell signaling, 9664)被用于免疫组化在人类样品上浓度为1:50 (图4c). J Natl Cancer Inst (2016) ncbi
兔 单克隆(8G10)
  • 免疫印迹; 人类; 图1
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9665)被用于免疫印迹在人类样品上 (图1). Oncotarget (2015) ncbi
兔 多克隆
  • 免疫组化-F; 鸡; 1:200; 表1
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Bioke, 9661S)被用于免疫组化-冰冻切片在鸡样品上浓度为1:200 (表1). PLoS ONE (2015) ncbi
兔 多克隆
  • 细胞化学; 人类; 图3
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell signaling, 9661)被用于免疫细胞化学在人类样品上 (图3). Oncotarget (2015) ncbi
兔 多克隆
  • 免疫印迹; 人类; 1:1000; 图2d
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫印迹在人类样品上浓度为1:1000 (图2d). Oncotarget (2016) ncbi
兔 多克隆
  • 免疫印迹; 人类; 图s3b
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9662)被用于免疫印迹在人类样品上 (图s3b). Int J Mol Sci (2015) ncbi
兔 多克隆
  • 免疫印迹; platanna; 图1
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫印迹在platanna样品上 (图1). J Biol Chem (2015) ncbi
兔 多克隆
  • 细胞化学; 人类; 图2c
  • 免疫组化; 人类; 图2d
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9661S)被用于免疫细胞化学在人类样品上 (图2c) 和 免疫组化在人类样品上 (图2d). Oncotarget (2015) ncbi
兔 单克隆(8G10)
  • 免疫印迹; 人类; 图5
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 8G10)被用于免疫印迹在人类样品上 (图5). Oncotarget (2015) ncbi
兔 单克隆(5A1E)
  • 免疫印迹; 人类; 1:1000; 图1
  • 免疫印迹; 小鼠; 1:1000; 图s2
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9664)被用于免疫印迹在人类样品上浓度为1:1000 (图1) 和 在小鼠样品上浓度为1:1000 (图s2). Proc Natl Acad Sci U S A (2015) ncbi
兔 单克隆(8G10)
  • 免疫印迹; 人类; 1:1000; 图2
  • 免疫印迹; 小鼠; 1:1000; 图3
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9665)被用于免疫印迹在人类样品上浓度为1:1000 (图2) 和 在小鼠样品上浓度为1:1000 (图3). Proc Natl Acad Sci U S A (2015) ncbi
兔 多克隆
  • 免疫组化-P; 小鼠; 图s5
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9661)被用于免疫组化-石蜡切片在小鼠样品上 (图s5). Nat Immunol (2015) ncbi
兔 单克隆(8G10)
  • 免疫印迹; 人类; 图5
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Tech, 9665)被用于免疫印迹在人类样品上 (图5). Oncogenesis (2015) ncbi
兔 单克隆(D3E9)
  • 免疫组化-P; 人类; 1:100; 图1
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9579)被用于免疫组化-石蜡切片在人类样品上浓度为1:100 (图1). Nat Med (2015) ncbi
兔 多克隆
  • 免疫印迹; 人类; 1:1000
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technologies, 9661)被用于免疫印迹在人类样品上浓度为1:1000. Oncoscience (2015) ncbi
兔 单克隆(8G10)
  • 免疫印迹; 大鼠; 图2
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9665)被用于免疫印迹在大鼠样品上 (图2). Am J Physiol Heart Circ Physiol (2015) ncbi
兔 多克隆
  • 免疫印迹; 小鼠; 图1c
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signalling, 9661)被用于免疫印迹在小鼠样品上 (图1c). Oncotarget (2015) ncbi
兔 单克隆(5A1E)
  • 免疫印迹; 人类; 图2e
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9664)被用于免疫印迹在人类样品上 (图2e). Oncotarget (2015) ncbi
兔 多克隆
  • 免疫印迹; 人类; 1:1000; 图2
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫印迹在人类样品上浓度为1:1000 (图2). PLoS ONE (2015) ncbi
兔 多克隆
  • 免疫印迹; 人类; 图4
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫印迹在人类样品上 (图4). Cell Death Dis (2015) ncbi
兔 多克隆
  • 免疫印迹; 人类; 1:500; 图1
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9661)被用于免疫印迹在人类样品上浓度为1:500 (图1). PLoS ONE (2015) ncbi
兔 多克隆
  • 免疫印迹; 人类; 图4
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫印迹在人类样品上 (图4). Oncotarget (2015) ncbi
兔 多克隆
  • 免疫印迹; 人类; 1:1000; 图7
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫印迹在人类样品上浓度为1:1000 (图7). Oncotarget (2015) ncbi
兔 多克隆
  • 免疫印迹; 人类; 1:1000; 图4C
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell signaling, 9661)被用于免疫印迹在人类样品上浓度为1:1000 (图4C). Am J Pathol (2015) ncbi
兔 多克隆
  • 免疫印迹; 人类; 1:1000; 图4C
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell signaling, 9662)被用于免疫印迹在人类样品上浓度为1:1000 (图4C). Am J Pathol (2015) ncbi
兔 单克隆(8G10)
  • 免疫印迹; 人类; 图6d
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9665)被用于免疫印迹在人类样品上 (图6d). Oncotarget (2015) ncbi
兔 多克隆
  • 免疫印迹; 大鼠; 图2
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫印迹在大鼠样品上 (图2). Cell Death Differ (2016) ncbi
兔 单克隆(8G10)
  • 免疫印迹; 人类; 1:2000; 图7c
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9665)被用于免疫印迹在人类样品上浓度为1:2000 (图7c). Cell Death Dis (2015) ncbi
兔 多克隆
  • 免疫印迹; 人类; 图2f
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫印迹在人类样品上 (图2f). Cell Death Dis (2015) ncbi
兔 单克隆(5A1E)
  • 免疫印迹; 人类; 图6
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9664)被用于免疫印迹在人类样品上 (图6). PLoS ONE (2015) ncbi
兔 单克隆(8G10)
  • 免疫印迹; 人类; 图6
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9665)被用于免疫印迹在人类样品上 (图6). PLoS ONE (2015) ncbi
兔 多克隆
  • 免疫组化-P; 小鼠; 1:200; 图8
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫组化-石蜡切片在小鼠样品上浓度为1:200 (图8). Oncotarget (2015) ncbi
兔 单克隆(8G10)
  • 免疫印迹; 人类; 图s1
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 8G10)被用于免疫印迹在人类样品上 (图s1). Oncotarget (2015) ncbi
兔 单克隆(5A1E)
  • 免疫组化; 小鼠; 1:50; 图s2
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 5A1E)被用于免疫组化在小鼠样品上浓度为1:50 (图s2). Nat Commun (2015) ncbi
兔 单克隆(5A1E)
  • 免疫组化-P; 小鼠
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9664)被用于免疫组化-石蜡切片在小鼠样品上. Angiogenesis (2016) ncbi
兔 单克隆(D3E9)
  • 免疫组化-F; 小鼠; 1:50; 图5
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9579)被用于免疫组化-冰冻切片在小鼠样品上浓度为1:50 (图5). PLoS ONE (2015) ncbi
兔 多克隆
  • 细胞化学; 人类; 1:300
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9661)被用于免疫细胞化学在人类样品上浓度为1:300. Nature (2015) ncbi
兔 单克隆(8G10)
  • 免疫印迹; 人类
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, #9665)被用于免疫印迹在人类样品上. Biochem Pharmacol (2015) ncbi
兔 多克隆
  • 免疫组化; 人类; 图6
  • 免疫印迹; 人类; 图2
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9661)被用于免疫组化在人类样品上 (图6) 和 免疫印迹在人类样品上 (图2). Sci Rep (2015) ncbi
兔 多克隆
  • 免疫组化; 小鼠; 图s15
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫组化在小鼠样品上 (图s15). Diabetes (2016) ncbi
兔 多克隆
  • 免疫组化-P; 人类; 1:100; 图7
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9661)被用于免疫组化-石蜡切片在人类样品上浓度为1:100 (图7). Oncotarget (2015) ncbi
兔 多克隆
  • 免疫印迹; 人类; 1:1000; 图5h
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫印迹在人类样品上浓度为1:1000 (图5h). Nat Commun (2015) ncbi
兔 多克隆
  • 免疫印迹; 人类; 图s4f
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9662)被用于免疫印迹在人类样品上 (图s4f). Nature (2015) ncbi
兔 多克隆
  • 免疫印迹; 大鼠; 1:1000; 图7
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9662)被用于免疫印迹在大鼠样品上浓度为1:1000 (图7). Sci Rep (2015) ncbi
兔 单克隆(5A1E)
  • 免疫印迹; 大鼠; 1:1000; 图7
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9664)被用于免疫印迹在大鼠样品上浓度为1:1000 (图7). Sci Rep (2015) ncbi
兔 单克隆(5A1E)
  • 免疫印迹; 人类; 1:100
  • 细胞化学; 人类; 图2
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9664)被用于免疫印迹在人类样品上浓度为1:100 和 免疫细胞化学在人类样品上 (图2). Nature (2015) ncbi
兔 单克隆(8G10)
  • 免疫印迹; 小鼠; 图s4f
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell signaling, 9665)被用于免疫印迹在小鼠样品上 (图s4f). Kidney Int (2016) ncbi
兔 多克隆
  • 免疫组化; 小鼠; 图6
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9661)被用于免疫组化在小鼠样品上 (图6). Neural Dev (2015) ncbi
兔 多克隆
  • 免疫组化-P; 人类; 图8c
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661S)被用于免疫组化-石蜡切片在人类样品上 (图8c). Oncotarget (2015) ncbi
兔 多克隆
  • 免疫组化; 小鼠; 图8
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫组化在小鼠样品上 (图8). Autophagy (2015) ncbi
兔 多克隆
  • 免疫印迹; 人类; 1:1000; 图4c
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technologies, 9661)被用于免疫印迹在人类样品上浓度为1:1000 (图4c). Oncogene (2016) ncbi
兔 多克隆
  • 免疫组化; 小鼠; 1:500
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9661)被用于免疫组化在小鼠样品上浓度为1:500. Mol Brain (2015) ncbi
兔 多克隆
  • 免疫印迹; 小鼠; 1:2500; 图6d
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9662)被用于免疫印迹在小鼠样品上浓度为1:2500 (图6d). FEBS Open Bio (2015) ncbi
兔 多克隆
  • 免疫组化-P; 小鼠; 1:200; 图3
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫组化-石蜡切片在小鼠样品上浓度为1:200 (图3). PLoS ONE (2015) ncbi
兔 单克隆(5A1E)
  • 免疫组化-P; 小鼠; 1:100; 图4
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9664)被用于免疫组化-石蜡切片在小鼠样品上浓度为1:100 (图4). Mol Cancer (2015) ncbi
兔 单克隆(5A1E)
  • 免疫印迹; 人类
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9664)被用于免疫印迹在人类样品上. PLoS ONE (2015) ncbi
兔 多克隆
  • 免疫组化; 小鼠; 1:600; 表2
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫组化在小鼠样品上浓度为1:600 (表2). PLoS ONE (2015) ncbi
兔 多克隆
  • 免疫印迹; 小鼠; 图s4c
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell signaling, 9662)被用于免疫印迹在小鼠样品上 (图s4c). Nature (2015) ncbi
兔 单克隆(8G10)
  • 免疫印迹; 人类; 图1b
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9665)被用于免疫印迹在人类样品上 (图1b). Microbes Infect (2016) ncbi
兔 单克隆(5A1E)
  • 免疫组化-P; 大鼠; 1:400; 图6
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signalling, 9664)被用于免疫组化-石蜡切片在大鼠样品上浓度为1:400 (图6). Toxicol Mech Methods (2015) ncbi
兔 多克隆
  • 免疫组化-P; 小鼠; 1:500; 图2b
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell signaling, 9661)被用于免疫组化-石蜡切片在小鼠样品上浓度为1:500 (图2b). PLoS ONE (2015) ncbi
兔 单克隆(8G10)
  • 免疫印迹; 人类; 图4
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 8G10)被用于免疫印迹在人类样品上 (图4). Oncotarget (2015) ncbi
兔 单克隆(5A1E)
  • 免疫印迹; 大鼠; 图3c
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 5A1E)被用于免疫印迹在大鼠样品上 (图3c). Sci Rep (2015) ncbi
兔 多克隆
  • 免疫印迹; 大鼠; 图4a
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9662)被用于免疫印迹在大鼠样品上 (图4a). Cell Mol Neurobiol (2016) ncbi
兔 多克隆
  • 免疫印迹; 牛; 1:1000
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫印迹在牛样品上浓度为1:1000. Endocrinology (2015) ncbi
兔 多克隆
  • 免疫组化-F; 小鼠; 1:500
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫组化-冰冻切片在小鼠样品上浓度为1:500. Glia (2016) ncbi
兔 单克隆(5A1E)
  • 免疫印迹; 人类; 图4
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9664)被用于免疫印迹在人类样品上 (图4). Oncotarget (2015) ncbi
兔 单克隆(5A1E)
  • 免疫印迹; 人类; 图6
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9664)被用于免疫印迹在人类样品上 (图6). PLoS ONE (2015) ncbi
兔 多克隆
  • 免疫印迹; 人类; 图3
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell signaling, 9661)被用于免疫印迹在人类样品上 (图3). J Cell Biol (2015) ncbi
兔 多克隆
  • 免疫印迹; 小鼠
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, #9661)被用于免疫印迹在小鼠样品上. PLoS ONE (2015) ncbi
兔 多克隆
  • 免疫印迹; 人类; 图2e
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell signaling, 9661)被用于免疫印迹在人类样品上 (图2e). Oncotarget (2015) ncbi
兔 单克隆(5A1E)
  • 细胞化学; 人类; 图7a
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 5A1E)被用于免疫细胞化学在人类样品上 (图7a). Photochem Photobiol (2015) ncbi
兔 多克隆
  • 免疫印迹; 大鼠; 1:1000; 图3
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫印迹在大鼠样品上浓度为1:1000 (图3). Front Cell Neurosci (2015) ncbi
兔 多克隆
  • 免疫组化-P; 小鼠; 1:250; 图s2
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫组化-石蜡切片在小鼠样品上浓度为1:250 (图s2). Stem Cell Reports (2015) ncbi
兔 多克隆
  • 免疫印迹; 小鼠; 1:1000; 图1
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9662)被用于免疫印迹在小鼠样品上浓度为1:1000 (图1). Stem Cell Reports (2015) ncbi
兔 多克隆
  • 免疫印迹; 小鼠
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(cell signaling, #9662)被用于免疫印迹在小鼠样品上. Biochem Pharmacol (2015) ncbi
兔 多克隆
  • 免疫组化; 小鼠; 1:300
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, #9661)被用于免疫组化在小鼠样品上浓度为1:300. Eur J Neurosci (2015) ncbi
兔 单克隆(8G10)
  • 免疫印迹; 人类; 1:1000; 图s7
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9665)被用于免疫印迹在人类样品上浓度为1:1000 (图s7). Nat Chem (2015) ncbi
兔 多克隆
  • 免疫印迹; 人类
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫印迹在人类样品上. PLoS ONE (2015) ncbi
兔 多克隆
  • 免疫印迹; 人类; 图2
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(CellSignalling, 9661)被用于免疫印迹在人类样品上 (图2). EBioMedicine (2015) ncbi
兔 多克隆
  • 细胞化学; 人类; 1:100; 图2
  • 免疫印迹; 人类; 图s4
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫细胞化学在人类样品上浓度为1:100 (图2) 和 免疫印迹在人类样品上 (图s4). PLoS ONE (2015) ncbi
兔 多克隆
  • 其他; 小鼠; 1:1000; 图s1
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于其他在小鼠样品上浓度为1:1000 (图s1). Front Microbiol (2015) ncbi
兔 单克隆(5A1E)
  • 免疫组化-F; 小鼠; 1:100; 图s7a
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 5A1E)被用于免疫组化-冰冻切片在小鼠样品上浓度为1:100 (图s7a). J Clin Invest (2015) ncbi
兔 多克隆
  • 免疫印迹; 人类
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9661)被用于免疫印迹在人类样品上. Oncogene (2016) ncbi
兔 多克隆
  • 免疫印迹; 人类; 图1k
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9661)被用于免疫印迹在人类样品上 (图1k). Oncogene (2016) ncbi
兔 多克隆
  • 免疫组化-P; 小鼠; 1:200; 图1
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫组化-石蜡切片在小鼠样品上浓度为1:200 (图1). Oncotarget (2015) ncbi
兔 多克隆
  • 免疫组化; 小鼠
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫组化在小鼠样品上. Cardiovasc Res (2015) ncbi
兔 单克隆(8G10)
  • 免疫印迹; 人类; 1:800; 图5d
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling TECHNOLOGY, 9665)被用于免疫印迹在人类样品上浓度为1:800 (图5d). Nat Commun (2015) ncbi
兔 多克隆
  • 免疫印迹; 人类; 图10
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9662)被用于免疫印迹在人类样品上 (图10). BMC Cancer (2015) ncbi
兔 单克隆(5A1E)
  • 免疫组化-P; 小鼠; 1:50
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9664)被用于免疫组化-石蜡切片在小鼠样品上浓度为1:50. J Mol Histol (2015) ncbi
兔 多克隆
  • 免疫印迹; 小鼠; 1:500; 图1
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell signaling, 9661)被用于免疫印迹在小鼠样品上浓度为1:500 (图1). Nat Commun (2015) ncbi
兔 单克隆(5A1E)
  • FC; 人类; 1:250; 图4
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9664)被用于流式细胞仪在人类样品上浓度为1:250 (图4). Stem Cell Reports (2015) ncbi
兔 单克隆(5A1E)
  • 免疫组化; 人类; 1:100; 图5
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell signaling, 9664)被用于免疫组化在人类样品上浓度为1:100 (图5). Nat Commun (2015) ncbi
兔 单克隆(5A1E)
  • 免疫组化-P; 大鼠; 图2
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signalling Technology, 9664P)被用于免疫组化-石蜡切片在大鼠样品上 (图2). PLoS ONE (2015) ncbi
兔 单克隆(5A1E)
  • 免疫印迹; 大鼠; 图6
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9664)被用于免疫印迹在大鼠样品上 (图6). PLoS ONE (2015) ncbi
兔 单克隆(8G10)
  • 免疫印迹; 人类; 1:500; 图4b
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 8G10)被用于免疫印迹在人类样品上浓度为1:500 (图4b). PLoS ONE (2015) ncbi
兔 单克隆(5A1E)
  • 免疫印迹; 人类; 1:500; 图4b
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 5A1E)被用于免疫印迹在人类样品上浓度为1:500 (图4b). PLoS ONE (2015) ncbi
兔 单克隆(D3E9)
  • 免疫印迹; 小鼠; 图s3
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9579S)被用于免疫印迹在小鼠样品上 (图s3). Mol Biol Cell (2015) ncbi
兔 单克隆(5A1E)
  • 免疫印迹; 小鼠; 1:1000; 图1
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9664)被用于免疫印迹在小鼠样品上浓度为1:1000 (图1). Nat Commun (2015) ncbi
兔 多克隆
  • 免疫印迹; 人类; 图3
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Tech, 9662)被用于免疫印迹在人类样品上 (图3). Sci Rep (2015) ncbi
兔 单克隆(D3E9)
  • 免疫印迹; 人类
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9579)被用于免疫印迹在人类样品上. Sci Rep (2015) ncbi
兔 多克隆
  • 免疫印迹; 人类; 图3a
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(细胞SIgnaling, 9661)被用于免疫印迹在人类样品上 (图3a). Oncogenesis (2015) ncbi
兔 单克隆(5A1E)
  • 免疫组化; 小鼠; 1:400; 图s3
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell signaling, 9664)被用于免疫组化在小鼠样品上浓度为1:400 (图s3). Cell Rep (2015) ncbi
兔 多克隆
  • 免疫组化; 小鼠; 图6
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9661)被用于免疫组化在小鼠样品上 (图6). Mol Neurobiol (2016) ncbi
兔 多克隆
  • 细胞化学; 人类
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling technologies, 9661)被用于免疫细胞化学在人类样品上. PLoS ONE (2015) ncbi
兔 多克隆
  • 免疫组化-P; 小鼠; 1:200; 图1e
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫组化-石蜡切片在小鼠样品上浓度为1:200 (图1e). Nat Commun (2015) ncbi
兔 多克隆
  • 免疫印迹; 人类; 图2
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫印迹在人类样品上 (图2). Acta Pharmacol Sin (2015) ncbi
兔 多克隆
  • 免疫印迹; 大鼠; 1:1000; 图8a
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661S)被用于免疫印迹在大鼠样品上浓度为1:1000 (图8a). BMC Complement Altern Med (2015) ncbi
兔 单克隆(5A1E)
  • 免疫组化-P; 人类; 1:200
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9664)被用于免疫组化-石蜡切片在人类样品上浓度为1:200. Dig Dis Sci (2015) ncbi
兔 多克隆
  • 细胞化学; 人类; 1:60
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell signaling, 9661)被用于免疫细胞化学在人类样品上浓度为1:60. PLoS ONE (2015) ncbi
兔 多克隆
  • 免疫组化-P; 小鼠; 1:200; 图7
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9661)被用于免疫组化-石蜡切片在小鼠样品上浓度为1:200 (图7). Cell Death Dis (2015) ncbi
兔 多克隆
  • 免疫组化-P; 小鼠; 1:200
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫组化-石蜡切片在小鼠样品上浓度为1:200. Br J Cancer (2015) ncbi
兔 多克隆
  • 免疫组化; 小鼠; 1:5000
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology Technology, 9661S)被用于免疫组化在小鼠样品上浓度为1:5000. J Neurosci (2015) ncbi
兔 单克隆(5A1E)
  • 免疫印迹; 人类; 图6
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9664S)被用于免疫印迹在人类样品上 (图6). PLoS ONE (2015) ncbi
兔 单克隆(5A1E)
  • 免疫印迹; 人类; 1:5000
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technologies, 9664)被用于免疫印迹在人类样品上浓度为1:5000. Am J Cancer Res (2015) ncbi
兔 单克隆(5A1E)
  • 细胞化学; 小鼠; 图6d
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 5A1E)被用于免疫细胞化学在小鼠样品上 (图6d). J Physiol (2015) ncbi
兔 多克隆
  • 细胞化学; 人类; 1:1600; 图st1
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signalling, 9661)被用于免疫细胞化学在人类样品上浓度为1:1600 (图st1). Sci Rep (2015) ncbi
兔 单克隆(8G10)
  • 免疫印迹; 人类
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9665)被用于免疫印迹在人类样品上. Oncotarget (2015) ncbi
兔 单克隆(8G10)
  • 免疫印迹; 人类; 图2
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Tech, 9665)被用于免疫印迹在人类样品上 (图2). Oncotarget (2015) ncbi
兔 多克隆
  • 细胞化学; 大鼠; 1:400
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫细胞化学在大鼠样品上浓度为1:400. Biochim Biophys Acta (2015) ncbi
兔 多克隆
  • 免疫组化-F; 小鼠; 1:100; 图ed6k
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫组化-冰冻切片在小鼠样品上浓度为1:100 (图ed6k). Nature (2015) ncbi
兔 多克隆
  • 免疫组化; 小鼠; 1:200; 图ev2
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Tech, 9661)被用于免疫组化在小鼠样品上浓度为1:200 (图ev2). EMBO Mol Med (2015) ncbi
兔 多克隆
  • IHC-Free; 小鼠; 1:250; 图3
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell signaling, 9661S)被用于immunohistochemistry - free floating section在小鼠样品上浓度为1:250 (图3). Development (2015) ncbi
兔 多克隆
  • 免疫组化-P; 人类; 1:250; 图1g
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫组化-石蜡切片在人类样品上浓度为1:250 (图1g). Heart Vessels (2016) ncbi
兔 单克隆(5A1E)
  • 细胞化学; 人类; 图2
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell signaling, 9664)被用于免疫细胞化学在人类样品上 (图2). Oncotarget (2015) ncbi
兔 多克隆
  • 免疫组化 (基因敲除); 小鼠
  • 免疫印迹 (基因敲除); 小鼠; 1:3000
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Tech, 9662)被用于免疫组化 (基因敲除)在小鼠样品上 和 免疫印迹 (基因敲除)在小鼠样品上浓度为1:3000. PLoS ONE (2015) ncbi
兔 单克隆(5A1E)
  • 免疫印迹; 人类; 图2
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell signaling, 9664)被用于免疫印迹在人类样品上 (图2). Oncogene (2016) ncbi
兔 多克隆
  • 免疫印迹; 人类; 图2
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell signaling, 9662)被用于免疫印迹在人类样品上 (图2). Oncogene (2016) ncbi
兔 单克隆(8G10)
  • 免疫印迹; 人类; 图6
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9665S)被用于免疫印迹在人类样品上 (图6). Nucleic Acids Res (2015) ncbi
兔 多克隆
  • 免疫印迹; 人类; 1:1000; 图5d
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9661)被用于免疫印迹在人类样品上浓度为1:1000 (图5d). Bioorg Med Chem (2015) ncbi
兔 单克隆(5A1E)
  • 免疫组化-P; 小鼠; 1:500
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell signaling, 9664)被用于免疫组化-石蜡切片在小鼠样品上浓度为1:500. Dev Biol (2016) ncbi
兔 多克隆
  • 免疫组化-F; 小鼠; 1:600
  • 细胞化学; 小鼠; 1:600
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫组化-冰冻切片在小鼠样品上浓度为1:600 和 免疫细胞化学在小鼠样品上浓度为1:600. Hum Gene Ther Methods (2015) ncbi
兔 单克隆(8G10)
  • 免疫印迹; 小鼠
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 8G10)被用于免疫印迹在小鼠样品上. Nat Immunol (2015) ncbi
兔 多克隆
  • 细胞化学; 人类; 图3
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell signaling, 9661)被用于免疫细胞化学在人类样品上 (图3). Oncogene (2016) ncbi
兔 多克隆
  • 免疫组化-P; 小鼠; 1:50; 图3
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9662)被用于免疫组化-石蜡切片在小鼠样品上浓度为1:50 (图3). Oncogene (2015) ncbi
兔 多克隆
  • 免疫印迹; 小鼠; 图2
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9661)被用于免疫印迹在小鼠样品上 (图2). Oncogene (2016) ncbi
兔 多克隆
  • 免疫组化; 小鼠; 1:500; 图6d
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell signaling, 9661)被用于免疫组化在小鼠样品上浓度为1:500 (图6d). Sci Rep (2015) ncbi
兔 多克隆
  • 免疫印迹; 人类; 图3c
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9662)被用于免疫印迹在人类样品上 (图3c). Oncotarget (2015) ncbi
兔 单克隆(8G10)
  • 免疫印迹; 人类; 图4K
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9665)被用于免疫印迹在人类样品上 (图4K). Autophagy (2015) ncbi
兔 多克隆
  • 免疫印迹; 人类; 图3
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9662)被用于免疫印迹在人类样品上 (图3). EBioMedicine (2015) ncbi
兔 多克隆
  • 免疫印迹; 大鼠; 1:1000
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell signaling technology, 9661)被用于免疫印迹在大鼠样品上浓度为1:1000. Arch Toxicol (2016) ncbi
兔 单克隆(5A1E)
  • 细胞化学; 小鼠
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9664)被用于免疫细胞化学在小鼠样品上. PLoS ONE (2015) ncbi
兔 多克隆
  • 免疫印迹; 人类; 图7
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signalling technology, 9661)被用于免疫印迹在人类样品上 (图7). PLoS ONE (2015) ncbi
兔 多克隆
  • 免疫组化-P; 小鼠; 1:400; 图7
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Tech, 9661)被用于免疫组化-石蜡切片在小鼠样品上浓度为1:400 (图7). Oxid Med Cell Longev (2015) ncbi
兔 多克隆
  • 免疫组化; medaka; 1:200; 图s1
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9661S)被用于免疫组化在medaka样品上浓度为1:200 (图s1). PLoS ONE (2015) ncbi
兔 多克隆
  • 免疫印迹; 人类; 图2a
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫印迹在人类样品上 (图2a). Oncotarget (2015) ncbi
兔 单克隆(5A1E)
  • 免疫组化-P; 人类
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9664)被用于免疫组化-石蜡切片在人类样品上. Biomaterials (2015) ncbi
兔 单克隆(5A1E)
  • 免疫组化-P; 小鼠; 1:400; 图5c
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9664)被用于免疫组化-石蜡切片在小鼠样品上浓度为1:400 (图5c). Cell Death Differ (2016) ncbi
兔 多克隆
  • 免疫组化-P; 小鼠; 图7a
  • 免疫印迹; 小鼠; 图s2f
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫组化-石蜡切片在小鼠样品上 (图7a) 和 免疫印迹在小鼠样品上 (图s2f). Cell Death Differ (2015) ncbi
兔 多克隆
  • 免疫印迹; 小鼠
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9662)被用于免疫印迹在小鼠样品上. J Biol Chem (2015) ncbi
兔 多克隆
  • 免疫印迹; 人类; 图4i
  • 免疫组化; 人类; 图5b
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(CST, 9661)被用于免疫印迹在人类样品上 (图4i) 和 免疫组化在人类样品上 (图5b). Mol Cancer (2015) ncbi
兔 多克隆
  • 免疫印迹; 人类; 图1
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell signaling, 9662)被用于免疫印迹在人类样品上 (图1). Oncotarget (2015) ncbi
兔 多克隆
  • 免疫印迹; 人类; 1:160; 图4b
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9661)被用于免疫印迹在人类样品上浓度为1:160 (图4b). Oncotarget (2015) ncbi
兔 多克隆
  • 免疫印迹; 大鼠; 图2
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell signaling, 9662s)被用于免疫印迹在大鼠样品上 (图2). Int J Mol Med (2015) ncbi
兔 多克隆
  • 免疫组化; 小鼠; 图3
  • 免疫印迹; 小鼠; 图2
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9662)被用于免疫组化在小鼠样品上 (图3) 和 免疫印迹在小鼠样品上 (图2). PLoS ONE (2015) ncbi
兔 多克隆
  • 免疫印迹; 小鼠; 图2
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫印迹在小鼠样品上 (图2). PLoS ONE (2015) ncbi
兔 多克隆
  • 免疫印迹; 人类
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9662)被用于免疫印迹在人类样品上. PLoS ONE (2015) ncbi
兔 单克隆(5A1E)
  • 免疫印迹; 人类; 1:800; 图 4
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9664)被用于免疫印迹在人类样品上浓度为1:800 (图 4). Reproduction (2015) ncbi
兔 多克隆
  • 免疫组化; 人类; 图6a
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫组化在人类样品上 (图6a). Oncotarget (2015) ncbi
兔 单克隆(5A1E)
  • 免疫印迹; 小鼠; 1:200; 图8
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9664)被用于免疫印迹在小鼠样品上浓度为1:200 (图8). PLoS ONE (2015) ncbi
兔 多克隆
  • 免疫组化-P; 小鼠; 1:500; 图2
  • 免疫印迹; 小鼠; 图e4
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫组化-石蜡切片在小鼠样品上浓度为1:500 (图2) 和 免疫印迹在小鼠样品上 (图e4). Nature (2015) ncbi
兔 单克隆(5A1E)
  • 免疫组化-P; 小鼠; 1:300; 图7
  • 免疫印迹; 小鼠; 图s10
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell signaling, 9664S)被用于免疫组化-石蜡切片在小鼠样品上浓度为1:300 (图7) 和 免疫印迹在小鼠样品上 (图s10). Nat Neurosci (2015) ncbi
兔 多克隆
  • 免疫印迹; 小鼠; 1:1000
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, #9662)被用于免疫印迹在小鼠样品上浓度为1:1000. Neuroscience (2015) ncbi
兔 单克隆(5A1E)
  • 免疫印迹; 小鼠; 1:1000; 图4e
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9664S)被用于免疫印迹在小鼠样品上浓度为1:1000 (图4e). PLoS ONE (2015) ncbi
兔 单克隆(5A1E)
  • 免疫印迹; 人类; 1:1000; 图5
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9664)被用于免疫印迹在人类样品上浓度为1:1000 (图5). Mol Med Rep (2015) ncbi
兔 单克隆(8G10)
  • 免疫印迹; 人类
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9665)被用于免疫印迹在人类样品上. Oncol Rep (2015) ncbi
兔 多克隆
  • 免疫印迹; 人类
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9661)被用于免疫印迹在人类样品上. Oncol Rep (2015) ncbi
兔 多克隆
  • 免疫组化-P; 小鼠; 图3
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell signaling, 9661)被用于免疫组化-石蜡切片在小鼠样品上 (图3). Sci Rep (2015) ncbi
兔 多克隆
  • 免疫组化; 小鼠; 1:1200
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signalling, #9661)被用于免疫组化在小鼠样品上浓度为1:1200. PLoS ONE (2015) ncbi
兔 多克隆
  • 免疫组化; 小鼠; 1:100; 图s8
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell signaling, 9661)被用于免疫组化在小鼠样品上浓度为1:100 (图s8). Nature (2015) ncbi
兔 单克隆(5A1E)
  • 免疫组化; 小鼠; 1:100; 图s8
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell signaling, 9664)被用于免疫组化在小鼠样品上浓度为1:100 (图s8). Nature (2015) ncbi
兔 多克隆
  • 免疫组化; 小鼠; 图2
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫组化在小鼠样品上 (图2). Proc Natl Acad Sci U S A (2015) ncbi
兔 单克隆(5A1E)
  • 细胞化学; 人类; 图1
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9664)被用于免疫细胞化学在人类样品上 (图1). Oncotarget (2015) ncbi
兔 多克隆
  • 免疫印迹; 小鼠
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫印迹在小鼠样品上. Brain (2015) ncbi
兔 单克隆(5A1E)赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9664S)被用于. J Comp Neurol (2016) ncbi
兔 多克隆
  • 免疫印迹; 人类
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫印迹在人类样品上. Cell Mol Life Sci (2015) ncbi
兔 多克隆
  • 免疫印迹; 小鼠; 1:1000; 图 3
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9662)被用于免疫印迹在小鼠样品上浓度为1:1000 (图 3). Neurobiol Aging (2015) ncbi
兔 单克隆(5A1E)
  • 免疫印迹; 大鼠; 图8
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell signaling, 9664)被用于免疫印迹在大鼠样品上 (图8). PLoS ONE (2015) ncbi
兔 多克隆
  • 免疫印迹; 人类
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9661)被用于免疫印迹在人类样品上. Oncogene (2016) ncbi
兔 多克隆
  • 免疫印迹; 小鼠
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 96625)被用于免疫印迹在小鼠样品上. Mol Oncol (2015) ncbi
兔 多克隆
  • 免疫组化-P; 人类; 1:2000
  • 免疫组化-P; 小鼠; 1:2000
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9662)被用于免疫组化-石蜡切片在人类样品上浓度为1:2000 和 在小鼠样品上浓度为1:2000. Placenta (2015) ncbi
兔 单克隆(5A1E)
  • 免疫组化-P; 人类; 1:800
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9664)被用于免疫组化-石蜡切片在人类样品上浓度为1:800. Placenta (2015) ncbi
兔 单克隆(5A1E)
  • 免疫组化-P; 小鼠; 图4a
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9664)被用于免疫组化-石蜡切片在小鼠样品上 (图4a). Cell Death Dis (2015) ncbi
兔 多克隆
  • 免疫印迹; 人类; 图3
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9662)被用于免疫印迹在人类样品上 (图3). Cell Death Dis (2015) ncbi
兔 多克隆
  • 免疫印迹; 人类; 1:1000; 图3
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9662S)被用于免疫印迹在人类样品上浓度为1:1000 (图3). Cell Death Dis (2015) ncbi
兔 单克隆(5A1E)
  • 免疫印迹; 人类; 1:1000; 图3
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9664S)被用于免疫印迹在人类样品上浓度为1:1000 (图3). Cell Death Dis (2015) ncbi
兔 多克隆
  • 免疫印迹; 小鼠; 1:1000; 图2d
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9662)被用于免疫印迹在小鼠样品上浓度为1:1000 (图2d). Oxid Med Cell Longev (2015) ncbi
兔 多克隆
  • 免疫印迹; 小鼠; 1:1000; 图2d
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9661)被用于免疫印迹在小鼠样品上浓度为1:1000 (图2d). Oxid Med Cell Longev (2015) ncbi
兔 多克隆
  • 免疫印迹; 大鼠; 图1c
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9662)被用于免疫印迹在大鼠样品上 (图1c). Mol Neurobiol (2016) ncbi
兔 单克隆(5A1E)
  • 免疫印迹; 人类
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9664)被用于免疫印迹在人类样品上. Mol Cancer Ther (2015) ncbi
兔 单克隆(5A1E)
  • 免疫印迹 (基因敲减); 人类; 图4e
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9664S)被用于免疫印迹 (基因敲减)在人类样品上 (图4e). Sci Rep (2015) ncbi
兔 多克隆
  • 细胞化学; 人类
  • 免疫印迹; 大鼠
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9662)被用于免疫细胞化学在人类样品上 和 免疫印迹在大鼠样品上. Toxicol Lett (2015) ncbi
兔 多克隆
  • 免疫印迹; 人类; 图s2
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫印迹在人类样品上 (图s2). PLoS ONE (2015) ncbi
兔 单克隆(8G10)
  • 免疫印迹; 人类
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technologies, 9665)被用于免疫印迹在人类样品上. Mol Cancer Res (2015) ncbi
兔 多克隆
  • 免疫印迹; 人类
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫印迹在人类样品上. Cell Commun Signal (2015) ncbi
兔 多克隆
  • 免疫印迹; 人类; 图5
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9662S)被用于免疫印迹在人类样品上 (图5). BMC Cancer (2015) ncbi
兔 多克隆
  • 免疫组化-P; 人类; 1:300; 图6
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫组化-石蜡切片在人类样品上浓度为1:300 (图6). Oncotarget (2015) ncbi
兔 多克隆
  • 免疫组化; 果蝇; 图6
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫组化在果蝇样品上 (图6). PLoS Pathog (2015) ncbi
兔 多克隆
  • 免疫组化; 小鼠; 1:200; 图7
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Tech, 9661)被用于免疫组化在小鼠样品上浓度为1:200 (图7). PLoS ONE (2015) ncbi
兔 单克隆(5A1E)
  • 免疫组化-P; 小鼠; 图6
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell signaling, 9664)被用于免疫组化-石蜡切片在小鼠样品上 (图6). Oncotarget (2015) ncbi
兔 多克隆
  • 免疫印迹; 小鼠
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9661)被用于免疫印迹在小鼠样品上. Cell Death Dis (2015) ncbi
兔 多克隆
  • 免疫印迹; 人类
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫印迹在人类样品上. Mol Cell Pharmacol (2014) ncbi
兔 多克隆
  • 免疫印迹; 人类
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9662)被用于免疫印迹在人类样品上. Mol Cell Pharmacol (2014) ncbi
兔 多克隆
  • 免疫印迹; 小鼠; 1:1000
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9662)被用于免疫印迹在小鼠样品上浓度为1:1000. Biochim Biophys Acta (2015) ncbi
兔 多克隆
  • 免疫组化-P; 人类; 图4
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(CST, 9661)被用于免疫组化-石蜡切片在人类样品上 (图4). Oncotarget (2015) ncbi
兔 多克隆
  • 免疫印迹; 人类; 图6a
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9662)被用于免疫印迹在人类样品上 (图6a). Mol Cancer (2015) ncbi
兔 单克隆(5A1E)
  • 免疫组化; 小鼠; 1:200
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9664)被用于免疫组化在小鼠样品上浓度为1:200. Mol Brain (2015) ncbi
兔 单克隆(5A1E)
  • 免疫印迹; 小鼠; 图5
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9664)被用于免疫印迹在小鼠样品上 (图5). Gastroenterology (2015) ncbi
兔 多克隆
  • 免疫印迹; 小鼠; 图5
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9662)被用于免疫印迹在小鼠样品上 (图5). Gastroenterology (2015) ncbi
兔 多克隆
  • 免疫组化-P; 小鼠; 0.2 ug/ml
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫组化-石蜡切片在小鼠样品上浓度为0.2 ug/ml. Endocrinology (2015) ncbi
兔 单克隆(5A1E)
  • 免疫组化-P; 小鼠; 1:200; 图s1
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9664)被用于免疫组化-石蜡切片在小鼠样品上浓度为1:200 (图s1). Nat Commun (2015) ncbi
兔 多克隆
  • 免疫印迹; 人类; 图f4
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(cell signaling technology, 9661s)被用于免疫印迹在人类样品上 (图f4). Oncotarget (2015) ncbi
兔 多克隆
  • 免疫印迹; 人类
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9661)被用于免疫印迹在人类样品上. J Biol Chem (2015) ncbi
兔 多克隆
  • 细胞化学; 小鼠; 1:200; 图7
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell signaling, 9661)被用于免疫细胞化学在小鼠样品上浓度为1:200 (图7). PLoS ONE (2015) ncbi
兔 单克隆(5A1E)
  • 免疫组化; 小鼠; 1:2000; 图7
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell signaling, 9664)被用于免疫组化在小鼠样品上浓度为1:2000 (图7). J Pathol (2015) ncbi
兔 单克隆(5A1E)
  • 细胞化学; 人类; 1:400; 图4
  • 免疫印迹; 人类; 1:1000; 图1
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9664)被用于免疫细胞化学在人类样品上浓度为1:400 (图4) 和 免疫印迹在人类样品上浓度为1:1000 (图1). EMBO Mol Med (2015) ncbi
兔 多克隆
  • 免疫组化; 大鼠; 1:500
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫组化在大鼠样品上浓度为1:500. Front Cell Neurosci (2015) ncbi
兔 单克隆(8G10)
  • 免疫印迹; 人类
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technologies, 9665)被用于免疫印迹在人类样品上. Lab Invest (2015) ncbi
兔 多克隆
  • 免疫印迹; platanna; 图4
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫印迹在platanna样品上 (图4). PLoS ONE (2015) ncbi
兔 多克隆
  • 免疫印迹; 人类; 图s5
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661L)被用于免疫印迹在人类样品上 (图s5). EMBO Mol Med (2015) ncbi
兔 单克隆(5A1E)
  • 免疫印迹; 人类; 图8c
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9664)被用于免疫印迹在人类样品上 (图8c). J Biol Chem (2015) ncbi
兔 多克隆
  • 免疫组化-P; 人类
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫组化-石蜡切片在人类样品上. Basic Res Cardiol (2015) ncbi
兔 多克隆
  • 免疫组化-P; 小鼠
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫组化-石蜡切片在小鼠样品上. Glia (2015) ncbi
兔 多克隆
  • 细胞化学; 小鼠; 1:200
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9661)被用于免疫细胞化学在小鼠样品上浓度为1:200. Ups J Med Sci (2015) ncbi
兔 多克隆
  • 免疫印迹; 人类; 1:1000; 图2a
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling TECHNOLOGY, 9662)被用于免疫印迹在人类样品上浓度为1:1000 (图2a). Sci Signal (2015) ncbi
兔 多克隆
  • 免疫印迹; 小鼠; 图3a
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9661)被用于免疫印迹在小鼠样品上 (图3a). Free Radic Biol Med (2015) ncbi
兔 多克隆
  • 免疫印迹; 小鼠
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9661)被用于免疫印迹在小鼠样品上. Basic Res Cardiol (2015) ncbi
兔 多克隆
  • 免疫印迹; 人类; 图5c
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9662s)被用于免疫印迹在人类样品上 (图5c). Oncotarget (2015) ncbi
兔 单克隆(8G10)
  • 免疫印迹; 人类; 图s5
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9665)被用于免疫印迹在人类样品上 (图s5). Cell Cycle (2015) ncbi
兔 多克隆
  • 免疫印迹; 人类; 图3
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9662)被用于免疫印迹在人类样品上 (图3). Breast Cancer Res (2015) ncbi
兔 多克隆
  • 免疫印迹; 人类; 图3
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫印迹在人类样品上 (图3). Breast Cancer Res (2015) ncbi
兔 单克隆(5A1E)
  • 免疫组化; 小鼠; 1:1000
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9664)被用于免疫组化在小鼠样品上浓度为1:1000. J Neurosci (2015) ncbi
兔 多克隆
  • 免疫组化; 小鼠; 图4c
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫组化在小鼠样品上 (图4c). Proc Natl Acad Sci U S A (2015) ncbi
兔 单克隆(8G10)
  • 免疫印迹; 大鼠; 1:1000
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9665S)被用于免疫印迹在大鼠样品上浓度为1:1000. Mol Med (2014) ncbi
兔 多克隆
  • 免疫组化; 小鼠; 0.2 ug/ml; 图s2
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9661)被用于免疫组化在小鼠样品上浓度为0.2 ug/ml (图s2). Oncotarget (2015) ncbi
兔 多克隆
  • 细胞化学; 小鼠
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9661)被用于免疫细胞化学在小鼠样品上. PLoS ONE (2015) ncbi
兔 单克隆(5A1E)
  • 免疫组化-F; 小鼠; 图3a
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9664)被用于免疫组化-冰冻切片在小鼠样品上 (图3a). PLoS ONE (2015) ncbi
兔 单克隆(5A1E)
  • 免疫组化-P; 小鼠; 1:200; 图s9
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technologies, 9664)被用于免疫组化-石蜡切片在小鼠样品上浓度为1:200 (图s9). Cell Death Dis (2015) ncbi
兔 单克隆(8G10)
  • 免疫印迹; 大鼠; 1:1000; 图4
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9665)被用于免疫印迹在大鼠样品上浓度为1:1000 (图4). PLoS ONE (2015) ncbi
兔 多克隆
  • 免疫印迹; 人类; 1:1000
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, CS9661)被用于免疫印迹在人类样品上浓度为1:1000. PLoS ONE (2015) ncbi
兔 单克隆(5A1E)
  • 免疫印迹; 人类; 1:1000; 图2b
  • 免疫印迹; 小鼠; 1:1000; 图2c
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9664)被用于免疫印迹在人类样品上浓度为1:1000 (图2b) 和 在小鼠样品上浓度为1:1000 (图2c). Nat Commun (2015) ncbi
兔 单克隆(D3E9)
  • 免疫组化-P; 小鼠; 1:300; 图3a
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9579)被用于免疫组化-石蜡切片在小鼠样品上浓度为1:300 (图3a). Nat Commun (2015) ncbi
兔 多克隆
  • 免疫组化-P; 小鼠; 1:250; 图6
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(CST, 9661)被用于免疫组化-石蜡切片在小鼠样品上浓度为1:250 (图6). PLoS ONE (2015) ncbi
兔 多克隆
  • 免疫组化-P; 小鼠; 1:100
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell signaling, 9661)被用于免疫组化-石蜡切片在小鼠样品上浓度为1:100. Int J Cardiol (2015) ncbi
兔 多克隆
  • 免疫印迹; 小鼠; 1:1000
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell signaling, 9662)被用于免疫印迹在小鼠样品上浓度为1:1000. Int J Cardiol (2015) ncbi
兔 多克隆
  • 细胞化学; 小鼠; 1:250
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫细胞化学在小鼠样品上浓度为1:250. J Biol Chem (2015) ncbi
兔 多克隆
  • 免疫印迹; 小鼠
  • 细胞化学; 小鼠
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9661)被用于免疫印迹在小鼠样品上 和 免疫细胞化学在小鼠样品上. Exp Neurol (2015) ncbi
兔 多克隆
  • 免疫印迹; 人类; 1:500
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9662S)被用于免疫印迹在人类样品上浓度为1:500. PLoS ONE (2015) ncbi
兔 多克隆
  • 免疫印迹; 人类; 图8
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9661)被用于免疫印迹在人类样品上 (图8). J Biol Chem (2015) ncbi
兔 多克隆
  • 免疫组化-P; 果蝇; 1:150
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661L)被用于免疫组化-石蜡切片在果蝇样品上浓度为1:150. Development (2015) ncbi
兔 多克隆
  • 免疫组化-P; 小鼠; 1:300; 图3
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9662S)被用于免疫组化-石蜡切片在小鼠样品上浓度为1:300 (图3). Nat Commun (2015) ncbi
兔 单克隆(5A1E)
  • 免疫印迹; 人类
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9664)被用于免疫印迹在人类样品上. Mediators Inflamm (2015) ncbi
兔 多克隆
  • 免疫印迹; 小鼠
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9661)被用于免疫印迹在小鼠样品上. J Cell Biol (2015) ncbi
兔 单克隆(5A1E)
  • 免疫组化; 小鼠; 1:200; 图5b
  • 免疫印迹; 人类; 1:1000; 图3c
  • 免疫印迹; 小鼠; 1:1000; 图5c
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9664)被用于免疫组化在小鼠样品上浓度为1:200 (图5b) 和 免疫印迹在人类样品上浓度为1:1000 (图3c) 和 在小鼠样品上浓度为1:1000 (图5c). Mol Med Rep (2015) ncbi
兔 单克隆(5A1E)
  • 免疫印迹; 人类
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9664)被用于免疫印迹在人类样品上. Int J Oncol (2015) ncbi
兔 多克隆
  • 免疫组化-P; 小鼠; 1:200
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫组化-石蜡切片在小鼠样品上浓度为1:200. J Biol Chem (2015) ncbi
兔 多克隆
  • 细胞化学; 人类; 1:400; 图1
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9661)被用于免疫细胞化学在人类样品上浓度为1:400 (图1). J Immunol (2015) ncbi
兔 多克隆
  • 其他; 小鼠; 1:400; 图5
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9661)被用于其他在小鼠样品上浓度为1:400 (图5). Mol Brain (2015) ncbi
小鼠 单克隆(3G2)
  • 免疫印迹; 人类; 1:200; 图3b
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9668)被用于免疫印迹在人类样品上浓度为1:200 (图3b). Int J Oncol (2015) ncbi
兔 多克隆
  • 免疫印迹; 人类; 1:2000
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9661)被用于免疫印迹在人类样品上浓度为1:2000. Mol Med Rep (2015) ncbi
兔 多克隆
  • 免疫印迹; 人类
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9662)被用于免疫印迹在人类样品上. J Invest Dermatol (2015) ncbi
兔 多克隆
  • IHC-Free; 大鼠; 1:250; 图5
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell signaling, 9661)被用于immunohistochemistry - free floating section在大鼠样品上浓度为1:250 (图5). Neurotox Res (2015) ncbi
兔 多克隆
  • FC; 人类; 1:250
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9661)被用于流式细胞仪在人类样品上浓度为1:250. Oncol Rep (2015) ncbi
兔 多克隆
  • 免疫印迹; 人类; 1:1000; 图3
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫印迹在人类样品上浓度为1:1000 (图3). PLoS ONE (2015) ncbi
兔 多克隆
  • 免疫印迹; 人类
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9661)被用于免疫印迹在人类样品上. PLoS Med (2015) ncbi
兔 多克隆
  • 免疫印迹; 人类; 图2
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell signaling, 9661)被用于免疫印迹在人类样品上 (图2). Pigment Cell Melanoma Res (2015) ncbi
兔 多克隆
  • 免疫印迹; 人类; 图1,2
  • 免疫印迹; 小鼠; 图1,2
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology Inc., 9662S)被用于免疫印迹在人类样品上 (图1,2) 和 在小鼠样品上 (图1,2). Oncogene (2015) ncbi
兔 单克隆(D3E9)
  • FC; 人类; 1:50
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9602)被用于流式细胞仪在人类样品上浓度为1:50. Mutat Res Genet Toxicol Environ Mutagen (2015) ncbi
兔 单克隆(5A1E)
  • 免疫组化-P; 小鼠; 图3e
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9664)被用于免疫组化-石蜡切片在小鼠样品上 (图3e). Cell Death Dis (2015) ncbi
兔 单克隆(5A1E)
  • 免疫印迹; 小鼠; 1:1000
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(CST, 9664)被用于免疫印迹在小鼠样品上浓度为1:1000. Mol Biol Cell (2015) ncbi
兔 多克隆
  • 免疫印迹; 人类
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9662)被用于免疫印迹在人类样品上. J Virol (2015) ncbi
兔 单克隆(5A1E)
  • 免疫印迹; 人类; 图6
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9664)被用于免疫印迹在人类样品上 (图6). Oncotarget (2015) ncbi
兔 多克隆
  • 免疫印迹; 人类; 图6
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9662)被用于免疫印迹在人类样品上 (图6). Oncotarget (2015) ncbi
兔 多克隆
  • 免疫组化; 人类
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9661L)被用于免疫组化在人类样品上. Clin Cancer Res (2015) ncbi
兔 多克隆
  • 免疫组化-F; 小鼠; 1:400
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell signaling, 9661)被用于免疫组化-冰冻切片在小鼠样品上浓度为1:400. Dev Genes Evol (2015) ncbi
兔 多克隆
  • 免疫印迹; 小鼠; 1:1000
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell signaling, 9661)被用于免疫印迹在小鼠样品上浓度为1:1000. Neuropharmacology (2015) ncbi
兔 多克隆
  • 细胞化学; 人类; 1:10,000; 图3
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫细胞化学在人类样品上浓度为1:10,000 (图3). Nat Med (2015) ncbi
兔 多克隆
  • 免疫印迹; 小鼠; 图3b
  • 免疫组化; 小鼠; 1:1600; 图3c
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫印迹在小鼠样品上 (图3b) 和 免疫组化在小鼠样品上浓度为1:1600 (图3c). J Biol Chem (2015) ncbi
兔 多克隆
  • 免疫组化-P; 小鼠; 图s3
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫组化-石蜡切片在小鼠样品上 (图s3). Proc Natl Acad Sci U S A (2015) ncbi
小鼠 单克隆(3G2)
  • 细胞化学; 小鼠; 1:200
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9668)被用于免疫细胞化学在小鼠样品上浓度为1:200. Cell Death Dis (2015) ncbi
兔 单克隆(5A1E)
  • 免疫印迹; 人类; 图4
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(cell Signaling Tech, 9664)被用于免疫印迹在人类样品上 (图4). Cell Death Dis (2015) ncbi
兔 单克隆(8G10)
  • 免疫印迹; 人类; 图s1
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 8G10)被用于免疫印迹在人类样品上 (图s1). Cell Death Dis (2015) ncbi
兔 单克隆(5A1E)
  • 其他; 斑马鱼; 图S2
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9664)被用于其他在斑马鱼样品上 (图S2). FASEB J (2015) ncbi
兔 单克隆(5A1E)
  • 免疫印迹; 人类; 图3
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signalling, 9664)被用于免疫印迹在人类样品上 (图3). Oncogene (2015) ncbi
兔 多克隆
  • 免疫印迹 (基因敲除); 小鼠; 图6
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9662)被用于免疫印迹 (基因敲除)在小鼠样品上 (图6). J Neurosci (2015) ncbi
兔 单克隆(8G10)
  • 免疫印迹; 小鼠; 图8f
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9665)被用于免疫印迹在小鼠样品上 (图8f). Autophagy (2015) ncbi
兔 多克隆
  • 免疫组化-P; 小鼠
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(DAKO, 9661L)被用于免疫组化-石蜡切片在小鼠样品上. FASEB J (2015) ncbi
兔 单克隆(5A1E)
  • 免疫印迹; 小鼠; 图2
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9664S)被用于免疫印迹在小鼠样品上 (图2). DNA Repair (Amst) (2015) ncbi
兔 多克隆
  • 免疫印迹; 人类; 1:1000
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫印迹在人类样品上浓度为1:1000. PLoS ONE (2015) ncbi
兔 多克隆
  • 免疫组化; 人类
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫组化在人类样品上. J Invest Dermatol (2015) ncbi
兔 多克隆
  • 免疫印迹; 人类; 图1
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9662)被用于免疫印迹在人类样品上 (图1). Biomed Res Int (2015) ncbi
兔 单克隆(5A1E)
  • 免疫组化-P; 小鼠; 1:2000; 图s9
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 5A1E)被用于免疫组化-石蜡切片在小鼠样品上浓度为1:2000 (图s9). Proc Natl Acad Sci U S A (2015) ncbi
兔 多克隆
  • 免疫组化-P; 小鼠; 1:200; 图s5
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell signaling, 9661)被用于免疫组化-石蜡切片在小鼠样品上浓度为1:200 (图s5). J Cell Biol (2015) ncbi
兔 多克隆
  • 免疫组化; 小鼠; 1:100
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫组化在小鼠样品上浓度为1:100. Dev Biol (2015) ncbi
兔 单克隆(5A1E)
  • 免疫印迹; 小鼠
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9664S)被用于免疫印迹在小鼠样品上. J Agric Food Chem (2015) ncbi
兔 单克隆(8G10)
  • 免疫印迹; 人类; 1:1000
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9665 s)被用于免疫印迹在人类样品上浓度为1:1000. J Exp Clin Cancer Res (2015) ncbi
兔 多克隆
  • 细胞化学; 人类
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9661)被用于免疫细胞化学在人类样品上. PLoS ONE (2015) ncbi
兔 单克隆(5A1E)
  • 免疫印迹; 人类
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9664)被用于免疫印迹在人类样品上. Biochim Biophys Acta (2015) ncbi
兔 单克隆(8G10)
  • 免疫印迹; 小鼠; 1:1000; 图5A
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9665)被用于免疫印迹在小鼠样品上浓度为1:1000 (图5A). Physiol Rep (2015) ncbi
兔 单克隆(5A1E)
  • 免疫组化-P; 小鼠; 1:200
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9664)被用于免疫组化-石蜡切片在小鼠样品上浓度为1:200. Oncotarget (2015) ncbi
兔 多克隆
  • 免疫印迹; 人类; 1:1000; 图1
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫印迹在人类样品上浓度为1:1000 (图1). Oncotarget (2015) ncbi
小鼠 单克隆(3G2)
  • 免疫印迹; 人类; 图6a
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell signaling, 9668)被用于免疫印迹在人类样品上 (图6a). PLoS Genet (2015) ncbi
兔 单克隆(8G10)
  • 免疫印迹; 人类; 1:1000; 图1A
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9665)被用于免疫印迹在人类样品上浓度为1:1000 (图1A). Mol Med Rep (2015) ncbi
兔 多克隆
  • 免疫印迹; 人类; 1:1000; 图1A
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫印迹在人类样品上浓度为1:1000 (图1A). Mol Med Rep (2015) ncbi
兔 单克隆(8G10)
  • 免疫印迹; 小鼠; 图1
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(CST, Danvers, 9665)被用于免疫印迹在小鼠样品上 (图1). Cell Death Dis (2015) ncbi
兔 单克隆(5A1E)
  • 免疫印迹; 小鼠
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9664)被用于免疫印迹在小鼠样品上. Cell Death Dis (2015) ncbi
兔 多克隆
  • 免疫印迹; 大鼠; 1:500
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫印迹在大鼠样品上浓度为1:500. Cell Death Dis (2015) ncbi
兔 多克隆
  • 免疫组化; 小鼠; 1:200
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫组化在小鼠样品上浓度为1:200. J Biol Chem (2015) ncbi
兔 多克隆
  • 免疫印迹; 人类; 1:1000; 图1
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell signaling, 9661)被用于免疫印迹在人类样品上浓度为1:1000 (图1). Oncotarget (2015) ncbi
兔 多克隆
  • 免疫印迹; 大鼠; 图4
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell signaling, 9661)被用于免疫印迹在大鼠样品上 (图4). Cell Cycle (2015) ncbi
兔 多克隆
  • 免疫组化-P; 小鼠; 图5
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫组化-石蜡切片在小鼠样品上 (图5). Am J Physiol Endocrinol Metab (2015) ncbi
兔 多克隆
  • 细胞化学; 人类
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661L)被用于免疫细胞化学在人类样品上. Curr Protoc Cytom (2015) ncbi
兔 单克隆(D3E9)
  • 免疫组化; 小鼠; 图2
  • 免疫印迹; 小鼠; 图2
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9579S)被用于免疫组化在小鼠样品上 (图2) 和 免疫印迹在小鼠样品上 (图2). Nucleic Acids Res (2015) ncbi
兔 多克隆
  • 免疫组化; 小鼠; 图1
  • 免疫印迹; 小鼠; 图2
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(cell signaling, 9662)被用于免疫组化在小鼠样品上 (图1) 和 免疫印迹在小鼠样品上 (图2). Nucleic Acids Res (2015) ncbi
兔 单克隆(8G10)
  • 免疫印迹; 大鼠; 图1f
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 8G10)被用于免疫印迹在大鼠样品上 (图1f). J Biol Chem (2015) ncbi
兔 多克隆
  • 免疫印迹; 小鼠; 1:1000; 图2
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell signaling, 9661)被用于免疫印迹在小鼠样品上浓度为1:1000 (图2). PLoS ONE (2014) ncbi
兔 多克隆
  • 细胞化学; 人类; 1:1600; 图5
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signalling, 9661S)被用于免疫细胞化学在人类样品上浓度为1:1600 (图5). Oncotarget (2015) ncbi
兔 多克隆
  • 免疫印迹; 大鼠
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9662S)被用于免疫印迹在大鼠样品上. Apoptosis (2015) ncbi
兔 单克隆(8G10)
  • 免疫印迹; 人类; 1:1000
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9665)被用于免疫印迹在人类样品上浓度为1:1000. Cancer Lett (2015) ncbi
兔 单克隆(5A1E)
  • 免疫组化; 小鼠; 图3
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9664)被用于免疫组化在小鼠样品上 (图3). Cancer Cell (2015) ncbi
兔 多克隆
  • 免疫组化; 小鼠; 1:200-1:500; 图2
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫组化在小鼠样品上浓度为1:200-1:500 (图2). Nat Cell Biol (2015) ncbi
兔 单克隆(8G10)
  • 免疫印迹; 小鼠; 图s1
  • 免疫印迹; 大鼠; 图1
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9665)被用于免疫印迹在小鼠样品上 (图s1) 和 在大鼠样品上 (图1). Mol Biol Cell (2015) ncbi
兔 单克隆(5A1E)
  • 免疫印迹; 人类; 图2
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9664)被用于免疫印迹在人类样品上 (图2). Br J Cancer (2015) ncbi
兔 单克隆(5A1E)
  • 免疫印迹; 小鼠; 1:200; 图s6
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell signaling, 5A1E)被用于免疫印迹在小鼠样品上浓度为1:200 (图s6). Development (2015) ncbi
兔 多克隆
  • 免疫组化; 小鼠; 1:300
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫组化在小鼠样品上浓度为1:300. PLoS ONE (2014) ncbi
小鼠 单克隆(3G2)
  • 免疫印迹; 人类
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 3G2)被用于免疫印迹在人类样品上. Cancer Cell (2015) ncbi
兔 单克隆(5A1E)
  • 免疫印迹; 人类
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 5A1E)被用于免疫印迹在人类样品上. Cancer Cell (2015) ncbi
兔 单克隆(5A1E)
  • 免疫印迹; 人类; 图3
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9664)被用于免疫印迹在人类样品上 (图3). Cancer Lett (2015) ncbi
兔 多克隆
  • 免疫组化-F; 大鼠; 1:500
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling/New England Biolabs, 9661)被用于免疫组化-冰冻切片在大鼠样品上浓度为1:500. Ann Clin Transl Neurol (2014) ncbi
兔 单克隆(8G10)
  • 免疫印迹; 人类; 图3a
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology Inc., 9665)被用于免疫印迹在人类样品上 (图3a). Mol Carcinog (2015) ncbi
兔 单克隆(5A1E)
  • 免疫组化; 小鼠; 图s7b
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell signaling, 9664)被用于免疫组化在小鼠样品上 (图s7b). Nat Med (2015) ncbi
兔 单克隆(8G10)
  • 免疫印迹; 小鼠; 图s7c
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell signaling, 9665)被用于免疫印迹在小鼠样品上 (图s7c). Nat Med (2015) ncbi
兔 多克隆
  • 免疫组化-F; 小鼠; 1:200; 图5
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9661)被用于免疫组化-冰冻切片在小鼠样品上浓度为1:200 (图5). Autophagy (2014) ncbi
兔 多克隆
  • 免疫组化; 小鼠; 图7
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9661)被用于免疫组化在小鼠样品上 (图7). Autophagy (2014) ncbi
兔 单克隆(5A1E)
  • 免疫组化-P; 小鼠
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9664)被用于免疫组化-石蜡切片在小鼠样品上. Dev Biol (2015) ncbi
兔 多克隆
  • 免疫印迹; 大鼠
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9661)被用于免疫印迹在大鼠样品上. Life Sci (2015) ncbi
兔 多克隆
  • 免疫组化-P; 小鼠; 1:200
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫组化-石蜡切片在小鼠样品上浓度为1:200. PLoS ONE (2014) ncbi
小鼠 单克隆(3G2)
  • 免疫印迹; 人类; 图4D
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9668)被用于免疫印迹在人类样品上 (图4D). Oncotarget (2015) ncbi
兔 单克隆(5A1E)
  • 免疫印迹; 人类; 1:1000
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9664)被用于免疫印迹在人类样品上浓度为1:1000. FASEB J (2015) ncbi
兔 单克隆(5A1E)
  • 免疫印迹; 小鼠; 图4c
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9664)被用于免疫印迹在小鼠样品上 (图4c). J Hepatol (2015) ncbi
兔 多克隆
  • 免疫印迹; 小鼠
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9661)被用于免疫印迹在小鼠样品上. Mol Cell Endocrinol (2015) ncbi
兔 多克隆
  • 细胞化学; 人类; 1:100
  • 细胞化学; 牛; 1:100
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9661S)被用于免疫细胞化学在人类样品上浓度为1:100 和 在牛样品上浓度为1:100. Toxicol Sci (2015) ncbi
兔 多克隆
  • 免疫组化; 果蝇; 1:200; 图4
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661S)被用于免疫组化在果蝇样品上浓度为1:200 (图4). elife (2014) ncbi
兔 单克隆(8G10)
  • 免疫组化-P; 人类; 图3
  • 免疫印迹; 人类; 图5
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 8G10)被用于免疫组化-石蜡切片在人类样品上 (图3) 和 免疫印迹在人类样品上 (图5). Phytother Res (2015) ncbi
兔 多克隆
  • 免疫印迹; 小鼠
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell signaling, 9662S)被用于免疫印迹在小鼠样品上. Mol Neurodegener (2014) ncbi
兔 多克隆
  • 免疫印迹; 人类; 图s1b
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫印迹在人类样品上 (图s1b). Cell (2014) ncbi
兔 多克隆
  • 免疫印迹; 小鼠; 1:1000; 图3
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell signaling, 9661)被用于免疫印迹在小鼠样品上浓度为1:1000 (图3). PLoS ONE (2014) ncbi
兔 单克隆(5A1E)
  • 免疫印迹; 小鼠; 1:1000
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9664l)被用于免疫印迹在小鼠样品上浓度为1:1000. Invest Ophthalmol Vis Sci (2014) ncbi
兔 多克隆
  • 免疫印迹 (基因敲减); 小鼠; 图6e
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell signaling, 9661)被用于免疫印迹 (基因敲减)在小鼠样品上 (图6e). Apoptosis (2015) ncbi
兔 多克隆
  • 免疫组化-F; 小鼠; 1:500; 图5
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫组化-冰冻切片在小鼠样品上浓度为1:500 (图5). Development (2014) ncbi
兔 单克隆(5A1E)
  • 免疫组化-P; 人类
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 5A1E)被用于免疫组化-石蜡切片在人类样品上. AIDS (2015) ncbi
兔 多克隆
  • 免疫印迹; 人类; 图2
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9662)被用于免疫印迹在人类样品上 (图2). Mol Cell Biol (2015) ncbi
兔 单克隆(8G10)
  • 免疫印迹; 人类; 1:1000
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, #9665)被用于免疫印迹在人类样品上浓度为1:1000. J Nat Prod (2014) ncbi
兔 单克隆(8G10)
  • 免疫印迹; 人类; 图6
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell signaling, 9665)被用于免疫印迹在人类样品上 (图6). Sci Rep (2014) ncbi
兔 多克隆
  • 免疫组化-P; 人类; 1:400
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signalling, 9661)被用于免疫组化-石蜡切片在人类样品上浓度为1:400. Dev Neurobiol (2015) ncbi
兔 单克隆(5A1E)
  • 免疫组化-P; 小鼠; 1:300; 图6
  • 免疫印迹; 小鼠; 1:1000; 图7
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9664)被用于免疫组化-石蜡切片在小鼠样品上浓度为1:300 (图6) 和 免疫印迹在小鼠样品上浓度为1:1000 (图7). PLoS ONE (2014) ncbi
兔 单克隆(5A1E)
  • 免疫组化-F; 小鼠; 1:100; 图s4d
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9664)被用于免疫组化-冰冻切片在小鼠样品上浓度为1:100 (图s4d). Development (2014) ncbi
兔 单克隆(5A1E)
  • 免疫组化-P; 小鼠; 1:200
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(cell signaling, cab 9664)被用于免疫组化-石蜡切片在小鼠样品上浓度为1:200. Hum Mol Genet (2015) ncbi
兔 单克隆(8G10)
  • 免疫印迹; 小鼠; 图4
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9665)被用于免疫印迹在小鼠样品上 (图4). Cell Death Dis (2014) ncbi
兔 多克隆
  • 免疫印迹; 人类; 1:500
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signalling, 9661L)被用于免疫印迹在人类样品上浓度为1:500. J Cell Biochem (2015) ncbi
兔 单克隆(5A1E)
  • 免疫印迹; 小鼠; 图7
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9664S)被用于免疫印迹在小鼠样品上 (图7). Circ Res (2015) ncbi
兔 多克隆
  • IHC-Free; 小鼠; 1:5000
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9661)被用于immunohistochemistry - free floating section在小鼠样品上浓度为1:5000. Cereb Cortex (2015) ncbi
兔 多克隆
  • 免疫印迹; 人类; 1:1000; 图s8
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9662)被用于免疫印迹在人类样品上浓度为1:1000 (图s8). PLoS Genet (2014) ncbi
兔 多克隆
  • 免疫印迹; 人类
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫印迹在人类样品上. J Mol Endocrinol (2014) ncbi
兔 多克隆
  • 免疫印迹; 人类
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9661)被用于免疫印迹在人类样品上. J Cancer Res Clin Oncol (2015) ncbi
兔 多克隆
  • 免疫印迹; 人类; 图s7
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9662)被用于免疫印迹在人类样品上 (图s7). Leukemia (2015) ncbi
兔 多克隆
  • 免疫印迹; 人类; 图s7
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫印迹在人类样品上 (图s7). Leukemia (2015) ncbi
兔 单克隆(5A1E)
  • 免疫印迹; 小鼠
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9664)被用于免疫印迹在小鼠样品上. Biochim Biophys Acta (2015) ncbi
兔 单克隆(D3E9)
  • 细胞化学; 人类; 图2
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9579)被用于免疫细胞化学在人类样品上 (图2). Mol Cancer Res (2015) ncbi
兔 单克隆(5A1E)
  • 免疫组化-P; 小鼠; 1:200
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9664)被用于免疫组化-石蜡切片在小鼠样品上浓度为1:200. Dev Biol (2014) ncbi
兔 多克隆
  • 细胞化学; 人类; 1:300; 图1
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technologies, 9661S)被用于免疫细胞化学在人类样品上浓度为1:300 (图1). Hum Mol Genet (2015) ncbi
兔 单克隆(8G10)
  • 免疫印迹; 人类
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 8G10)被用于免疫印迹在人类样品上. Oncotarget (2014) ncbi
兔 多克隆
  • 免疫组化; 小鼠; 1:500
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9661S)被用于免疫组化在小鼠样品上浓度为1:500. J Comp Neurol (2015) ncbi
兔 多克隆
  • 免疫组化-P; 人类; 1:800
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫组化-石蜡切片在人类样品上浓度为1:800. Mucosal Immunol (2015) ncbi
兔 多克隆
  • 免疫印迹; 人类
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9661)被用于免疫印迹在人类样品上. Cancer Res (2014) ncbi
兔 单克隆(5A1E)
  • 免疫组化-P; 人类; 1:200; 图7
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9664)被用于免疫组化-石蜡切片在人类样品上浓度为1:200 (图7). Nat Cell Biol (2014) ncbi
兔 单克隆(5A1E)
  • 细胞化学; 人类; 图4
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(cell signaling, 9664)被用于免疫细胞化学在人类样品上 (图4). Oncotarget (2014) ncbi
兔 多克隆
  • FC; 人类
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell signaling Technology, #9661)被用于流式细胞仪在人类样品上. Anticancer Agents Med Chem (2015) ncbi
兔 单克隆(8G10)
  • 免疫印迹; 人类; 图4
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9665)被用于免疫印迹在人类样品上 (图4). Mol Cancer Res (2014) ncbi
兔 多克隆
  • 免疫印迹; 人类; 图4
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫印迹在人类样品上 (图4). Mol Cancer Res (2014) ncbi
兔 多克隆
  • 免疫组化-F; 小鼠; 1:1000; 图s3
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9661)被用于免疫组化-冰冻切片在小鼠样品上浓度为1:1000 (图s3). Nat Commun (2014) ncbi
兔 多克隆
  • 免疫组化-F; 小鼠; 1:200
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technologies, 9661S)被用于免疫组化-冰冻切片在小鼠样品上浓度为1:200. J Virol (2014) ncbi
兔 多克隆
  • 免疫组化-P; 小鼠; 1:200; 图1
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫组化-石蜡切片在小鼠样品上浓度为1:200 (图1). Development (2014) ncbi
兔 单克隆(5A1E)
  • 细胞化学; 人类; 1:400; 图4d
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9664)被用于免疫细胞化学在人类样品上浓度为1:400 (图4d). Int J Med Microbiol (2014) ncbi
兔 多克隆
  • 免疫印迹; 人类
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9661)被用于免疫印迹在人类样品上. Cancer Res (2014) ncbi
兔 多克隆
  • 免疫组化-P; 小鼠; 1:200
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫组化-石蜡切片在小鼠样品上浓度为1:200. Mol Oncol (2015) ncbi
兔 多克隆
  • IHC-Free; 小鼠; 1:100
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9661S)被用于immunohistochemistry - free floating section在小鼠样品上浓度为1:100. Front Aging Neurosci (2014) ncbi
兔 单克隆(5A1E)
  • 免疫组化; 小鼠; 图3
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9664)被用于免疫组化在小鼠样品上 (图3). Nat Med (2014) ncbi
兔 多克隆
  • 免疫印迹; 人类
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9661)被用于免疫印迹在人类样品上. Yale J Biol Med (2014) ncbi
兔 单克隆(5A1E)
  • 免疫组化; 人类; 1:50
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9664)被用于免疫组化在人类样品上浓度为1:50. Cell Death Dis (2014) ncbi
兔 多克隆
  • 免疫印迹; 小鼠; 图4
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9661)被用于免疫印迹在小鼠样品上 (图4). Nature (2014) ncbi
兔 单克隆(5A1E)
  • 免疫组化-F; 小鼠; 1:100
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9664L)被用于免疫组化-冰冻切片在小鼠样品上浓度为1:100. J Neurosci (2014) ncbi
兔 多克隆
  • IHC-Free; 小鼠
  • 细胞化学; 小鼠
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9661)被用于immunohistochemistry - free floating section在小鼠样品上 和 免疫细胞化学在小鼠样品上. J Neurosci (2014) ncbi
兔 单克隆(5A1E)
  • 免疫组化-P; 小鼠
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9664)被用于免疫组化-石蜡切片在小鼠样品上. Prostate (2014) ncbi
兔 单克隆(D3E9)
  • 免疫组化; 小鼠; 1:200
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, mAb9579)被用于免疫组化在小鼠样品上浓度为1:200. Int J Cancer (2015) ncbi
兔 多克隆
  • 免疫组化-P; 小鼠; 1:200
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫组化-石蜡切片在小鼠样品上浓度为1:200. Oncogene (2015) ncbi
兔 多克隆
  • 免疫印迹; 小鼠; 1:1000; 图3
  • 细胞化学; 人类; 1:250; 图2
  • 细胞化学; 小鼠; 1:250; 图3
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell signaling, 9661)被用于免疫印迹在小鼠样品上浓度为1:1000 (图3) 和 免疫细胞化学在人类样品上浓度为1:250 (图2) 和 在小鼠样品上浓度为1:250 (图3). Acta Neuropathol (2014) ncbi
兔 多克隆
  • 免疫组化-P; domestic ferret; 1:100; 图6
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9661)被用于免疫组化-石蜡切片在domestic ferret样品上浓度为1:100 (图6). Vet Res (2014) ncbi
兔 多克隆
  • 免疫印迹; 人类; 图1c
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9662)被用于免疫印迹在人类样品上 (图1c). Oncogene (2015) ncbi
兔 多克隆
  • 免疫印迹; 人类
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9661)被用于免疫印迹在人类样品上. Ann Neurol (2014) ncbi
兔 单克隆(5A1E)
  • 免疫印迹; 人类
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9664)被用于免疫印迹在人类样品上. Br J Cancer (2014) ncbi
兔 多克隆
  • 免疫印迹; 人类
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9661)被用于免疫印迹在人类样品上. Cell Death Differ (2014) ncbi
兔 多克隆
  • 免疫印迹; 人类
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9661)被用于免疫印迹在人类样品上. Int J Cancer (2015) ncbi
兔 单克隆(5A1E)
  • 免疫组化; 人类; 图4
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9664s)被用于免疫组化在人类样品上 (图4). Oncotarget (2014) ncbi
兔 多克隆
  • 免疫组化; 小鼠; 1:500
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫组化在小鼠样品上浓度为1:500. Nat Neurosci (2014) ncbi
兔 单克隆(5A1E)
  • 免疫印迹; 人类
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9664)被用于免疫印迹在人类样品上. J Biol Chem (2014) ncbi
兔 多克隆
  • 免疫组化; 果蝇; 1:200; 图1
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell signaling, 9661)被用于免疫组化在果蝇样品上浓度为1:200 (图1). elife (2014) ncbi
兔 多克隆
  • 免疫组化; 人类
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫组化在人类样品上. Oncogene (2015) ncbi
兔 单克隆(5A1E)
  • 免疫印迹; 小鼠
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9664)被用于免疫印迹在小鼠样品上. Biochem Biophys Res Commun (2014) ncbi
兔 多克隆
  • 免疫组化; 果蝇; 1:400; 图3s
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫组化在果蝇样品上浓度为1:400 (图3s). Dis Model Mech (2014) ncbi
兔 多克隆
  • 免疫组化-P; 人类; 1:50
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫组化-石蜡切片在人类样品上浓度为1:50. Nature (2014) ncbi
兔 多克隆
  • 免疫组化-P; 人类
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9661)被用于免疫组化-石蜡切片在人类样品上. Mol Cell Biol (2014) ncbi
兔 多克隆
  • 免疫组化-P; 人类; 1:250
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, #9661)被用于免疫组化-石蜡切片在人类样品上浓度为1:250. Aging (Albany NY) (2014) ncbi
兔 多克隆
  • 免疫印迹; 人类
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9662)被用于免疫印迹在人类样品上. Biochem Biophys Res Commun (2014) ncbi
兔 单克隆(5A1E)
  • 免疫组化-P; 人类; 图1
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell signaling, 9664)被用于免疫组化-石蜡切片在人类样品上 (图1). Cancer Res (2014) ncbi
兔 多克隆
  • 免疫印迹; 人类
  • 免疫印迹; 小鼠
  • 免疫印迹; 大鼠
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9661)被用于免疫印迹在人类样品上, 在小鼠样品上, 和 在大鼠样品上. J Neurosci (2014) ncbi
兔 单克隆(5A1E)
  • 免疫印迹; 小鼠
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9664)被用于免疫印迹在小鼠样品上. J Biol Chem (2014) ncbi
兔 单克隆(5A1E)
  • 免疫印迹; African green monkey
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9664)被用于免疫印迹在African green monkey样品上. PLoS ONE (2014) ncbi
兔 多克隆
  • 免疫组化-P; 小鼠; 1:500
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, #9661)被用于免疫组化-石蜡切片在小鼠样品上浓度为1:500. Toxicology (2014) ncbi
兔 多克隆
  • 免疫组化-P; 人类; 1:50
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫组化-石蜡切片在人类样品上浓度为1:50. Nat Med (2014) ncbi
兔 多克隆
  • 免疫组化; 小鼠; 1:300
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9661)被用于免疫组化在小鼠样品上浓度为1:300. Cancer Res (2014) ncbi
兔 单克隆(5A1E)
  • 免疫组化; 斑马鱼; 1:200
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9664)被用于免疫组化在斑马鱼样品上浓度为1:200. Development (2014) ncbi
兔 多克隆
  • 免疫组化-F; 小鼠; 1:250
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661S)被用于免疫组化-冰冻切片在小鼠样品上浓度为1:250. J Clin Invest (2014) ncbi
兔 多克隆
  • 免疫印迹; 人类
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9661S)被用于免疫印迹在人类样品上. Oncotarget (2014) ncbi
兔 多克隆
  • 细胞化学; 大鼠; 1:500; 图2
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫细胞化学在大鼠样品上浓度为1:500 (图2). Mol Cell Neurosci (2014) ncbi
兔 多克隆
  • 免疫印迹; 人类; 图7b
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫印迹在人类样品上 (图7b). J Biol Chem (2014) ncbi
兔 多克隆
  • 免疫印迹; 人类; 图7b
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9662)被用于免疫印迹在人类样品上 (图7b). J Biol Chem (2014) ncbi
兔 多克隆
  • 免疫组化-F; 小鼠; 1:600
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9661)被用于免疫组化-冰冻切片在小鼠样品上浓度为1:600. J Neurosci (2014) ncbi
兔 单克隆(5A1E)
  • 细胞化学; 大鼠
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9654s)被用于免疫细胞化学在大鼠样品上. J Neurol Sci (2014) ncbi
兔 多克隆
  • 免疫组化-P; 人类; 1:200
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫组化-石蜡切片在人类样品上浓度为1:200. Oncogene (2015) ncbi
兔 多克隆
  • 免疫组化-F; 人类
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫组化-冰冻切片在人类样品上. Cardiovasc Pathol (2014) ncbi
兔 多克隆
  • 免疫组化; platanna; 1:50; 图s9
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫组化在platanna样品上浓度为1:50 (图s9). Development (2014) ncbi
兔 多克隆
  • 免疫印迹; 小鼠; 1:1000
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9662-1)被用于免疫印迹在小鼠样品上浓度为1:1000. PLoS ONE (2014) ncbi
兔 多克隆
  • 免疫印迹; 人类
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661S)被用于免疫印迹在人类样品上. Cell Death Dis (2014) ncbi
兔 多克隆
  • 免疫组化; 小鼠
  • 免疫印迹; 小鼠
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9661)被用于免疫组化在小鼠样品上 和 免疫印迹在小鼠样品上. Cell Death Dis (2014) ncbi
兔 多克隆
  • 免疫印迹; 小鼠; 图3
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signalling, 9661)被用于免疫印迹在小鼠样品上 (图3). Cell Death Differ (2014) ncbi
兔 单克隆(5A1E)
  • 免疫组化-P; 小鼠; 1:100
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9664)被用于免疫组化-石蜡切片在小鼠样品上浓度为1:100. Cancer Res (2014) ncbi
兔 多克隆
  • 免疫印迹; 小鼠; 1:1000
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9662S)被用于免疫印迹在小鼠样品上浓度为1:1000. Neurobiol Dis (2014) ncbi
兔 多克隆
  • 免疫印迹; 大鼠; 1:1000
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9661S)被用于免疫印迹在大鼠样品上浓度为1:1000. Arch Biochem Biophys (2014) ncbi
兔 多克隆
  • 免疫组化; 小鼠
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9661)被用于免疫组化在小鼠样品上. Ann Neurol (2014) ncbi
兔 单克隆(5A1E)
  • 免疫印迹; 大鼠; 1:500
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9664S)被用于免疫印迹在大鼠样品上浓度为1:500. J Biol Chem (2014) ncbi
兔 多克隆
  • 免疫印迹; 人类; 图6
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9661)被用于免疫印迹在人类样品上 (图6). J Pathol (2014) ncbi
兔 单克隆(8G10)
  • 免疫印迹; 人类
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9665S)被用于免疫印迹在人类样品上. PLoS ONE (2014) ncbi
兔 单克隆(5A1E)
  • 细胞化学; 小鼠; 1:200
  • 免疫印迹; 小鼠; 1:1000
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 5A1E)被用于免疫细胞化学在小鼠样品上浓度为1:200 和 免疫印迹在小鼠样品上浓度为1:1000. J Neural Transm (Vienna) (2015) ncbi
兔 单克隆(5A1E)
  • 免疫印迹; 人类; 图2c
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9664)被用于免疫印迹在人类样品上 (图2c). Anticancer Agents Med Chem (2015) ncbi
兔 多克隆
  • 细胞化学; 牛
  • 免疫印迹; 牛
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9661)被用于免疫细胞化学在牛样品上 和 免疫印迹在牛样品上. Biomed Res Int (2014) ncbi
兔 多克隆
  • 免疫组化-P; 人类; 1:100
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9661)被用于免疫组化-石蜡切片在人类样品上浓度为1:100. Orphanet J Rare Dis (2014) ncbi
兔 单克隆(5A1E)
  • 免疫印迹; 小鼠; 1:1000; 图7
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9664)被用于免疫印迹在小鼠样品上浓度为1:1000 (图7). Mol Neurodegener (2014) ncbi
兔 多克隆
  • 免疫印迹; 大鼠; 1:1000
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9661)被用于免疫印迹在大鼠样品上浓度为1:1000. Can J Cardiol (2014) ncbi
兔 多克隆
  • 免疫印迹; 小鼠; 图5
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9661S)被用于免疫印迹在小鼠样品上 (图5). Autophagy (2014) ncbi
兔 多克隆
  • 免疫印迹; 小鼠
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9661S)被用于免疫印迹在小鼠样品上. J Biol Chem (2014) ncbi
兔 单克隆(5A1E)
  • 免疫组化-P; 小鼠; 1:800
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 5A1E)被用于免疫组化-石蜡切片在小鼠样品上浓度为1:800. J Biol Chem (2014) ncbi
兔 单克隆(5A1E)
  • 免疫组化-F; 小鼠; 1:200
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9664)被用于免疫组化-冰冻切片在小鼠样品上浓度为1:200. Nat Neurosci (2014) ncbi
兔 单克隆(5A1E)
  • 免疫印迹; 小鼠; 图4
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9664)被用于免疫印迹在小鼠样品上 (图4). J Am Soc Nephrol (2014) ncbi
兔 多克隆
  • 免疫组化-P; 小鼠
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signalling Technology, 9661)被用于免疫组化-石蜡切片在小鼠样品上. PLoS Genet (2014) ncbi
兔 单克隆(5A1E)
  • 免疫印迹; 人类; 1:1000
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signalling, 5A1E)被用于免疫印迹在人类样品上浓度为1:1000. Mol Hum Reprod (2014) ncbi
兔 多克隆
  • 免疫印迹; 人类; 1:1000
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9662)被用于免疫印迹在人类样品上浓度为1:1000. Oncol Rep (2014) ncbi
兔 单克隆(5A1E)
  • 免疫印迹; 小鼠; 1:1000; 图6c
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell signaling, 9664)被用于免疫印迹在小鼠样品上浓度为1:1000 (图6c). Mol Neurobiol (2015) ncbi
兔 多克隆
  • 免疫印迹; 人类
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(CST, 9662s)被用于免疫印迹在人类样品上. PLoS ONE (2014) ncbi
兔 多克隆
  • 免疫印迹; 人类
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9661)被用于免疫印迹在人类样品上. PLoS ONE (2014) ncbi
兔 多克隆
  • 免疫印迹; 小鼠
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9661)被用于免疫印迹在小鼠样品上. Toxicology (2014) ncbi
兔 多克隆
  • 免疫组化-P; 小鼠; 1:50
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signalling, 9661)被用于. EMBO J (2014) ncbi
兔 多克隆
  • 细胞化学; 人类
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫细胞化学在人类样品上. Clin Cancer Res (2014) ncbi
兔 多克隆
  • 免疫印迹; 人类
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661S)被用于免疫印迹在人类样品上. Cell Death Differ (2014) ncbi
兔 单克隆(8G10)
  • 免疫印迹; 人类
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9665)被用于免疫印迹在人类样品上. Cell Death Differ (2014) ncbi
兔 多克隆
  • 免疫组化; 小鼠
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫组化在小鼠样品上. Antioxid Redox Signal (2014) ncbi
兔 多克隆
  • 免疫组化-F; 小鼠; 1:500
  • 免疫印迹; 小鼠; 1:1000
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9661)被用于免疫组化-冰冻切片在小鼠样品上浓度为1:500 和 免疫印迹在小鼠样品上浓度为1:1000. J Neurosci (2014) ncbi
兔 多克隆
  • 细胞化学; 小鼠; 1:200
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell signalling technology, 9661)被用于免疫细胞化学在小鼠样品上浓度为1:200. PLoS ONE (2014) ncbi
兔 多克隆
  • IHC-Free; 小鼠; 1:100
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9661)被用于immunohistochemistry - free floating section在小鼠样品上浓度为1:100. Front Cell Neurosci (2014) ncbi
兔 多克隆
  • 免疫组化-P; 小鼠
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫组化-石蜡切片在小鼠样品上. Cancer Discov (2014) ncbi
兔 单克隆(5A1E)
  • 免疫印迹; 人类; 图6b
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9664)被用于免疫印迹在人类样品上 (图6b). Mol Endocrinol (2014) ncbi
兔 单克隆(5A1E)
  • 免疫组化-P; 人类; 1:200
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9664)被用于免疫组化-石蜡切片在人类样品上浓度为1:200. J Biol Chem (2014) ncbi
兔 多克隆
  • 免疫印迹; 人类; 1:500
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫印迹在人类样品上浓度为1:500. PPAR Res (2014) ncbi
兔 单克隆(5A1E)
  • 细胞化学; 人类; 1:200
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9664)被用于免疫细胞化学在人类样品上浓度为1:200. Biochem Biophys Res Commun (2014) ncbi
兔 多克隆
  • 免疫组化-P; 小鼠
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9661)被用于免疫组化-石蜡切片在小鼠样品上. Dev Biol (2014) ncbi
兔 多克隆
  • FC; 人类; 1:800
  • 细胞化学; 人类; 1:800
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9661)被用于流式细胞仪在人类样品上浓度为1:800 和 免疫细胞化学在人类样品上浓度为1:800. PLoS ONE (2014) ncbi
兔 单克隆(8G10)
  • 免疫印迹; 人类; 1:1000
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9665)被用于免疫印迹在人类样品上浓度为1:1000. PLoS ONE (2014) ncbi
兔 单克隆(5A1E)
  • IHC-Free; 小鼠; 1:200
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9664)被用于immunohistochemistry - free floating section在小鼠样品上浓度为1:200. PLoS ONE (2014) ncbi
兔 多克隆
  • 免疫组化-F; 大鼠; 1:100
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661S)被用于免疫组化-冰冻切片在大鼠样品上浓度为1:100. J Comp Neurol (2014) ncbi
兔 单克隆(8G10)
  • 免疫印迹; 人类; 1:1000
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 8G10)被用于免疫印迹在人类样品上浓度为1:1000. PLoS ONE (2014) ncbi
兔 多克隆
  • 免疫印迹; 人类
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9661)被用于免疫印迹在人类样品上. Biol Pharm Bull (2014) ncbi
兔 单克隆(5A1E)
  • 免疫组化-P; 小鼠
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9664S)被用于免疫组化-石蜡切片在小鼠样品上. BMC Biol (2014) ncbi
兔 单克隆(5A1E)
  • 免疫印迹; 大鼠
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(CST, 9664)被用于免疫印迹在大鼠样品上. FASEB J (2014) ncbi
兔 单克隆(5A1E)
  • 免疫组化-P; 小鼠; 1:500; 图3
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell signaling, 9664L)被用于免疫组化-石蜡切片在小鼠样品上浓度为1:500 (图3). Nature (2014) ncbi
兔 多克隆
  • 免疫印迹; 大鼠
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technologies, 9661)被用于免疫印迹在大鼠样品上. PLoS ONE (2014) ncbi
兔 单克隆(5A1E)
  • 免疫组化; 人类; 1:200
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, ASP175 5A1E)被用于免疫组化在人类样品上浓度为1:200. Leuk Lymphoma (2014) ncbi
兔 多克隆
  • 免疫印迹; 小鼠
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫印迹在小鼠样品上. PLoS Pathog (2014) ncbi
兔 多克隆
  • 免疫印迹; 人类; 1:1000
  • 免疫印迹; 小鼠; 1:1000
  • 免疫组化; 小鼠
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9661)被用于免疫印迹在人类样品上浓度为1:1000 和 在小鼠样品上浓度为1:1000 和 免疫组化在小鼠样品上. Cell Death Dis (2014) ncbi
兔 单克隆(8G10)
  • 免疫印迹; 人类; 图3a
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell signaling, 9665)被用于免疫印迹在人类样品上 (图3a). PLoS ONE (2014) ncbi
兔 多克隆
  • 免疫印迹; 人类
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫印迹在人类样品上. Mol Cancer Ther (2014) ncbi
兔 单克隆(5A1E)
  • 免疫印迹; 人类
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9664)被用于免疫印迹在人类样品上. PLoS ONE (2014) ncbi
兔 多克隆
  • 免疫组化-F; 大鼠; 1:100
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫组化-冰冻切片在大鼠样品上浓度为1:100. Glia (2014) ncbi
兔 单克隆(5A1E)
  • 细胞化学; 人类; 1:400
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell-Signaling, 9664P)被用于免疫细胞化学在人类样品上浓度为1:400. PLoS ONE (2014) ncbi
兔 多克隆
  • 免疫印迹; 大鼠; 1:1000
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9661)被用于免疫印迹在大鼠样品上浓度为1:1000. PLoS ONE (2014) ncbi
兔 单克隆(8G10)
  • 免疫印迹; 人类
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technologies, 8G10)被用于免疫印迹在人类样品上. BMC Cancer (2014) ncbi
兔 多克隆
  • 免疫组化; 果蝇; 1:100
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫组化在果蝇样品上浓度为1:100. Biol Open (2014) ncbi
兔 多克隆
  • 免疫组化-P; 小鼠; 1:100; 图6
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9661)被用于免疫组化-石蜡切片在小鼠样品上浓度为1:100 (图6). Nat Commun (2014) ncbi
兔 多克隆
  • 免疫组化; 小鼠; 1:200
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫组化在小鼠样品上浓度为1:200. Mol Cell Biol (2014) ncbi
兔 多克隆
  • 免疫组化; 小鼠; 1:1000
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9661)被用于免疫组化在小鼠样品上浓度为1:1000. J Biol Chem (2014) ncbi
兔 多克隆
  • 免疫组化; 小鼠; 1:200
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9661)被用于免疫组化在小鼠样品上浓度为1:200. Invest Ophthalmol Vis Sci (2014) ncbi
兔 多克隆
  • 免疫印迹; 猪; 1:1000
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9661S)被用于免疫印迹在猪样品上浓度为1:1000. PLoS ONE (2014) ncbi
兔 多克隆
  • 免疫组化-P; 人类; 1:200
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫组化-石蜡切片在人类样品上浓度为1:200. Cell Death Dis (2014) ncbi
兔 单克隆(5A1E)
  • 免疫印迹; 人类
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 5A1E)被用于免疫印迹在人类样品上. Cell Death Dis (2014) ncbi
兔 多克隆
  • 细胞化学; 小鼠; 1:200
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(CST, 9669)被用于免疫细胞化学在小鼠样品上浓度为1:200. Methods Mol Biol (2014) ncbi
兔 单克隆(5A1E)
  • 免疫组化-P; 小鼠; 图1e
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 5A1E)被用于免疫组化-石蜡切片在小鼠样品上 (图1e). PLoS ONE (2014) ncbi
兔 单克隆(5A1E)
  • 免疫印迹; 人类
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9654)被用于免疫印迹在人类样品上. PLoS ONE (2014) ncbi
兔 单克隆(5A1E)
  • 免疫印迹; 大鼠; 1:1000
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9664)被用于免疫印迹在大鼠样品上浓度为1:1000. Biochim Biophys Acta (2014) ncbi
兔 多克隆
  • 免疫印迹; 人类
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫印迹在人类样品上. Cell Death Dis (2014) ncbi
兔 多克隆
  • 细胞化学; 小鼠; 1:250
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9661)被用于免疫细胞化学在小鼠样品上浓度为1:250. J Neurosci (2014) ncbi
兔 多克隆
  • 免疫组化; 大鼠; 1:50
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9661)被用于免疫组化在大鼠样品上浓度为1:50. Arthritis Res Ther (2014) ncbi
兔 单克隆(5A1E)
  • 免疫印迹; 人类
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9664)被用于免疫印迹在人类样品上. Gastroenterology (2014) ncbi
兔 单克隆(5A1E)
  • 免疫组化-P; 小鼠
  • 免疫印迹; 大鼠
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9664)被用于免疫组化-石蜡切片在小鼠样品上 和 免疫印迹在大鼠样品上. Kidney Int (2014) ncbi
兔 单克隆(5A1E)
  • 免疫印迹; 人类
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9664)被用于免疫印迹在人类样品上. Carcinogenesis (2014) ncbi
兔 单克隆(5A1E)
  • 免疫印迹; 小鼠; 1:200
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9664S)被用于免疫印迹在小鼠样品上浓度为1:200. Dev Biol (2014) ncbi
兔 多克隆
  • 免疫组化-P; 小鼠; 1:100
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661s)被用于免疫组化-石蜡切片在小鼠样品上浓度为1:100. Dev Biol (2014) ncbi
兔 单克隆(5A1E)
  • 细胞化学; 人类
  • 免疫印迹; 人类
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9664)被用于免疫细胞化学在人类样品上 和 免疫印迹在人类样品上. J Am Soc Nephrol (2014) ncbi
兔 多克隆
  • 免疫组化-F; 小鼠; 1:200
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9661L)被用于免疫组化-冰冻切片在小鼠样品上浓度为1:200. Br J Anaesth (2014) ncbi
兔 单克隆(8G10)
  • 免疫印迹; 小鼠
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 8G10)被用于免疫印迹在小鼠样品上. PLoS ONE (2014) ncbi
兔 多克隆
  • 细胞化学; 小鼠; 1:300
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9661)被用于免疫细胞化学在小鼠样品上浓度为1:300. J Biol Chem (2014) ncbi
兔 多克隆
  • 免疫印迹; 小鼠; 图1, 2
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9662)被用于免疫印迹在小鼠样品上 (图1, 2). Cell Commun Signal (2014) ncbi
兔 多克隆
  • 免疫印迹; 小鼠; 图5, 7
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9662)被用于免疫印迹在小鼠样品上 (图5, 7). J Cell Sci (2014) ncbi
兔 单克隆(5A1E)
  • 免疫组化; 小鼠
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9664)被用于免疫组化在小鼠样品上. J Biol Chem (2014) ncbi
兔 多克隆
  • 免疫组化-F; 小鼠; 1:500
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫组化-冰冻切片在小鼠样品上浓度为1:500. Dev Biol (2014) ncbi
兔 单克隆(5A1E)
  • 细胞化学; 人类; 1:100
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9664)被用于免疫细胞化学在人类样品上浓度为1:100. Toxicol Lett (2014) ncbi
兔 单克隆(8G10)
  • 免疫印迹; 人类; 图s1
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9665)被用于免疫印迹在人类样品上 (图s1). Nat Chem Biol (2014) ncbi
兔 多克隆
  • 免疫印迹; 小鼠
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9661)被用于免疫印迹在小鼠样品上. Am J Pathol (2014) ncbi
兔 多克隆
  • IHC-Free; 小鼠; 1:1000
  • 免疫印迹; 小鼠; 1:1000
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9661)被用于immunohistochemistry - free floating section在小鼠样品上浓度为1:1000 和 免疫印迹在小鼠样品上浓度为1:1000. Neuroscience (2014) ncbi
兔 多克隆
  • 免疫印迹; 小鼠; 图3
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9662)被用于免疫印迹在小鼠样品上 (图3). Autophagy (2014) ncbi
兔 单克隆(8G10)
  • 免疫印迹; 人类; 图5
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9665)被用于免疫印迹在人类样品上 (图5). Free Radic Biol Med (2014) ncbi
兔 单克隆(5A1E)
  • 免疫印迹; 人类; 图5
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9664)被用于免疫印迹在人类样品上 (图5). Free Radic Biol Med (2014) ncbi
兔 多克隆
  • 免疫印迹; 小鼠; 1:1000; 图1
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9661)被用于免疫印迹在小鼠样品上浓度为1:1000 (图1). Am J Physiol Renal Physiol (2014) ncbi
兔 多克隆
  • 免疫组化-F; 小鼠; 1:200; 图6
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫组化-冰冻切片在小鼠样品上浓度为1:200 (图6). Development (2014) ncbi
兔 多克隆
  • 免疫组化-F; 小鼠; 1:500
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9661)被用于免疫组化-冰冻切片在小鼠样品上浓度为1:500. PLoS ONE (2013) ncbi
兔 单克隆(5A1E)
  • 免疫组化-P; 小鼠
  • 免疫印迹; 小鼠
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9664)被用于免疫组化-石蜡切片在小鼠样品上 和 免疫印迹在小鼠样品上. J Neurosci (2013) ncbi
兔 单克隆(5A1E)
  • 免疫组化-F; 小鼠
  • 免疫印迹; 小鼠
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9664)被用于免疫组化-冰冻切片在小鼠样品上 和 免疫印迹在小鼠样品上. Dev Biol (2014) ncbi
兔 多克隆
  • 免疫组化-F; 小鼠
  • 免疫印迹; 小鼠
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫组化-冰冻切片在小鼠样品上 和 免疫印迹在小鼠样品上. Dev Biol (2014) ncbi
兔 单克隆(5A1E)
  • 细胞化学; 人类; 1:100
  • 免疫印迹; 人类; 1:1000
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technologies, 9664)被用于免疫细胞化学在人类样品上浓度为1:100 和 免疫印迹在人类样品上浓度为1:1000. Endocrinology (2013) ncbi
兔 多克隆
  • 免疫印迹; 人类
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫印迹在人类样品上. Br J Cancer (2013) ncbi
兔 多克隆
  • 细胞化学; 人类
  • 免疫印迹; 人类
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9661)被用于免疫细胞化学在人类样品上 和 免疫印迹在人类样品上. J Dermatol Sci (2014) ncbi
兔 多克隆
  • 免疫组化-F; 小鼠; 1:200
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫组化-冰冻切片在小鼠样品上浓度为1:200. Biol Reprod (2013) ncbi
兔 多克隆
  • 免疫印迹; 人类
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9661)被用于免疫印迹在人类样品上. J Biol Chem (2013) ncbi
兔 多克隆
  • 免疫组化-P; 小鼠; 1:1000
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫组化-石蜡切片在小鼠样品上浓度为1:1000. Breast Cancer Res (2013) ncbi
兔 多克隆
  • 免疫印迹; 人类
  • 免疫印迹; 大鼠
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9661S)被用于免疫印迹在人类样品上 和 在大鼠样品上. J Neurosci (2013) ncbi
兔 多克隆
  • 免疫组化-P; 小鼠; 1:200
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9661)被用于免疫组化-石蜡切片在小鼠样品上浓度为1:200. Food Chem Toxicol (2013) ncbi
兔 多克隆
  • 免疫组化-P; 小鼠; 1:200
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9661)被用于免疫组化-石蜡切片在小鼠样品上浓度为1:200. Cell Reprogram (2013) ncbi
兔 单克隆(5A1E)
  • 免疫印迹; 人类; 1:50-500
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 5A1E)被用于免疫印迹在人类样品上浓度为1:50-500. Reprod Biol Endocrinol (2013) ncbi
兔 多克隆
  • 免疫组化-P; 小鼠; 1:250
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9661)被用于免疫组化-石蜡切片在小鼠样品上浓度为1:250. Thyroid (2014) ncbi
兔 单克隆(8G10)
  • 免疫印迹; 人类; 图4c
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(cell signalling, 9665)被用于免疫印迹在人类样品上 (图4c). Int J Cancer (2014) ncbi
兔 多克隆
  • 免疫组化; 小鼠
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9661L)被用于免疫组化在小鼠样品上. Neural Dev (2013) ncbi
兔 多克隆
  • 细胞化学; 大鼠
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫细胞化学在大鼠样品上. J Biol Chem (2013) ncbi
兔 多克隆
  • IHC-Free; 小鼠
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9661)被用于immunohistochemistry - free floating section在小鼠样品上. Cell Transplant (2014) ncbi
兔 多克隆
  • 免疫组化-F; 小鼠; 1:100
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9661)被用于免疫组化-冰冻切片在小鼠样品上浓度为1:100. J Comp Neurol (2014) ncbi
兔 多克隆
  • 免疫组化-F; 小鼠; 1:1500
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫组化-冰冻切片在小鼠样品上浓度为1:1500. Angiogenesis (2013) ncbi
兔 多克隆
  • 免疫组化-P; 大鼠
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(细胞, 9661S)被用于免疫组化-石蜡切片在大鼠样品上. Ann Transplant (2013) ncbi
兔 多克隆
  • 免疫印迹; 人类
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫印迹在人类样品上. Epigenetics (2013) ncbi
兔 多克隆
  • 免疫组化-P; 小鼠; 1:5000
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9661)被用于免疫组化-石蜡切片在小鼠样品上浓度为1:5000. Toxicology (2013) ncbi
兔 多克隆
  • 免疫组化; 鸡
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell signalling, 9661)被用于免疫组化在鸡样品上. J Mol Neurosci (2013) ncbi
兔 单克隆(5A1E)
  • 免疫组化; 小鼠
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9664)被用于免疫组化在小鼠样品上. Kidney Int (2013) ncbi
兔 多克隆
  • 细胞化学; 人类
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫细胞化学在人类样品上. Neurobiol Dis (2013) ncbi
兔 单克隆(8G10)
  • 免疫印迹; 人类
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 8G10)被用于免疫印迹在人类样品上. FASEB J (2013) ncbi
兔 多克隆
  • 免疫印迹; 人类
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9661)被用于免疫印迹在人类样品上. Cancer Cell Int (2013) ncbi
兔 多克隆
  • 免疫组化; 小鼠; 1:100
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(cell signaling, 9661S)被用于免疫组化在小鼠样品上浓度为1:100. Mol Cell Neurosci (2013) ncbi
兔 多克隆
  • 免疫印迹; 人类
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9661)被用于免疫印迹在人类样品上. Cell Death Dis (2013) ncbi
兔 多克隆
  • 免疫印迹; 人类; 1:500
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫印迹在人类样品上浓度为1:500. Neurochem Res (2013) ncbi
兔 单克隆(5A1E)
  • 免疫印迹; 大鼠
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9664)被用于免疫印迹在大鼠样品上. Apoptosis (2013) ncbi
兔 单克隆(5A1E)
  • 免疫印迹; 小鼠; 1:200
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9664)被用于免疫印迹在小鼠样品上浓度为1:200. Brain Res (2013) ncbi
兔 多克隆
  • 免疫印迹; 大鼠; 1:1,000
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9662S)被用于免疫印迹在大鼠样品上浓度为1:1,000. Am J Physiol Endocrinol Metab (2013) ncbi
兔 单克隆(5A1E)
  • 免疫印迹; 人类; 1:1000
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell signal, 9664)被用于免疫印迹在人类样品上浓度为1:1000. J Cell Mol Med (2013) ncbi
兔 多克隆
  • 免疫组化-F; 鸡; 1:4000
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫组化-冰冻切片在鸡样品上浓度为1:4000. PLoS ONE (2013) ncbi
兔 单克隆(5A1E)
  • IHC-Free; 大鼠; 1:400
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9664)被用于immunohistochemistry - free floating section在大鼠样品上浓度为1:400. Int J Dev Neurosci (2013) ncbi
兔 单克隆(5A1E)
  • 免疫印迹; 小鼠
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9664)被用于免疫印迹在小鼠样品上. Free Radic Biol Med (2013) ncbi
兔 单克隆(5A1E)
  • 免疫组化-P; 小鼠; 1:200
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9664)被用于免疫组化-石蜡切片在小鼠样品上浓度为1:200. PLoS ONE (2013) ncbi
兔 多克隆
  • 免疫印迹; 小鼠; 1:1000
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫印迹在小鼠样品上浓度为1:1000. Neurobiol Dis (2013) ncbi
兔 单克隆(5A1E)
  • 免疫组化-F; 小鼠; 1:200
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9664)被用于免疫组化-冰冻切片在小鼠样品上浓度为1:200. PLoS ONE (2013) ncbi
兔 多克隆
  • 免疫印迹; 小鼠
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫印迹在小鼠样品上. Cell Death Dis (2013) ncbi
兔 单克隆(5A1E)
  • 免疫印迹; 大鼠
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signalling Technology, 9664)被用于免疫印迹在大鼠样品上. Autophagy (2013) ncbi
兔 多克隆
  • 免疫组化-P; 小鼠; 1:200
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9661)被用于免疫组化-石蜡切片在小鼠样品上浓度为1:200. Cilia (2012) ncbi
兔 多克隆
  • 免疫印迹; 小鼠
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9661)被用于免疫印迹在小鼠样品上. PLoS ONE (2013) ncbi
兔 单克隆(5A1E)
  • 免疫印迹; 人类
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9664)被用于免疫印迹在人类样品上. Mol Cancer Res (2013) ncbi
兔 单克隆(5A1E)
  • 细胞化学; 人类
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9664)被用于免疫细胞化学在人类样品上. Mol Oncol (2013) ncbi
兔 多克隆
  • 免疫印迹; 人类
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫印迹在人类样品上. Evid Based Complement Alternat Med (2012) ncbi
兔 多克隆
  • 免疫印迹; 人类
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661S)被用于免疫印迹在人类样品上. Mol Cancer Res (2013) ncbi
兔 单克隆(5A1E)
  • 免疫组化-P; 大鼠; 1:400
  • 免疫印迹; 大鼠; 1:1000
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9664)被用于免疫组化-石蜡切片在大鼠样品上浓度为1:400 和 免疫印迹在大鼠样品上浓度为1:1000. PLoS ONE (2012) ncbi
兔 多克隆
  • FC; 小鼠
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9661)被用于流式细胞仪在小鼠样品上. Int J Oncol (2013) ncbi
兔 单克隆(5A1E)
  • 免疫组化-P; 小鼠; 1:100
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9664)被用于免疫组化-石蜡切片在小鼠样品上浓度为1:100. Nat Genet (2013) ncbi
兔 单克隆(5A1E)
  • 免疫印迹; 狗
  • 细胞化学; 狗
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9664)被用于免疫印迹在狗样品上 和 免疫细胞化学在狗样品上. J Biol Chem (2012) ncbi
兔 多克隆
  • 免疫组化; 小鼠
  • 免疫印迹; 小鼠
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫组化在小鼠样品上 和 免疫印迹在小鼠样品上. Am J Pathol (2012) ncbi
兔 多克隆
  • 免疫组化; 小鼠; 1:100; 图5
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9661)被用于免疫组化在小鼠样品上浓度为1:100 (图5). Front Neurosci (2012) ncbi
兔 多克隆
  • FC; 小鼠; 图2d
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于流式细胞仪在小鼠样品上 (图2d). Stem Cells (2012) ncbi
兔 多克隆
  • 免疫印迹; 小鼠; 1:1000
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫印迹在小鼠样品上浓度为1:1000. Mol Cancer Res (2012) ncbi
兔 多克隆
  • 免疫组化-P; 小鼠; 1:200
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫组化-石蜡切片在小鼠样品上浓度为1:200. Mol Cell Biol (2012) ncbi
兔 多克隆
  • 免疫印迹; 人类
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫印迹在人类样品上. Toxicol Appl Pharmacol (2012) ncbi
兔 多克隆
  • 免疫印迹; 人类; 1:1500
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫印迹在人类样品上浓度为1:1500. Exp Hematol (2012) ncbi
兔 多克隆
  • 免疫组化-P; 小鼠
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9661S)被用于免疫组化-石蜡切片在小鼠样品上. Hepatol Res (2012) ncbi
兔 多克隆
  • 免疫组化-P; 大鼠; 1:400
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signal, 9661)被用于免疫组化-石蜡切片在大鼠样品上浓度为1:400. Histochem Cell Biol (2012) ncbi
兔 多克隆
  • 免疫印迹; 人类; 图2
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signalling, #9662)被用于免疫印迹在人类样品上 (图2). Eur J Haematol (2012) ncbi
兔 多克隆
  • 免疫组化-F; 小鼠
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9662)被用于免疫组化-冰冻切片在小鼠样品上. J Biol Chem (2012) ncbi
兔 多克隆
  • 免疫组化-F; 小鼠; 1:100
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell signaling, 9661S)被用于免疫组化-冰冻切片在小鼠样品上浓度为1:100. J Comp Neurol (2012) ncbi
兔 多克隆
  • 免疫组化-P; 小鼠; 图4
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9661)被用于免疫组化-石蜡切片在小鼠样品上 (图4). PLoS ONE (2011) ncbi
兔 多克隆
  • 免疫印迹; 小鼠
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9661)被用于免疫印迹在小鼠样品上. Eur J Immunol (2011) ncbi
兔 多克隆
  • 免疫组化-F; 小鼠; 1:200
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9661)被用于免疫组化-冰冻切片在小鼠样品上浓度为1:200. J Comp Neurol (2011) ncbi
兔 多克隆
  • 免疫印迹; 人类
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫印迹在人类样品上. Neuro Oncol (2011) ncbi
兔 多克隆
  • 免疫印迹; 人类; 1:1000
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫印迹在人类样品上浓度为1:1000. Int J Cancer (2011) ncbi
兔 多克隆
  • 免疫印迹; 人类; 1:1000
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9661)被用于免疫印迹在人类样品上浓度为1:1000. PLoS ONE (2010) ncbi
兔 多克隆
  • 免疫组化-F; 大鼠; 1:200
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫组化-冰冻切片在大鼠样品上浓度为1:200. J Comp Neurol (2010) ncbi
兔 多克隆
  • 免疫组化-F; 小鼠; 1:200
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9661)被用于免疫组化-冰冻切片在小鼠样品上浓度为1:200. J Comp Neurol (2010) ncbi
兔 单克隆(5A1E)
  • 免疫印迹; 人类
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9664)被用于免疫印迹在人类样品上. Int J Cancer (2011) ncbi
兔 多克隆
  • 免疫组化-F; 小鼠; 1:200
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9661S)被用于免疫组化-冰冻切片在小鼠样品上浓度为1:200. J Comp Neurol (2010) ncbi
兔 多克隆
  • 细胞化学; 小鼠
  • 免疫印迹; 小鼠
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫细胞化学在小鼠样品上 和 免疫印迹在小鼠样品上. J Biol Chem (2010) ncbi
兔 多克隆
  • IHC-Free; 小鼠; 1:100; 图5
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于immunohistochemistry - free floating section在小鼠样品上浓度为1:100 (图5). PLoS ONE (2009) ncbi
兔 多克隆
  • 免疫印迹; 人类
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫印迹在人类样品上. J Neurochem (2008) ncbi
兔 多克隆
  • 免疫组化-P; 小鼠; 1:200-400
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫组化-石蜡切片在小鼠样品上浓度为1:200-400. J Comp Neurol (2008) ncbi
兔 多克隆
  • 免疫印迹; 人类
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Sign, 9661)被用于免疫印迹在人类样品上. Cell Res (2008) ncbi
兔 多克隆
  • 免疫组化; 鸡; 1:50
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫组化在鸡样品上浓度为1:50. J Comp Neurol (2007) ncbi
兔 多克隆
  • 免疫组化; 小鼠
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫组化在小鼠样品上. J Comp Neurol (2007) ncbi
兔 多克隆
  • 免疫组化; 小鼠; 1:500
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling Technology, 9661)被用于免疫组化在小鼠样品上浓度为1:500. J Comp Neurol (2006) ncbi
兔 多克隆
  • 免疫印迹; 小鼠; 1:1000
赛信通(上海)生物试剂有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Cell Signaling, 9661)被用于免疫印迹在小鼠样品上浓度为1:1000. Proc Natl Acad Sci U S A (2006) ncbi
碧迪BD
小鼠 单克隆(19/Caspase-3/CPP32)
  • 免疫印迹 (基因敲除); 人类; 1:1000; 图4a
碧迪BD胱氨酸-天冬氨酸蛋白酶3抗体(BD Biosciences, 610323)被用于免疫印迹 (基因敲除)在人类样品上浓度为1:1000 (图4a). Cell Death Dis (2017) ncbi
兔 单克隆(C92-605)
  • 中和/激活的; 小鼠; 图4b
碧迪BD胱氨酸-天冬氨酸蛋白酶3抗体(BD Biosciences, C92-605)被用于抑制或激活实验在小鼠样品上 (图4b). Science (2017) ncbi
兔 单克隆(C92-605)
  • FC; 人类; 图6d
碧迪BD胱氨酸-天冬氨酸蛋白酶3抗体(BD Pharmingen, 559341)被用于流式细胞仪在人类样品上 (图6d). EMBO J (2017) ncbi
兔 单克隆(C92-605)
  • 免疫组化-F; 小鼠; 1:500; 图s6f
碧迪BD胱氨酸-天冬氨酸蛋白酶3抗体(BD Biosciences, 559565)被用于免疫组化-冰冻切片在小鼠样品上浓度为1:500 (图s6f). Nat Commun (2017) ncbi
兔 单克隆(C92-605)
  • FC; 人类; 图1a
碧迪BD胱氨酸-天冬氨酸蛋白酶3抗体(BD Biosciences, 559341)被用于流式细胞仪在人类样品上 (图1a). Cell Stress Chaperones (2017) ncbi
兔 单克隆(C92-605)
  • FC; 小鼠; 图s2e
碧迪BD胱氨酸-天冬氨酸蛋白酶3抗体(BD, 560626)被用于流式细胞仪在小鼠样品上 (图s2e). Stem Cell Reports (2017) ncbi
兔 单克隆(C92-605)
  • FC; 食蟹猴; 图5d
碧迪BD胱氨酸-天冬氨酸蛋白酶3抗体(BD Biosciences, C92-605)被用于流式细胞仪在食蟹猴样品上 (图5d). J Immunol (2017) ncbi
兔 单克隆(C92-605)
  • FC; 食蟹猴; 图5d
碧迪BD胱氨酸-天冬氨酸蛋白酶3抗体(BD Biosciences, C92-605)被用于流式细胞仪在食蟹猴样品上 (图5d). J Immunol (2017) ncbi
兔 单克隆(C92-605)
  • FC; 食蟹猴; 图5d
碧迪BD胱氨酸-天冬氨酸蛋白酶3抗体(BD Biosciences, C92-605)被用于流式细胞仪在食蟹猴样品上 (图5d). J Immunol (2017) ncbi
小鼠 单克隆(19/Caspase-3/CPP32)
  • 免疫印迹; 人类; 图2a
碧迪BD胱氨酸-天冬氨酸蛋白酶3抗体(BD Transduction Laboratories, 610322)被用于免疫印迹在人类样品上 (图2a). Cell Death Differ (2017) ncbi
兔 单克隆(C92-605)
  • FC; 小鼠; 图3f
碧迪BD胱氨酸-天冬氨酸蛋白酶3抗体(BD Biosciences, C92-605)被用于流式细胞仪在小鼠样品上 (图3f). Proc Natl Acad Sci U S A (2017) ncbi
兔 单克隆(C92-605)
  • FC; 小鼠; 图3f
碧迪BD胱氨酸-天冬氨酸蛋白酶3抗体(BD Biosciences, C92-605)被用于流式细胞仪在小鼠样品上 (图3f). Proc Natl Acad Sci U S A (2017) ncbi
兔 单克隆(C92-605)
  • FC; 小鼠; 图3f
碧迪BD胱氨酸-天冬氨酸蛋白酶3抗体(BD Biosciences, C92-605)被用于流式细胞仪在小鼠样品上 (图3f). Proc Natl Acad Sci U S A (2017) ncbi
兔 单克隆(C92-605)
  • FC; 小鼠; 图3f
碧迪BD胱氨酸-天冬氨酸蛋白酶3抗体(BD Biosciences, C92-605)被用于流式细胞仪在小鼠样品上 (图3f). Proc Natl Acad Sci U S A (2017) ncbi
兔 单克隆(C92-605)
  • FC; 小鼠; 图3f
碧迪BD胱氨酸-天冬氨酸蛋白酶3抗体(BD Biosciences, C92-605)被用于流式细胞仪在小鼠样品上 (图3f). Proc Natl Acad Sci U S A (2017) ncbi
兔 单克隆(C92-605)
  • 免疫组化; 小鼠; 1:200; 表1
碧迪BD胱氨酸-天冬氨酸蛋白酶3抗体(BD Biosciences, 559565)被用于免疫组化在小鼠样品上浓度为1:200 (表1). elife (2016) ncbi
兔 单克隆(C92-605)
  • FC; 人类; 1:200; 图6c
碧迪BD胱氨酸-天冬氨酸蛋白酶3抗体(BD, 560626)被用于流式细胞仪在人类样品上浓度为1:200 (图6c). Int J Mol Sci (2016) ncbi
兔 单克隆(C92-605)
  • 免疫组化-F; 小鼠; 图2
碧迪BD胱氨酸-天冬氨酸蛋白酶3抗体(BD BioSciences, 559565)被用于免疫组化-冰冻切片在小鼠样品上 (图2). Mol Cell Neurosci (2016) ncbi
兔 单克隆(C92-605)
  • FC; 人类; 1:500; 图2c
  • FC; 小鼠; 1:500
碧迪BD胱氨酸-天冬氨酸蛋白酶3抗体(BD Pharmingen, 559565)被用于流式细胞仪在人类样品上浓度为1:500 (图2c) 和 在小鼠样品上浓度为1:500. Cell Death Dis (2016) ncbi
兔 单克隆(C92-605)
  • 免疫组化; 斑马鱼; 1:500; 图6
碧迪BD胱氨酸-天冬氨酸蛋白酶3抗体(BD Pharmingen, 559565)被用于免疫组化在斑马鱼样品上浓度为1:500 (图6). Dis Model Mech (2016) ncbi
兔 单克隆(C92-605)
  • FC; 小鼠; 图s3
碧迪BD胱氨酸-天冬氨酸蛋白酶3抗体(BD Biosciences, C92-605)被用于流式细胞仪在小鼠样品上 (图s3). J Clin Invest (2016) ncbi
兔 单克隆(C92-605)
  • FC; 小鼠; 图s3
碧迪BD胱氨酸-天冬氨酸蛋白酶3抗体(BD Biosciences, C92-605)被用于流式细胞仪在小鼠样品上 (图s3). J Clin Invest (2016) ncbi
兔 单克隆(C92-605)
  • FC; 小鼠; 图s3
碧迪BD胱氨酸-天冬氨酸蛋白酶3抗体(BD Biosciences, C92-605)被用于流式细胞仪在小鼠样品上 (图s3). J Clin Invest (2016) ncbi
小鼠 单克隆(19/Caspase-3/CPP32)
  • 免疫印迹; 人类; 图3
碧迪BD胱氨酸-天冬氨酸蛋白酶3抗体(BD Transduction Laboratories, 610322)被用于免疫印迹在人类样品上 (图3). Sci Rep (2016) ncbi
兔 单克隆(C92-605)
  • FC; 人类; 图s3b
碧迪BD胱氨酸-天冬氨酸蛋白酶3抗体(BD Biosciences, C92-605)被用于流式细胞仪在人类样品上 (图s3b). J Leukoc Biol (2016) ncbi
兔 单克隆(C92-605)
  • FC; 人类; 图s3b
碧迪BD胱氨酸-天冬氨酸蛋白酶3抗体(BD Biosciences, C92-605)被用于流式细胞仪在人类样品上 (图s3b). J Leukoc Biol (2016) ncbi
兔 单克隆(C92-605)
  • FC; 人类; 图s3b
碧迪BD胱氨酸-天冬氨酸蛋白酶3抗体(BD Biosciences, C92-605)被用于流式细胞仪在人类样品上 (图s3b). J Leukoc Biol (2016) ncbi
兔 单克隆(C92-605)
  • FC; 人类; 图s3b
碧迪BD胱氨酸-天冬氨酸蛋白酶3抗体(BD Biosciences, C92-605)被用于流式细胞仪在人类样品上 (图s3b). J Leukoc Biol (2016) ncbi
兔 单克隆(C92-605)
  • FC; 人类; 图s3b
碧迪BD胱氨酸-天冬氨酸蛋白酶3抗体(BD Biosciences, C92-605)被用于流式细胞仪在人类样品上 (图s3b). J Leukoc Biol (2016) ncbi
兔 单克隆(C92-605)
  • FC; 人类; 图s3b
碧迪BD胱氨酸-天冬氨酸蛋白酶3抗体(BD Biosciences, C92-605)被用于流式细胞仪在人类样品上 (图s3b). J Leukoc Biol (2016) ncbi
兔 单克隆(C92-605)
  • FC; 人类; 图2
碧迪BD胱氨酸-天冬氨酸蛋白酶3抗体(BD Bioscience, 559341)被用于流式细胞仪在人类样品上 (图2). PLoS ONE (2016) ncbi
兔 单克隆(C92-605)
  • 免疫组化-F; 小鼠
碧迪BD胱氨酸-天冬氨酸蛋白酶3抗体(BD bioscience, 559565)被用于免疫组化-冰冻切片在小鼠样品上. Oncotarget (2016) ncbi
兔 单克隆(C92-605)
  • FC; 人类; 图5e
碧迪BD胱氨酸-天冬氨酸蛋白酶3抗体(BD Biosciences, C92-605)被用于流式细胞仪在人类样品上 (图5e). J Crohns Colitis (2016) ncbi
兔 单克隆(C92-605)
  • FC; 人类; 图5e
碧迪BD胱氨酸-天冬氨酸蛋白酶3抗体(BD Biosciences, C92-605)被用于流式细胞仪在人类样品上 (图5e). J Crohns Colitis (2016) ncbi
兔 单克隆(C92-605)
  • FC; 人类; 图5e
碧迪BD胱氨酸-天冬氨酸蛋白酶3抗体(BD Biosciences, C92-605)被用于流式细胞仪在人类样品上 (图5e). J Crohns Colitis (2016) ncbi
兔 单克隆(C92-605)
  • FC; 人类; 图4
碧迪BD胱氨酸-天冬氨酸蛋白酶3抗体(BD BioSciences, 559565)被用于流式细胞仪在人类样品上 (图4). BMC Cancer (2016) ncbi
小鼠 单克隆(19/Caspase-3/CPP32)
  • 免疫印迹; 大鼠; 1:1000; 图2
碧迪BD胱氨酸-天冬氨酸蛋白酶3抗体(BD Biosciences, 610322)被用于免疫印迹在大鼠样品上浓度为1:1000 (图2). Mol Med Rep (2016) ncbi
兔 单克隆(C92-605)
  • 免疫组化-P; 小鼠; 1:200; 图6
碧迪BD胱氨酸-天冬氨酸蛋白酶3抗体(BD Biosciences, 559565)被用于免疫组化-石蜡切片在小鼠样品上浓度为1:200 (图6). Development (2016) ncbi
小鼠 单克隆(19/Caspase-3/CPP32)
  • 其他; 人类; 图st1
碧迪BD胱氨酸-天冬氨酸蛋白酶3抗体(BD, 19)被用于其他在人类样品上 (图st1). Mol Cell Proteomics (2016) ncbi
小鼠 单克隆(19/Caspase-3/CPP32)
  • 其他; 人类; 图st1
碧迪BD胱氨酸-天冬氨酸蛋白酶3抗体(BD, 19)被用于其他在人类样品上 (图st1). Mol Cell Proteomics (2016) ncbi
兔 单克隆(C92-605)
  • 免疫组化; 小鼠; 1:100; 图5
碧迪BD胱氨酸-天冬氨酸蛋白酶3抗体(BD Pharmingen, 559565)被用于免疫组化在小鼠样品上浓度为1:100 (图5). Autophagy (2016) ncbi
兔 单克隆(C92-605)
  • FC; 小鼠; 图5a
碧迪BD胱氨酸-天冬氨酸蛋白酶3抗体(BD Pharmingen, C92-605)被用于流式细胞仪在小鼠样品上 (图5a). Int J Cancer (2016) ncbi
兔 单克隆(C92-605)
  • FC; 小鼠; 图5a
碧迪BD胱氨酸-天冬氨酸蛋白酶3抗体(BD Pharmingen, C92-605)被用于流式细胞仪在小鼠样品上 (图5a). Int J Cancer (2016) ncbi
兔 单克隆(C92-605)
  • FC; 小鼠; 图5a
碧迪BD胱氨酸-天冬氨酸蛋白酶3抗体(BD Pharmingen, C92-605)被用于流式细胞仪在小鼠样品上 (图5a). Int J Cancer (2016) ncbi
兔 单克隆(C92-605)
  • FC; 小鼠; 图5a
碧迪BD胱氨酸-天冬氨酸蛋白酶3抗体(BD Pharmingen, C92-605)被用于流式细胞仪在小鼠样品上 (图5a). Int J Cancer (2016) ncbi
兔 单克隆(C92-605)
  • FC; 小鼠; 图5a
碧迪BD胱氨酸-天冬氨酸蛋白酶3抗体(BD Pharmingen, C92-605)被用于流式细胞仪在小鼠样品上 (图5a). Int J Cancer (2016) ncbi
兔 单克隆(C92-605)
  • FC; 小鼠; 图5a
碧迪BD胱氨酸-天冬氨酸蛋白酶3抗体(BD Pharmingen, C92-605)被用于流式细胞仪在小鼠样品上 (图5a). Int J Cancer (2016) ncbi
兔 单克隆(C92-605)
  • FC; 人类; 图7
碧迪BD胱氨酸-天冬氨酸蛋白酶3抗体(BD, 550821)被用于流式细胞仪在人类样品上 (图7). Oncotarget (2015) ncbi
兔 单克隆(C92-605)
  • 免疫组化-F; 小鼠; 1:500; 图2
碧迪BD胱氨酸-天冬氨酸蛋白酶3抗体(BD Biosciences, 559565)被用于免疫组化-冰冻切片在小鼠样品上浓度为1:500 (图2). J Neurosci (2015) ncbi
兔 单克隆(C92-605)
  • 免疫印迹; 小鼠; 1:1000; 图7
碧迪BD胱氨酸-天冬氨酸蛋白酶3抗体(BD Pharmigen, 559565)被用于免疫印迹在小鼠样品上浓度为1:1000 (图7). Mol Neurodegener (2015) ncbi
兔 单克隆(C92-605)
  • 免疫组化; 斑马鱼; 1:1000; 图1
碧迪BD胱氨酸-天冬氨酸蛋白酶3抗体(BD Pharmingen, 559565)被用于免疫组化在斑马鱼样品上浓度为1:1000 (图1). J Am Soc Nephrol (2016) ncbi
兔 单克隆(C92-605)
  • FC; 小鼠; 图s9a
碧迪BD胱氨酸-天冬氨酸蛋白酶3抗体(Pharmingen, C92-605)被用于流式细胞仪在小鼠样品上 (图s9a). Proc Natl Acad Sci U S A (2015) ncbi
兔 单克隆(C92-605)
  • FC; 小鼠; 图s9a
碧迪BD胱氨酸-天冬氨酸蛋白酶3抗体(Pharmingen, C92-605)被用于流式细胞仪在小鼠样品上 (图s9a). Proc Natl Acad Sci U S A (2015) ncbi
兔 单克隆(C92-605)
  • FC; 小鼠; 图s9a
碧迪BD胱氨酸-天冬氨酸蛋白酶3抗体(Pharmingen, C92-605)被用于流式细胞仪在小鼠样品上 (图s9a). Proc Natl Acad Sci U S A (2015) ncbi
兔 单克隆(C92-605)
  • FC; 人类
碧迪BD胱氨酸-天冬氨酸蛋白酶3抗体(Pharmingen, 559341)被用于流式细胞仪在人类样品上. Springerplus (2015) ncbi
兔 单克隆(C92-605)
  • 免疫印迹; 人类
碧迪BD胱氨酸-天冬氨酸蛋白酶3抗体(BD Biosciences, 559565)被用于免疫印迹在人类样品上. Oncotarget (2015) ncbi
兔 单克隆(C92-605)
  • 细胞化学; 斑马鱼; 图5
碧迪BD胱氨酸-天冬氨酸蛋白酶3抗体(BD Biosciences, 559565)被用于免疫细胞化学在斑马鱼样品上 (图5). Dev Dyn (2015) ncbi
兔 单克隆(C92-605)
  • FC; 人类; 图3
碧迪BD胱氨酸-天冬氨酸蛋白酶3抗体(BD Pharmingen, 559341)被用于流式细胞仪在人类样品上 (图3). Int J Cancer (2015) ncbi
兔 单克隆(C92-605)
  • 免疫组化; 小鼠; 1:100
碧迪BD胱氨酸-天冬氨酸蛋白酶3抗体(BD Biosciences, 559565)被用于免疫组化在小鼠样品上浓度为1:100. Mol Cell Biol (2014) ncbi
兔 单克隆(C92-605)
  • FC; 人类
碧迪BD胱氨酸-天冬氨酸蛋白酶3抗体(BD Biosciences, C92-605)被用于流式细胞仪在人类样品上. J Immunol (2014) ncbi
兔 单克隆(C92-605)
  • FC; 人类
碧迪BD胱氨酸-天冬氨酸蛋白酶3抗体(BD Biosciences, C92-605)被用于流式细胞仪在人类样品上. J Immunol (2014) ncbi
兔 单克隆(C92-605)
  • FC; 人类
碧迪BD胱氨酸-天冬氨酸蛋白酶3抗体(BD Biosciences, C92-605)被用于流式细胞仪在人类样品上. J Immunol (2014) ncbi
兔 单克隆(C92-605)
  • 免疫印迹; 人类
碧迪BD胱氨酸-天冬氨酸蛋白酶3抗体(BD Biosciences, 559565)被用于免疫印迹在人类样品上. Int J Cancer (2015) ncbi
兔 单克隆(C92-605)
  • 免疫组化; 小鼠; 1:100
碧迪BD胱氨酸-天冬氨酸蛋白酶3抗体(BD Pharmingen, C92-605)被用于免疫组化在小鼠样品上浓度为1:100. Development (2014) ncbi
兔 单克隆(C92-605)
  • 免疫组化; 小鼠; 1:100
碧迪BD胱氨酸-天冬氨酸蛋白酶3抗体(BD Pharmingen, C92-605)被用于免疫组化在小鼠样品上浓度为1:100. Development (2014) ncbi
兔 单克隆(C92-605)
  • 免疫组化; 小鼠; 1:100
碧迪BD胱氨酸-天冬氨酸蛋白酶3抗体(BD Pharmingen, C92-605)被用于免疫组化在小鼠样品上浓度为1:100. Development (2014) ncbi
兔 单克隆(C92-605)
  • FC; 人类; 图2
碧迪BD胱氨酸-天冬氨酸蛋白酶3抗体(Becton Dickinson, 559341)被用于流式细胞仪在人类样品上 (图2). PLoS ONE (2014) ncbi
兔 单克隆(C92-605)
  • 细胞化学; 人类
碧迪BD胱氨酸-天冬氨酸蛋白酶3抗体(BD Biosciences, 559565)被用于免疫细胞化学在人类样品上. J Biol Chem (2014) ncbi
兔 单克隆(C92-605)
  • 免疫组化; 斑马鱼
碧迪BD胱氨酸-天冬氨酸蛋白酶3抗体(BD Pharmingen, C92-605)被用于免疫组化在斑马鱼样品上. Br J Haematol (2014) ncbi
兔 单克隆(C92-605)
  • 免疫组化; 斑马鱼
碧迪BD胱氨酸-天冬氨酸蛋白酶3抗体(BD Pharmingen, C92-605)被用于免疫组化在斑马鱼样品上. Br J Haematol (2014) ncbi
兔 单克隆(C92-605)
  • 免疫组化; 斑马鱼
碧迪BD胱氨酸-天冬氨酸蛋白酶3抗体(BD Pharmingen, C92-605)被用于免疫组化在斑马鱼样品上. Br J Haematol (2014) ncbi
兔 单克隆(C92-605)
  • 免疫印迹; 人类
碧迪BD胱氨酸-天冬氨酸蛋白酶3抗体(BD Biosciences, C92-605)被用于免疫印迹在人类样品上. Mol Pharmacol (2014) ncbi
兔 单克隆(C92-605)
  • 免疫印迹; 人类
碧迪BD胱氨酸-天冬氨酸蛋白酶3抗体(BD Biosciences, C92-605)被用于免疫印迹在人类样品上. Mol Pharmacol (2014) ncbi
兔 单克隆(C92-605)
  • 免疫印迹; 人类
碧迪BD胱氨酸-天冬氨酸蛋白酶3抗体(BD Biosciences, C92-605)被用于免疫印迹在人类样品上. Mol Pharmacol (2014) ncbi
兔 单克隆(C92-605)
  • 细胞化学; 人类
碧迪BD胱氨酸-天冬氨酸蛋白酶3抗体(BD pharmingen, 559565)被用于免疫细胞化学在人类样品上. Neurobiol Dis (2014) ncbi
兔 单克隆(C92-605)
  • 免疫组化; Apteronotus leptorhynchus; 图5
碧迪BD胱氨酸-天冬氨酸蛋白酶3抗体(BD, C92-605)被用于免疫组化在Apteronotus leptorhynchus样品上 (图5). Dev Neurobiol (2014) ncbi
兔 单克隆(C92-605)
  • 免疫组化; Apteronotus leptorhynchus; 图5
碧迪BD胱氨酸-天冬氨酸蛋白酶3抗体(BD, C92-605)被用于免疫组化在Apteronotus leptorhynchus样品上 (图5). Dev Neurobiol (2014) ncbi
兔 单克隆(C92-605)
  • 免疫组化; Apteronotus leptorhynchus; 图5
碧迪BD胱氨酸-天冬氨酸蛋白酶3抗体(BD, C92-605)被用于免疫组化在Apteronotus leptorhynchus样品上 (图5). Dev Neurobiol (2014) ncbi
兔 单克隆(C92-605)
  • FC; 人类
碧迪BD胱氨酸-天冬氨酸蛋白酶3抗体(BD Horizon, 560627)被用于流式细胞仪在人类样品上. Cell Cycle (2014) ncbi
兔 单克隆(C92-605)
  • 免疫印迹; 人类
碧迪BD胱氨酸-天冬氨酸蛋白酶3抗体(BD Biosciences, 559565)被用于免疫印迹在人类样品上. Oncogene (2014) ncbi
兔 单克隆(C92-605)
  • FC; 人类
碧迪BD胱氨酸-天冬氨酸蛋白酶3抗体(BD Biosciences, C92-605)被用于流式细胞仪在人类样品上. Leuk Res (2012) ncbi
兔 单克隆(C92-605)
  • FC; 人类
碧迪BD胱氨酸-天冬氨酸蛋白酶3抗体(BD Biosciences, C92-605)被用于流式细胞仪在人类样品上. Leuk Res (2012) ncbi
兔 单克隆(C92-605)
  • 免疫印迹; 人类
碧迪BD胱氨酸-天冬氨酸蛋白酶3抗体(BD Pharmingen, C92-605)被用于免疫印迹在人类样品上. Clin Cancer Res (2011) ncbi
兔 单克隆(C92-605)
  • 免疫印迹; 人类
碧迪BD胱氨酸-天冬氨酸蛋白酶3抗体(BD Pharmingen, C92-605)被用于免疫印迹在人类样品上. Clin Cancer Res (2011) ncbi
兔 单克隆(C92-605)
  • 免疫印迹; 人类
碧迪BD胱氨酸-天冬氨酸蛋白酶3抗体(BD Pharmingen, C92-605)被用于免疫印迹在人类样品上. Clin Cancer Res (2011) ncbi
小鼠 单克隆(19/Caspase-3/CPP32)
  • 免疫印迹; 人类
碧迪BD胱氨酸-天冬氨酸蛋白酶3抗体(BD Biosciences, 610322)被用于免疫印迹在人类样品上. Int J Cancer (2011) ncbi
兔 单克隆(C92-605)
  • 免疫组化-P; 人类
碧迪BD胱氨酸-天冬氨酸蛋白酶3抗体(BD Biosciences, C92-605)被用于免疫组化-石蜡切片在人类样品上. Hepatology (2007) ncbi
兔 单克隆(C92-605)
  • 免疫组化-P; 人类
碧迪BD胱氨酸-天冬氨酸蛋白酶3抗体(BD Biosciences, C92-605)被用于免疫组化-石蜡切片在人类样品上. Hepatology (2007) ncbi
兔 单克隆(C92-605)
  • 免疫组化-P; 人类
碧迪BD胱氨酸-天冬氨酸蛋白酶3抗体(BD Biosciences, C92-605)被用于免疫组化-石蜡切片在人类样品上. Hepatology (2007) ncbi
默克密理博中国
兔 多克隆
  • 细胞化学; 大鼠; 图s2b
默克密理博中国胱氨酸-天冬氨酸蛋白酶3抗体(Millipore, AB3623)被用于免疫细胞化学在大鼠样品上 (图s2b). Front Cell Neurosci (2017) ncbi
小鼠 单克隆(3D9.3)
  • 免疫组化; 小鼠; 图S3
默克密理博中国胱氨酸-天冬氨酸蛋白酶3抗体(Sigma, MAB10753)被用于免疫组化在小鼠样品上 (图S3). Oncogene (2017) ncbi
兔 多克隆
  • 免疫印迹; 小鼠; 1:100; 图1a
默克密理博中国胱氨酸-天冬氨酸蛋白酶3抗体(Millipore, AB3623)被用于免疫印迹在小鼠样品上浓度为1:100 (图1a). Invest Ophthalmol Vis Sci (2016) ncbi
兔 多克隆
  • 免疫组化-P; 小鼠; 图4-s1
默克密理博中国胱氨酸-天冬氨酸蛋白酶3抗体(EMD Millipore, AB3623)被用于免疫组化-石蜡切片在小鼠样品上 (图4-s1). elife (2016) ncbi
兔 多克隆
  • 免疫组化; 大鼠; 图1
默克密理博中国胱氨酸-天冬氨酸蛋白酶3抗体(Millipore, AB3623)被用于免疫组化在大鼠样品上 (图1). Sci Rep (2016) ncbi
兔 多克隆
  • 免疫印迹; 小鼠; 图6
默克密理博中国胱氨酸-天冬氨酸蛋白酶3抗体(Millipore, AB3623)被用于免疫印迹在小鼠样品上 (图6). Proc Natl Acad Sci U S A (2016) ncbi
兔 多克隆
  • 免疫组化; 小鼠; 1:500; 图13
默克密理博中国胱氨酸-天冬氨酸蛋白酶3抗体(chemicon, AB3623)被用于免疫组化在小鼠样品上浓度为1:500 (图13). Mol Brain (2016) ncbi
兔 多克隆
  • 免疫组化-F; 大鼠; 1:100; 图3
默克密理博中国胱氨酸-天冬氨酸蛋白酶3抗体(Millipore, AB3623)被用于免疫组化-冰冻切片在大鼠样品上浓度为1:100 (图3). Exp Ther Med (2016) ncbi
兔 单克隆
  • 免疫印迹; 大鼠; 1:1500; 图4a
默克密理博中国胱氨酸-天冬氨酸蛋白酶3抗体(EMD Millipore, 04-439)被用于免疫印迹在大鼠样品上浓度为1:1500 (图4a). Mol Med Rep (2016) ncbi
兔 多克隆
  • 细胞化学; 小鼠; 1:200; 图s1
默克密理博中国胱氨酸-天冬氨酸蛋白酶3抗体(Millipore, AB3623)被用于免疫细胞化学在小鼠样品上浓度为1:200 (图s1). Sci Rep (2015) ncbi
兔 多克隆
  • 免疫组化-F; 大鼠; 1:10; 图7
默克密理博中国胱氨酸-天冬氨酸蛋白酶3抗体(Millipore, AB3623)被用于免疫组化-冰冻切片在大鼠样品上浓度为1:10 (图7). Nat Commun (2015) ncbi
兔 单克隆
  • 免疫印迹; 人类; 图4
默克密理博中国胱氨酸-天冬氨酸蛋白酶3抗体(Millipore, 04-439)被用于免疫印迹在人类样品上 (图4). Sci Rep (2015) ncbi
兔 多克隆
  • 免疫组化; 斑马鱼; 1:100
默克密理博中国胱氨酸-天冬氨酸蛋白酶3抗体(Millipore, AB3623)被用于免疫组化在斑马鱼样品上浓度为1:100. Dev Biol (2015) ncbi
兔 多克隆
  • 免疫印迹; 小鼠; 1:1000
默克密理博中国胱氨酸-天冬氨酸蛋白酶3抗体(Millipore, AB3623)被用于免疫印迹在小鼠样品上浓度为1:1000. Endocrinology (2015) ncbi
兔 单克隆
  • 免疫沉淀; 小鼠
默克密理博中国胱氨酸-天冬氨酸蛋白酶3抗体(EMD Millipore, 04-439)被用于免疫沉淀在小鼠样品上. J Cell Mol Med (2015) ncbi
兔 多克隆
  • 免疫组化; Styela plicata; 1:10
默克密理博中国胱氨酸-天冬氨酸蛋白酶3抗体(Millipore, AB3623)被用于免疫组化在Styela plicata样品上浓度为1:10. Dev Neurobiol (2015) ncbi
兔 多克隆
  • 细胞化学; 大鼠; 1:100
默克密理博中国胱氨酸-天冬氨酸蛋白酶3抗体(Merck Millipore, AB3623)被用于免疫细胞化学在大鼠样品上浓度为1:100. Dev Growth Differ (2014) ncbi
兔 多克隆
  • 细胞化学; 人类; 1:50
默克密理博中国胱氨酸-天冬氨酸蛋白酶3抗体(Millipore, AB3623)被用于免疫细胞化学在人类样品上浓度为1:50. F1000Res (2014) ncbi
兔 多克隆
  • 免疫组化-F; 大鼠; 1:50
默克密理博中国胱氨酸-天冬氨酸蛋白酶3抗体(Millipore, AB3623)被用于免疫组化-冰冻切片在大鼠样品上浓度为1:50. J Anat (2014) ncbi
兔 多克隆
  • 免疫印迹; 大鼠
默克密理博中国胱氨酸-天冬氨酸蛋白酶3抗体(Millipore, 06-735)被用于免疫印迹在大鼠样品上. J Physiol (2014) ncbi
兔 多克隆
  • 细胞化学; 人类; 1:300
默克密理博中国胱氨酸-天冬氨酸蛋白酶3抗体(Millipore, AB3623)被用于免疫细胞化学在人类样品上浓度为1:300. PLoS ONE (2014) ncbi
兔 多克隆
  • 免疫组化-F; 大鼠; 1:50
默克密理博中国胱氨酸-天冬氨酸蛋白酶3抗体(Millipore, AB3623)被用于免疫组化-冰冻切片在大鼠样品上浓度为1:50. Glia (2014) ncbi
兔 多克隆
  • 免疫印迹; 人类
默克密理博中国胱氨酸-天冬氨酸蛋白酶3抗体(Millipore, AB3623)被用于免疫印迹在人类样品上. Free Radic Biol Med (2014) ncbi
兔 多克隆
  • 免疫组化; 斑马鱼; 1:500; 图4
默克密理博中国胱氨酸-天冬氨酸蛋白酶3抗体(Millipore, AB3623)被用于免疫组化在斑马鱼样品上浓度为1:500 (图4). Development (2014) ncbi
兔 多克隆
  • 免疫印迹; 人类; 图6
默克密理博中国胱氨酸-天冬氨酸蛋白酶3抗体(Chemicon International, #AB1899)被用于免疫印迹在人类样品上 (图6). J Pharmacol Sci (2014) ncbi
兔 多克隆
  • 免疫印迹; 人类; 1:1000
默克密理博中国胱氨酸-天冬氨酸蛋白酶3抗体(Millipore, 06735)被用于免疫印迹在人类样品上浓度为1:1000. PLoS Pathog (2013) ncbi
兔 多克隆
  • 免疫印迹; 小鼠; 1:500; 图2h
默克密理博中国胱氨酸-天冬氨酸蛋白酶3抗体(Millipore, AB3623)被用于免疫印迹在小鼠样品上浓度为1:500 (图2h). Sci Signal (2013) ncbi
兔 多克隆
  • 免疫印迹; 人类; 1:1000
默克密理博中国胱氨酸-天冬氨酸蛋白酶3抗体(Millipore, AB1899)被用于免疫印迹在人类样品上浓度为1:1000. Cancer Biomark (2012) ncbi
兔 多克隆
  • 免疫印迹; 小鼠
默克密理博中国胱氨酸-天冬氨酸蛋白酶3抗体(Millipore, AB3623)被用于免疫印迹在小鼠样品上. Free Radic Biol Med (2013) ncbi
西格玛奥德里奇
兔 多克隆
  • 细胞化学; 人类; 1:2000; 图s5b
  • 细胞化学; 小鼠; 1:2000; 图s5a
西格玛奥德里奇胱氨酸-天冬氨酸蛋白酶3抗体(SigmaAldrich, C8487)被用于免疫细胞化学在人类样品上浓度为1:2000 (图s5b) 和 在小鼠样品上浓度为1:2000 (图s5a). Am J Hum Genet (2017) ncbi
兔 多克隆
  • 免疫印迹 (基因敲减); 人类; 1:500; 图7a
西格玛奥德里奇胱氨酸-天冬氨酸蛋白酶3抗体(Sigma-Aldrich, C8487)被用于免疫印迹 (基因敲减)在人类样品上浓度为1:500 (图7a). Oncotarget (2017) ncbi
兔 多克隆
  • 细胞化学; 人类; 图6
西格玛奥德里奇胱氨酸-天冬氨酸蛋白酶3抗体(Sigma, C8487)被用于免疫细胞化学在人类样品上 (图6). Oncotarget (2017) ncbi
兔 多克隆
  • 免疫印迹; 大鼠; 1:500; 图4
西格玛奥德里奇胱氨酸-天冬氨酸蛋白酶3抗体(Sigma-Aldrich, SAB 4503294)被用于免疫印迹在大鼠样品上浓度为1:500 (图4). Int J Mol Med (2016) ncbi
兔 多克隆
  • 免疫印迹; 人类; 1:1000
西格玛奥德里奇胱氨酸-天冬氨酸蛋白酶3抗体(Sigma-Aldrich, 8487)被用于免疫印迹在人类样品上浓度为1:1000. PLoS ONE (2014) ncbi
兔 多克隆
  • 免疫印迹; 大鼠
西格玛奥德里奇胱氨酸-天冬氨酸蛋白酶3抗体(Sigma, C8487)被用于免疫印迹在大鼠样品上. Ophthalmol Eye Dis (2014) ncbi
上海普洛麦格生物产品有限公司
兔 多克隆
  • 免疫组化; 大鼠; 图33
上海普洛麦格生物产品有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Promega, G748)被用于免疫组化在大鼠样品上 (图33). J Toxicol Pathol (2017) ncbi
兔 多克隆
  • 免疫组化-F; 小鼠; 图s2m
上海普洛麦格生物产品有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Promega, G7481)被用于免疫组化-冰冻切片在小鼠样品上 (图s2m). Development (2015) ncbi
兔 多克隆
  • 免疫组化-P; 人类; 1:150
上海普洛麦格生物产品有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Promega, G7481)被用于免疫组化-石蜡切片在人类样品上浓度为1:150. PLoS ONE (2015) ncbi
兔 多克隆
  • 细胞化学; 小鼠; 1:250
上海普洛麦格生物产品有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Promega, G7481)被用于免疫细胞化学在小鼠样品上浓度为1:250. J Comp Neurol (2014) ncbi
兔 多克隆
  • IHC-Free; 小鼠; 1:500
上海普洛麦格生物产品有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Promega, G7481)被用于immunohistochemistry - free floating section在小鼠样品上浓度为1:500. J Neurosci (2013) ncbi
兔 多克隆
  • 免疫组化-F; 小鼠
上海普洛麦格生物产品有限公司胱氨酸-天冬氨酸蛋白酶3抗体(Promega, G7481)被用于免疫组化-冰冻切片在小鼠样品上. J Comp Neurol (2007) ncbi
GeneTex
兔 多克隆
  • 免疫印迹; 人类; 1:1000; 图5
GeneTex胱氨酸-天冬氨酸蛋白酶3抗体(GeneTex, GTX110543)被用于免疫印迹在人类样品上浓度为1:1000 (图5). Oncotarget (2016) ncbi
兔 多克隆
  • 免疫组化; 小鼠; 1:250; 图4
GeneTex胱氨酸-天冬氨酸蛋白酶3抗体(Gene Tex, GTX22302)被用于免疫组化在小鼠样品上浓度为1:250 (图4). J Negat Results Biomed (2015) ncbi
兔 多克隆
  • 免疫组化; 大鼠
GeneTex胱氨酸-天冬氨酸蛋白酶3抗体(GeneTex, GTX22302)被用于免疫组化在大鼠样品上. Urology (2012) ncbi
Affinity Biosciences
兔 多克隆
  • 免疫印迹; 人类; 1:1000; 图8c
  • 免疫印迹; 小鼠; 1:1000; 图7c
Affinity Biosciences胱氨酸-天冬氨酸蛋白酶3抗体(Affinity Biosciences, AF7022)被用于免疫印迹在人类样品上浓度为1:1000 (图8c) 和 在小鼠样品上浓度为1:1000 (图7c). Front Mol Neurosci (2017) ncbi
文章列表
  1. Vitaliya Sagulenko et al. (2017). "Caspase-1 Is an Apical Caspase Leading to Caspase-3 Cleavage in the AIM2 Inflammasome Response, Independent of Caspase-8".PMID 29100888
  2. Emilia Peuhu et al. (2017). "Integrin beta 1 inhibition alleviates the chronic hyperproliferative dermatitis phenotype of SHARPIN-deficient mice".PMID 29040328
  3. Mark A Miles et al. (2017). "Executioner caspases and CAD are essential for mutagenesis induced by TRAIL or vincristine".PMID 28981092
  4. Jaume Padilla et al. (2017). "TRAF3IP2 mediates high glucose-induced endothelin-1 production as well as endothelin-1-induced inflammation in endothelial cells.".PMID 28971844
  5. Christian T Mayer et al. (2017). "The microanatomic segregation of selection by apoptosis in the germinal center".PMID 28935768
  6. Yujun Xu et al. (2017). "Low Frequency Magnetic Fields Induce Autophagy-associated Cell Death in Lung Cancer through miR-486-mediated Inhibition of Akt/mTOR Signaling Pathway.".PMID 28924214
  7. Frances K Turrell et al. (2017). "Lung tumors with distinct p53 mutations respond similarly to p53 targeted therapy but exhibit genotype-specific statin sensitivity.".PMID 28790158
  8. Jia Qu et al. (2017). "Correction: Phosphoglycerate mutase 1 regulates dNTP pool and promotes homologous recombination repair in cancer cells".PMID 28739677
  9. Wei Wang et al. (2017). "TRIM37, a novel E3 ligase for PEX5-mediated peroxisomal matrix protein import.".PMID 28724525
  10. Yun Wei Shi et al. (2017). "Schisantherin A attenuates ischemia/reperfusion-induced neuronal injury in rats via regulation of TLR4 and C5aR1 signaling pathways.".PMID 28690033
  11. Limei Xu et al. (2017). "SH3BGRL as a novel prognostic biomarker is down-regulated in acute myeloid leukemia.".PMID 28679293
  12. Matteo Marchesini et al. (2017). "ILF2 Is a Regulator of RNA Splicing and DNA Damage Response in 1q21-Amplified Multiple Myeloma.".PMID 28669490
  13. Lena Ho et al. (2017). "ELABELA deficiency promotes preeclampsia and cardiovascular malformations in mice".PMID 28663440
  14. Melissa A Lang et al. (2017). "Engaging Ly-6A/Sca-1 triggers lipid raft-dependent and -independent responses in CD4(+) T-cell lines.".PMID 28660664
  15. Zhihui Li et al. (2017). "Silencing of solute carrier family 13 member 5 disrupts energy homeostasis and inhibits proliferation of human hepatocarcinoma cells.".PMID 28655760
  16. Shu Zhu et al. (2017). "Nlrp9b inflammasome restricts rotavirus infection in intestinal epithelial cells".PMID 28636595
  17. Angela Bononi et al. (2017). "BAP1 regulates IP3R3-mediated Ca2+ flux to mitochondria suppressing cell transformation".PMID 28614305
  18. Shafi Kuchay et al. (2017). "PTEN counteracts FBXL2 to promote IP3R3- and Ca2+-mediated apoptosis limiting tumour growth".PMID 28614300
  19. Sydney M Shaffer et al. (2017). "Rare cell variability and drug-induced reprogramming as a mode of cancer drug resistance".PMID 28607484
  20. Man Ding et al. (2017). "Purkinje Cell Degeneration and Motor Coordination Deficits in a New Mouse Model of Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay.".PMID 28588446
  21. Mathieu Iampietro et al. (2017). "Ebola virus glycoprotein directly triggers T lymphocyte death despite of the lack of infection.".PMID 28542576
  22. Hui Sun et al. (2017). "Mesencephalic astrocyte-derived neurotrophic factor reduces cell apoptosis via upregulating HSP70 in SHSY-5Y cells.".PMID 28536652
  23. Cheol Hee Shin et al. (2017). "Identification of XAF1-MT2A mutual antagonism as a molecular switch in cell-fate decisions under stressful conditions.".PMID 28507149
  24. Zonglin Zhang et al. (2017). "HuR promotes breast cancer cell proliferation and survival via binding to CDK3 mRNA.".PMID 28501005
  25. Anja Feldner et al. (2017). "Loss of Mpdz impairs ependymal cell integrity leading to perinatal-onset hydrocephalus in mice.".PMID 28500065
  26. Lara Barazzuol et al. (2017). "A coordinated DNA damage response promotes adult quiescent neural stem cell activation.".PMID 28489848
  27. Jing Shan Lim et al. (2017). "Intratumoural heterogeneity generated by Notch signalling promotes small-cell lung cancer.".PMID 28489825
  28. Xin Yue et al. (2017). "Identification of 4-arylidene curcumin analogues as novel proteasome inhibitors for potential anticancer agents targeting 19S regulatory particle associated deubiquitinase.".PMID 28476333
  29. Hongxing Shen et al. (2017). "MicroRNA-30a attenuates mutant KRAS-driven colorectal tumorigenesis via direct suppression of ME1.".PMID 28475173
  30. Blandine Monel et al. (2017). "Zika virus induces massive cytoplasmic vacuolization and paraptosis-like death in infected cells.".PMID 28473450
  31. Ming Xiu Hao et al. (2017). "MicroRNA-17-5p mediates hypoxia-induced autophagy and inhibits apoptosis by targeting signal transducer and activator of transcription 3 in vascular smooth muscle cells.".PMID 28450922
  32. Yujie Liu et al. (2017). "Resveratrol protects against oxidized low‑density lipoprotein‑induced human umbilical vein endothelial cell apoptosis via inhibition of mitochondrial‑derived oxidative stress.".PMID 28447714
  33. Sander B Frank et al. (2017). "Human prostate luminal cell differentiation requires NOTCH3 induction by p38-MAPK and MYC.".PMID 28446540
  34. Thomas Kammertoens et al. (2017). "Tumour ischaemia by interferon-γ resembles physiological blood vessel regression.".PMID 28445461
  35. Peixiang Lan et al. (2017). "TNF superfamily receptor OX40 triggers invariant NKT cell pyroptosis and liver injury.".PMID 28436935
  36. Jingang Hou et al. (2017). "Ginsenoside Rd as a potential neuroprotective agent prevents trimethyltin injury".PMID 28413642
  37. Ping Jiang et al. (2017). "Tiron ameliorates high glucose-induced cardiac myocyte apoptosis by PKCδ-dependent inhibition of osteopontin.".PMID 28394420
  38. Meilan He et al. (2017). "SIRT1 and AMPK pathways are essential for the proliferation and survival of primary effusion lymphoma cells.".PMID 28393364
  39. Zhiguang Xiao et al. (2017). "Metformin Triggers Autophagy to Attenuate Drug-Induced Apoptosis in NSCLC Cells, with Minor Effects on Tumors of Diabetic Patients.".PMID 28391030
  40. Yongyue Gao et al. (2017). "Tetrahydrocurcumin reduces oxidative stress-induced apoptosis via the mitochondrial apoptotic pathway by modulating autophagy in rats after traumatic brain injury.".PMID 28386319
  41. Rina Wassermann-Dozorets et al. (2017). "C/EBPβ LIP augments cell death by inducing osteoglycin".PMID 28383550
  42. Haoyu Deng et al. (2017). "Cleavage of Grb2-Associated Binding Protein 2 by Viral Proteinase 2A during Coxsackievirus Infection.".PMID 28361043
  43. Valentina Latina et al. (2017). "Impaired NGF/TrkA Signaling Causes Early AD-Linked Presynaptic Dysfunction in Cholinergic Primary Neurons.".PMID 28360840
  44. Xuening Ji et al. (2017). "Trametes robiniophila may induce apoptosis and inhibit MMPs expression in the human gastric carcinoma cell line MKN-45.".PMID 28356967
  45. Kensuke Mitsunari et al. (2017). "Stromal expression of Fer suppresses tumor progression in renal cell carcinoma and is a predictor of survival.".PMID 28356966
  46. Haifeng Wang et al. (2017). "LASS2 inhibits growth and invasion of bladder cancer by regulating ATPase activity.".PMID 28356943
  47. Mariko Shimokawa et al. (2017). "Visualization and targeting of LGR5+ human colon cancer stem cells".PMID 28355176
  48. Xuyao Zhang et al. (2017). "Targeting CD47 and Autophagy Elicited Enhanced Antitumor Effects in Non-Small Cell Lung Cancer.".PMID 28351890
  49. Jennifer Mytych et al. (2017). "Long-term culture with lipopolysaccharide induces dose-dependent cytostatic and cytotoxic effects in THP-1 monocytes.".PMID 28341289
  50. Colby R Keistler et al. (2017). "Regulation of Alcohol Extinction and Cue-Induced Reinstatement by Specific Projections among Medial Prefrontal Cortex, Nucleus Accumbens, and Basolateral Amygdala".PMID 28336571
  51. Mar a M Leal-Lasarte et al. (2017). "Extracellular TDP-43 aggregates target MAPK/MAK/MRK overlapping kinase (MOK) and trigger caspase-3/IL-18 signaling in microglia.".PMID 28336525
  52. Souparno Bhattacharya et al. (2017). "RAD51 interconnects between DNA replication, DNA repair and immunity.".PMID 28334891
  53. Guangyan Xiong et al. (2017). "The PERK arm of the unfolded protein response regulates satellite cell-mediated skeletal muscle regeneration.".PMID 28332979
  54. Zuzana Keckesova et al. (2017). "LACTB is a tumour suppressor that modulates lipid metabolism and cell state.".PMID 28329758
  55. Yuyan Wang et al. (2017). "A piRNA-like Small RNA Induces Chemoresistance to Cisplatin-Based Therapy by Inhibiting Apoptosis in Lung Squamous Cell Carcinoma".PMID 28325293
  56. Lynette Caizhen Foo et al. (2017). "miR-31 mutants reveal continuous glial homeostasis in the adult Drosophila brain.".PMID 28320737
  57. Chen Zhang et al. (2017). "Transcription factor NF-kappa B represses ANT1 transcription and leads to mitochondrial dysfunctions".PMID 28317877
  58. Weijun Feng et al. (2017). "Chd7 is indispensable for mammalian brain development through activation of a neuronal differentiation programme.".PMID 28317875
  59. Yun Jia Wang et al. (2017). "Hemin protects against oxygen-glucose deprivation-induced apoptosis activation via neuroglobin in SH-SY5Y cells.".PMID 28316021
  60. Tara P Chambers et al. (2017). "Sab mediates mitochondrial dysfunction involved in imatinib mesylate-induced cardiotoxicity.".PMID 28315715
  61. Dario F Riascos Bernal et al. (2017). "Inhibition of Smooth Muscle β-Catenin Hinders Neointima Formation After Vascular Injury.".PMID 28302627
  62. Hui Rong et al. (2017). "The effects of dexmedetomidine pretreatment on the pro- and anti-inflammation systems after spinal cord injury in rats.".PMID 28302458
  63. Upasana Sahu et al. (2017). "Induction of intestinal stemness and tumorigenicity by aberrant internalization of commensal non-pathogenic E. coli.".PMID 28300841
  64. Silvia Grasso et al. (2017). "The scaffold protein p140Cap limits ERBB2-mediated breast cancer progression interfering with Rac GTPase-controlled circuitries".PMID 28300085
  65. Adam T Boutin et al. (2017). "Oncogenic Kras drives invasion and maintains metastases in colorectal cancer.".PMID 28289141
  66. Hu Huang et al. (2017). "Age-related macular degeneration phenotypes are associated with increased tumor necrosis-alpha and subretinal immune cells in aged Cxcr5 knockout mice.".PMID 28282423
  67. Bart C Jongbloets et al. (2017). "Stage-specific functions of Semaphorin7A during adult hippocampal neurogenesis rely on distinct receptors.".PMID 28281529
  68. Samson Mathews Samuel et al. (2017). "Metformin represses glucose starvation induced autophagic response in microvascular endothelial cells and promotes cell death.".PMID 28274614
  69. Patrick Strangward et al. (2017). "A quantitative brain map of experimental cerebral malaria pathology.".PMID 28273147
  70. Lit Hsin Loo et al. (2017). "Early spatiotemporal-specific changes in intermediate signals are predictive of cytotoxic sensitivity to TNFα and co-treatments".PMID 28272488
  71. Haaglim Cho et al. (2017). "ENOblock, a unique small molecule inhibitor of the non-glycolytic functions of enolase, alleviates the symptoms of type 2 diabetes.".PMID 28272459
  72. Ruchira Sharma et al. (2017). "Olfactory receptor accessory proteins play crucial roles in receptor function and gene choice".PMID 28262096
  73. Yue Tian et al. (2017). "Minocycline attenuates sevoflurane-induced cell injury via activation of Nrf2".PMID 28260081
  74. Kai Li et al. (2017). "DDX17 nucleocytoplasmic shuttling promotes acquired gefitinib resistance in non-small cell lung cancer cells via activation of β-catenin.".PMID 28259822
  75. Elodie Lafont et al. (2017). "The linear ubiquitin chain assembly complex regulates TRAIL-induced gene activation and cell death.".PMID 28258062
  76. Shi Fu et al. (2017). "Adiponectin deficiency contributes to the development and progression of benign prostatic hyperplasia in obesity.".PMID 28256562
  77. Sheah Lin Lee et al. (2017). "Re-examining HSPC1 inhibitors.".PMID 28255900
  78. Jing Shi et al. (2017). "miR-17-3p Contributes to Exercise-Induced Cardiac Growth and Protects against Myocardial Ischemia-Reperfusion Injury.".PMID 28255358
  79. Pengfei Kong et al. (2017). "The microRNA-423-3p-Bim Axis Promotes Cancer Progression and Activates Oncogenic Autophagy in Gastric Cancer.".PMID 28254439
  80. Raffaella Iurlaro et al. (2017). "Glucose Deprivation Induces ATF4-Mediated Apoptosis through TRAIL Death Receptors".PMID 28242652
  81. Michael A Schumacher et al. (2017). "ErbB4 signaling stimulates pro-inflammatory macrophage apoptosis and limits colonic inflammation.".PMID 28230865
  82. Stefanie Menges et al. (2017). "Alpha-synuclein prevents the formation of spherical mitochondria and apoptosis under oxidative stress".PMID 28224980
  83. Qian Dong et al. (2017). "Blockage of transient receptor potential vanilloid 4 alleviates myocardial ischemia/reperfusion injury in mice.".PMID 28205608
  84. Cong Wang et al. (2017). "Anti-proliferative effect of Jesridonin on paclitaxel-resistant EC109 human esophageal carcinoma cells.".PMID 28204832
  85. Mingqiu Cen et al. (2017). "TIEG1 deficiency confers enhanced myocardial protection in the infarcted heart by mediating the Pten/Akt signalling pathway.".PMID 28204828
  86. I D Tonks et al. (2017). "Melanocyte transformation requires complete loss of all pocket protein function via a mechanism that mitigates the need for MAPK pathway activation".PMID 28192409
  87. Feng Cheng et al. (2017). "RNA-Binding Protein Dnd1 Promotes Breast Cancer Apoptosis by Stabilizing the Bim mRNA in a miR-221 Binding Site".PMID 28191469
  88. Satoshi Furukawa et al. (2017). "Databases for technical aspects of immunohistochemistry.".PMID 28190929
  89. D sir e Schatton et al. (2017). "CLUH regulates mitochondrial metabolism by controlling translation and decay of target mRNAs.".PMID 28188211
  90. Qiang Wu et al. (2017). "XIAP 3'-untranslated region as a ceRNA promotes FSCN1 function in inducing the progression of breast cancer by binding endogenous miR-29a-5p.".PMID 28186968
  91. Ebru Ercan et al. (2017). "Neuronal CTGF/CCN2 negatively regulates myelination in a mouse model of tuberous sclerosis complex.".PMID 28183733
  92. Giannicola Genovese et al. (2017). "Synthetic vulnerabilities of mesenchymal subpopulations in pancreatic cancer".PMID 28178232
  93. Nicholas J Genovese et al. (2017). "Enhanced Development of Skeletal Myotubes from Porcine Induced Pluripotent Stem Cells.".PMID 28165492
  94. Yichen Zhu et al. (2017). "Restenosis Inhibition and Re-differentiation of TGFβ/Smad3-activated Smooth Muscle Cells by Resveratrol".PMID 28165488
  95. Danielle E Whittaker et al. (2017). "The chromatin remodeling factor CHD7 controls cerebellar development by regulating reelin expression.".PMID 28165338
  96. Nan Wu et al. (2017). "A mouse model of MYCN-driven retinoblastoma reveals MYCN-independent tumor reemergence.".PMID 28165337
  97. Congcong Shen et al. (2017). "Angiotensin-II-induced Muscle Wasting is Mediated by 25-Hydroxycholesterol via GSK3β Signaling Pathway.".PMID 28161398
  98. John Y W Lee et al. (2017). "Large Intragenic Deletion in DSTYK Underlies Autosomal-Recessive Complicated Spastic Paraparesis, SPG23.".PMID 28157540
  99. Izabela Nita et al. (2017). "Hepatocyte growth factor secreted by bone marrow stem cell reduce ER stress and improves repair in alveolar epithelial II cells".PMID 28157203
  100. Jinichi Mori et al. (2017). "EPSIN 3, A Novel p53 Target, Regulates the Apoptotic Pathway and Gastric Carcinogenesis".PMID 28152424
  101. Patrizia Mondello et al. (2017). "Dual inhibition of histone deacetylases and phosphoinositide 3-kinase enhances therapeutic activity against B cell lymphoma".PMID 28147336
  102. Frank P Vendetti et al. (2017). "Pharmacologic ATM but not ATR kinase inhibition abrogates p21-dependent G1 arrest and promotes gastrointestinal syndrome after total body irradiation".PMID 28145510
  103. Asmaa M S Gomaa et al. (2017). "Vitamin D reduces high-fat diet induced weight gain and C-reactive protein, increases interleukin-10, and reduces CD86 and caspase-3".PMID 28143686
  104. William C W Chen et al. (2016). "Decellularized zebrafish cardiac extracellular matrix induces mammalian heart regeneration".PMID 28138518
  105. Freyja M Bruce et al. (2017). "DSCAM promotes axon fasciculation and growth in the developing optic pathway".PMID 28137836
  106. Sun Hyung Ha et al. (2017). "Jellyfish extract induces apoptotic cell death through the p38 pathway and cell cycle arrest in chronic myelogenous leukemia K562 cells".PMID 28133573
  107. Juan Liu et al. (2017). "BECN1-dependent CASP2 incomplete autophagy induction by binding to rabies virus phosphoprotein".PMID 28129024
  108. Wenbo Liu et al. (2017). "BCAS2 is involved in alternative mRNA splicing in spermatogonia and the transition to meiosis".PMID 28128212
  109. Jiang Liu et al. (2017). "A critical role of DDRGK1 in endoplasmic reticulum homoeostasis via regulation of IRE1α stability".PMID 28128204
  110. Clare E Weeden et al. (2017). "Lung Basal Stem Cells Rapidly Repair DNA Damage Using the Error-Prone Nonhomologous End-Joining Pathway".PMID 28125611
  111. Mengqian Li et al. (2017). "Study on Lentivirus-Mediated ABCA7 Improves Neurocognitive Function and Related Mechanisms in the C57BL/6 Mouse Model of Alzheimer's Disease".PMID 28124230
  112. Le Cai et al. (2017). "CRKL overexpression promotes cell proliferation and inhibits apoptosis in endometrial carcinoma".PMID 28123521
  113. In Young Choi et al. (2017). "Dexmedetomidine alleviates cerebral ischemia-induced short-term memory impairment by inhibiting the expression of apoptosis-related molecules in the hippocampus of gerbils".PMID 28123477
  114. Lijie Feng et al. (2017). "Ubiquitin ligase SYVN1/HRD1 facilitates degradation of the SERPINA1 Z variant/alpha-1-antitrypsin Z variant via SQSTM1/p62-dependent selective autophagy".PMID 28121484
  115. Yuchen Qi et al. (2017). "Combined small-molecule inhibition accelerates the derivation of functional cortical neurons from human pluripotent stem cells".PMID 28112759
  116. Victor H Villar et al. (2017). "mTORC1 inhibition in cancer cells protects from glutaminolysis-mediated apoptosis during nutrient limitation".PMID 28112156
  117. Marina Bershteyn et al. (2017). "Human iPSC-Derived Cerebral Organoids Model Cellular Features of Lissencephaly and Reveal Prolonged Mitosis of Outer Radial Glia".PMID 28111201
  118. Adriana Carol Eleonora Graziano et al. (2017). "Wilms' tumor gene 1 silencing inhibits proliferation of human osteosarcoma MG-63 cell line by cell cycle arrest and apoptosis activation".PMID 28107196
  119. Shan Xu et al. (2016). "Curcumin enhances temsirolimus-induced apoptosis in human renal carcinoma cells through upregulation of YAP/p53".PMID 28105206
  120. Jing Gan et al. (2016). "RNA interference targeting Aurora-A sensitizes glioblastoma cells to temozolomide chemotherapy".PMID 28105161
  121. Vincent Hung Shu Chang et al. (2017). "Krüpple-like factor 10 regulates radio-sensitivity of pancreatic cancer via UV radiation resistance-associated gene".PMID 28104298
  122. Yu Tao Peng et al. (2016). "Particularly interesting Cys-His-rich protein is highly expressed in human intracranial aneurysms and resists aneurysmal rupture".PMID 28101173
  123. Harumasa Nakazawa et al. (2017). "iNOS as a Driver of Inflammation and Apoptosis in Mouse Skeletal Muscle after Burn Injury: Possible Involvement of Sirt1 S-Nitrosylation-Mediated Acetylation of p65 NF-κB and p53".PMID 28099528
  124. Naser Jafari et al. (2017). "CRISPR-Cas9 Mediated NOX4 Knockout Inhibits Cell Proliferation and Invasion in HeLa Cells".PMID 28099519
  125. Bhawna Chandravanshi et al. (2017). "Shielding Engineered Islets with Mesenchymal Stem Cells Enhance Survival Under Hypoxia".PMID 28098405
  126. Haixia Cao et al. (2017). "Liver X receptor agonist T0901317 reverses resistance of A549 human lung cancer cells to EGFR-TKI treatment".PMID 28097086
  127. Natasha Irrera et al. (2017). "BAY 11-7082 inhibits the NF-kB and NLRP3 inflammasome pathways and protects against IMQ-induced psoriasis".PMID 28096316
  128. Melina Mescher et al. (2017). "The epidermal polarity protein Par3 is a non-cell autonomous suppressor of malignant melanoma".PMID 28096290
  129. Pinar Aksoy et al. (2017). "The Role of DCT in HPV16 Infection of HaCaTs".PMID 28095444
  130. Clare M Adams et al. (2017). "BCL-W has a fundamental role in B cell survival and lymphomagenesis.".PMID 28094768
  131. Saman Sizdahkhani et al. (2017). "Somatostatin receptor expression on von Hippel-Lindau-associated hemangioblastomas offers novel therapeutic target".PMID 28094316
  132. Debjani Pal et al. (2017). "TGF-β reduces DNA ds-break repair mechanisms to heighten genetic diversity and adaptability of CD44+/CD24- cancer cells".PMID 28092266
  133. Jie Xu et al. (2017). "The β-TrCP-FBXW2-SKP2 axis regulates lung cancer cell growth with FBXW2 acting as a tumour suppressor".PMID 28090088
  134. Antonio Lo Nigro et al. (2017). "PDGFRα+ Cells in Embryonic Stem Cell Cultures Represent the In Vitro Equivalent of the Pre-implantation Primitive Endoderm Precursors".PMID 28089671
  135. Liam A Hurst et al. (2017). "TNFα drives pulmonary arterial hypertension by suppressing the BMP type-II receptor and altering NOTCH signalling".PMID 28084316
  136. Karine Z Oben et al. (2017). "Radiation Induced Apoptosis of Murine Bone Marrow Cells Is Independent of Early Growth Response 1 (EGR1)".PMID 28081176
  137. N Yang et al. (2017). "Propofol inhibits lung cancer cell viability and induces cell apoptosis by upregulating microRNA-486 expression".PMID 28076456
  138. Taru Muranen et al. (2017). "Starved epithelial cells uptake extracellular matrix for survival".PMID 28071763
  139. Hualong Bai et al. (2017). "Covalent modification of pericardial patches for sustained rapamycin delivery inhibits venous neointimal hyperplasia".PMID 28071663
  140. Takayoshi Yamauchi et al. (2017). "FBXL5 Inactivation in Mouse Brain Induces Aberrant Proliferation of Neural Stem-Progenitor Cells".PMID 28069738
  141. M Riverso et al. (2017). "KLF4 is regulated by RAS/RAF/MEK/ERK signaling through E2F1 and promotes melanoma cell growth".PMID 28068326
  142. Jakub Grzesiak et al. (2017). "Ultrastructural changes during osteogenic differentiation in mesenchymal stromal cells cultured in alginate hydrogel".PMID 28066541
  143. Elizabeth R Wonderlich et al. (2017). "Widespread Virus Replication in Alveoli Drives Acute Respiratory Distress Syndrome in Aerosolized H5N1 Influenza Infection of Macaques".PMID 28062701
  144. Laurens J Ceulemans et al. (2017). "Farnesoid X Receptor Activation Attenuates Intestinal Ischemia Reperfusion Injury in Rats".PMID 28060943
  145. Guo Bing Li et al. (2017). "Polyphyllin I induces mitophagic and apoptotic cell death in human breast cancer cells by increasing mitochondrial PINK1 levels".PMID 28060722
  146. Daniella Brasacchio et al. (2017). "Epigenetic control of mitochondrial cell death through PACS1-mediated regulation of BAX/BAK oligomerization".PMID 28060382
  147. Mona Malek Mohammadi et al. (2017). "The transcription factor GATA4 promotes myocardial regeneration in neonatal mice".PMID 28053183
  148. Tammy Hennika et al. (2017). "Pre-Clinical Study of Panobinostat in Xenograft and Genetically Engineered Murine Diffuse Intrinsic Pontine Glioma Models".PMID 28052119
  149. Xiangyu Liu et al. (2017). "PAXX promotes KU accumulation at DNA breaks and is essential for end-joining in XLF-deficient mice".PMID 28051062
  150. Jan Broder Engler et al. (2017). "Glucocorticoid receptor in T cells mediates protection from autoimmunity in pregnancy".PMID 28049829
  151. Konstantin V Dergilev et al. (2016). "Comparison of cardiac stem cell sheets detached by Versene solution and from thermoresponsive dishes reveals similar properties of constructs".PMID 28041835
  152. Nour S Erekat et al. (2016). "Cerebellar Purkinje Cells Die by Apoptosis in the Shaker Mutant Rat".PMID 28040459
  153. Hyun Jung Kim et al. (2016). "Subcellular localization of FOXO3a as a potential biomarker of response to combined treatment with inhibitors of PI3K and autophagy in PIK3CA-mutant cancer cells".PMID 28036259
  154. Lanying Song et al. (2016). "Bipolar cell reduction precedes retinal ganglion neuron loss in a complex 1 knockout mouse model".PMID 28027875
  155. Xiuzu Song et al. (2016). "Autophagy deficient keratinocytes display increased DNA damage, senescence and aberrant lipid composition after oxidative stress in vitro and in vivo".PMID 28012437
  156. Jennifer Mytych et al. (2016). "Protective role of klotho protein on epithelial cells upon co-culture with activated or senescent monocytes".PMID 28011195
  157. Jian Sun et al. (2016). "Overexpression of colorectal cancer oncogene CHRDL2 predicts a poor prognosis".PMID 28009989
  158. Meng Lin Chao et al. (2016). "Loss of Caspase-Activated DNase Protects Against Atherosclerosis in Apolipoprotein E-Deficient Mice".PMID 28007744
  159. Zhuo Ren et al. (2016). "Phosphorylated STAT5 regulates p53 expression via BRCA1/BARD1-NPM1 and MDM2".PMID 28005077
  160. Nkerorema Djodji Damas et al. (2016). "SNHG5 promotes colorectal cancer cell survival by counteracting STAU1-mediated mRNA destabilization".PMID 28004750
  161. Maria José Polanco et al. (2016). "Adenylyl cyclase activating polypeptide reduces phosphorylation and toxicity of the polyglutamine-expanded androgen receptor in spinobulbar muscular atrophy".PMID 28003546
  162. Andrea Braganza et al. (2016). "UBE3B is a Calmodulin-Regulated, Mitochondria-Associated E3 Ubiquitin Ligase".PMID 28003368
  163. San Min Leow et al. (2016). "Sub-lethal oxidative stress induces lysosome biogenesis via a lysosomal membrane permeabilization-cathepsin-caspase 3-transcription factor EB-dependent pathway".PMID 28002813
  164. Raluca Ştefania Fodor et al. (2016). "Caspase 3 expression and plasma level of Fas ligand as apoptosis biomarkers in inflammatory endotoxemic lung injury".PMID 28002510
  165. Eliza Vakana et al. (2016). "LY3009120, a panRAF inhibitor, has significant anti-tumor activity in BRAF and KRAS mutant preclinical models of colorectal cancer".PMID 27999210
  166. Nadine Kirschmer et al. (2016). "TRPC4α and TRPC4β Similarly Affect Neonatal Cardiomyocyte Survival during Chronic GPCR Stimulation".PMID 27992507
  167. Fulong Wang et al. (2016). "High glucose facilitated endothelial heparanase transfer to the cardiomyocyte modifies its cell death signature".PMID 27979811
  168. Gloria Pascual et al. (2016). "Targeting metastasis-initiating cells through the fatty acid receptor CD36".PMID 27974793
  169. Bethan Lloyd-Lewis et al. (2016). "Imaging the mammary gland and mammary tumours in 3D: optical tissue clearing and immunofluorescence methods".PMID 27964754
  170. Richard Graveline et al. (2016). "The chromatin associated Phf12 protein maintains nucleolar integrity and prevents premature cellular senescence".PMID 27956701
  171. Junya Suzuki et al. (2017). "Chaperone-mediated autophagy promotes lung cancer cell survival through selective stabilization of the pro-survival protein, MCL1".PMID 27939888
  172. Arvind Chhabra et al. (2016). "Activation induced cell death (AICD) of human melanoma antigen-specific TCR engineered CD8 T cells involves JNK, Bim and p53".PMID 27935327
  173. Chandrani Mukhopadhyay et al. (2016). "Casitas B-cell lymphoma (Cbl) proteins protect mammary epithelial cells from proteotoxicity of active c-Src accumulation".PMID 27930322
  174. Seiyoung Lim et al. (2016). "Lycopene inhibits regulator of calcineurin 1-mediated apoptosis by reducing oxidative stress and down-regulating Nucling in neuronal cells".PMID 27928873
  175. Bo Ram Seo et al. (2017). "Inhibition of Cathepsin S Induces Mitochondrial ROS That Sensitizes TRAIL-Mediated Apoptosis Through p53-Mediated Downregulation of Bcl-2 and c-FLIP".PMID 27927016
  176. Seok Soon Park et al. (2016). "Ibulocydine sensitizes human hepatocellular carcinoma cells to TRAIL-induced apoptosis via calpain-mediated Bax cleavage".PMID 27923747
  177. Hanna Retallack et al. (2016). "Zika virus cell tropism in the developing human brain and inhibition by azithromycin".PMID 27911847
  178. Melody M H Li et al. (2016). "Interferon regulatory factor 2 protects mice from lethal viral neuroinvasion".PMID 27899441
  179. Erdem Bangi et al. (2016). "Functional exploration of colorectal cancer genomes using Drosophila".PMID 27897178
  180. Callum McKenzie et al. (2016). "Investigating cytokinesis failure as a strategy in cancer therapy".PMID 27895316
  181. Lluc Mosteiro et al. (2016). "Tissue damage and senescence provide critical signals for cellular reprogramming in vivo".PMID 27884981
  182. Juan Hu et al. (2016). "ER stress inhibitor attenuates hearing loss and hair cell death in Cdh23erl/erl mutant mice".PMID 27882946
  183. Feifei Su et al. (2016). "Bcl-2-associated athanogene 3 protects the heart from ischemia/reperfusion injury".PMID 27882354
  184. Xue Zhu et al. (2016). "Ziyuglycoside I Inhibits the Proliferation of MDA-MB-231 Breast Carcinoma Cells through Inducing p53-Mediated G2/M Cell Cycle Arrest and Intrinsic/Extrinsic Apoptosis".PMID 27879682
  185. Masayuki Morishita et al. (2017). "AICAR induces mitochondrial apoptosis in human osteosarcoma cells through an AMPK-dependent pathway".PMID 27878239
  186. Peter J Bosch et al. (2016). "Akirin2 is essential for the formation of the cerebral cortex".PMID 27871306
  187. Seung Hoon Yang et al. (2017). "Nec-1 alleviates cognitive impairment with reduction of Aβ and tau abnormalities in APP/PS1 mice".PMID 27861127
  188. Micol Ravà et al. (2016). "Mutual epithelium-macrophage dependency in liver carcinogenesis mediated by ST18".PMID 27859418
  189. Nicole D Paris et al. (2016). "Smad4 restricts differentiation to promote expansion of satellite cell derived progenitors during skeletal muscle regeneration".PMID 27855784
  190. Dan Shi et al. (2016). "Caveolin-1 contributes to realgar nanoparticle therapy in human chronic myelogenous leukemia K562 cells".PMID 27853367
  191. Mandy O J Grootaert et al. (2016). "Caspase-3 Deletion Promotes Necrosis in Atherosclerotic Plaques of ApoE Knockout Mice".PMID 27847551
  192. Nadja Zeltner et al. (2016). "Capturing the biology of disease severity in a PSC-based model of familial dysautonomia".PMID 27841875
  193. J M Thompson et al. (2016). "Rho-associated kinase 1 inhibition is synthetically lethal with von Hippel-Lindau deficiency in clear cell renal cell carcinoma".PMID 27841867
  194. Fernanda Marconi Roversi et al. (2017). "Hematopoietic cell kinase (HCK) is a potential therapeutic target for dysplastic and leukemic cells due to integration of erythropoietin/PI3K pathway and regulation of erythropoiesis: HCK in erythropoietin/PI3K pathway".PMID 27840303
  195. Heba M A Abdelrazek et al. (2016). "Ameliorating effects of green tea extract on cadmium induced reproductive injury in male Wistar rats with respect to androgen receptors and caspase- 3".PMID 27840064
  196. Macario Martínez-Castillo et al. (2016). "A Subpopulation of the K562 Cells Are Killed by Curcumin Treatment after G2/M Arrest and Mitotic Catastrophe".PMID 27832139
  197. Aveline Filliol et al. (2016). "RIPK1 protects from TNF-α-mediated liver damage during hepatitis".PMID 27831558
  198. Joon Suk Park et al. (2016). "Suppression of the metastatic spread of breast cancer by DN10764 (AZD7762)-mediated inhibition of AXL signaling".PMID 27829217
  199. Fiona L Cousins et al. (2016). "Evidence for a dynamic role for mononuclear phagocytes during endometrial repair and remodelling".PMID 27827431
  200. Erin A Bassett et al. (2016). "Norrin/Frizzled4 signalling in the preneoplastic niche blocks medulloblastoma initiation".PMID 27823583
  201. Marian C Okondo et al. (2017). "DPP8 and DPP9 inhibition induces pro-caspase-1-dependent monocyte and macrophage pyroptosis".PMID 27820798
  202. Thomas Marichal et al. (2016). "Guanine nucleotide exchange factor RABGEF1 regulates keratinocyte-intrinsic signaling to maintain skin homeostasis.".PMID 27820702
  203. Cecilia Dallavalle et al. (2016). "MicroRNA-424 impairs ubiquitination to activate STAT3 and promote prostate tumor progression.".PMID 27820701
  204. Juan Lin et al. (2016). "RIPK1 counteracts ZBP1-mediated necroptosis to inhibit inflammation".PMID 27819681
  205. Yandi Wang et al. (2016). "Regulation of steroid hormones and energy status with cysteamine and its effect on spermatogenesis".PMID 27815134
  206. Shulin Pan et al. (2016). "Resveratrol post-treatment protects against neonatal brain injury after hypoxia-ischemia".PMID 27811363
  207. Natalia Kitsati et al. (2016). "Hydroxytyrosol inhibits hydrogen peroxide-induced apoptotic signaling via labile iron chelation".PMID 27810738
  208. Xiaochen Liu et al. (2016). "Expression of Carbonic Anhydrase I in Motor Neurons and Alterations in ALS".PMID 27809276
  209. Xuan Pu et al. (2016). "Caspase-3 and caspase-8 expression in breast cancer: caspase-3 is associated with survival".PMID 27798717
  210. Wei Yu et al. (2016). "Oxidation of KCNB1 Potassium Channels Causes Neurotoxicity and Cognitive Impairment in a Mouse Model of Traumatic Brain Injury".PMID 27798188
  211. Brian D Cholewa et al. (2017). "Small molecule inhibition of polo-like kinase 1 by volasertib (BI 6727) causes significant melanoma growth delay and regression in vivo".PMID 27793694
  212. Soroush Tahmasebi et al. (2016). "Control of embryonic stem cell self-renewal and differentiation via coordinated alternative splicing and translation of YY2".PMID 27791185
  213. Gewei Lian et al. (2016). "Filamin A- and formin 2-dependent endocytosis regulates proliferation via the canonical Wnt pathway".PMID 27789627
  214. Katherine D Laclair et al. (2016). "Depletion of TDP-43 decreases fibril and plaque β-amyloid and exacerbates neurodegeneration in an Alzheimer's mouse model".PMID 27785573
  215. Haojie Sun et al. (2016). "Resistance of glioma cells to nutrient-deprived microenvironment can be enhanced by CD133-mediated autophagy".PMID 27780926
  216. Francielle Graus-Nunes et al. (2017). "Differential effects of angiotensin receptor blockers on pancreatic islet remodelling and glucose homeostasis in diet-induced obese mice".PMID 27780713
  217. Alejandro Parrales et al. (2016). "DNAJA1 controls the fate of misfolded mutant p53 through the mevalonate pathway".PMID 27775703
  218. Anita Schlierf et al. (2016). "Targeted inhibition of the COP9 signalosome for treatment of cancer".PMID 27774986
  219. Alice Kunzler et al. (2016). "Changes in Cell Cycle and Up-Regulation of Neuronal Markers During SH-SY5Y Neurodifferentiation by Retinoic Acid are Mediated by Reactive Species Production and Oxidative Stress".PMID 27771902
  220. Kathrin Fielitz et al. (2016). "Characterization of pancreatic glucagon-producing tumors and pituitary gland tumors in transgenic mice overexpressing MYCN in hGFAP-positive cells".PMID 27769070
  221. Boris Redko et al. (2017). "Toward the development of a novel non-RGD cyclic peptide drug conjugate for treatment of human metastatic melanoma".PMID 27768593
  222. Felix Ulbrich et al. (2016). "The CORM ALF-186 Mediates Anti-Apoptotic Signaling via an Activation of the p38 MAPK after Ischemia and Reperfusion Injury in Retinal Ganglion Cells".PMID 27764224
  223. Ken Takai et al. (2016). "Targeting the cancer-associated fibroblasts as a treatment in triple-negative breast cancer".PMID 27756881
  224. Rashi Arora et al. (2016). "Esculetin induces antiproliferative and apoptotic response in pancreatic cancer cells by directly binding to KEAP1".PMID 27756327
  225. Lin Yang et al. (2016). "Quercetin-induced apoptosis of HT-29 colon cancer cells via inhibition of the Akt-CSN6-Myc signaling axis".PMID 27748879
  226. Kasra Khalaj et al. (2016). "RNA binding protein, tristetraprolin in a murine model of recurrent pregnancy loss".PMID 27732963
  227. Sheryl Southard et al. (2016). "Myofiber-specific TEAD1 overexpression drives satellite cell hyperplasia and counters pathological effects of dystrophin deficiency".PMID 27725085
  228. Yi Pang et al. (2016). "Early Postnatal Lipopolysaccharide Exposure Leads to Enhanced Neurogenesis and Impaired Communicative Functions in Rats".PMID 27723799
  229. Igor Hrgovic et al. (2016). "The histone deacetylase inhibitor trichostatin a decreases lymphangiogenesis by inducing apoptosis and cell cycle arrest via p21-dependent pathways".PMID 27716272
  230. Semjon Seemann et al. (2016). "Administration of AMD3100 in endotoxemia is associated with pro-inflammatory, pro-oxidative, and pro-apoptotic effects in vivo".PMID 27716214
  231. Saba Parween et al. (2016). "Intra-islet lesions and lobular variations in β-cell mass expansion in ob/ob mice revealed by 3D imaging of intact pancreas".PMID 27713548
  232. Shan Guan et al. (2016). "Second-generation proteasome inhibitor carfilzomib sensitizes neuroblastoma cells to doxorubicin-induced apoptosis".PMID 27713150
  233. Shrikant Pradhan et al. (2016). "Scriptaid overcomes hypoxia-induced cisplatin resistance in both wild-type and mutant p53 lung cancer cells".PMID 27708247
  234. Yuma Nonomiya et al. (2016). "Effect of AKT3 expression on MYC- and caspase-8-dependent apoptosis caused by polo-like kinase inhibitors in HCT 116 cells".PMID 27699933
  235. Petr Vodicka et al. (2016). "Autophagy Activation by Transcription Factor EB (TFEB) in Striatum of HDQ175/Q7 Mice".PMID 27689619
  236. Chen Wang et al. (2016). "Etoposide Induces Apoptosis in Activated Human Hepatic Stellate Cells via ER Stress".PMID 27680712
  237. Ren Jie Wei et al. (2016). "A microtubule inhibitor, ABT-751, induces autophagy and delays apoptosis in Huh-7 cells".PMID 27678524
  238. Donghyun Joo et al. (2016). "Regulation of Linear Ubiquitin Chain Assembly Complex by Caspase-Mediated Cleavage of RNF31".PMID 27669734
  239. Lauren C Fogarty et al. (2016). "Bcl-xL dependency coincides with the onset of neurogenesis in the developing mammalian spinal cord".PMID 27665712
  240. Yael Yoffe et al. (2016). "Cap-independent translation by DAP5 controls cell fate decisions in human embryonic stem cells".PMID 27664238
  241. Rui Cao et al. (2016). "Decreased TRPM7 inhibits activities and induces apoptosis of bladder cancer cells via ERK1/2 pathway".PMID 27662662
  242. Margaret Po shan Luke et al. (2016). "Polysialylated Neural Cell Adhesion Molecule Protects Against Light-Induced Retinal Degeneration".PMID 27661859
  243. Laura Asnaghi et al. (2016). "Targeting Notch signaling as a novel therapy for retinoblastoma".PMID 27661116
  244. Atanu Ghorai et al. (2016). "PARP-1 depletion in combination with carbon ion exposure significantly reduces MMPs activity and overall increases TIMPs expression in cultured HeLa cells".PMID 27659937
  245. Fridolin Treindl et al. (2016). "A bead-based western for high-throughput cellular signal transduction analyses".PMID 27659302
  246. Jing Xiong et al. (2016). "Protein Kinase D2 Protects against Acute Colitis Induced by Dextran Sulfate Sodium in Mice".PMID 27659202
  247. Clemens Krepler et al. (2016). "Targeting Notch enhances the efficacy of ERK inhibitors in BRAF-V600E melanoma".PMID 27655717
  248. Yonghua Shi et al. (2016). "Second-generation proteasome inhibitor carfilzomib enhances doxorubicin-induced cytotoxicity and apoptosis in breast cancer cells".PMID 27655642
  249. Joanna M Dragich et al. (2016). "Autophagy linked FYVE (Alfy/WDFY3) is required for establishing neuronal connectivity in the mammalian brain".PMID 27648578
  250. Aleco D'Andrea et al. (2016). "The mitochondrial translation machinery as a therapeutic target in Myc-driven lymphomas".PMID 27635472
  251. Virginia E Bain et al. (2016). "Tissue-specific roles for sonic hedgehog signaling in establishing thymus and parathyroid organ fate".PMID 27633995
  252. Donglai Wang et al. (2016). "Acetylation-regulated interaction between p53 and SET reveals a widespread regulatory mode".PMID 27626385
  253. Mélissa Carbonneau et al. (2016). "The oncometabolite 2-hydroxyglutarate activates the mTOR signalling pathway".PMID 27624942
  254. Heather L Hayes et al. (2016). "A Pdx-1-Regulated Soluble Factor Activates Rat and Human Islet Cell Proliferation".PMID 27620967
  255. A Pérez-Cañamás et al. (2016). "Sphingomyelin-induced inhibition of the plasma membrane calcium ATPase causes neurodegeneration in type A Niemann-Pick disease".PMID 27620840
  256. Kishu Ranjan et al. (2016). "Expression of FADD and cFLIPL balances mitochondrial integrity and redox signaling to substantiate apoptotic cell death".PMID 27619661
  257. Maaike Waasdorp et al. (2016). "Protease-activated receptor-1 deficiency protects against streptozotocin-induced diabetic nephropathy in mice".PMID 27618774
  258. Maria C Olianas et al. (2016). "LPA1 Mediates Antidepressant-Induced ERK1/2 Signaling and Protection from Oxidative Stress in Glial Cells".PMID 27605627
  259. Vasanth Thamodaran et al. (2016). "p38 (Mapk14/11) occupies a regulatory node governing entry into primitive endoderm differentiation during preimplantation mouse embryo development".PMID 27605380
  260. Rachel A Hesler et al. (2016). "TGF-β-induced stromal CYR61 promotes resistance to gemcitabine in pancreatic ductal adenocarcinoma through downregulation of the nucleoside transporters hENT1 and hCNT3".PMID 27604902
  261. Mathieu Heulot et al. (2016). "The TAT-RasGAP317-326 anti-cancer peptide can kill in a caspase-, apoptosis-, and necroptosis-independent manner".PMID 27602963
  262. Shenqi Wang et al. (2016). "Urokinase-type plasminogen activator receptor promotes proliferation and invasion with reduced cisplatin sensitivity in malignant mesothelioma".PMID 27602956
  263. So Jung Park et al. (2016). "Inhibition of never in mitosis A (NIMA)-related kinase-4 reduces survivin expression and sensitizes cancer cells to TRAIL-induced cell death".PMID 27602754
  264. Jun Hee Lee et al. (2016). "Antioxidant effects of Cirsium setidens extract on oxidative stress in human mesenchymal stem cells".PMID 27599894
  265. Hong Phuc Cudré-Cung et al. (2016). "Ammonium accumulation is a primary effect of 2-methylcitrate exposure in an in vitro model for brain damage in methylmalonic aciduria".PMID 27599447
  266. Nufar Edinger et al. (2016). "Targeting polyIC to EGFR over-expressing cells using a dsRNA binding protein domain tethered to EGF".PMID 27598772
  267. Yi Chuan Chen et al. (2016). "Foxp2 controls synaptic wiring of corticostriatal circuits and vocal communication by opposing Mef2c".PMID 27595386
  268. Monika Twardziok et al. (2016). "Multiple Active Compounds from Viscum album L. Synergistically Converge to Promote Apoptosis in Ewing Sarcoma".PMID 27589063
  269. Mandar Deepak Muzumdar et al. (2016). "Clonal dynamics following p53 loss of heterozygosity in Kras-driven cancers".PMID 27585860
  270. Ana Cathia Magalhães et al. (2016). "NKCC1-Deficiency Results in Abnormal Proliferation of Neural Progenitor Cells of the Lateral Ganglionic Eminence".PMID 27582690
  271. Yao Wu et al. (2016). "Knockdown of FOXK1 alone or in combination with apoptosis-inducing 5-FU inhibits cell growth in colorectal cancer".PMID 27571921
  272. Robert A Jones et al. (2016). "RB1 deficiency in triple-negative breast cancer induces mitochondrial protein translation.".PMID 27571409
  273. Vanesa Fernández-Majada et al. (2016). "The tumour suppressor CYLD regulates the p53 DNA damage response".PMID 27561390
  274. Yuan Peng et al. (2016). "ABHD5 interacts with BECN1 to regulate autophagy and tumorigenesis of colon cancer independent of PNPLA2".PMID 27559856
  275. Natalia Kasica et al. (2016). "Protective Effects of Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) Against Oxidative Stress in Zebrafish Hair Cells".PMID 27557978
  276. Chelsea E Cunningham et al. (2016). "Therapeutic relevance of the protein phosphatase 2A in cancer".PMID 27557495
  277. Nicole Vincent Jordan et al. (2016). "HER2 expression identifies dynamic functional states within circulating breast cancer cells".PMID 27556950
  278. Seshiru Nakazawa et al. (2016). "Linear ubiquitination is involved in the pathogenesis of optineurin-associated amyotrophic lateral sclerosis".PMID 27552911
  279. Rana S Dhillon et al. (2016). "Axonal plasticity underpins the functional recovery following surgical decompression in a rat model of cervical spondylotic myelopathy".PMID 27552807
  280. Shuai Yuan et al. (2016). "Hydrogen sulfide metabolism regulates endothelial solute barrier function".PMID 27552214
  281. Taiki Nagano et al. (2016). "Identification of cellular senescence-specific genes by comparative transcriptomics".PMID 27545311
  282. Helena Pomares et al. (2016). "Targeting prohibitins induces apoptosis in acute myeloid leukemia cells".PMID 27542247
  283. Huafeng Wang et al. (2016). "MyD88 Shapes Vaccine Immunity by Extrinsically Regulating Survival of CD4+ T Cells during the Contraction Phase".PMID 27542117
  284. Michaela Ohmer et al. (2016). "Anti-apoptotic Bcl-XL but not Mcl-1 contributes to protection against virus-induced apoptosis".PMID 27537523
  285. Katherine Martin et al. (2016). "PAK proteins and YAP-1 signalling downstream of integrin beta-1 in myofibroblasts promote liver fibrosis".PMID 27535340
  286. Lili Cao et al. (2016). "A Hybrid Chalcone Combining the Trimethoxyphenyl and Isatinyl Groups Targets Multiple Oncogenic Proteins and Pathways in Hepatocellular Carcinoma Cells".PMID 27525972
  287. Matthew Hoare et al. (2016). "NOTCH1 mediates a switch between two distinct secretomes during senescence".PMID 27525720
  288. Juliana Maynard et al. (2016). "The use of (18)F-fluorodeoxyglucose positron emission tomography ((18)F-FDG PET) as a pathway-specific biomarker with AZD8186, a PI3Kβ/δ inhibitor".PMID 27515445
  289. Jason A Pfister et al. (2016). "Regulation of Neuronal Survival by Nucleophosmin 1 (NPM1) Is Dependent on Its Expression Level, Subcellular Localization, and Oligomerization Status".PMID 27510036
  290. Moo Rim Kang et al. (2016). "miR-6734 Up-Regulates p21 Gene Expression and Induces Cell Cycle Arrest and Apoptosis in Colon Cancer Cells".PMID 27509128
  291. Haijie Li et al. (2016). "KDM4B plays an important role in mitochondrial apoptosis by upregulating HAX1 expression in colorectal cancer".PMID 27506941
  292. Hongliang Duan et al. (2016). "Discovery, Synthesis, and Evaluation of 2,4-Diaminoquinazolines as a Novel Class of Pancreatic β-Cell-Protective Agents against Endoplasmic Reticulum (ER) Stress".PMID 27505441
  293. Yuqi Shi et al. (2016). "Inhibitory effect of metformin combined with gemcitabine on pancreatic cancer cells in vitro and in vivo".PMID 27499118
  294. Siv Vingill et al. (2016). "Loss of FBXO7 (PARK15) results in reduced proteasome activity and models a parkinsonism-like phenotype in mice".PMID 27497298
  295. Honghong Shen et al. (2016). "Lin28A activates androgen receptor via regulation of c-myc and promotes malignancy of ER-/Her2+ breast cancer".PMID 27494865
  296. Natalie J Ronaghan et al. (2016). "The serine protease-mediated increase in intestinal epithelial barrier function is dependent on occludin and requires an intact tight junction".PMID 27492333
  297. Marco Gerling et al. (2016). "Stromal Hedgehog signalling is downregulated in colon cancer and its restoration restrains tumour growth".PMID 27492255
  298. Haley R Noonan et al. (2016). "Loss of vhl in the zebrafish pronephros recapitulates early stages of human clear cell renal cell carcinoma".PMID 27491085
  299. Jordan J Bartlett et al. (2016). "Doxorubicin impairs cardiomyocyte viability by suppressing transcription factor EB expression and disrupting autophagy".PMID 27487838
  300. Boris Strilic et al. (2016). "Tumour-cell-induced endothelial cell necroptosis via death receptor 6 promotes metastasis".PMID 27487218
  301. Wenqi Ma et al. (2016). "The clinical significance of forkhead box protein A1 and its role in colorectal cancer".PMID 27484093
  302. Hsin Yuan Cheng et al. (2016). "Loss of ABCG1 influences regulatory T cell differentiation and atherosclerosis.".PMID 27482882
  303. Li Zhang et al. (2016). "Peroxisome proliferator-activated receptor alpha acts as a mediator of endoplasmic reticulum stress-induced hepatocyte apoptosis in acute liver failure".PMID 27482818
  304. Antoine Reginensi et al. (2016). "A critical role for NF2 and the Hippo pathway in branching morphogenesis".PMID 27480037
  305. Andrew M Freddo et al. (2016). "Coordination of signaling and tissue mechanics during morphogenesis of murine intestinal villi: a role for mitotic cell rounding".PMID 27476872
  306. Oliver A Krupke et al. (2016). "Eph and Ephrin function in dispersal and epithelial insertion of pigmented immunocytes in sea urchin embryos".PMID 27474796
  307. Luis Martinez et al. (2016). "Increased sensitivity of African American triple negative breast cancer cells to nitric oxide-induced mitochondria-mediated apoptosis".PMID 27473585
  308. Haidan Liu et al. (2016). "EZH2-mediated Puma gene repression regulates non-small cell lung cancer cell proliferation and cisplatin-induced apoptosis".PMID 27472460
  309. Yuan Wang et al. (2016). "TRPC1/TRPC3 channels mediate lysophosphatidylcholine-induced apoptosis in cultured human coronary artery smooth muscles cells".PMID 27472391
  310. B Anta et al. (2016). "PGA1-induced apoptosis involves specific activation of H-Ras and N-Ras in cellular endomembranes".PMID 27468687
  311. Sandro Alves et al. (2016). "Lentiviral vector-mediated overexpression of mutant ataxin-7 recapitulates SCA7 pathology and promotes accumulation of the FUS/TLS and MBNL1 RNA-binding proteins".PMID 27465358
  312. Jinwei Pang et al. (2016). "Potential implications of Apolipoprotein E in early brain injury after experimental subarachnoid hemorrhage: Involvement in the modulation of blood-brain barrier integrity".PMID 27463015
  313. Jar Yi Ho et al. (2016). "Reduced miR-550a-3p leads to breast cancer initiation, growth, and metastasis by increasing levels of ERK1 and 2".PMID 27462780
  314. Linh Nguyen et al. (2016). "Vascular disruptive agent OXi4503 and anti-angiogenic agent Sunitinib combination treatment prolong survival of mice with CRC liver metastasis".PMID 27460820
  315. Miao Liu et al. (2016). "A Novel Bufalin Derivative Exhibited Stronger Apoptosis-Inducing Effect than Bufalin in A549 Lung Cancer Cells and Lower Acute Toxicity in Mice".PMID 27459387
  316. Hyeon Soo Jeong et al. (2016). "Anti-lipoapoptotic effects of Alisma orientalis extract on non-esterified fatty acid-induced HepG2 cells".PMID 27456850
  317. Sa Kan Yoo et al. (2016). "Plexins function in epithelial repair in both Drosophila and zebrafish".PMID 27452696
  318. Jingjing Wu et al. (2016). "Momordin Ic, a new natural SENP1 inhibitor, inhibits prostate cancer cell proliferation".PMID 27449295
  319. Athanasios Stergiopoulos et al. (2016). "Nuclear receptor NR5A2 controls neural stem cell fate decisions during development".PMID 27447294
  320. Haidong Bao et al. (2016). "Huaier polysaccharide induces apoptosis in hepatocellular carcinoma cells through p38 MAPK".PMID 27446394
  321. Yu Che Cheng et al. (2016). "Knocking down of heat-shock protein 27 directs differentiation of functional glutamatergic neurons from placenta-derived multipotent cells".PMID 27444754
  322. T Fujiwara et al. (2016). "RNA-binding protein Musashi2 induced by RANKL is critical for osteoclast survival".PMID 27441652
  323. Marina Saisana et al. (2016). "Importance of the type I insulin-like growth factor receptor in HER2, FGFR2 and MET-unamplified gastric cancer with and without Ras pathway activation".PMID 27437872
  324. Yoko Kojima et al. (2016). "CD47-blocking antibodies restore phagocytosis and prevent atherosclerosis".PMID 27437576
  325. Sun Woo Lim et al. (2016). "Effect of Exendin-4 on Autophagy Clearance in Beta Cell of Rats with Tacrolimus-induced Diabetes Mellitus".PMID 27436514
  326. Ji Geng et al. (2016). "A novel manganese complex selectively induces malignant glioma cell death by targeting mitochondria".PMID 27432745
  327. Borja Ocón et al. (2016). "The glucocorticoid budesonide has protective and deleterious effects in experimental colitis in mice".PMID 27431777
  328. Maren Q DeGottardi et al. (2016). "Effect of Anti-IL-15 Administration on T Cell and NK Cell Homeostasis in Rhesus Macaques".PMID 27430715
  329. Lin Ding et al. (2016). "Schlafen 4-expressing myeloid-derived suppressor cells are induced during murine gastric metaplasia.".PMID 27427984
  330. Patrick E Gygli et al. (2016). "Cyclin A2 promotes DNA repair in the brain during both development and aging".PMID 27425845
  331. Masashi Naito et al. (2016). "Dnmt3a Regulates Proliferation of Muscle Satellite Cells via p57Kip2".PMID 27415617
  332. Carolina N Perdigoto et al. (2016). "Polycomb-Mediated Repression and Sonic Hedgehog Signaling Interact to Regulate Merkel Cell Specification during Skin Development".PMID 27414999
  333. Raffaella Belvedere et al. (2016). "Annexin A1 contributes to pancreatic cancer cell phenotype, behaviour and metastatic potential independently of Formyl Peptide Receptor pathway".PMID 27412958
  334. Junko Tsuboki et al. (2016). "Onionin A inhibits ovarian cancer progression by suppressing cancer cell proliferation and the protumour function of macrophages".PMID 27404320
  335. Yaqing Zhang et al. (2017). "Myeloid cells are required for PD-1/PD-L1 checkpoint activation and the establishment of an immunosuppressive environment in pancreatic cancer".PMID 27402485
  336. Jia Feng Fang et al. (2016). "Periprostatic implantation of neural differentiated mesenchymal stem cells restores cavernous nerve injury-mediated erectile dysfunction".PMID 27398139
  337. Chun Yan Wang et al. (2016). "Reactivation of ERK and Akt confers resistance of mutant BRAF colon cancer cells to the HSP90 inhibitor AUY922".PMID 27391062
  338. Zhihui Huang et al. (2016). "YAP stabilizes SMAD1 and promotes BMP2-induced neocortical astrocytic differentiation".PMID 27381227
  339. Zhenghu Chen et al. (2016). "Multiple CDK inhibitor dinaciclib suppresses neuroblastoma growth via inhibiting CDK2 and CDK9 activity".PMID 27378523
  340. Hanaa Z Nooh et al. (2016). "The dual anti-inflammatory and antioxidant activities of natural honey promote cell proliferation and neural regeneration in a rat model of colitis".PMID 27378376
  341. David Forsberg et al. (2016). "CO2-evoked release of PGE2 modulates sighs and inspiration as demonstrated in brainstem organotypic culture".PMID 27377173
  342. Michelle Rozo et al. (2016). "Targeting β1-integrin signaling enhances regeneration in aged and dystrophic muscle in mice".PMID 27376575
  343. Hsuan Yu Peng et al. (2016). "MPT0B098, a Microtubule Inhibitor, Suppresses JAK2/STAT3 Signaling Pathway through Modulation of SOCS3 Stability in Oral Squamous Cell Carcinoma".PMID 27367272
  344. Kristin Stock et al. (2016). "Capturing tumor complexity in vitro: Comparative analysis of 2D and 3D tumor models for drug discovery".PMID 27364600
  345. Maria M Simile et al. (2016). "Post-translational deregulation of YAP1 is genetically controlled in rat liver cancer and determines the fate and stem-like behavior of the human disease".PMID 27359056
  346. Hualong Bai et al. (2016). "Pericardial patch venoplasty heals via attraction of venous progenitor cells".PMID 27354544
  347. Kevin K Park et al. (2017). "Retinal ganglion cell survival and axon regeneration after optic nerve injury in naked mole-rats".PMID 27350178
  348. Cornelis J Boogerd et al. (2016). "Probing chromatin landscape reveals roles of endocardial TBX20 in septation.".PMID 27348591
  349. Yusuke Takagi et al. (2016). "SPIB is a novel prognostic factor in diffuse large B-cell lymphoma that mediates apoptosis via the PI3K-AKT pathway".PMID 27348272
  350. Dawid Walerych et al. (2016). "Proteasome machinery is instrumental in a common gain-of-function program of the p53 missense mutants in cancer".PMID 27347849
  351. Gesche Frohwitter et al. (2016). "Cytokeratin and protein expression patterns in squamous cell carcinoma of the oral cavity provide evidence for two distinct pathogenetic pathways".PMID 27347109
  352. Qiang Li et al. (2016). "Stromal cell-derived factor-1 promotes human adipose tissue-derived stem cell survival and chronic wound healing".PMID 27347016
  353. Q Su et al. (2016). "Jagged1 upregulation in prostate epithelial cells promotes formation of reactive stroma in the Pten null mouse model for prostate cancer".PMID 27345403
  354. Jing Shen et al. (2016). "Vascular-targeted TNFα and IFNγ inhibits orthotopic colorectal tumor growth".PMID 27342639
  355. Solene M Evrard et al. (2016). "Endothelial to mesenchymal transition is common in atherosclerotic lesions and is associated with plaque instability".PMID 27340017
  356. Dakai Yang et al. (2016). "MicroRNA-125b-5p mimic inhibits acute liver failure".PMID 27336362
  357. Zoe Hall et al. (2016). "Myc Expression Drives Aberrant Lipid Metabolism in Lung Cancer".PMID 27335109
  358. Andrew L Hong et al. (2016). "Integrated genetic and pharmacologic interrogation of rare cancers".PMID 27329820
  359. Hiroaki Ono et al. (2016). "P300 inhibition enhances gemcitabine-induced apoptosis of pancreatic cancer".PMID 27322077
  360. Gudrun Meinhardt et al. (2016). "Wingless ligand 5a is a critical regulator of placental growth and survival".PMID 27311852
  361. Shiori Akabane et al. (2016). "Constitutive Activation of PINK1 Protein Leads to Proteasome-mediated and Non-apoptotic Cell Death Independently of Mitochondrial Autophagy".PMID 27302064
  362. Sanjoy Roychowdhury et al. (2016). "Receptor interacting protein 3 protects mice from high-fat diet-induced liver injury".PMID 27301788
  363. Weiwei Zhai et al. (2016). "A1 adenosine receptor attenuates intracerebral hemorrhage-induced secondary brain injury in rats by activating the P38-MAPKAP2-Hsp27 pathway".PMID 27301321
  364. Konstantina Rowald et al. (2016). "Negative Selection and Chromosome Instability Induced by Mad2 Overexpression Delay Breast Cancer but Facilitate Oncogene-Independent Outgrowth".PMID 27292643
  365. Guoliang Ding et al. (2016). "Allicin inhibits oxidative stress-induced mitochondrial dysfunction and apoptosis by promoting PI3K/AKT and CREB/ERK signaling in osteoblast cells".PMID 27284348
  366. Wei Bin Fang et al. (2016). "Targeted gene silencing of CCL2 inhibits triple negative breast cancer progression by blocking cancer stem cell renewal and M2 macrophage recruitment".PMID 27283985
  367. Min Cheng et al. (2016). "MicroRNA-181a suppresses parkin-mediated mitophagy and sensitizes neuroblastoma cells to mitochondrial uncoupler-induced apoptosis".PMID 27281615
  368. Tingting Wang et al. (2016). "Dectin-3 Deficiency Promotes Colitis Development due to Impaired Antifungal Innate Immune Responses in the Gut".PMID 27280399
  369. Xuerong Zhao et al. (2016). "Effects of 17-AAG on the cell cycle and apoptosis of H446 cells and the associated mechanisms".PMID 27279418
  370. Yaling Yin et al. (2016). "Accumulation of human full-length tau induces degradation of nicotinic acetylcholine receptor α4 via activating calpain-2".PMID 27277673
  371. Thor Tejada et al. (2016). "IGF-1 degradation by mouse mast cell protease 4 promotes cell death and adverse cardiac remodeling days after a myocardial infarction".PMID 27274047
  372. Emilio Boada-Romero et al. (2016). "The T300A Crohn's disease risk polymorphism impairs function of the WD40 domain of ATG16L1".PMID 27273576
  373. M C De Cian et al. (2017). "Amplification of R-spondin1 signaling induces granulosa cell fate defects and cancers in mouse adult ovary".PMID 27270435
  374. Karnam Shruthi et al. (2016). "Amelioration of neuronal cell death in a spontaneous obese rat model by dietary restriction through modulation of ubiquitin proteasome system".PMID 27260470
  375. Xiaodong Li et al. (2016). "Loss of AP-2delta reduces retinal ganglion cell numbers and axonal projections to the superior colliculus".PMID 27259519
  376. Marco Quarta et al. (2016). "An artificial niche preserves the quiescence of muscle stem cells and enhances their therapeutic efficacy".PMID 27240197
  377. Jianni Qi et al. (2016). "SNAI1 promotes the development of HCC through the enhancement of proliferation and inhibition of apoptosis".PMID 27239445
  378. Wei Cheng et al. (2016). "Mainstream smoke and sidestream smoke affect the cardiac differentiation of mouse embryonic stem cells discriminately".PMID 27237783
  379. Jung ha Park et al. (2016). "Promotion of Intestinal Epithelial Cell Turnover by Commensal Bacteria: Role of Short-Chain Fatty Acids".PMID 27232601
  380. Karolina O Hain et al. (2016). "Prolonged mitotic arrest induces a caspase-dependent DNA damage response at telomeres that determines cell survival".PMID 27230693
  381. Vera Chesnokova et al. (2016). "Growth hormone is permissive for neoplastic colon growth".PMID 27226307
  382. Ananya Roy et al. (2016). "Targeting Serglycin Prevents Metastasis in Murine Mammary Carcinoma".PMID 27223472
  383. Takanori Tatsuno et al. (2016). "Nonsense-mediated mRNA decay factor Upf2 exists in both the nucleoplasm and the cytoplasm".PMID 27221324
  384. Evelyn Fessler et al. (2016). "TGFβ signaling directs serrated adenomas to the mesenchymal colorectal cancer subtype".PMID 27221051
  385. Kun Yuan Lin et al. (2016). "Delivery of a survivin promoter-driven antisense survivin-expressing plasmid DNA as a cancer therapeutic: a proof-of-concept study".PMID 27217778
  386. Ying Huang et al. (2016). "Overcoming resistance to TRAIL-induced apoptosis in solid tumor cells by simultaneously targeting death receptors, c-FLIP and IAPs".PMID 27210546
  387. Takashi Ashino et al. (2016). "Nrf2/Keap1 system regulates vascular smooth muscle cell apoptosis for vascular homeostasis: role in neointimal formation after vascular injury".PMID 27198574
  388. Susanne Thiesen Gren et al. (2016). "The protease inhibitor cystatin C down-regulates the release of IL-β and TNF-α in lipopolysaccharide activated monocytes".PMID 27190304
  389. Alok Ranjan et al. (2016). "Penfluridol suppresses pancreatic tumor growth by autophagy-mediated apoptosis".PMID 27189859
  390. Olga A Cherepanova et al. (2016). "Activation of the pluripotency factor OCT4 in smooth muscle cells is atheroprotective".PMID 27183216
  391. Lei Liu et al. (2016). "Suppression of calcium‑sensing receptor ameliorates cardiac hypertrophy through inhibition of autophagy".PMID 27176663
  392. Zhenhua Xu et al. (2016). "miR-216b regulation of c-Jun mediates GADD153/CHOP-dependent apoptosis".PMID 27173017
  393. Zhe Shen et al. (2016). "Delta-Like Ligand 4 Modulates Liver Damage by Down-Regulating Chemokine Expression".PMID 27171900
  394. Gerburg Keilhoff et al. (2016). "Selected gene profiles of stressed NSC-34 cells and rat spinal cord following peripheral nerve reconstruction and minocycline treatment".PMID 27168790
  395. Jianyun Zhao et al. (2016). "Inhibition of CHK1 enhances cell death induced by the Bcl-2-selective inhibitor ABT-199 in acute myeloid leukemia cells".PMID 27166183
  396. Hao Xue et al. (2016). "A novel tumor-promoting mechanism of IL6 and the therapeutic efficacy of tocilizumab: Hypoxia-induced IL6 is a potent autophagy initiator in glioblastoma via the p-STAT3-MIR155-3p-CREBRF pathway".PMID 27163161
  397. Luigi Tortola et al. (2016). "The Tumor Suppressor Hace1 Is a Critical Regulator of TNFR1-Mediated Cell Fate".PMID 27160902
  398. Lidia De Filippis et al. (2016). "Ethanol-mediated activation of the NLRP3 inflammasome in iPS cells and iPS cells-derived neural progenitor cells".PMID 27160314
  399. Rajni Kant et al. (2016). "Identification of 1,2,3,4,6-Penta-O-galloyl-β-d-glucopyranoside as a Glycine N-Methyltransferase Enhancer by High-Throughput Screening of Natural Products Inhibits Hepatocellular Carcinoma".PMID 27153064
  400. Thao Phuong Le et al. (2016). "14-3-3 proteins regulate Tctp-Rheb interaction for organ growth in Drosophila".PMID 27151460
  401. Yan Wang et al. (2016). "The transplantation of Akt-overexpressing amniotic fluid-derived mesenchymal stem cells protects the heart against ischemia-reperfusion injury in rabbits".PMID 27151366
  402. Xiang Zeng et al. (2016). "The Effects of Thermal Preconditioning on Oncogenic and Intraspinal Cord Growth Features of Human Glioma Cells.".PMID 27151267
  403. Elisa Onesto et al. (2016). "Gene-specific mitochondria dysfunctions in human TARDBP and C9ORF72 fibroblasts".PMID 27151080
  404. Adriana O Santos et al. (2016). "RalGPS2 Is Essential for Survival and Cell Cycle Progression of Lung Cancer Cells Independently of Its Established Substrates Ral GTPases".PMID 27149377
  405. Paloma K Maza et al. (2016). "Histoplasma capsulatum-Induced Cytokine Secretion in Lung Epithelial Cells Is Dependent on Host Integrins, Src-Family Kinase Activation, and Membrane Raft Recruitment".PMID 27148251
  406. Pin Fang Chen et al. (2016). "RBFOX1 and RBFOX2 are dispensable in iPSCs and iPSC-derived neurons and do not contribute to neural-specific paternal UBE3A silencing".PMID 27146458
  407. Catherine C Bell et al. (2016). "Characterization of primary human hepatocyte spheroids as a model system for drug-induced liver injury, liver function and disease".PMID 27143246
  408. Jakob Körbelin et al. (2016). "A brain microvasculature endothelial cell-specific viral vector with the potential to treat neurovascular and neurological diseases".PMID 27137490
  409. Suelen Feitoza Silva et al. (2016). "Oxysterols in adipose tissue-derived mesenchymal stem cell proliferation and death".PMID 27133385
  410. Shuning He et al. (2016). "Synergy between loss of NF1 and overexpression of MYCN in neuroblastoma is mediated by the GAP-related domain".PMID 27130733
  411. Wei Wang et al. (2016). "FXR agonists enhance the sensitivity of biliary tract cancer cells to cisplatin via SHP dependent inhibition of Bcl-xL expression".PMID 27127878
  412. Anna Guinot et al. (2016). "Combined deletion of Vhl, Trp53 and Kif3a causes cystic and neoplastic renal lesions".PMID 27126173
  413. Ishita Chatterjee et al. (2016). "Endothelial lipid phosphate phosphatase-3 deficiency that disrupts the endothelial barrier function is a modifier of cardiovascular development".PMID 27125875
  414. Jennifer McKey et al. (2016). "LIX1 regulates YAP1 activity and controls the proliferation and differentiation of stomach mesenchymal progenitors".PMID 27125505
  415. Hyeong Sim Choi et al. (2016). "Rhus verniciflua Stokes (RVS) and butein induce apoptosis of paclitaxel-resistant SKOV-3/PAX ovarian cancer cells through inhibition of AKT phosphorylation".PMID 27121110
  416. Travis D Hull et al. (2016). "Heme oxygenase-1 regulates mitochondrial quality control in the heart".PMID 27110594
  417. Jingjing Song et al. (2016). "Cordyceps militaris induces tumor cell death via the caspase‑dependent mitochondrial pathway in HepG2 and MCF‑7 cells".PMID 27109250
  418. Laura Wagstaff et al. (2016). "Mechanical cell competition kills cells via induction of lethal p53 levels".PMID 27109213
  419. Zheng Hu et al. (2016). "Enhancement of anti-tumor effects of 5-fluorouracil on hepatocellular carcinoma by low-intensity ultrasound".PMID 27102814
  420. Anne C Rios et al. (2016). "Essential role for a novel population of binucleated mammary epithelial cells in lactation".PMID 27102712
  421. Yan Zhang et al. (2016). "JMJD3 promotes survival of diffuse large B-cell lymphoma subtypes via distinct mechanisms".PMID 27102442
  422. Shu Yi Yin et al. (2016). "Induction of IL-25 secretion from tumour-associated fibroblasts suppresses mammary tumour metastasis".PMID 27089063
  423. Sandrine Delbary-Gossart et al. (2016). "A novel inhibitor of p75-neurotrophin receptor improves functional outcomes in two models of traumatic brain injury".PMID 27084575
  424. Wenrong Zeng et al. (2016). "Silencing of hERG1 Gene Inhibits Proliferation and Invasion, and Induces Apoptosis in Human Osteosarcoma Cells by Targeting the NF-κB Pathway".PMID 27076857
  425. Luyan Shen et al. (2016). "Calcium efflux from the endoplasmic reticulum regulates cisplatin-induced apoptosis in human cervical cancer HeLa cells".PMID 27073489
  426. Jong Hee Jeong et al. (2016). "Neuroprotective and antioxidant activities of bamboo salt soy sauce against H2O2-induced oxidative stress in rat cortical neurons".PMID 27073423
  427. Lan Xiao et al. (2016). "YAP induces cisplatin resistance through activation of autophagy in human ovarian carcinoma cells".PMID 27073322
  428. Anne E Conway et al. (2016). "Enhanced CLIP Uncovers IMP Protein-RNA Targets in Human Pluripotent Stem Cells Important for Cell Adhesion and Survival".PMID 27068461
  429. Mats Hellstrom et al. (2016). "Bioengineered uterine tissue supports pregnancy in a rat model".PMID 27068301
  430. Marta Carrasco-Rando et al. (2016). "Fear-of-intimacy-mediated zinc transport controls the function of zinc-finger transcription factors involved in myogenesis".PMID 27068109
  431. Guopei Zheng et al. (2016). "MYCN-mediated miR-21 overexpression enhances chemo-resistance via targeting CADM1 in tongue cancer".PMID 27055844
  432. A E Hall et al. (2016). "The cytoskeleton adaptor protein ankyrin-1 is upregulated by p53 following DNA damage and alters cell migration".PMID 27054339
  433. Atsushi Iida et al. (2016). "Endogenous GIP ameliorates impairment of insulin secretion in proglucagon-deficient mice under moderate beta cell damage induced by streptozotocin".PMID 27053237
  434. Tania Løve Aaes et al. (2016). "Vaccination with Necroptotic Cancer Cells Induces Efficient Anti-tumor Immunity".PMID 27050509
  435. Anindya Dey et al. (2016). "Inhibition of BMI1 induces autophagy-mediated necroptosis".PMID 27050456
  436. Philipp Seidel et al. (2016). "Epidermal Nbn deletion causes premature hair loss and a phenotype resembling psoriasiform dermatitis".PMID 27050272
  437. Reut Yosef et al. (2016). "Directed elimination of senescent cells by inhibition of BCL-W and BCL-XL".PMID 27048913
  438. Kuo Hui Su et al. (2016). "HSF1 critically attunes proteotoxic stress sensing by mTORC1 to combat stress and promote growth".PMID 27043084
  439. Yesim Negis et al. (2016). "Expression of cell cycle proteins in cortical neurons-Correlation with glutamate-induced neurotoxicity".PMID 27040651
  440. Ksenia Kurbatskaya et al. (2016). "Upregulation of calpain activity precedes tau phosphorylation and loss of synaptic proteins in Alzheimer's disease brain".PMID 27036949
  441. Tobias S Slørdahl et al. (2016). "The phosphatase of regenerating liver-3 (PRL-3) is important for IL-6-mediated survival of myeloma cells".PMID 27036022
  442. Chao Cheng et al. (2016). "Curcumin induces G2/M arrest and triggers apoptosis via FoxO1 signaling in U87 human glioma cells".PMID 27035875
  443. Hua Wang et al. (2016). "The decreased expression of electron transfer flavoprotein β is associated with tubular cell apoptosis in diabetic nephropathy".PMID 27035869
  444. Hiroki Sumiyoshi et al. (2016). "Suppression of STAT5b in pancreatic cancer cells leads to attenuated gemcitabine chemoresistance, adhesion and invasion".PMID 27035235
  445. Jingjing Li et al. (2016). "Pretreatment with Fucoidan from Fucus vesiculosus Protected against ConA-Induced Acute Liver Injury by Inhibiting Both Intrinsic and Extrinsic Apoptosis".PMID 27035150
  446. Yi Fan Lian et al. (2016). "Upregulation of KLHDC4 Predicts a Poor Prognosis in Human Nasopharyngeal Carcinoma".PMID 27030985
  447. Carolina Paola Garcia et al. (2016). "Human Pluripotent Stem Cells and Derived Neuroprogenitors Display Differential Degrees of Susceptibility to BH3 Mimetics ABT-263, WEHI-539 and ABT-199".PMID 27030982
  448. Maitreyi Upadhyay et al. (2016). "Transposon Dysregulation Modulates dWnt4 Signaling to Control Germline Stem Cell Differentiation in Drosophila".PMID 27019121
  449. Song Chen et al. (2016). "Distinct roles of autophagy-dependent and -independent functions of FIP200 revealed by generation and analysis of a mutant knock-in mouse model".PMID 27013233
  450. Jhy Shrian Huang et al. (2016). "Honokiol inhibits sphere formation and xenograft growth of oral cancer side population cells accompanied with JAK/STAT signaling pathway suppression and apoptosis induction".PMID 27012679
  451. Sohee Jun et al. (2016). "LIG4 mediates Wnt signalling-induced radioresistance".PMID 27009971
  452. Ishaq A Viringipurampeer et al. (2016). "NLRP3 inflammasome activation drives bystander cone photoreceptor cell death in a P23H rhodopsin model of retinal degeneration".PMID 27008885
  453. Yu Yang et al. (2016). "Comparison of 2, 5, and 20 % O2 on the development of post-thaw human embryos".PMID 27007876
  454. Tina Gruosso et al. (2016). "Chronic oxidative stress promotes H2AX protein degradation and enhances chemosensitivity in breast cancer patients".PMID 27006338
  455. Motoshi Nagao et al. (2016). "Zbtb20 promotes astrocytogenesis during neocortical development".PMID 27000654
  456. Xiaowen Liu et al. (2016). "LncRNA NBR2 engages a metabolic checkpoint by regulating AMPK under energy stress".PMID 26999735
  457. Issei Ezawa et al. (2016). "Novel p53 target gene FUCA1 encodes a fucosidase and regulates growth and survival of cancer cells".PMID 26998741
  458. Bin Li et al. (2016). "20(S)-Protopanaxadiol saponins inhibit SKOV3 cell migration".PMID 26998063
  459. Masaru Matsumoto et al. (2016). "Cisplatin-induced apoptosis in non-small-cell lung cancer cells is dependent on Bax- and Bak-induction pathway and synergistically activated by BH3-mimetic ABT-263 in p53 wild-type and mutant cells".PMID 26996126
  460. Anna Carrasco et al. (2016). "Regional Specialisation of T Cell Subsets and Apoptosis in the Human Gut Mucosa: Differences Between Ileum and Colon in Healthy Intestine and Inflammatory Bowel Diseases".PMID 26995182
  461. Maria Galán et al. (2016). "Induction of histone deacetylases (HDACs) in human abdominal aortic aneurysm: therapeutic potential of HDAC inhibitors".PMID 26989193
  462. Eleni Panousopoulou et al. (2016). "Epiboly generates the epidermal basal monolayer and spreads the nascent mammalian skin to enclose the embryonic body".PMID 26989131
  463. Carmen M Wong et al. (2016). "Adenovirus-Mediated Expression of the p14 Fusion-Associated Small Transmembrane Protein Promotes Cancer Cell Fusion and Apoptosis In Vitro but Does Not Provide Therapeutic Efficacy in a Xenograft Mouse Model of Cancer".PMID 26986751
  464. Katerina Vlantis et al. (2016). "NEMO Prevents RIP Kinase 1-Mediated Epithelial Cell Death and Chronic Intestinal Inflammation by NF-κB-Dependent and -Independent Functions".PMID 26982364
  465. Ying Hsien Huang et al. (2016). "Postnatal High-Fat Diet Increases Liver Steatosis and Apoptosis Threatened by Prenatal Dexamethasone through the Oxidative Effect".PMID 26978357
  466. Kishu Ranjan et al. (2016). "FADD regulates NF-κB activation and promotes ubiquitination of cFLIPL to induce apoptosis".PMID 26972597
  467. Xuejuan Gao et al. (2016). "hnRNPK inhibits GSK3β Ser9 phosphorylation, thereby stabilizing c-FLIP and contributes to TRAIL resistance in H1299 lung adenocarcinoma cells".PMID 26972480
  468. Hongling Zhao et al. (2016). "Deletions of Retinoblastoma 1 (Rb1) and Its Repressing Target S Phase Kinase-associated protein 2 (Skp2) Are Synthetic Lethal in Mouse Embryogenesis".PMID 26966181
  469. Michala Prause et al. (2016). "JNK1 Deficient Insulin-Producing Cells Are Protected against Interleukin-1β-Induced Apoptosis Associated with Abrogated Myc Expression".PMID 26962537
  470. Rawan Atiq et al. (2016). "Suppression of B-Raf(V600E) cancers by MAPK hyper-activation".PMID 26959890
  471. Maartje van der Heijden et al. (2016). "Bcl-2 is a critical mediator of intestinal transformation".PMID 26956214
  472. Pradeep K Shukla et al. (2016). "Chronic ethanol feeding promotes azoxymethane and dextran sulfate sodium-induced colonic tumorigenesis potentially by enhancing mucosal inflammation".PMID 26951793
  473. Guohao Wang et al. (2016). "Ablation of huntingtin in adult neurons is nondeleterious but its depletion in young mice causes acute pancreatitis".PMID 26951659
  474. J Barroso-González et al. (2016). "PACS-2 mediates the ATM and NF-κB-dependent induction of anti-apoptotic Bcl-xL in response to DNA damage".PMID 26943323
  475. Swati Dhar et al. (2016). "Dietary pterostilbene is a novel MTA1-targeted chemopreventive and therapeutic agent in prostate cancer".PMID 26943043
  476. Michael G Kemp et al. (2016). "ATR Kinase Inhibition Protects Non-cycling Cells from the Lethal Effects of DNA Damage and Transcription Stress".PMID 26940878
  477. Elena Ardini et al. (2016). "Entrectinib, a Pan-TRK, ROS1, and ALK Inhibitor with Activity in Multiple Molecularly Defined Cancer Indications".PMID 26939704
  478. Wei Wang et al. (2016). "Feedback regulation of apical progenitor fate by immature neurons through Wnt7-Celsr3-Fzd3 signalling".PMID 26939553
  479. Horacio Cárdenas et al. (2016). "Dietary Apigenin Exerts Immune-Regulatory Activity in Vivo by Reducing NF-κB Activity, Halting Leukocyte Infiltration and Restoring Normal Metabolic Function".PMID 26938530
  480. Huiling Jing et al. (2016). "Shikonin induces apoptosis of HaCaT cells via the mitochondrial, Erk and Akt pathways".PMID 26935874
  481. Junqi Wu et al. (2016). "Functional analysis of the TMPRSS2:ERG fusion gene in cisplatin‑induced cell death".PMID 26935606
  482. Shawna D Persaud et al. (2016). "All trans-retinoic acid analogs promote cancer cell apoptosis through non-genomic Crabp1 mediating ERK1/2 phosphorylation".PMID 26935534
  483. Marion Gilormini et al. (2016). "Preferential targeting of cancer stem cells in the radiosensitizing effect of ABT-737 on HNSCC".PMID 26934442
  484. S Yang et al. (2016). "A HSP60-targeting peptide for cell apoptosis imaging".PMID 26926787
  485. Carsten Köhler et al. (2016). "Cdc45 is limiting for replication initiation in humans".PMID 26919204
  486. Yan Lai Tang et al. (2016). "Butein inhibits cell proliferation and induces cell cycle arrest in acute lymphoblastic leukemia via FOXO3a/p27kip1 pathway".PMID 26919107
  487. Johanna Eriksson et al. (2016). "Gene expression analyses of primary melanomas reveal CTHRC1 as an important player in melanoma progression".PMID 26918341
  488. Kelly Waldeck et al. (2016). "Long term, continuous exposure to panobinostat induces terminal differentiation and long term survival in the TH-MYCN neuroblastoma mouse model".PMID 26914605
  489. Tomoki Kai et al. (2016). "Kidney-specific knockout of Sav1 in the mouse promotes hyperproliferation of renal tubular epithelium through suppression of the Hippo pathway".PMID 26913567
  490. Li Wang et al. (2016). "Foxc1 reinforces quiescence in self-renewing hair follicle stem cells".PMID 26912704
  491. Juyeong Hong et al. (2016). "Telomerase activates transcription of cyclin D1 gene through an interaction with NOL1".PMID 26906424
  492. Shinya Yufune et al. (2016). "Suppression of ERK phosphorylation through oxidative stress is involved in the mechanism underlying sevoflurane-induced toxicity in the developing brain".PMID 26905012
  493. Cláudio Gouveia Roque et al. (2016). "Tumor protein Tctp regulates axon development in the embryonic visual system".PMID 26903505
  494. André B Gonçalves et al. (2016). "Rapid and simple method for in vivo ex utero development of mouse embryo explants".PMID 26897458
  495. Yulong Ma et al. (2016). "Estrogen replacement therapy-induced neuroprotection against brain ischemia-reperfusion injury involves the activation of astrocytes via estrogen receptor β".PMID 26891996
  496. Nina Stojcheva et al. (2016). "MicroRNA-138 promotes acquired alkylator resistance in glioblastoma by targeting the Bcl-2-interacting mediator BIM".PMID 26887050
  497. Bing M Liao et al. (2016). "Flavin-Containing Monooxygenase 3 Reduces Endoplasmic Reticulum Stress in Lipid-Treated Hepatocytes".PMID 26886171
  498. Andrea Farini et al. (2016). "Inositol 1,4,5-trisphosphate (IP3)-dependent Ca2+ signaling mediates delayed myogenesis in Duchenne muscular dystrophy fetal muscle".PMID 26884398
  499. Wei Zhang et al. (2016). "MiRNA-128 regulates the proliferation and neurogenesis of neural precursors by targeting PCM1 in the developing cortex".PMID 26883496
  500. Wenliang Zhang et al. (2016). "Poly C binding protein 1 represses autophagy through downregulation of LC3B to promote tumor cell apoptosis in starvation".PMID 26880484
  501. Michelle J Nyhan et al. (2016). "MiR-193b promotes autophagy and non-apoptotic cell death in oesophageal cancer cells".PMID 26878873
  502. Daniela A Braun et al. (2016). "Mutations in nuclear pore genes NUP93, NUP205 and XPO5 cause steroid-resistant nephrotic syndrome".PMID 26878725
  503. Veronika Zámbó et al. (2016). "Cytosolic localization of NADH cytochrome b₅ oxidoreductase (Ncb5or)".PMID 26878259
  504. Mi Na Hong et al. (2016). "The small molecule '1-(4-biphenylylcarbonyl)-4-(5-bromo-2-methoxybenzyl) piperazine oxalate' and its derivatives regulate global protein synthesis by inactivating eukaryotic translation initiation factor 2-alpha".PMID 26873011
  505. Sandra Rotondi et al. (2016). "Expression of Peroxisome Proliferator-Activated Receptor alpha (PPARα) in somatotropinomas: Relationship with Aryl hydrocarbon receptor Interacting Protein (AIP) and in vitro effects of fenofibrate in GH3 cells".PMID 26872613
  506. Yan Tang et al. (2016). "Plant Homeo Domain Finger Protein 8 Regulates Mesodermal and Cardiac Differentiation of Embryonic Stem Cells Through Mediating the Histone Demethylation of pmaip1".PMID 26866517
  507. Micha Sam Brickman Raredon et al. (2015). "A Rotating Bioreactor for Scalable Culture and Differentiation of Respiratory Epithelium".PMID 26858899
  508. Fabrice Bouilloux et al. (2016). "Loss of the transcription factor Meis1 prevents sympathetic neurons target-field innervation and increases susceptibility to sudden cardiac death".PMID 26857994
  509. Akifumi Nakagawa et al. (2016). "Selective and reversible suppression of intestinal stem cell differentiation by pharmacological inhibition of BET bromodomains".PMID 26856877
  510. Yan Guo et al. (2016). "Saussurea tridactyla Sch. Bip.-derived polysaccharides and flavones reduce oxidative damage in ultraviolet B-irradiated HaCaT cells via a p38MAPK-independent mechanism".PMID 26855564
  511. Shawn M Davidson et al. (2016). "Environment Impacts the Metabolic Dependencies of Ras-Driven Non-Small Cell Lung Cancer".PMID 26853747
  512. Yan Zhang et al. (2016). "P120 catenin attenuates the angiotensin II-induced apoptosis of human umbilical vein endothelial cells by suppressing the mitochondrial pathway".PMID 26848040
  513. Ying He et al. (2016). "Overexpression of uncoupling protein 2 inhibits the high glucose-induced apoptosis of human umbilical vein endothelial cells".PMID 26846204
  514. Claudio A Franco et al. (2016). "Non-canonical Wnt signalling modulates the endothelial shear stress flow sensor in vascular remodelling".PMID 26845523
  515. L Flanagan et al. (2016). "Low levels of Caspase-3 predict favourable response to 5FU-based chemotherapy in advanced colorectal cancer: Caspase-3 inhibition as a therapeutic approach".PMID 26844701
  516. Enrico N De Toni et al. (2016). "Inactivation of BRCA2 in human cancer cells identifies a subset of tumors with enhanced sensitivity towards death receptor-mediated apoptosis".PMID 26843614
  517. Edmilson Ozorio Dos Santos et al. (2016). "Aurora kinase targeting in lung cancer reduces KRAS-induced transformation".PMID 26842935
  518. Daan R M G Ophelders et al. (2016). "Neuroinflammation and structural injury of the fetal ovine brain following intra-amniotic Candida albicans exposure".PMID 26842664
  519. Han Sun et al. (2016). "A monoclonal antibody against KCNK9 K(+) channel extracellular domain inhibits tumour growth and metastasis".PMID 26842342
  520. Fabian Jacob et al. (2016). "Analysis of Tyrosine Kinase Inhibitor-Mediated Decline in Contractile Force in Rat Engineered Heart Tissue".PMID 26840448
  521. Peizhou Jiang et al. (2016). "Proaggregant nuclear factor(s) trigger rapid formation of α-synuclein aggregates in apoptotic neurons".PMID 26839082
  522. Nien Cheng Chen et al. (2016). "Promotion of mitotic catastrophe via activation of PTEN by paclitaxel with supplement of mulberry water extract in bladder cancer cells".PMID 26838546
  523. Michael S Nakazawa et al. (2016). "Epigenetic re-expression of HIF-2α suppresses soft tissue sarcoma growth".PMID 26837714
  524. Jonathan Lopez et al. (2016). "Mito-priming as a method to engineer Bcl-2 addiction".PMID 26833356
  525. Eric W Ottesen et al. (2016). "Severe impairment of male reproductive organ development in a low SMN expressing mouse model of spinal muscular atrophy".PMID 26830971
  526. S R Podmirseg et al. (2016). "Caspases uncouple p27(Kip1) from cell cycle regulated degradation and abolish its ability to stimulate cell migration and invasion".PMID 26829051
  527. Anne Laure Bouge et al. (2016). "Tau excess impairs mitosis and kinesin-5 function, leading to aneuploidy and cell death".PMID 26822478
  528. Tina M Thornton et al. (2016). "Inactivation of nuclear GSK3β by Ser(389) phosphorylation promotes lymphocyte fitness during DNA double-strand break response".PMID 26822034
  529. Cong Long et al. (2016). "Triptolide decreases expression of latency-associated nuclear antigen 1 and reduces viral titers in Kaposi's sarcoma-associated and herpesvirus-related primary effusion lymphoma cells".PMID 26821279
  530. Hua Wang et al. (2016). "17β-estradiol suppresses hyperoxia-induced apoptosis of oligodendrocytes through paired-immunoglobulin-like receptor B".PMID 26821234
  531. Tong Min Xue et al. (2016). "Intestinal ischemic preconditioning reduces liver ischemia reperfusion injury in rats".PMID 26821057
  532. Emily Powell et al. (2016). "p53 deficiency linked to B cell translocation gene 2 (BTG2) loss enhances metastatic potential by promoting tumor growth in primary and metastatic sites in patient-derived xenograft (PDX) models of triple-negative breast cancer".PMID 26818199
  533. Robert W Button et al. (2016). "Dual PI-3 kinase/mTOR inhibition impairs autophagy flux and induces cell death independent of apoptosis and necroptosis".PMID 26814436
  534. Tomomi Tadokoro et al. (2016). "BMP signaling and cellular dynamics during regeneration of airway epithelium from basal progenitors".PMID 26811382
  535. Christophe Couderc et al. (2016). "AMOTL1 Promotes Breast Cancer Progression and Is Antagonized by Merlin".PMID 26806348
  536. Yan Yan et al. (2016). "Human nasal epithelial cells derived from multiple subjects exhibit differential responses to H3N2 influenza virus infection in vitro".PMID 26806046
  537. Etienne Audet-Walsh et al. (2016). "The PGC-1α/ERRα Axis Represses One-Carbon Metabolism and Promotes Sensitivity to Anti-folate Therapy in Breast Cancer".PMID 26804918
  538. Jong Ik Heo et al. (2016). "XIAP-associating factor 1, a transcriptional target of BRD7, contributes to endothelial cell senescence".PMID 26802028
  539. Maria Goulielmaki et al. (2016). "BRAF associated autophagy exploitation: BRAF and autophagy inhibitors synergise to efficiently overcome resistance of BRAF mutant colorectal cancer cells".PMID 26802026
  540. Chintan N Koyani et al. (2016). "Activation of the MAPK/Akt/Nrf2-Egr1/HO-1-GCLc axis protects MG-63 osteosarcoma cells against 15d-PGJ2-mediated cell death".PMID 26801686
  541. Chunming Jiang et al. (2016). "TNF-α induces vascular endothelial cells apoptosis through overexpressing pregnancy induced noncoding RNA in Kawasaki disease model".PMID 26794462
  542. Yasuhito Watanabe et al. (2015). "Age-Dependent Degeneration of Mature Dentate Gyrus Granule Cells Following NMDA Receptor Ablation".PMID 26793056
  543. Alan Baer et al. (2016). "Venezuelan Equine Encephalitis Virus Induces Apoptosis through the Unfolded Protein Response Activation of EGR1".PMID 26792742
  544. Shyan Yuan Kao et al. (2016). "Activation of TRAIL-DR5 pathway promotes sensorineural degeneration in the inner ear".PMID 26791792
  545. Franz Villarroel-Espíndola et al. (2016). "Polyglucosan Molecules Induce Mitochondrial Impairment and Apoptosis in Germ Cells Without Affecting the Integrity and Functionality of Sertoli Cells".PMID 26790645
  546. Carrie Draney et al. (2016). "Cdk5r1 Overexpression Induces Primary β-Cell Proliferation".PMID 26788519
  547. Rina Kato et al. (2015). "Factors affecting platinum sensitivity in cervical cancer".PMID 26788175
  548. Guobin Wang et al. (2015). "Study of the mechanism underlying the inhibitory effects of transglutaminase II on apoptosis in the osteosarcoma MG-63 cell line under hypoxic conditions".PMID 26788145
  549. Kenta Moriwaki et al. (2016). "Regulation of RIPK3- and RHIM-dependent Necroptosis by the Proteasome".PMID 26786097
  550. Veronika Kanderová et al. (2016). "High-resolution Antibody Array Analysis of Childhood Acute Leukemia Cells".PMID 26785729
  551. Ni Zhu et al. (2016). "A Member of the Nuclear Receptor Superfamily, Designated as NR2F2, Supports the Self-Renewal Capacity and Pluripotency of Human Bone Marrow-Derived Mesenchymal Stem Cells".PMID 26783404
  552. Anne Korwitz et al. (2016). "Loss of OMA1 delays neurodegeneration by preventing stress-induced OPA1 processing in mitochondria".PMID 26783299
  553. M Schirmer et al. (2016). "Intrinsic and chemo-sensitizing activity of SMAC-mimetics on high-risk childhood acute lymphoblastic leukemia".PMID 26775704
  554. Xiaobin Liu et al. (2016). "The novel triterpenoid RTA 408 protects human retinal pigment epithelial cells against H2O2-induced cell injury via NF-E2-related factor 2 (Nrf2) activation".PMID 26773873
  555. David A F Loebel et al. (2016). "Thyroid bud morphogenesis requires CDC42- and SHROOM3-dependent apical constriction".PMID 26772200
  556. Yaping Liu et al. (2016). "Overexpression of PRL7D1 in Leydig Cells Causes Male Reproductive Dysfunction in Mice".PMID 26771609
  557. Zhi Xin Qiu et al. (2016). "The p70S6K Specific Inhibitor PF-4708671 Impedes Non-Small Cell Lung Cancer Growth".PMID 26771549
  558. Shaogui Wang et al. (2016). "Increased hepatic receptor interacting protein kinase 3 expression due to impaired proteasomal functions contributes to alcohol-induced steatosis and liver injury".PMID 26769846
  559. Nicole J Camlin et al. (2016). "Maternal Smoke Exposure Impairs the Long-Term Fertility of Female Offspring in a Murine Model".PMID 26764348
  560. Yunho Kim et al. (2016). "Methylation-dependent regulation of HIF-1α stability restricts retinal and tumour angiogenesis".PMID 26757928
  561. Roslyn N Crowder et al. (2016). "The Deubiquitinase Inhibitor PR-619 Sensitizes Normal Human Fibroblasts to Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL)-mediated Cell Death".PMID 26757822
  562. Akira Kitamura et al. (2016). "Interaction of RNA with a C-terminal fragment of the amyotrophic lateral sclerosis-associated TDP43 reduces cytotoxicity".PMID 26757674
  563. Jyoti Chhibber-Goel et al. (2016). "γ-Secretase Activity Is Required for Regulated Intramembrane Proteolysis of Tumor Necrosis Factor (TNF) Receptor 1 and TNF-mediated Pro-apoptotic Signaling".PMID 26755728
  564. Kyung Ran Park et al. (2016). "4-Methoxydalbergione suppresses growth and induces apoptosis in human osteosarcoma cells in vitro and in vivo xenograft model through down-regulation of the JAK2/STAT3 pathway".PMID 26755649
  565. Katherine R Amato et al. (2016). "EPHA2 Blockade Overcomes Acquired Resistance to EGFR Kinase Inhibitors in Lung Cancer".PMID 26744526
  566. Gemma E Rooney et al. (2016). "Human iPS Cell-Derived Neurons Uncover the Impact of Increased Ras Signaling in Costello Syndrome".PMID 26740656
  567. Nelson Ho et al. (2016). "The effect of 3-bromopyruvate on human colorectal cancer cells is dependent on glucose concentration but not hexokinase II expression".PMID 26740252
  568. Manuela Terranova-Barberio et al. (2016). "Valproic acid potentiates the anticancer activity of capecitabine in vitro and in vivo in breast cancer models via induction of thymidine phosphorylase expression".PMID 26735339
  569. Kerstin Wilhelm et al. (2016). "FOXO1 couples metabolic activity and growth state in the vascular endothelium".PMID 26735015
  570. Fei Zhao et al. (2016). "Triptolide induces protective autophagy through activation of the CaMKKβ-AMPK signaling pathway in prostate cancer cells".PMID 26734992
  571. Long hui Cao et al. (2016). "Morphine, a potential antagonist of cisplatin cytotoxicity, inhibits cisplatin-induced apoptosis and suppression of tumor growth in nasopharyngeal carcinoma xenografts".PMID 26729257
  572. Huiqing Lv et al. (2016). "Preclinical Evaluation of Liposomal C8 Ceramide as a Potent anti-Hepatocellular Carcinoma Agent".PMID 26727592
  573. Cuicui Xie et al. (2016). "Neuroprotection by selective neuronal deletion of Atg7 in neonatal brain injury".PMID 26727396
  574. A Dey et al. (2016). "YB-1 is elevated in medulloblastoma and drives proliferation in Sonic hedgehog-dependent cerebellar granule neuron progenitor cells and medulloblastoma cells".PMID 26725322
  575. Hua Zhang et al. (2016). "Glucagon-like peptide-1 protects cardiomyocytes from advanced oxidation protein product-induced apoptosis via the PI3K/Akt/Bad signaling pathway".PMID 26717963
  576. Chia Yi Yu et al. (2015). "Dengue Virus Impairs Mitochondrial Fusion by Cleaving Mitofusins".PMID 26717518
  577. Susanne Lub et al. (2016). "Inhibiting the anaphase promoting complex/cyclosome induces a metaphase arrest and cell death in multiple myeloma cells".PMID 26716651
  578. Yan Ming Xu et al. (2016). "Proteome profiling of cadmium-induced apoptosis by antibody array analyses in human bronchial epithelial cells".PMID 26716417
  579. Andrei N Mardaryev et al. (2016). "Cbx4 maintains the epithelial lineage identity and cell proliferation in the developing stratified epithelium".PMID 26711500
  580. Ying Lin et al. (2016). "Vaspin attenuates the progression of atherosclerosis by inhibiting ER stress-induced macrophage apoptosis in apoE‑/‑ mice".PMID 26708512
  581. Anna Benedykcinska et al. (2016). "Generation of brain tumours in mice by Cre-mediated recombination of neural progenitors in situ with the tamoxifen metabolite endoxifen".PMID 26704996
  582. Ahmed A M Abdel-Hamid et al. (2016). "Effect of memantine: A NMDA receptor blocker, on ethambutol-induced retinal injury".PMID 26704355
  583. Fei Wang et al. (2016). "RASSF10 is an epigenetically inactivated tumor suppressor and independent prognostic factor in hepatocellular carcinoma".PMID 26701853
  584. Kei Suga et al. (2015). "Data supporting ER stress response in NG108-15 cells involves upregulation of syntaxin 5 expression and reduced amyloid β peptide secretion".PMID 26693512
  585. X Lei et al. (2016). "Exogenous Estradiol Benzoate Induces Spermatogenesis Disorder through Influencing Apoptosis and Oestrogen Receptor Signalling Pathway".PMID 26684898
  586. Victor Garcia et al. (2016). "Galiellalactone induces cell cycle arrest and apoptosis through the ATM/ATR pathway in prostate cancer cells".PMID 26683224
  587. Joana Marquez et al. (2016). "Ocoxin® oral solution slows down tumor growth in an experimental model of colorectal cancer metastasis to the liver in Balb/c mice".PMID 26676882
  588. Ying Wang et al. (2016). "Sodium formate induces autophagy and apoptosis via the JNK signaling pathway of photoreceptor cells".PMID 26676762
  589. Yun Ru Chen et al. (2016). "Autophagy induction causes a synthetic lethal sensitization to ribonucleotide reductase inhibition in breast cancer cells".PMID 26675256
  590. Kaliappan Gopal et al. (2015). "Attrition of Hepatic Damage Inflicted by Angiotensin II with α-Tocopherol and β-Carotene in Experimental Apolipoprotein E Knock-out Mice".PMID 26670291
  591. Prashant Monian et al. (2016). "The Cellular Apoptosis Susceptibility Protein (CAS) Promotes Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL)-induced Apoptosis and Cell Proliferation".PMID 26668314
  592. Ami Patel et al. (2015). "RCAN1 links impaired neurotrophin trafficking to aberrant development of the sympathetic nervous system in Down syndrome".PMID 26658127
  593. Efrat Dvash et al. (2015). "Leukotriene C4 is the major trigger of stress-induced oxidative DNA damage".PMID 26656251
  594. Yuji Ogura et al. (2015). "TAK1 modulates satellite stem cell homeostasis and skeletal muscle repair".PMID 26648529
  595. Xin Huang et al. (2016). "Dose-dependent inhibitory effects of zoledronic acid on osteoblast viability and function in vitro".PMID 26648136
  596. Takeshi Kaizuka et al. (2015). "Atg13 Is Essential for Autophagy and Cardiac Development in Mice".PMID 26644405
  597. Maribel Soto-Nuñez et al. (2015). "Single-cell microinjection assay indicates that 7-hydroxycoumarin induces rapid activation of caspase-3 in A549 cancer cells".PMID 26640551
  598. Anna Trzeciecka et al. (2016). "Dimeric peroxiredoxins are druggable targets in human Burkitt lymphoma".PMID 26636537
  599. Katharina Seidensaal et al. (2015). "Impaired aldehyde dehydrogenase 1 subfamily member 2A-dependent retinoic acid signaling is related with a mesenchymal-like phenotype and an unfavorable prognosis of head and neck squamous cell carcinoma".PMID 26634247
  600. Alessandra Cataldo et al. (2016). "miR-302b enhances breast cancer cell sensitivity to cisplatin by regulating E2F1 and the cellular DNA damage response".PMID 26623722
  601. Qi Fu Bo et al. (2015). "Antitumor action of the peroxisome proliferator-activated receptor-γ agonist rosiglitazone in hepatocellular carcinoma".PMID 26622783
  602. Ashlie A Tronnes et al. (2016). "Effects of Lipopolysaccharide and Progesterone Exposures on Embryonic Cerebral Cortex Development in Mice".PMID 26621965
  603. Martina Zemke et al. (2015). "Loss of Ezh2 promotes a midbrain-to-forebrain identity switch by direct gene derepression and Wnt-dependent regulation".PMID 26621269
  604. Lisa Andzinski et al. (2016). "Type I IFNs induce anti-tumor polarization of tumor associated neutrophils in mice and human".PMID 26619320
  605. Baofang Yang et al. (2015). "Small molecule RL71 targets SERCA2 at a novel site in the treatment of human colorectal cancer".PMID 26608678
  606. Simon J Ittig et al. (2015). "A bacterial type III secretion-based protein delivery tool for broad applications in cell biology".PMID 26598622
  607. Rosa A Uribe et al. (2015). "Histone demethylase KDM4B regulates otic vesicle invagination via epigenetic control of Dlx3 expression".PMID 26598618
  608. Carolin Dahlke et al. (2015). "Inflammation and neuronal death in the motor cortex of the wobbler mouse, an ALS animal model".PMID 26597538
  609. M I Ashraf et al. (2016). "Exogenous Lipocalin 2 Ameliorates Acute Rejection in a Mouse Model of Renal Transplantation".PMID 26595644
  610. Nadya Dimitrova et al. (2016). "Stromal Expression of miR-143/145 Promotes Neoangiogenesis in Lung Cancer Development".PMID 26586766
  611. Stoyana Alexandrova et al. (2016). "Selection and dynamics of embryonic stem cell integration into early mouse embryos".PMID 26586221
  612. Ellen Merrick Schill et al. (2016). "Ibuprofen slows migration and inhibits bowel colonization by enteric nervous system precursors in zebrafish, chick and mouse".PMID 26586201
  613. Agnese Cristini et al. (2016). "DNA-PK triggers histone ubiquitination and signaling in response to DNA double-strand breaks produced during the repair of transcription-blocking topoisomerase I lesions".PMID 26578593
  614. Marie Josée Beaudet et al. (2015). "High yield extraction of pure spinal motor neurons, astrocytes and microglia from single embryo and adult mouse spinal cord".PMID 26577180
  615. Samar Alsafadi et al. (2016). "Nuclear localization of the caspase-3-cleaved form of p73 in anoikis".PMID 26575022
  616. Milica Momcilovic et al. (2015). "Heightening Energetic Stress Selectively Targets LKB1-Deficient Non-Small Cell Lung Cancers".PMID 26574479
  617. Yen Ta Huang et al. (2016). "Resveratrol alleviates the cytotoxicity induced by the radiocontrast agent, ioxitalamate, by reducing the production of reactive oxygen species in HK-2 human renal proximal tubule epithelial cells in vitro".PMID 26573558
  618. Aida Rodrigo Albors et al. (2015). "Planar cell polarity-mediated induction of neural stem cell expansion during axolotl spinal cord regeneration".PMID 26568310
  619. Kimberly E Maxfield et al. (2015). "Comprehensive functional characterization of cancer-testis antigens defines obligate participation in multiple hallmarks of cancer".PMID 26567849
  620. Jon Sin et al. (2016). "Mitophagy is required for mitochondrial biogenesis and myogenic differentiation of C2C12 myoblasts".PMID 26566717
  621. Zhenheng Wang et al. (2015). "Autophagy mediated CoCrMo particle-induced peri-implant osteolysis by promoting osteoblast apoptosis".PMID 26566231
  622. D C Phillips et al. (2015). "Loss in MCL-1 function sensitizes non-Hodgkin's lymphoma cell lines to the BCL-2-selective inhibitor venetoclax (ABT-199)".PMID 26565405
  623. Ranjan Das et al. (2015). "Transforming Growth Factor β1-induced Apoptosis in Podocytes via the Extracellular Signal-regulated Kinase-Mammalian Target of Rapamycin Complex 1-NADPH Oxidase 4 Axis".PMID 26565025
  624. Sae Won Lee et al. (2015). "AKAP6 inhibition impairs myoblast differentiation and muscle regeneration: Positive loop between AKAP6 and myogenin".PMID 26563778
  625. Birgit Lohberger et al. (2015). "Diacerein retards cell growth of chondrosarcoma cells at the G2/M cell cycle checkpoint via cyclin B1/CDK1 and CDK2 downregulation".PMID 26555773
  626. Dobrin Draganov et al. (2015). "Modulation of P2X4/P2X7/Pannexin-1 sensitivity to extracellular ATP via Ivermectin induces a non-apoptotic and inflammatory form of cancer cell death".PMID 26552848
  627. Jan J Zylicz et al. (2015). "Chromatin dynamics and the role of G9a in gene regulation and enhancer silencing during early mouse development".PMID 26551560
  628. Shengyi Sun et al. (2015). "IRE1α is an endogenous substrate of endoplasmic-reticulum-associated degradation".PMID 26551274
  629. Vasileios Askoxylakis et al. (2016). "Preclinical Efficacy of Ado-trastuzumab Emtansine in the Brain Microenvironment".PMID 26547932
  630. Hee Jin Ahn et al. (2015). "Ell3 stabilizes p53 following CDDP treatment via its effects on ubiquitin-dependent and -independent proteasomal degradation pathways in breast cancer cells".PMID 26540344
  631. Marc Pirson et al. (2015). "Thioredoxin-2 Modulates Neuronal Programmed Cell Death in the Embryonic Chick Spinal Cord in Basal and Target-Deprived Conditions".PMID 26540198
  632. Christina A Kearns et al. (2015). "Fbxw7 Limits Myelination by Inhibiting mTOR Signaling".PMID 26538655
  633. Jianqiang Hu et al. (2016). "Luteolin alleviates post-infarction cardiac dysfunction by up-regulating autophagy through Mst1 inhibition".PMID 26538370
  634. Daibiao Xiao et al. (2015). "Myc promotes glutaminolysis in human neuroblastoma through direct activation of glutaminase 2".PMID 26528759
  635. Tun Kiat Ko et al. (2016). "The BIM deletion polymorphism: A paradigm of a permissive interaction between germline and acquired TKI resistance factors in chronic myeloid leukemia".PMID 26517680
  636. Ya Han Wu et al. (2015). "miR-134 Modulates the Proliferation of Human Cardiomyocyte Progenitor Cells by Targeting Meis2".PMID 26512644
  637. Jicheng Yue et al. (2015). "Hyperosmotic Shock Engages Two Positive Feedback Loops through Caspase-3-dependent Proteolysis of JNK1-2 and Bid".PMID 26511318
  638. Wenchao Zhou et al. (2015). "Arsenic trioxide disrupts glioma stem cells via promoting PML degradation to inhibit tumor growth".PMID 26510911
  639. Xiaoying Zhou et al. (2015). "Epigenetic downregulation of the ISG15-conjugating enzyme UbcH8 impairs lipolysis and correlates with poor prognosis in nasopharyngeal carcinoma".PMID 26506425
  640. Chandrashekara Kyathanahalli et al. (2015). "Uterine endoplasmic reticulum stress-unfolded protein response regulation of gestational length is caspase-3 and -7-dependent".PMID 26504199
  641. Shlomi Finkin et al. (2015). "Ectopic lymphoid structures function as microniches for tumor progenitor cells in hepatocellular carcinoma".PMID 26502405
  642. W Shen et al. (2015). "TIFA, an inflammatory signaling adaptor, is tumor suppressive for liver cancer".PMID 26501855
  643. Ling Huang et al. (2015). "Ductal pancreatic cancer modeling and drug screening using human pluripotent stem cell- and patient-derived tumor organoids".PMID 26501191
  644. Philip J Webber et al. (2015). "Combination of heat shock protein 90 and focal adhesion kinase inhibitors synergistically inhibits the growth of non-small cell lung cancer cells".PMID 26501082
  645. Roger Ramcharan et al. (2015). "IGF-1R inhibition induces schedule-dependent sensitization of human melanoma to temozolomide".PMID 26497996
  646. Cody E Nichols et al. (2015). "Cardiac and mitochondrial dysfunction following acute pulmonary exposure to mountaintop removal mining particulate matter".PMID 26497962
  647. Cristina Moncunill-Massaguer et al. (2015). "A novel prohibitin-binding compound induces the mitochondrial apoptotic pathway through NOXA and BIM upregulation".PMID 26497683
  648. Kai Li et al. (2015). "ZNF32 protects against oxidative stress-induced apoptosis by modulating C1QBP transcription".PMID 26497555
  649. Luigi Pasini et al. (2015). "TrkA is amplified in malignant melanoma patients and induces an anti-proliferative response in cell lines".PMID 26496938
  650. Katherine K Slemmons et al. (2015). "Role of the YAP Oncoprotein in Priming Ras-Driven Rhabdomyosarcoma".PMID 26496700
  651. C Liu et al. (2015). "The RCAN1 inhibits NF-κB and suppresses lymphoma growth in mice".PMID 26492364
  652. Jarmila Lauková et al. (2015). "Loss of PTEN Facilitates Rosiglitazone-Mediated Enhancement of Platinum(IV) Complex LA-12-Induced Apoptosis in Colon Cancer Cells".PMID 26492315
  653. Yufeng Wang et al. (2015). "CGK733-induced LC3 II formation is positively associated with the expression of cyclin-dependent kinase inhibitor p21Waf1/Cip1 through modulation of the AMPK and PERK/CHOP signaling pathways".PMID 26486079
  654. Alexandra Vétillard et al. (2015). "Akt inhibition improves irinotecan treatment and prevents cell emergence by switching the senescence response to apoptosis".PMID 26485768
  655. Lili Gao et al. (2015). "Glycyrrhizic acid alleviates bleomycin-induced pulmonary fibrosis in rats".PMID 26483688
  656. Kosuke Fujino et al. (2015). "Insulinoma-Associated Protein 1 Is a Crucial Regulator of Neuroendocrine Differentiation in Lung Cancer".PMID 26482608
  657. Fiorella Campo Verde Arboccó et al. (2016). "Hypothyroidism advances mammary involution in lactating rats through inhibition of PRL signaling and induction of LIF/STAT3 mRNAs".PMID 26472537
  658. Xinyu Ci et al. (2015). "Bortezomib-mediated down-regulation of telomerase and disruption of telomere homeostasis contributes to apoptosis of malignant cells".PMID 26472030
  659. B Sabirzhanov et al. (2016). "miR-711 upregulation induces neuronal cell death after traumatic brain injury".PMID 26470728
  660. W Guo et al. (2015). "Caspase-3 feedback loop enhances Bid-induced AIF/endoG and Bak activation in Bax and p53-independent manner".PMID 26469967
  661. L R Palam et al. (2015). "Integrated stress response is critical for gemcitabine resistance in pancreatic ductal adenocarcinoma".PMID 26469962
  662. Katrin Spiesberger et al. (2015). "Large-Scale Purification of r28M: A Bispecific scFv Antibody Targeting Human Melanoma Produced in Transgenic Cattle".PMID 26469402
  663. Tsion Zewdu Minas et al. (2015). "YK-4-279 effectively antagonizes EWS-FLI1 induced leukemia in a transgenic mouse model".PMID 26462019
  664. Guijun Song et al. (2015). "Anti-autophagic and anti-apoptotic effects of memantine in a SH-SY5Y cell model of Alzheimer's disease via mammalian target of rapamycin-dependent and -independent pathways".PMID 26459718
  665. Flavie Courtaut et al. (2015). "Liver X receptor ligand cytotoxicity in colon cancer cells and not in normal colon epithelial cells depends on LXRβ subcellular localization".PMID 26450852
  666. Xue Song Liu et al. (2015). "LRF maintains genome integrity by regulating the non-homologous end joining pathway of DNA repair".PMID 26446488
  667. Hande Login et al. (2015). "The Stimulus-Dependent Gradient of Cyp26B1+ Olfactory Sensory Neurons Is Necessary for the Functional Integrity of the Olfactory Sensory Map".PMID 26446231
  668. Lauriane Janssen et al. (2016). "ADAMTS3 activity is mandatory for embryonic lymphangiogenesis and regulates placental angiogenesis".PMID 26446156
  669. Ismail S Zaitoun et al. (2015). "Endothelium Expression of Bcl-2 Is Essential for Normal and Pathological Ocular Vascularization".PMID 26444547
  670. Minoru Takasato et al. (2015). "Kidney organoids from human iPS cells contain multiple lineages and model human nephrogenesis".PMID 26444236
  671. Paolo Mattiolo et al. (2015). "Autophagy exacerbates caspase-dependent apoptotic cell death after short times of starvation".PMID 26441250
  672. Adam J Shuhendler et al. (2015). "Molecular Magnetic Resonance Imaging of Tumor Response to Therapy".PMID 26440059
  673. Hélène O B Gautier et al. (2015). "Neuronal activity regulates remyelination via glutamate signalling to oligodendrocyte progenitors".PMID 26439639
  674. Jackalina M Van Kampen et al. (2015). "The Progressive BSSG Rat Model of Parkinson's: Recapitulating Multiple Key Features of the Human Disease".PMID 26439489
  675. Stefan Norlin et al. (2016). "Asna1/TRC40 Controls β-Cell Function and Endoplasmic Reticulum Homeostasis by Ensuring Retrograde Transport".PMID 26438609
  676. Stephen P Fink et al. (2015). "Induction of KIAA1199/CEMIP is associated with colon cancer phenotype and poor patient survival".PMID 26437221
  677. Dong Hu et al. (2015). "Interplay between arginine methylation and ubiquitylation regulates KLF4-mediated genome stability and carcinogenesis".PMID 26420673
  678. Henry E Pelish et al. (2015). "Mediator kinase inhibition further activates super-enhancer-associated genes in AML".PMID 26416749
  679. Li Liu et al. (2015). "Baclofen mediates neuroprotection on hippocampal CA1 pyramidal cells through the regulation of autophagy under chronic cerebral hypoperfusion".PMID 26412641
  680. Shiyuan Song et al. (2015). "The inhibition of histone deacetylase 8 suppresses proliferation and inhibits apoptosis in gastric adenocarcinoma".PMID 26412386
  681. Achim Werner et al. (2015). "Cell-fate determination by ubiquitin-dependent regulation of translation".PMID 26399832
  682. Sara L Sorrell et al. (2016). "Renal peroxiredoxin 6 interacts with anion exchanger 1 and plays a novel role in pH homeostasis".PMID 26398495
  683. Zhong L Hua et al. (2015). "Rac1 plays an essential role in axon growth and guidance and in neuronal survival in the central and peripheral nervous systems".PMID 26395878
  684. Erik W Martin et al. (2015). "Targeting the membrane-anchored serine protease testisin with a novel engineered anthrax toxin prodrug to kill tumor cells and reduce tumor burden".PMID 26392335
  685. Mandy Oj Grootaert et al. (2015). "Defective autophagy in vascular smooth muscle cells accelerates senescence and promotes neointima formation and atherogenesis".PMID 26391655
  686. F F Blanco et al. (2016). "The mRNA-binding protein HuR promotes hypoxia-induced chemoresistance through posttranscriptional regulation of the proto-oncogene PIM1 in pancreatic cancer cells".PMID 26387536
  687. Rui Liu et al. (2015). "Fstl1 is involved in the regulation of radial glial scaffold development".PMID 26382033
  688. Kimberley J Anderson et al. (2015). "NDRG2 promotes myoblast proliferation and caspase 3/7 activities during differentiation, and attenuates hydrogen peroxide - But not palmitate-induced toxicity".PMID 26380811
  689. Heather C Hatcher et al. (2015). "Cytoprotective Effect of Ferritin H in Renal Ischemia Reperfusion Injury".PMID 26379029
  690. Furong Tian et al. (2015). "Investigating the role of shape on the biological impact of gold nanoparticles in vitro".PMID 26377045
  691. Helen B Pearson et al. (2015). "The polarity protein Scrib mediates epidermal development and exerts a tumor suppressive function during skin carcinogenesis".PMID 26376988
  692. Kapil Sirohi et al. (2015). "A Glaucoma-Associated Variant of Optineurin, M98K, Activates Tbk1 to Enhance Autophagosome Formation and Retinal Cell Death Dependent on Ser177 Phosphorylation of Optineurin".PMID 26376340
  693. Semjon Seemann et al. (2015). "Administration of a CXCL12 Analog in Endotoxemia Is Associated with Anti-Inflammatory, Anti-Oxidative and Cytoprotective Effects In Vivo".PMID 26375818
  694. Jianjin Shi et al. (2015). "Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death".PMID 26375003
  695. Bianca C S C Barros et al. (2016). "Paracoccidioides brasiliensis induces recruitment of α3 and α5 integrins into epithelial cell membrane rafts, leading to cytokine secretion".PMID 26369712
  696. Syed Kazim Hasan et al. (2015). "Geraniol attenuates 2-acetylaminofluorene induced oxidative stress, inflammation and apoptosis in the liver of wistar rats".PMID 26364502
  697. Shashi P Singh et al. (2015). "HIF-1α Plays a Critical Role in the Gestational Sidestream Smoke-Induced Bronchopulmonary Dysplasia in Mice".PMID 26361040
  698. João Agostinho Machado-Neto et al. (2015). "Stathmin 1 inhibition amplifies ruxolitinib-induced apoptosis in JAK2V617F cells".PMID 26356819
  699. Yoshinori Seko et al. (2015). "Secreted tyrosine sulfated-eIF5A mediates oxidative stress-induced apoptosis".PMID 26348594
  700. Kai Yao et al. (2016). "Protective Effect of DHT on Apoptosis Induced by U18666A via PI3K/Akt Signaling Pathway in C6 Glial Cell Lines".PMID 26340949
  701. Allyson Agostini-Dreyer et al. (2015). "Endogenous IGFBP-3 Mediates Intrinsic Apoptosis Through Modulation of Nur77 Phosphorylation and Nuclear Export".PMID 26340041
  702. Rachel E James et al. (2016). "Loss of galectin-3 decreases the number of immune cells in the subventricular zone and restores proliferation in a viral model of multiple sclerosis".PMID 26337870
  703. Or Bida et al. (2015). "A novel mitosis-associated lncRNA, MA-linc1, is required for cell cycle progression and sensitizes cancer cells to Paclitaxel".PMID 26337085
  704. Kazuki Heishima et al. (2015). "MicroRNA-214 Promotes Apoptosis in Canine Hemangiosarcoma by Targeting the COP1-p53 Axis".PMID 26335793
  705. Hong Guang Xia et al. (2015). "Degradation of HK2 by chaperone-mediated autophagy promotes metabolic catastrophe and cell death".PMID 26323688
  706. Michael Heide et al. (2015). "Lhx5 controls mamillary differentiation in the developing hypothalamus of the mouse".PMID 26321924
  707. Kanako Noritake et al. (2015). "Direct Exposure to Ethanol Disrupts Junctional Cell-Cell Contact and Hippo-YAP Signaling in HL-1 Murine Atrial Cardiomyocytes".PMID 26317911
  708. Andrew R Lavik et al. (2015). "A synthetic peptide targeting the BH4 domain of Bcl-2 induces apoptosis in multiple myeloma and follicular lymphoma cells alone or in combination with agents targeting the BH3-binding pocket of Bcl-2".PMID 26317541
  709. Hande Yapislar et al. (2016). "Counteraction of Apoptotic and Inflammatory Effects of Adriamycin in the Liver Cell Culture by Clinopitolite".PMID 26306587
  710. Katrin Agnes Salva et al. (2015). "Epigenetically Enhanced Photodynamic Therapy (ePDT) is Superior to Conventional Photodynamic Therapy for Inducing Apoptosis in Cutaneous T-Cell Lymphoma".PMID 26302991
  711. Shunsuke Nishimoto et al. (2015). "Methylcobalamin promotes the differentiation of Schwann cells and remyelination in lysophosphatidylcholine-induced demyelination of the rat sciatic nerve".PMID 26300733
  712. Chi Hsuan Chang et al. (2015). "Mammary Stem Cells and Tumor-Initiating Cells Are More Resistant to Apoptosis and Exhibit Increased DNA Repair Activity in Response to DNA Damage".PMID 26300228
  713. Sabine Wolter et al. (2015). "cCMP causes caspase-dependent apoptosis in mouse lymphoma cell lines".PMID 26300059
  714. Nico Angliker et al. (2015). "mTORC1 and mTORC2 have largely distinct functions in Purkinje cells".PMID 26296489
  715. Il Shin Lee et al. (2015). "Human neural stem cells alleviate Alzheimer-like pathology in a mouse model".PMID 26293123
  716. Tatiana Cañeque et al. (2015). "Synthesis of marmycin A and investigation into its cellular activity".PMID 26291947
  717. Floria Lizarraga et al. (2015). "Tissue Inhibitor of Metalloproteinase-4 Triggers Apoptosis in Cervical Cancer Cells".PMID 26291714
  718. David S Pitcher et al. (2015). "Bortezomib Amplifies Effect on Intracellular Proteasomes by Changing Proteasome Structure".PMID 26288836
  719. Jianhui Liu et al. (2015). "Effects of Sevoflurane on Young Male Adult C57BL/6 Mice Spatial Cognition".PMID 26285216
  720. Dario Barbone et al. (2015). "Autophagy Correlates with the Therapeutic Responsiveness of Malignant Pleural Mesothelioma in 3D Models".PMID 26284517
  721. Chih Yuan Chiang et al. (2015). "A reverse-phase protein microarray-based screen identifies host signaling dynamics upon Burkholderia spp. infection".PMID 26284031
  722. Nicholas A Manieri et al. (2015). "Mucosally transplanted mesenchymal stem cells stimulate intestinal healing by promoting angiogenesis".PMID 26280574
  723. X Li et al. (2016). "Ras association domain family member 10 suppresses gastric cancer growth by cooperating with GSTP1 to regulate JNK/c-Jun/AP-1 pathway".PMID 26279301
  724. L Fan et al. (2016). "Regulation of c-Myc expression by the histone demethylase JMJD1A is essential for prostate cancer cell growth and survival".PMID 26279298
  725. Michael W Pickup et al. (2015). "Deletion of the BMP receptor BMPR1a impairs mammary tumor formation and metastasis".PMID 26274893
  726. Kishor K Sivaraj et al. (2015). "Endothelial Gαq/11 is required for VEGF-induced vascular permeability and angiogenesis".PMID 26272756
  727. Pedro Zuazua-Villar et al. (2015). "Extensive RPA2 hyperphosphorylation promotes apoptosis in response to DNA replication stress in CHK1 inhibited cells".PMID 26271993
  728. Xiaoyang Wan et al. (2016). "Loss of Epithelial Membrane Protein 2 Aggravates Podocyte Injury via Upregulation of Caveolin-1".PMID 26264854
  729. Valeria Iansante et al. (2015). "PARP14 promotes the Warburg effect in hepatocellular carcinoma by inhibiting JNK1-dependent PKM2 phosphorylation and activation".PMID 26258887
  730. Marie Genin et al. (2015). "M1 and M2 macrophages derived from THP-1 cells differentially modulate the response of cancer cells to etoposide".PMID 26253167
  731. Barbora Veselá et al. (2015). "Non-apoptotic role for caspase-7 in hair follicles and the surrounding tissue".PMID 26253163
  732. Fong Kuan Wong et al. (2015). "Sustained Pax6 Expression Generates Primate-like Basal Radial Glia in Developing Mouse Neocortex".PMID 26252244
  733. Heng Wang et al. (2015). "Turning terminally differentiated skeletal muscle cells into regenerative progenitors".PMID 26243583
  734. Alejandra González-Loyola et al. (2015). "Aurora B Overexpression Causes Aneuploidy and p21Cip1 Repression during Tumor Development".PMID 26240282
  735. Alex Laperle et al. (2015). "α-5 Laminin Synthesized by Human Pluripotent Stem Cells Promotes Self-Renewal".PMID 26235893
  736. Shanshan He et al. (2015). "Truncating mutation in the autophagy gene UVRAG confers oncogenic properties and chemosensitivity in colorectal cancers".PMID 26234763
  737. Richard Nuccitelli et al. (2015). "Nanoelectroablation of Murine Tumors Triggers a CD8-Dependent Inhibition of Secondary Tumor Growth".PMID 26231031
  738. Mohamed Bejaoui et al. (2015). "Carbonic Anhydrase Protects Fatty Liver Grafts against Ischemic Reperfusion Damage".PMID 26225852
  739. Monica Marzagalli et al. (2015). "Estrogen Receptor β Agonists Differentially Affect the Growth of Human Melanoma Cell Lines".PMID 26225426
  740. Yuki Miyamoto et al. (2015). "Involvement of the Tyro3 receptor and its intracellular partner Fyn signaling in Schwann cell myelination".PMID 26224309
  741. Gareth E Lim et al. (2015). "14-3-3ζ coordinates adipogenesis of visceral fat".PMID 26220403
  742. Xiyu Zhang et al. (2015). "Isoliensinine induces apoptosis in triple-negative human breast cancer cells through ROS generation and p38 MAPK/JNK activation".PMID 26219228
  743. Shyan Yuan Kao et al. (2015). "Transactivation of human osteoprotegerin promoter by GATA-3".PMID 26216189
  744. L Lefevre et al. (2015). "Combined transcriptome studies identify AFF3 as a mediator of the oncogenic effects of β-catenin in adrenocortical carcinoma".PMID 26214578
  745. Ronald J Parchem et al. (2015). "miR-302 Is Required for Timing of Neural Differentiation, Neural Tube Closure, and Embryonic Viability".PMID 26212322
  746. Yu Yi Chu et al. (2016). "Astrocytic CCAAT/Enhancer Binding Protein δ Regulates Neuronal Viability and Spatial Learning Ability via miR-135a".PMID 26208701
  747. Jin Woo Park et al. (2015). "RE-IIBP Methylates H3K79 and Induces MEIS1-mediated Apoptosis via H2BK120 Ubiquitination by RNF20".PMID 26206755
  748. Hui Mei Wu et al. (2015). "Hypoxia-induced autophagy mediates cisplatin resistance in lung cancer cells".PMID 26201611
  749. Alfredo I Penzo-Méndez et al. (2015). "Spontaneous Cell Competition in Immortalized Mammalian Cell Lines".PMID 26200654
  750. Jan Pencik et al. (2015). "STAT3 regulated ARF expression suppresses prostate cancer metastasis".PMID 26198641
  751. Lu Zhang et al. (2015). "Resveratrol analogue 3,4,4'-trihydroxy-trans-stilbene induces apoptosis and autophagy in human non-small-cell lung cancer cells in vitro".PMID 26190500
  752. Chin Yi Cheng et al. (2015). "Electroacupuncture at different frequencies (5Hz and 25Hz) ameliorates cerebral ischemia-reperfusion injury in rats: possible involvement of p38 MAPK-mediated anti-apoptotic signaling pathways".PMID 26187498
  753. Li Jiao et al. (2015). "Deficiency of Group VIA Phospholipase A2 (iPLA2β) Renders Susceptibility for Chemical-Induced Colitis".PMID 26182903
  754. Stryder M Meadows et al. (2015). "Annexin A3 Regulates Early Blood Vessel Formation".PMID 26182056
  755. S Haupt et al. (2015). "Targeting Mdmx to treat breast cancers with wild-type p53".PMID 26181202
  756. J Xu et al. (2015). "AIP1-mediated actin disassembly is required for postnatal germ cell migration and spermatogonial stem cell niche establishment".PMID 26181199
  757. I Lohse et al. (2015). "BRCA1 and BRCA2 mutations sensitize to chemotherapy in patient-derived pancreatic cancer xenografts".PMID 26180923
  758. Youjun Chen et al. (2015). "Pten Mutations Alter Brain Growth Trajectory and Allocation of Cell Types through Elevated β-Catenin Signaling".PMID 26180201
  759. Suhua Jiang et al. (2015). "Synergistic Effects between mTOR Complex 1/2 and Glycolysis Inhibitors in Non-Small-Cell Lung Carcinoma Cells".PMID 26176608
  760. Hans Richard Demel et al. (2015). "Effects of topoisomerase inhibitors that induce DNA damage response on glucose metabolism and PI3K/Akt/mTOR signaling in multiple myeloma cells".PMID 26175935
  761. Patrice Quintana et al. (2015). "Acid-sensing ion channel 1a drives AMPA receptor plasticity following ischaemia and acidosis in hippocampal CA1 neurons".PMID 26174503
  762. Anna J Jones et al. (2015). "Evidence for bystander signalling between human trophoblast cells and human embryonic stem cells".PMID 26170169
  763. Sheng Huei Yang et al. (2015). "Lovastatin overcomes gefitinib resistance through TNF-α signaling in human cholangiocarcinomas with different LKB1 statuses in vitro and in vivo".PMID 26160843
  764. Jodi K Regan et al. (2016). "Damage-Associated Molecular Pattern and Fetal Membrane Vascular Injury and Collagen Disorganization in Lipopolysaccharide-Induced Intra-amniotic Inflammation in Fetal Sheep".PMID 26156854
  765. Simone Patergnani et al. (2015). "The endoplasmic reticulum mitochondrial calcium cross talk is downregulated in malignant pleural mesothelioma cells and plays a critical role in apoptosis inhibition".PMID 26156019
  766. Nathan M Krah et al. (2015). "The acinar differentiation determinant PTF1A inhibits initiation of pancreatic ductal adenocarcinoma".PMID 26151762
  767. Chuanyue Wu et al. (2015). "Kindlin-2 controls TGF-β signalling and Sox9 expression to regulate chondrogenesis".PMID 26151572
  768. Tomasz Zajkowski et al. (2015). "Stabilization of microtubular cytoskeleton protects neurons from toxicity of N-terminal fragment of cytosolic prion protein".PMID 26149502
  769. J Zhu et al. (2016). "RING finger protein 31 promotes p53 degradation in breast cancer cells".PMID 26148235
  770. Ana Pardo-Saganta et al. (2015). "Parent stem cells can serve as niches for their daughter cells".PMID 26147083
  771. Lian Zhao et al. (2015). "Microglial phagocytosis of living photoreceptors contributes to inherited retinal degeneration".PMID 26139610
  772. Stephen M Ostrowski et al. (2015). "Ectopic Atoh1 expression drives Merkel cell production in embryonic, postnatal and adult mouse epidermis".PMID 26138479
  773. Romulo Hurtado et al. (2015). "Pbx1-dependent control of VMC differentiation kinetics underlies gross renal vascular patterning".PMID 26138478
  774. Claudio Pulito et al. (2015). "Cynara scolymus affects malignant pleural mesothelioma by promoting apoptosis and restraining invasion".PMID 26136339
  775. Liwei Dong et al. (2015). "Echinacoside Induces Apoptosis in Human SW480 Colorectal Cancer Cells by Induction of Oxidative DNA Damages".PMID 26132569
  776. Nimrat Grewal et al. (2016). "Histopathology of aortic complications in bicuspid aortic valve versus Marfan syndrome: relevance for therapy?".PMID 26129868
  777. Zhenran Wang et al. (2015). "Protection of rat intestinal epithelial cells from ischemia/reperfusion injury by (D-Ala2, D-Leu5)-enkephalin through inhibition of the MKK7-JNK signaling pathway".PMID 26126577
  778. Jiayi Wang et al. (2015). "Doxorubicin induces apoptosis by targeting Madcam1 and AKT and inhibiting protein translation initiation in hepatocellular carcinoma cells".PMID 26124182
  779. Maria Cardona et al. (2015). "Executioner Caspase-3 and 7 Deficiency Reduces Myocyte Number in the Developing Mouse Heart".PMID 26121671
  780. E Ciamporcero et al. (2016). "YAP activation protects urothelial cell carcinoma from treatment-induced DNA damage".PMID 26119935
  781. Chan Shan et al. (2015). "Chemical intervention of the NM23-H2 transcriptional programme on c-MYC via a novel small molecule".PMID 26117539
  782. Aoife O'Shaughnessy-Kirwan et al. (2015). "Constraint of gene expression by the chromatin remodelling protein CHD4 facilitates lineage specification".PMID 26116663
  783. Hongliang Duan et al. (2015). "Identification of 5-nitrofuran-2-amide derivatives that induce apoptosis in triple negative breast cancer cells by activating C/EBP-homologous protein expression".PMID 26116180
  784. Kazuo Noda et al. (2016). "Constitutively active mutation of ACVR1 in oral epithelium causes submucous cleft palate in mice".PMID 26116174
  785. Keh Min Liu et al. (2015). "Ketamine-induced ulcerative cystitis and bladder apoptosis involve oxidative stress mediated by mitochondria and the endoplasmic reticulum".PMID 26109091
  786. Marina Theodorou et al. (2015). "Limitations of In Vivo Reprogramming to Dopaminergic Neurons via a Tricistronic Strategy".PMID 26107288
  787. Mélanie Bruchard et al. (2015). "The receptor NLRP3 is a transcriptional regulator of TH2 differentiation".PMID 26098997
  788. C R Goodman et al. (2016). "Steroid induction of therapy-resistant cytokeratin-5-positive cells in estrogen receptor-positive breast cancer through a BCL6-dependent mechanism".PMID 26096934
  789. S Castillo-Lluva et al. (2015). "A new role of SNAI2 in postlactational involution of the mammary gland links it to luminal breast cancer development".PMID 26096931
  790. J Y Wang et al. (2016). "A central role of TRAX in the ATM-mediated DNA repair".PMID 26096928
  791. Robert Tacke et al. (2015). "The transcription factor NR4A1 is essential for the development of a novel macrophage subset in the thymus".PMID 26091486
  792. Ming Huang Chen et al. (2015). "Identification of SPHK1 as a therapeutic target and marker of poor prognosis in cholangiocarcinoma".PMID 26090720
  793. Valerie R Wiersma et al. (2015). "The epithelial polarity regulator LGALS9/galectin-9 induces fatal frustrated autophagy in KRAS mutant colon carcinoma that depends on elevated basal autophagic flux".PMID 26086204
  794. Lu Yang et al. (2015). "Inhibition of ERBB2-overexpressing Tumors by Recombinant Human Prolidase and Its Enzymatically Inactive Mutant".PMID 26086037
  795. Gang Liu et al. (2016). "Mitochondrial permeability transition and its regulatory components are implicated in apoptosis of primary cultures of rat proximal tubular cells exposed to lead".PMID 26082307
  796. Shunsuke Yuri et al. (2015). "Maintenance of Mouse Nephron Progenitor Cells in Aggregates with Gamma-Secretase Inhibitor".PMID 26075891
  797. C Cerella et al. (2015). "Early downregulation of Mcl-1 regulates apoptosis triggered by cardiac glycoside UNBS1450".PMID 26068790
  798. In Su Park et al. (2015). "Enhancement of Ischemic Wound Healing by Spheroid Grafting of Human Adipose-Derived Stem Cells Treated with Low-Level Light Irradiation".PMID 26065900
  799. Dhivya Thiyagarajan et al. (2015). "TNFα Amplifies DNaseI Expression in Renal Tubular Cells while IL-1β Promotes Nuclear DNaseI Translocation in an Endonuclease-Inactive Form".PMID 26065428
  800. Joo Wan Kim et al. (2015). "Schisandrae Fructus Supplementation Ameliorates Sciatic Neurectomy-Induced Muscle Atrophy in Mice".PMID 26064425
  801. Takako Yasuda et al. (2015). "Embryonic Medaka Model of Microglia in the Developing CNS Allowing In Vivo Analysis of Their Spatiotemporal Recruitment in Response to Irradiation".PMID 26061282
  802. Rama P Kotipatruni et al. (2015). "NDRG4 is a novel oncogenic protein and p53 associated regulator of apoptosis in malignant meningioma cells".PMID 26053091
  803. Christian Hirt et al. (2015). "Bioreactor-engineered cancer tissue-like structures mimic phenotypes, gene expression profiles and drug resistance patterns observed "in vivo"".PMID 26051518
  804. F Schuler et al. (2016). "The BH3-only protein BIM contributes to late-stage involution in the mouse mammary gland".PMID 26045049
  805. L Boutaffala et al. (2015). "NIK promotes tissue destruction independently of the alternative NF-κB pathway through TNFR1/RIP1-induced apoptosis".PMID 26045047
  806. Dawid Krokowski et al. (2015). "Coordinated Regulation of the Neutral Amino Acid Transporter SNAT2 and the Protein Phosphatase Subunit GADD34 Promotes Adaptation to Increased Extracellular Osmolarity".PMID 26041779
  807. Hye Young Min et al. (2015). "Targeting the insulin-like growth factor receptor and Src signaling network for the treatment of non-small cell lung cancer".PMID 26041671
  808. Jesus Garcia-Cano et al. (2015). "Exploiting the potential of autophagy in cisplatin therapy: A new strategy to overcome resistance".PMID 26036632
  809. Sebastian Krossa et al. (2015). "Down regulation of Akirin-2 increases chemosensitivity in human glioblastomas more efficiently than Twist-1".PMID 26036627
  810. Fengyun Zhang et al. (2015). "Nicorandil protects mesenchymal stem cells against hypoxia and serum deprivation-induced apoptosis".PMID 26035532
  811. Bettina Weigelin et al. (2015). "Focusing and sustaining the antitumor CTL effector killer response by agonist anti-CD137 mAb".PMID 26034288
  812. Emanuela Papaianni et al. (2015). "Phylogenetically Distant Viruses Use the Same BH3-Only Protein Puma to Trigger Bax/Bak-Dependent Apoptosis of Infected Mouse and Human Cells".PMID 26030884
  813. Chien Chang Huang et al. (2015). "Autophagy-Regulated ROS from Xanthine Oxidase Acts as an Early Effector for Triggering Late Mitochondria-Dependent Apoptosis in Cathepsin S-Targeted Tumor Cells".PMID 26029922
  814. Qian Zhang et al. (2015). "New insights into the function of Cullin 3 in trophoblast invasion and migration".PMID 26021998
  815. Andrea Di Cristofori et al. (2015). "The vacuolar H+ ATPase is a novel therapeutic target for glioblastoma".PMID 26020805
  816. Takanobu Nagata et al. (2015). "Cardiac-Specific SOCS3 Deletion Prevents In Vivo Myocardial Ischemia Reperfusion Injury through Sustained Activation of Cardioprotective Signaling Molecules".PMID 26010537
  817. E M Alexandrova et al. (2015). "Improving survival by exploiting tumour dependence on stabilized mutant p53 for treatment".PMID 26009011
  818. Jing Qiong Kang et al. (2015). "The human epilepsy mutation GABRG2(Q390X) causes chronic subunit accumulation and neurodegeneration".PMID 26005849
  819. D Reigada et al. (2015). "Acute administration of ucf-101 ameliorates the locomotor impairments induced by a traumatic spinal cord injury".PMID 26004679
  820. Wei Hua et al. (2015). "CD36 Mediated Fatty Acid-Induced Podocyte Apoptosis via Oxidative Stress".PMID 26000608
  821. Yong Seok Han et al. (2015). "Fucoidan inhibits the migration and proliferation of HT-29 human colon cancer cells via the phosphoinositide-3 kinase/Akt/mechanistic target of rapamycin pathways".PMID 25998232
  822. Ji Hong Moon et al. (2015). "Quercetin-induced autophagy flux enhances TRAIL-mediated tumor cell death".PMID 25997470
  823. Shinya Yufune et al. (2015). "Transient Blockade of ERK Phosphorylation in the Critical Period Causes Autistic Phenotypes as an Adult in Mice".PMID 25993696
  824. Clara Zoe Wende et al. (2015). "Hairy/Enhancer-of-Split MEGANE and Proneural MASH1 Factors Cooperate Synergistically in Midbrain GABAergic Neurogenesis".PMID 25993409
  825. Linda Klotz et al. (2015). "Cardiac lymphatics are heterogeneous in origin and respond to injury".PMID 25992544
  826. Xiaojuan Yang et al. (2015). "VEGF-B promotes cancer metastasis through a VEGF-A-independent mechanism and serves as a marker of poor prognosis for cancer patients".PMID 25991856
  827. Marie Magdelaine Coudé et al. (2015). "BET inhibitor OTX015 targets BRD2 and BRD4 and decreases c-MYC in acute leukemia cells".PMID 25989842
  828. Ximei Shen et al. (2015). "Fetuin A promotes lipotoxicity in β cells through the TLR4 signaling pathway and the role of pioglitazone in anti-lipotoxicity".PMID 25986658
  829. David B Wang et al. (2015). "Loss of endophilin-B1 exacerbates Alzheimer's disease pathology".PMID 25981964
  830. Andrew Hamilton et al. (2015). "Loss of Serglycin Promotes Primary Tumor Growth and Vessel Functionality in the RIP1-Tag2 Mouse Model for Spontaneous Insulinoma Formation".PMID 25978773
  831. William D Andrews et al. (2016). "Altered proliferative ability of neuronal progenitors in PlexinA1 mutant mice".PMID 25975775
  832. Daniela De Zio et al. (2015). "Apaf1-deficient cortical neurons exhibit defects in axonal outgrowth".PMID 25975226
  833. Somnath Ghosh et al. (2015). "Partial loss of the DNA repair scaffolding protein, Xrcc1, results in increased brain damage and reduced recovery from ischemic stroke in mice".PMID 25971543
  834. Tatsuki Matsumoto et al. (2015). "Small Heat Shock Protein Beta-1 (HSPB1) Is Upregulated and Regulates Autophagy and Apoptosis of Renal Tubular Cells in Acute Kidney Injury".PMID 25962073
  835. F Scala et al. (2016). "Direct relationship between the level of p53 stabilization induced by rRNA synthesis-inhibiting drugs and the cell ribosome biogenesis rate".PMID 25961931
  836. K V Woan et al. (2015). "Targeting histone deacetylase 6 mediates a dual anti-melanoma effect: Enhanced antitumor immunity and impaired cell proliferation".PMID 25957812
  837. D Sarr et al. (2015). "Differential roles of inflammation and apoptosis in initiation of mid-gestational abortion in malaria-infected C57BL/6 and A/J mice".PMID 25956987
  838. M Deutsch et al. (2015). "Divergent effects of RIP1 or RIP3 blockade in murine models of acute liver injury".PMID 25950489
  839. S Kumar et al. (2015). "IPS-1 differentially induces TRAIL, BCL2, BIRC3 and PRKCE in type I interferons-dependent and -independent anticancer activity".PMID 25950488
  840. H W Cheng et al. (2015). "Identification of thioridazine, an antipsychotic drug, as an antiglioblastoma and anticancer stem cell agent using public gene expression data".PMID 25950483
  841. Jingqi Fu et al. (2015). "Protective Role of Nuclear Factor E2-Related Factor 2 against Acute Oxidative Stress-Induced Pancreatic β -Cell Damage".PMID 25949772
  842. Chuen Lin Huang et al. (2016). "Paraquat Induces Cell Death Through Impairing Mitochondrial Membrane Permeability".PMID 25947082
  843. Alicia M Waters et al. (2015). "Preclinical Evaluation of a Novel RXR Agonist for the Treatment of Neuroblastoma".PMID 25944918
  844. Emma K Baker et al. (2015). "BET inhibitors induce apoptosis through a MYC independent mechanism and synergise with CDK inhibitors to kill osteosarcoma cells".PMID 25944566
  845. Li Zhang et al. (2015). "FTY720 induces autophagy-related apoptosis and necroptosis in human glioblastoma cells".PMID 25939952
  846. Weiqi Dai et al. (2015). "By reducing hexokinase 2, resveratrol induces apoptosis in HCC cells addicted to aerobic glycolysis and inhibits tumor growth in mice".PMID 25938543
  847. Gunjan Guha et al. (2015). "Novel Pactamycin Analogs Induce p53 Dependent Cell-Cycle Arrest at S-Phase in Human Head and Neck Squamous Cell Carcinoma (HNSCC) Cells".PMID 25938491
  848. Matthew L Fisher et al. (2015). "Transglutaminase Is Required for Epidermal Squamous Cell Carcinoma Stem Cell Survival".PMID 25934691
  849. Suk Ho Bhang et al. (2015). "pH-triggered release of manganese from MnAu nanoparticles that enables cellular neuronal differentiation without cellular toxicity".PMID 25934450
  850. Nicola R Brindle et al. (2015). "Deficiency for the cysteine protease cathepsin L impairs Myc-induced tumorigenesis in a mouse model of pancreatic neuroendocrine cancer".PMID 25927437
  851. Stephan Philipp et al. (2015). "Homoharringtonine, a clinically approved anti-leukemia drug, sensitizes tumor cells for TRAIL-induced necroptosis".PMID 25925126
  852. Hao Liu et al. (2015). "DNA Polymerases as targets for gene therapy of hepatocellular carcinoma".PMID 25924900
  853. Jeong Won Park et al. (2015). "Oncogenic mutations of thyroid hormone receptor β".PMID 25924236
  854. Wassan Jarrar et al. (2015). "Nkx2.2 and Nkx2.9 are the key regulators to determine cell fate of branchial and visceral motor neurons in caudal hindbrain".PMID 25919494
  855. Xiaoping Xiao et al. (2015). "A neuron-specific antiviral mechanism prevents lethal flaviviral infection of mosquitoes".PMID 25915054
  856. Paschalis Theotokis et al. (2015). "Connexin43 and connexin47 alterations after neural precursor cells transplantation in experimental autoimmune encephalomyelitis".PMID 25914045
  857. Maria Caruso et al. (2015). "R-spondin 1/dickkopf-1/beta-catenin machinery is involved in testicular embryonic angiogenesis".PMID 25910078
  858. Han Liu et al. (2015). "High frequency of loss of PTEN expression in human solid salivary adenoid cystic carcinoma and its implication for targeted therapy".PMID 25909167
  859. K Kataoka et al. (2015). "Macrophage- and RIP3-dependent inflammasome activation exacerbates retinal detachment-induced photoreceptor cell death".PMID 25906154
  860. Janeen H Trembley et al. (2014). "Tenfibgen-DMAT Nanocapsule Delivers CK2 Inhibitor DMAT to Prostate Cancer Xenograft Tumors Causing Inhibition of Cell Proliferation".PMID 25893034
  861. Zhan Yang et al. (2015). "miR-155-dependent regulation of mammalian sterile 20-like kinase 2 (MST2) coordinates inflammation, oxidative stress and proliferation in vascular smooth muscle cells".PMID 25892184
  862. Jalaj Gupta et al. (2015). "Pharmacological inhibition of p38 MAPK reduces tumor growth in patient-derived xenografts from colon tumors".PMID 25890501
  863. Magali Rebucci et al. (2015). "miRNA-196b inhibits cell proliferation and induces apoptosis in HepG2 cells by targeting IGF2BP1".PMID 25889892
  864. Keng Ioi Vong et al. (2015). "Sox9 is critical for suppression of neurogenesis but not initiation of gliogenesis in the cerebellum".PMID 25888505
  865. Ahmed Bettaieb et al. (2015). "Hepatocyte Nicotinamide Adenine Dinucleotide Phosphate Reduced Oxidase 4 Regulates Stress Signaling, Fibrosis, and Insulin Sensitivity During Development of Steatohepatitis in Mice".PMID 25888330
  866. Clifford J Cookman et al. (2015). "Estrogen Receptor-β Up-Regulates IGF1R Expression and Activity to Inhibit Apoptosis and Increase Growth of Medulloblastoma".PMID 25885794
  867. Luis Donis-Maturano et al. (2015). "Prolonged exposure to neutrophil extracellular traps can induce mitochondrial damage in macrophages and dendritic cells".PMID 25883887
  868. C L Wilson et al. (2015). "NFκB1 is a suppressor of neutrophil-driven hepatocellular carcinoma".PMID 25879839
  869. Lujun Yang et al. (2015). "Targeting Notch1 and proteasome as an effective strategy to suppress T-cell lymphoproliferative neoplasms".PMID 25879451
  870. Ali Tebbi et al. (2015). "Caspase-dependent Proteolysis of Human Ribonucleotide Reductase Small Subunits R2 and p53R2 during Apoptosis".PMID 25878246
  871. Audrey Laurent et al. (2015). "ChIP-Seq and RNA-Seq analyses identify components of the Wnt and Fgf signaling pathways as Prep1 target genes in mouse embryonic stem cells".PMID 25875616
  872. Nelma Pértega-Gomes et al. (2015). "A glycolytic phenotype is associated with prostate cancer progression and aggressiveness: a role for monocarboxylate transporters as metabolic targets for therapy".PMID 25875424
  873. Simone Meidhof et al. (2015). "ZEB1-associated drug resistance in cancer cells is reversed by the class I HDAC inhibitor mocetinostat".PMID 25872941
  874. Patricia Rivera et al. (2015). "Pharmacological blockade of the fatty acid amide hydrolase (FAAH) alters neural proliferation, apoptosis and gliosis in the rat hippocampus, hypothalamus and striatum in a negative energy context".PMID 25870539
  875. Gargi Maity et al. (2015). "Aspirin blocks growth of breast tumor cells and tumor-initiating cells and induces reprogramming factors of mesenchymal to epithelial transition".PMID 25867761
  876. Nabil Ben Messaoud et al. (2015). "Osmostress-induced apoptosis in Xenopus oocytes: role of stress protein kinases, calpains and Smac/DIABLO".PMID 25866890
  877. Xia Sheng et al. (2015). "Divergent androgen regulation of unfolded protein response pathways drives prostate cancer".PMID 25864123
  878. Wei Wang et al. (2015). "TRAF Family Member-associated NF-κB Activator (TANK) Inhibits Genotoxic Nuclear Factor κB Activation by Facilitating Deubiquitinase USP10-dependent Deubiquitination of TRAF6 Ligase".PMID 25861989
  879. Dongmei Zhang et al. (2015). "Sialyltransferase7A, a Klf4-responsive gene, promotes cardiomyocyte apoptosis during myocardial infarction".PMID 25860962
  880. Katelin E Ahlers et al. (2015). "Transient activation of microglia following acute alcohol exposure in developing mouse neocortex is primarily driven by BAX-dependent neurodegeneration".PMID 25856413
  881. Guangxiang Zang et al. (2015). "Activated pancreatic stellate cells can impair pancreatic islet function in mice".PMID 25854824
  882. Kevin A Janes et al. (2015). "An analysis of critical factors for quantitative immunoblotting".PMID 25852189
  883. Malte Buchholz et al. (2015). "A multistep high-content screening approach to identify novel functionally relevant target genes in pancreatic cancer".PMID 25849100
  884. Ruijian Zhang et al. (2015). "Inhibition of autophagy using 3-methyladenine increases cisplatin-induced apoptosis by increasing endoplasmic reticulum stress in U251 human glioma cells".PMID 25846607
  885. M Pilar Valdecantos et al. (2015). "Essential role of Nrf2 in the protective effect of lipoic acid against lipoapoptosis in hepatocytes".PMID 25841776
  886. Ming wei Bao et al. (2015). "Dickkopf-3 protects against cardiac dysfunction and ventricular remodelling following myocardial infarction".PMID 25840773
  887. Jun Mei Yi et al. (2015). "Dual targeting of microtubule and topoisomerase II by α-carboline derivative YCH337 for tumor proliferation and growth inhibition".PMID 25840421
  888. Xiaoyu Xia et al. (2015). "A LCMT1-PME-1 methylation equilibrium controls mitotic spindle size".PMID 25839665
  889. Betsy T Kren et al. (2015). "Preclinical evaluation of cyclin dependent kinase 11 and casein kinase 2 survival kinases as RNA interference targets for triple negative breast cancer therapy".PMID 25837326
  890. Nora E Szabo et al. (2015). "Hoxb8 intersection defines a role for Lmx1b in excitatory dorsal horn neuron development, spinofugal connectivity, and nociception".PMID 25834049
  891. Fong Ming Koh et al. (2015). "Emergence of hematopoietic stem and progenitor cells involves a Chd1-dependent increase in total nascent transcription".PMID 25831528
  892. Ying Ding et al. (2014). "Reg3α Overexpression Protects Pancreatic Beta-Cells From Cytokine-Induced Damage and Improves Islet Transplant Outcome".PMID 25826674
  893. Sébastien Tabariès et al. (2015). "Lyn modulates Claudin-2 expression and is a therapeutic target for breast cancer liver metastasis".PMID 25823815
  894. Tomohito Higashi et al. (2015). "Deficiency of angulin-2/ILDR1, a tricellular tight junction-associated membrane protein, causes deafness with cochlear hair cell degeneration in mice".PMID 25822906
  895. Dongwei Jia et al. (2015). "Pyrroloquinoline-quinone suppresses liver fibrogenesis in mice".PMID 25822822
  896. S Marathe et al. (2015). "Notch signaling in response to excitotoxicity induces neurodegeneration via erroneous cell cycle reentry".PMID 25822340
  897. Christopher Scott et al. (2015). "Hepatocyte-specific deletion of ARNT (aryl hydrocarbon Receptor Nuclear Translocator) results in altered fibrotic gene expression in the thioacetamide model of liver injury".PMID 25812120
  898. J Ngo et al. (2015). "Bax deficiency extends the survival of Ku70 knockout mice that develop lung and heart diseases".PMID 25811803
  899. Michael K Wong et al. (2015). "Maternal nicotine exposure leads to impaired disulfide bond formation and augmented endoplasmic reticulum stress in the rat placenta".PMID 25811377
  900. Monica Sakai et al. (2015). "In search of the molecular mechanisms mediating the inhibitory effect of the GnRH antagonist degarelix on human prostate cell growth".PMID 25811175
  901. Maximilian W Popp et al. (2015). "Attenuation of nonsense-mediated mRNA decay facilitates the response to chemotherapeutics".PMID 25808464
  902. Ombretta Salvucci et al. (2015). "EphrinB2 controls vessel pruning through STAT1-JNK3 signalling".PMID 25807892
  903. Anna Iervolino et al. (2015). "Selective dicer suppression in the kidney alters GSK3β/β-catenin pathways promoting a glomerulocystic disease".PMID 25799508
  904. Rugmani Padmanabhan Iyer et al. (2015). "Early matrix metalloproteinase-12 inhibition worsens post-myocardial infarction cardiac dysfunction by delaying inflammation resolution".PMID 25797678
  905. Gokhan Dalgin et al. (2015). "Differential levels of Neurod establish zebrafish endocrine pancreas cell fates".PMID 25797153
  906. Rieko Muramatsu et al. (2015). "Prostacyclin prevents pericyte loss and demyelination induced by lysophosphatidylcholine in the central nervous system".PMID 25795781
  907. Christian Roux et al. (2015). "NMDA receptor blockade in the developing cortex induces autophagy-mediated death of immature cortical GABAergic interneurons: An ex vivo and in vivo study in Gad67-GFP mice".PMID 25795167
  908. Lionel Leclere et al. (2015). "Heat-modified citrus pectin induces apoptosis-like cell death and autophagy in HepG2 and A549 cancer cells".PMID 25794149
  909. Michael G Kemp et al. (2015). "UV Light Potentiates STING (Stimulator of Interferon Genes)-dependent Innate Immune Signaling through Deregulation of ULK1 (Unc51-like Kinase 1)".PMID 25792739
  910. Catarina Bras-Pereira et al. (2015). "The retinal determination gene Dachshund restricts cell proliferation by limiting the activity of the Homothorax-Yorkie complex".PMID 25790852
  911. Han Seok Koh et al. (2015). "The HIF-1/glial TIM-3 axis controls inflammation-associated brain damage under hypoxia".PMID 25790768
  912. Xiaoyue Shen et al. (2015). "Altered viral replication and cell responses by inserting microRNA recognition element into PB1 in pandemic influenza A virus (H1N1) 2009".PMID 25788763
  913. Catherine Itman et al. (2015). "Murine Inhibin α-Subunit Haploinsufficiency Causes Transient Abnormalities in Prepubertal Testis Development Followed by Adult Testicular Decline".PMID 25781564
  914. J Sebastian Gomez-Cavazos et al. (2015). "The nucleoporin gp210/Nup210 controls muscle differentiation by regulating nuclear envelope/ER homeostasis".PMID 25778917
  915. Wei Ma et al. (2015). "Overexpression of N-myc downstream-regulated gene 1 inhibits human glioma proliferation and invasion via phosphoinositide 3-kinase/AKT pathways".PMID 25777142
  916. Yifei Wang et al. (2015). "The cranberry flavonoids PAC DP-9 and quercetin aglycone induce cytotoxicity and cell cycle arrest and increase cisplatin sensitivity in ovarian cancer cells".PMID 25776829
  917. Linya You et al. (2015). "The chromatin regulator Brpf1 regulates embryo development and cell proliferation".PMID 25773539
  918. Eloy Cuadrado et al. (2015). "Phenotypic variation in Aicardi-Goutières syndrome explained by cell-specific IFN-stimulated gene response and cytokine release".PMID 25769924
  919. Audrey P Le et al. (2015). "Plexin-B2 promotes invasive growth of malignant glioma".PMID 25762646
  920. Wenliang Chen et al. (2015). "TRPM7 inhibitor carvacrol protects brain from neonatal hypoxic-ischemic injury".PMID 25761704
  921. Youn Jee Chung et al. (2015). "Transcriptome analysis reveals that Müllerian inhibiting substance regulates signaling pathways that contribute to endometrial carcinogenesis".PMID 25760378
  922. Weipeng Zhang et al. (2015). "Paclitaxel resistance in MCF-7/PTX cells is reversed by paeonol through suppression of the SET/phosphatidylinositol 3-kinase/Akt pathway".PMID 25760096
  923. Sue Kyung Kim et al. (2015). "Upregulated RIP3 Expression Potentiates MLKL Phosphorylation-Mediated Programmed Necrosis in Toxic Epidermal Necrolysis".PMID 25748555
  924. Bo Li et al. (2015). "Evidence for the role of phosphatidylcholine-specific phospholipase in experimental subarachnoid hemorrhage in rats".PMID 25743218
  925. Jeremy Duncan et al. (2015). "Chronic Social Stress and Ethanol Increase Expression of KLF11, a Cell Death Mediator, in Rat Brain".PMID 25739536
  926. Jakub Neradil et al. (2015). "DHFR-mediated effects of methotrexate in medulloblastoma and osteosarcoma cells: the same outcome of treatment with different doses in sensitive cell lines".PMID 25739012
  927. Frank K Braun et al. (2015). "Inhibition of methyltransferases accelerates degradation of cFLIP and sensitizes B-cell lymphoma cells to TRAIL-induced apoptosis".PMID 25738497
  928. Ana Carolina Martinez-Torres et al. (2015). "CD47 agonist peptides induce programmed cell death in refractory chronic lymphocytic leukemia B cells via PLCγ1 activation: evidence from mice and humans".PMID 25734483
  929. Celia J Vogel et al. (2015). "Cooperative induction of apoptosis in NRAS mutant melanoma by inhibition of MEK and ROCK".PMID 25728708
  930. R K Bikkavilli et al. (2015). "Wnt7a is a novel inducer of β-catenin-independent tumor-suppressive cellular senescence in lung cancer".PMID 25728679
  931. Jennifer R Cheung et al. (2015). "Histone markers identify the mode of action for compounds positive in the TK6 micronucleus assay".PMID 25726170
  932. Nikolai V Gorbunov et al. (2015). "Autophagy and mitochondrial remodelling in mouse mesenchymal stromal cells challenged with Staphylococcus epidermidis".PMID 25721260
  933. C Tran Quang et al. (2015). "The calcineurin/NFAT pathway is activated in diagnostic breast cancer cases and is essential to survival and metastasis of mammary cancer cells".PMID 25719243
  934. Sun ErLin et al. (2015). "Musashi-1 maintains blood-testis barrier structure during spermatogenesis and regulates stress granule formation upon heat stress".PMID 25717188
  935. Tomomi Nakahara et al. (2015). "Activation of NF-κB by human papillomavirus 16 E1 limits E1-dependent viral replication through degradation of E1".PMID 25717108
  936. Wei Xiang et al. (2015). "miR-106b-5p targets tumor suppressor gene SETD2 to inactive its function in clear cell renal cell carcinoma".PMID 25714014
  937. Jeffery D Haines et al. (2015). "Nuclear export inhibitors avert progression in preclinical models of inflammatory demyelination".PMID 25706475
  938. Renée de Leeuw et al. (2015). "Novel actions of next-generation taxanes benefit advanced stages of prostate cancer".PMID 25691773
  939. Naoko Fujimura et al. (2015). "Genetic interaction between Pax6 and β-catenin in the developing retinal pigment epithelium".PMID 25689933
  940. Shih Ya Hung et al. (2015). "LC3 overexpression reduces Aβ neurotoxicity through increasing α7nAchR expression and autophagic activity in neurons and mice".PMID 25686800
  941. Benjamin G Bitler et al. (2015). "Synthetic lethality by targeting EZH2 methyltransferase activity in ARID1A-mutated cancers".PMID 25686104
  942. Shaoqing Shi et al. (2015). "Synergistic anticancer effect of cisplatin and Chal-24 combination through IAP and c-FLIPL degradation, Ripoptosome formation and autophagy-mediated apoptosis".PMID 25682199
  943. Marc I Diamond et al. (2015). "Subcellular localization and Ser-137 phosphorylation regulate tumor-suppressive activity of profilin-1".PMID 25681442
  944. Fabienne Guillaumond et al. (2015). "Cholesterol uptake disruption, in association with chemotherapy, is a promising combined metabolic therapy for pancreatic adenocarcinoma".PMID 25675507
  945. S Miyake et al. (2015). "Prolyl hydroxylase regulates axonal rewiring and motor recovery after traumatic brain injury".PMID 25675298
  946. D Kramer et al. (2015). "A pro-apoptotic function of iASPP by stabilizing p300 and CBP through inhibition of BRMS1 E3 ubiquitin ligase activity".PMID 25675294
  947. A Morlé et al. (2015). "Hyperthermia restores apoptosis induced by death receptors through aggregation-induced c-FLIP cytosolic depletion".PMID 25675293
  948. Jessie Jeffery et al. (2015). "Cep55 regulates embryonic growth and development by promoting Akt stability in zebrafish".PMID 25667221
  949. J S Long et al. (2015). "p73 engages A2B receptor signalling to prime cancer cells to chemotherapy-induced death".PMID 25659586
  950. Shih Ching Lo et al. (2015). "Caspase-3 deficiency results in disrupted synaptic homeostasis and impaired attention control".PMID 25653368
  951. Kun Liu et al. (2015). "Impaired macrophage autophagy increases the immune response in obese mice by promoting proinflammatory macrophage polarization".PMID 25650776
  952. Xiaoyan Mao et al. (2015). "Interference with protease-activated receptor 1 does not reduce damage to subventricular zone cells of immature rodent brain following exposure to blood or blood plasma".PMID 25649264
  953. Cheryl D Zimberlin et al. (2015). "HDAC1 and HDAC2 collectively regulate intestinal stem cell homeostasis".PMID 25648995
  954. Rangaswamy Suganya et al. (2015). "Suppression of oxidative phosphorylation in mouse embryonic fibroblast cells deficient in apurinic/apyrimidinic endonuclease".PMID 25645679
  955. Jeffrey C Yu et al. (2015). "Hedgehog signaling regulates dental papilla formation and tooth size during zebrafish odontogenesis".PMID 25645398
  956. Zhewei Shen et al. (2015). "YAP regulates S-phase entry in endothelial cells".PMID 25635998
  957. Roselyne Y Wagner et al. (2015). "Altered E-Cadherin Levels and Distribution in Melanocytes Precede Clinical Manifestations of Vitiligo".PMID 25634357
  958. J J Guan et al. (2015). "DRAM1 regulates apoptosis through increasing protein levels and lysosomal localization of BAX".PMID 25633293
  959. Pei Rong Huang et al. (2015). "N-(1-pyrenyl) maleimide induces bak oligomerization and mitochondrial dysfunction in Jurkat Cells".PMID 25632401
  960. Huayi Suo et al. (2015). "Induction of apoptosis in HCT-116 colon cancer cells by polysaccharide of Larimichthys crocea swim bladder".PMID 25624917
  961. Shingo Eikawa et al. (2015). "Immune-mediated antitumor effect by type 2 diabetes drug, metformin".PMID 25624476
  962. Kevin Roarty et al. (2015). "Ror2 regulates branching, differentiation, and actin-cytoskeletal dynamics within the mammary epithelium".PMID 25624393
  963. Lisa D Urness et al. (2015). "Fgf10 is required for specification of non-sensory regions of the cochlear epithelium".PMID 25624266
  964. Zachary Yu Ching Lin et al. (2015). "Gene expression ontogeny of spermatogenesis in the marmoset uncovers primate characteristics during testicular development".PMID 25624265
  965. Shu Lin Xian et al. (2015). "3-Bromopyruvate inhibits human gastric cancer tumor growth in nude mice via the inhibition of glycolysis".PMID 25621044
  966. Sung Phil Kim et al. (2015). "The Tomato Glycoalkaloid α-Tomatine Induces Caspase-Independent Cell Death in Mouse Colon Cancer CT-26 Cells and Transplanted Tumors in Mice".PMID 25614934
  967. Yan Fang Tao et al. (2015). "Early B-cell factor 3 (EBF3) is a novel tumor suppressor gene with promoter hypermethylation in pediatric acute myeloid leukemia".PMID 25609158
  968. Craig E Barcus et al. (2015). "Dense collagen-I matrices enhance pro-tumorigenic estrogen-prolactin crosstalk in MCF-7 and T47D breast cancer cells".PMID 25607819
  969. Jessica Seeßle et al. (2015). "Palmitate activation by fatty acid transport protein 4 as a model system for hepatocellular apoptosis and steatosis".PMID 25603556
  970. Yajuan Xiao et al. (2015). "Suppressed autophagy flux in skeletal muscle of an amyotrophic lateral sclerosis mouse model during disease progression".PMID 25602021
  971. Hoi Yee Chow et al. (2015). "Group I Paks as therapeutic targets in NF2-deficient meningioma".PMID 25596744
  972. Guobing Li et al. (2015). "Mitochondrial translocation and interaction of cofilin and Drp1 are required for erucin-induced mitochondrial fission and apoptosis".PMID 25595902
  973. Rui Gao et al. (2015). "Inactivation of PNKP by mutant ATXN3 triggers apoptosis by activating the DNA damage-response pathway in SCA3".PMID 25590633
  974. Jun Xia et al. (2015). "ZGDHu-1 induces G₂/M phase arrest and apoptosis in Kasumi-1 cells".PMID 25573277
  975. S Saveljeva et al. (2015). "Endoplasmic reticulum stress induces ligand-independent TNFR1-mediated necroptosis in L929 cells".PMID 25569104
  976. L Liu et al. (2015). "Tamoxifen reduces fat mass by boosting reactive oxygen species".PMID 25569103
  977. S Liu et al. (2015). "Disrupted autophagy after spinal cord injury is associated with ER stress and neuronal cell death".PMID 25569099
  978. Linya You et al. (2015). "Deficiency of the chromatin regulator BRPF1 causes abnormal brain development".PMID 25568313
  979. Sarah Moyon et al. (2015). "Demyelination causes adult CNS progenitors to revert to an immature state and express immune cues that support their migration".PMID 25568099
  980. Barbara Jonchère et al. (2015). "Irinotecan treatment and senescence failure promote the emergence of more transformed and invasive cells that depend on anti-apoptotic Mcl-1".PMID 25565667
  981. Matthildi Valianou et al. (2015). "Pharmacological inhibition of Polo-like kinase 1 (PLK1) by BI-2536 decreases the viability and survival of hamartin and tuberin deficient cells via induction of apoptosis and attenuation of autophagy".PMID 25565629
  982. Zhanguo Gao et al. (2015). "P65 inactivation in adipocytes and macrophages attenuates adipose inflammatory response in lean but not in obese mice".PMID 25564477
  983. Paolo Cappella et al. (2015). "Application of click chemistry conditions for 5-bromo-2'-deoxyuridine determination through fenton and related reactions".PMID 25559225
  984. Xiao Fei Zhang et al. (2016). "Expression and prognostic role of ubiquitination factor E4B in primary hepatocellular carcinoma".PMID 25557723
  985. Peter Sykora et al. (2015). "DNA polymerase β deficiency leads to neurodegeneration and exacerbates Alzheimer disease phenotypes".PMID 25552414
  986. Shakeel U R Mir et al. (2015). "Inhibition of autophagic turnover in β-cells by fatty acids and glucose leads to apoptotic cell death".PMID 25548282
  987. Chien Cheng Chen et al. (2014). "Berberine protects against neuronal damage via suppression of glia-mediated inflammation in traumatic brain injury".PMID 25546475
  988. Elodie A Pérès et al. (2015). "Silencing erythropoietin receptor on glioma cells reinforces efficacy of temozolomide and X-rays through senescence and mitotic catastrophe".PMID 25544764
  989. Saurabh Bharti et al. (2015). "5-HT2B receptor blockade attenuates β-adrenergic receptor-stimulated myocardial remodeling in rats via inhibiting apoptosis: role of MAPKs and HSPs".PMID 25544272
  990. Alfeu Zanotto-Filho et al. (2015). "Autophagy inhibition improves the efficacy of curcumin/temozolomide combination therapy in glioblastomas".PMID 25542083
  991. Rebecca M Hill et al. (2015). "Combined MYC and P53 defects emerge at medulloblastoma relapse and define rapidly progressive, therapeutically targetable disease".PMID 25533335
  992. Masamichi Imajo et al. (2015). "Dual role of YAP and TAZ in renewal of the intestinal epithelium".PMID 25531778
  993. Shiyu Wang et al. (2015). "Identification of protein disulfide isomerase 1 as a key isomerase for disulfide bond formation in apolipoprotein B100".PMID 25518935
  994. Patricia Gomez-Bougie et al. (2015). "Curcumin induces cell death of the main molecular myeloma subtypes, particularly the poor prognosis subgroups".PMID 25517601
  995. D Hennig et al. (2015). "Antagonism between granulocytic maturation and deacetylase inhibitor-induced apoptosis in acute promyelocytic leukaemia cells".PMID 25514379
  996. Daisuke Suzuki et al. (2015). "The carboxy-terminus of p63 links cell cycle control and the proliferative potential of epidermal progenitor cells".PMID 25503409
  997. Valentina Grande et al. (2014). "Neuroprotective and anti-inflammatory roles of the phosphatase and tensin homolog deleted on chromosome Ten (PTEN) Inhibition in a Mouse Model of Temporal Lobe Epilepsy".PMID 25501575
  998. Maria Romina Girotti et al. (2015). "Paradox-breaking RAF inhibitors that also target SRC are effective in drug-resistant BRAF mutant melanoma".PMID 25500121
  999. Guan Yu Chen et al. (2015). "Graphene oxide as a chemosensitizer: diverted autophagic flux, enhanced nuclear import, elevated necrosis and improved antitumor effects".PMID 25498801
  1000. Yu Hsuan Chen et al. (2015). "Dual phosphoinositide 3-kinase/mammalian target of rapamycin inhibitor is an effective radiosensitizer for colorectal cancer".PMID 25497009
  1001. Chika Okusa et al. (2014). "Subplate in a rat model of preterm hypoxia-ischemia".PMID 25493282
  1002. Gaurav Kaushik et al. (2015). "Honokiol inhibits melanoma stem cells by targeting notch signaling".PMID 25491779
  1003. Akinori Yoda et al. (2015). "Mutations in G protein β subunits promote transformation and kinase inhibitor resistance".PMID 25485910
  1004. Bianca N S P Medina et al. (2015). "3-acetylpyridine-induced degeneration in the adult ascidian neural complex: Reactive and regenerative changes in glia and blood cells".PMID 25484282
  1005. Chinmoy Sarkar et al. (2014). "Impaired autophagy flux is associated with neuronal cell death after traumatic brain injury".PMID 25484084
  1006. Michelle Cicchini et al. (2014). "Autophagy regulator BECN1 suppresses mammary tumorigenesis driven by WNT1 activation and following parity".PMID 25483966
  1007. Joseph A Bisson et al. (2015). "Wnt5a and Wnt11 inhibit the canonical Wnt pathway and promote cardiac progenitor development via the Caspase-dependent degradation of AKT".PMID 25482987
  1008. Hong Liu et al. (2015). "Inhibition of autophagy recovers cardiac dysfunction and atrophy in response to tail-suspension".PMID 25476825
  1009. Zachary B Smithline et al. (2014). "Inhibiting heat shock protein 90 (HSP90) limits the formation of liver cysts induced by conditional deletion of Pkd1 in mice".PMID 25474361
  1010. Rosalba Parenti et al. (2014). "Wilms' tumor gene 1 (WT1) silencing inhibits proliferation of malignant peripheral nerve sheath tumor sNF96.2 cell line".PMID 25474318
  1011. Hongxin Ma et al. (2015). "ZHX2 enhances the cytotoxicity of chemotherapeutic drugs in liver tumor cells by repressing MDR1 via interfering with NF-YA".PMID 25473899
  1012. Zeinab Mohamed Kamel Ismail et al. (2014). "Enhancement of Neural Stem Cells after Induction of Depression in Male Albino Rats (A histological & Immunohistochemical Study)".PMID 25473444
  1013. Courtney Bricker-Anthony et al. (2014). "Exacerbation of blast-induced ocular trauma by an immune response".PMID 25472427
  1014. Wei Liu et al. (2015). "Hepatitis B virus core protein inhibits Fas-mediated apoptosis of hepatoma cells via regulation of mFas/FasL and sFas expression".PMID 25466893
  1015. Marin E Healy et al. (2015). "Dietary effects on liver tumor burden in mice treated with the hepatocellular carcinogen diethylnitrosamine".PMID 25450719
  1016. Katerina Kapodistria et al. (2015). "Nephrin, a transmembrane protein, is involved in pancreatic beta-cell survival signaling".PMID 25448064
  1017. Ikram El Zaoui et al. (2015). "Glucocorticoids exert direct toxicity on microvasculature: analysis of cell death mechanisms".PMID 25447644
  1018. Angela Castanieto et al. (2014). "EGFR signaling promotes self-renewal through the establishment of cell polarity in Drosophila follicle stem cells".PMID 25437306
  1019. Hayley Davis et al. (2015). "Aberrant epithelial GREM1 expression initiates colonic tumorigenesis from cells outside the stem cell niche".PMID 25419707
  1020. Li Da Guo et al. (2015). "Curcumin combined with oxaliplatin effectively suppress colorectal carcinoma in vivo through inducing apoptosis".PMID 25418925
  1021. Xiaoyan Hu et al. (2014). "Tau pathogenesis is promoted by Aβ1-42 but not Aβ1-40".PMID 25417177
  1022. Edmond Chipumuro et al. (2014). "CDK7 inhibition suppresses super-enhancer-linked oncogenic transcription in MYCN-driven cancer".PMID 25416950
  1023. Chun Hu Wu et al. (2014). "Post-injury treatment with 7,8-dihydroxyflavone, a TrkB receptor agonist, protects against experimental traumatic brain injury via PI3K/Akt signaling".PMID 25415296
  1024. Sonali Nashine et al. (2014). "Role of C/EBP homologous protein in retinal ganglion cell death after ischemia/reperfusion injury".PMID 25414185
  1025. Amy Holloway et al. (2015). "Resistance to UV-induced apoptosis by β-HPV5 E6 involves targeting of activated BAK for proteolysis by recruitment of the HERC1 ubiquitin ligase".PMID 25408501
  1026. Guozhu Chen et al. (2015). "RIP1-dependent Bid cleavage mediates TNFα-induced but Caspase-3-independent cell death in L929 fibroblastoma cells".PMID 25398540
  1027. Erin J Plosa et al. (2014). "Epithelial β1 integrin is required for lung branching morphogenesis and alveolarization".PMID 25395457
  1028. Tzung Hai Yen et al. (2015). "Epidermal growth factor attenuates tubular necrosis following mercuric chloride damage by regeneration of indigenous, not bone marrow-derived cells".PMID 25389045
  1029. Francisco Ortiz et al. (2015). "Melatonin blunts the mitochondrial/NLRP3 connection and protects against radiation-induced oral mucositis".PMID 25388914
  1030. Ma Somsouk et al. (2015). "Gut epithelial barrier and systemic inflammation during chronic HIV infection".PMID 25387317
  1031. Stefanie L Makowski et al. (2015). "A protease-independent function for SPPL3 in NFAT activation".PMID 25384971
  1032. Camille Dejos et al. (2014). "Canthin-6-one displays antiproliferative activity and causes accumulation of cancer cells in the G2/M phase".PMID 25379743
  1033. Shang Ze Li et al. (2014). "UbcH10 overexpression increases carcinogenesis and blocks ALLN susceptibility in colorectal cancer".PMID 25376843
  1034. Paulius Venalis et al. (2015). "Cardiomyopathy in murine models of systemic sclerosis".PMID 25371068
  1035. Elisabeth J Pechriggl et al. (2015). "Development of the innervation of the human inner ear".PMID 25363666
  1036. Wensi Tao et al. (2014). "Hormonal induction and roles of Disabled-2 in lactation and involution".PMID 25360623
  1037. Fengshan Xie et al. (2015). "Vaccarin attenuates the human EA.hy926 endothelial cell oxidative stress injury through inhibition of Notch signaling".PMID 25352009
  1038. Maria E Cuevas et al. (2015). "In vitro cytotoxicity of 4'-OH-tamoxifen and estradiol in human endometrial adenocarcinoma cells HEC-1A and HEC-1B".PMID 25351552
  1039. Alessandra Stacchiotti et al. (2014). "Mitochondrial and metabolic dysfunction in renal convoluted tubules of obese mice: protective role of melatonin".PMID 25347680
  1040. Amandine Vanhoutteghem et al. (2014). "The zinc-finger protein basonuclin 2 is required for proper mitotic arrest, prevention of premature meiotic initiation and meiotic progression in mouse male germ cells".PMID 25344072
  1041. Jean Ha Baek et al. (2015). "Expression of progerin in aging mouse brains reveals structural nuclear abnormalities without detectible significant alterations in gene expression, hippocampal stem cells or behavior".PMID 25343989
  1042. H H Lin et al. (2014). "Dynamic involvement of ATG5 in cellular stress responses".PMID 25341032
  1043. Shaun Martin et al. (2015). "Cell-type variation in stress responses as a consequence of manipulating GRP78 expression in neuroectodermal cells".PMID 25336069
  1044. H Shang et al. (2015). "Effects of maternal dexamethasone treatment early in pregnancy on glucocorticoid receptors in the ovine placenta".PMID 25332218
  1045. Yoshiyuki Ikeda et al. (2015). "Endogenous Drp1 mediates mitochondrial autophagy and protects the heart against energy stress".PMID 25332205
  1046. Yee Hsieh Evelyn Heng et al. (2015). "NFIX Regulates Proliferation and Migration Within the Murine SVZ Neurogenic Niche".PMID 25331604
  1047. Tao Zhang et al. (2014). "RNA-processing protein TDP-43 regulates FOXO-dependent protein quality control in stress response".PMID 25329970
  1048. Lykke Blaabjerg et al. (2014). "CRFR1 activation protects against cytokine-induced β-cell death".PMID 25324488
  1049. William S Holland et al. (2015). "Effects of AKT inhibition on HGF-mediated erlotinib resistance in non-small cell lung cancer cell lines".PMID 25323938
  1050. Hea Jin Jung et al. (2014). "An absence of nuclear lamins in keratinocytes leads to ichthyosis, defective epidermal barrier function, and intrusion of nuclear membranes and endoplasmic reticulum into the nuclear chromatin".PMID 25312645
  1051. M Ortega et al. (2015). "A microRNA-mediated regulatory loop modulates NOTCH and MYC oncogenic signals in B- and T-cell malignancies".PMID 25311243
  1052. Jason Tchao et al. (2014). "Combined biophysical and soluble factor modulation induces cardiomyocyte differentiation from human muscle derived stem cells".PMID 25310989
  1053. Hairong Xu et al. (2015). "AMPKα1 deficiency promotes cellular proliferation and DNA damage via p21 reduction in mouse embryonic fibroblasts".PMID 25307521
  1054. Brandon A Kocher et al. (2015). "DAPK3 suppresses acini morphogenesis and is required for mouse development".PMID 25304685
  1055. Marie M Lockhart et al. (2014). "Alk3 mediated Bmp signaling controls the contribution of epicardially derived cells to the tissues of the atrioventricular junction".PMID 25300579
  1056. Hongpeng He et al. (2014). "SAHA inhibits the transcription initiation of HPV18 E6/E7 genes in HeLa cervical cancer cells".PMID 25300249
  1057. Kazushi Aoto et al. (2015). "Co-ordinated brain and craniofacial development depend upon Patched1/XIAP regulation of cell survival".PMID 25292199
  1058. Nicola J Maney et al. (2014). "Dendritic cell maturation and survival are differentially regulated by TNFR1 and TNFR2".PMID 25288570
  1059. Daniel B L Teh et al. (2014). "Regulation of later neurogenic stages of adult-derived neural stem/progenitor cells by L-type Ca2+ channels".PMID 25283796
  1060. Masashi Idogawa et al. (2014). "Array-based genome-wide RNAi screening to identify shRNAs that enhance p53-related apoptosis in human cancer cells".PMID 25277188
  1061. SANDRA PFISTER et al. (2015). "Novel role of cystic fibrosis transmembrane conductance regulator in maintaining adult mouse olfactory neuronal homeostasis".PMID 25271146
  1062. A Jarry et al. (2015). "Subversion of human intestinal mucosa innate immunity by a Crohn's disease-associated E. coli".PMID 25269707
  1063. A P Sobinoff et al. (2014). "Damaging legacy: maternal cigarette smoking has long-term consequences for male offspring fertility".PMID 25269568
  1064. Chitra Pattabiraman et al. (2014). "CD66+ cells in cervical precancers are partially differentiated progenitors with neoplastic traits".PMID 25267065
  1065. Haihui Lu et al. (2014). "A breast cancer stem cell niche supported by juxtacrine signalling from monocytes and macrophages".PMID 25266422
  1066. Yona Goldshmit et al. (2014). "Interfering with the interaction between ErbB1, nucleolin and Ras as a potential treatment for glioblastoma".PMID 25261371
  1067. Milan Zaric et al. (2015). "Chrysin induces apoptosis in peripheral blood lymphocytes isolated from human chronic lymphocytic leukemia".PMID 25257897
  1068. Patryk Moskwa et al. (2014). "A functional screen identifies miRs that induce radioresistance in glioblastomas".PMID 25256711
  1069. Shabnam Pooya et al. (2014). "The tumour suppressor LKB1 regulates myelination through mitochondrial metabolism".PMID 25256100
  1070. Sangmin Lee et al. (2014). "Novel somatic single nucleotide variants within the RNA binding protein hnRNP A1 in multiple sclerosis patients".PMID 25254102
  1071. Maria Abildgaard Steffensen et al. (2014). "Suppressors of cytokine signaling 1 and 3 are upregulated in brain resident cells in response to virus-induced inflammation of the central nervous system via at least two distinctive pathways".PMID 25253351
  1072. Chang Yi Cui et al. (2014). "Involvement of Wnt, Eda and Shh at defined stages of sweat gland development".PMID 25249463
  1073. Jennifer Zur Bruegge et al. (2014). "Arcobacter butzleri induces a pro-inflammatory response in THP-1 derived macrophages and has limited ability for intracellular survival".PMID 25245281
  1074. Kalina Andreeva et al. (2014). "Time-dependent Gene Profiling Indicates the Presence of Different Phases for Ischemia/Reperfusion Injury in Retina".PMID 25210480
  1075. Teruki Yanagi et al. (2014). "PCTAIRE1 phosphorylates p27 and regulates mitosis in cancer cells".PMID 25205104
  1076. Michael W Pickup et al. (2015). "BMPR2 loss in fibroblasts promotes mammary carcinoma metastasis via increased inflammation".PMID 25205038
  1077. Debora Cutuli et al. (2014). "n-3 polyunsaturated fatty acids supplementation enhances hippocampal functionality in aged mice".PMID 25202271
  1078. Pierre Jean Ferron et al. (2014). "Comparative analysis of the cytotoxic effects of okadaic acid-group toxins on human intestinal cell lines".PMID 25196936
  1079. Daniel Herranz et al. (2014). "A NOTCH1-driven MYC enhancer promotes T cell development, transformation and acute lymphoblastic leukemia".PMID 25194570
  1080. Lynn S Model et al. (2014). "Arterial shear stress reduces eph-b4 expression in adult human veins".PMID 25191151
  1081. W Guo et al. (2014). "Targeting Btk/Etk of prostate cancer cells by a novel dual inhibitor".PMID 25188519
  1082. Lih Fen Lue et al. (2015). "TREM2 Protein Expression Changes Correlate with Alzheimer's Disease Neurodegenerative Pathologies in Post-Mortem Temporal Cortices".PMID 25186950
  1083. Nozomi Takahashi et al. (2014). "RIPK1 ensures intestinal homeostasis by protecting the epithelium against apoptosis".PMID 25186904
  1084. Yifeng Lin et al. (2014). "Impaired eukaryotic translation initiation factor 2B activity specifically in oligodendrocytes reproduces the pathology of vanishing white matter disease in mice".PMID 25186761
  1085. Kazuhito Toyo-oka et al. (2014). "14-3-3ε and ζ regulate neurogenesis and differentiation of neuronal progenitor cells in the developing brain".PMID 25186760
  1086. G Berdugo-Vega et al. (2014). "GFAP immunoreactivity within the rat nucleus ambiguus after laryngeal nerve injury".PMID 25181319
  1087. Sandra M Garraway et al. (2014). "Peripheral noxious stimulation reduces withdrawal threshold to mechanical stimuli after spinal cord injury: role of tumor necrosis factor alpha and apoptosis".PMID 25180012
  1088. Kenneth C Valkenburg et al. (2014). "Activation of Wnt/β-catenin signaling in a subpopulation of murine prostate luminal epithelial cells induces high grade prostate intraepithelial neoplasia".PMID 25175604
  1089. Maya Jeitany et al. (2015). "A preclinical mouse model of glioma with an alternative mechanism of telomere maintenance (ALT)".PMID 25175359
  1090. K Althoff et al. (2015). "A Cre-conditional MYCN-driven neuroblastoma mouse model as an improved tool for preclinical studies".PMID 25174395
  1091. Yong Jie Zhang et al. (2014). "Aggregation-prone c9FTD/ALS poly(GA) RAN-translated proteins cause neurotoxicity by inducing ER stress".PMID 25173361
  1092. Beatriz Vidaña et al. (2014). "Heterogeneous pathological outcomes after experimental pH1N1 influenza infection in ferrets correlate with viral replication and host immune responses in the lung".PMID 25163545
  1093. Iryna Kolosenko et al. (2015). "Cell crowding induces interferon regulatory factor 9, which confers resistance to chemotherapeutic drugs".PMID 25156627
  1094. C S Yang et al. (2015). "Fatty acid synthase inhibition engages a novel caspase-2 regulatory mechanism to induce ovarian cancer cell death".PMID 25151963
  1095. Vanessa Ginet et al. (2014). "Dying neurons in thalamus of asphyxiated term newborns and rats are autophagic".PMID 25146903
  1096. Anna Liakhovitskaia et al. (2014). "Runx1 is required for progression of CD41+ embryonic precursors into HSCs but not prior to this".PMID 25139854
  1097. Carmela Passaro et al. (2015). "PARP inhibitor olaparib increases the oncolytic activity of dl922-947 in in vitro and in vivo model of anaplastic thyroid carcinoma".PMID 25139258
  1098. B P Kaistha et al. (2014). "Key role of dual specificity kinase TTK in proliferation and survival of pancreatic cancer cells".PMID 25137017
  1099. V Derangère et al. (2014). "Liver X receptor β activation induces pyroptosis of human and murine colon cancer cells".PMID 25124554
  1100. Antonios N Gargalionis et al. (2015). "Polycystin-1 and polycystin-2 are involved in the acquisition of aggressive phenotypes in colorectal cancer".PMID 25123959
  1101. Tingfang Yi et al. (2014). "4EGI-1 targets breast cancer stem cells by selective inhibition of translation that persists in CSC maintenance, proliferation and metastasis".PMID 25115391
  1102. Guoliang Chai et al. (2014). "Celsr3 is required in motor neurons to steer their axons in the hindlimb".PMID 25108913
  1103. Michael G Kemp et al. (2014). "DNA repair synthesis and ligation affect the processing of excised oligonucleotides generated by human nucleotide excision repair".PMID 25107903
  1104. Justin A Bosch et al. (2014). "The Drosophila F-box protein Fbxl7 binds to the protocadherin fat and regulates Dachs localization and Hippo signaling".PMID 25107277
  1105. A Patsialou et al. (2015). "Autocrine CSF1R signaling mediates switching between invasion and proliferation downstream of TGFβ in claudin-low breast tumor cells".PMID 25088194
  1106. Shane Deegan et al. (2014). "ER stress responses in the absence of apoptosome: a comparative study in CASP9 proficient vs deficient mouse embryonic fibroblasts".PMID 25086361
  1107. Jonathon L Burman et al. (2014). "A Drosophila model of mitochondrial disease caused by a complex I mutation that uncouples proton pumping from electron transfer".PMID 25085991
  1108. Andriy Marusyk et al. (2014). "Non-cell-autonomous driving of tumour growth supports sub-clonal heterogeneity".PMID 25079331
  1109. Jun Ueda et al. (2014). "The hypoxia-inducible epigenetic regulators Jmjd1a and G9a provide a mechanistic link between angiogenesis and tumor growth".PMID 25071150
  1110. Maarja Laos et al. (2014). "DNA damage signaling regulates age-dependent proliferative capacity of quiescent inner ear supporting cells".PMID 25063730
  1111. Tadashi Watanabe et al. (2014). "Pyrrolidinium fullerene induces apoptosis by activation of procaspase-9 via suppression of Akt in primary effusion lymphoma".PMID 25063029
  1112. Katherine T Ostapoff et al. (2014). "Neutralizing murine TGFβR2 promotes a differentiated tumor cell phenotype and inhibits pancreatic cancer metastasis".PMID 25060520
  1113. Boris Sabirzhanov et al. (2014). "Downregulation of miR-23a and miR-27a following experimental traumatic brain injury induces neuronal cell death through activation of proapoptotic Bcl-2 proteins".PMID 25057207
  1114. Ulrike Resch et al. (2014). "Polyubiquitinated tristetraprolin protects from TNF-induced, caspase-mediated apoptosis".PMID 25056949
  1115. Akihiro Kuma et al. (2014). "Role of WNT10A-expressing kidney fibroblasts in acute interstitial nephritis".PMID 25054240
  1116. Enrico Desideri et al. (2014). "MAPK14/p38α-dependent modulation of glucose metabolism affects ROS levels and autophagy during starvation".PMID 25046111
  1117. Robert Domitrovic et al. (2014). "Renoprotective mechanisms of chlorogenic acid in cisplatin-induced kidney injury".PMID 25043994
  1118. W T Wang et al. (2015). "Differential response of normal and malignant urothelial cells to CHK1 and ATM inhibitors".PMID 25043304
  1119. Marta Fernández-Nogales et al. (2014). "Huntington's disease is a four-repeat tauopathy with tau nuclear rods".PMID 25038828
  1120. Gabriel Skogberg et al. (2014). "Altered expression of autoimmune regulator in infant down syndrome thymus, a possible contributor to an autoimmune phenotype".PMID 25038256
  1121. Gregory J Baker et al. (2014). "Natural killer cells eradicate galectin-1-deficient glioma in the absence of adaptive immunity".PMID 25038230
  1122. Hillary F McGraw et al. (2014). "Kremen1 restricts Dkk activity during posterior lateral line development in zebrafish".PMID 25038040
  1123. Everett J Moding et al. (2014). "Atm deletion with dual recombinase technology preferentially radiosensitizes tumor endothelium".PMID 25036710
  1124. Suraj Konnath George et al. (2014). "The ALK inhibitor ASP3026 eradicates NPM-ALK⁺ T-cell anaplastic large-cell lymphoma in vitro and in a systemic xenograft lymphoma model".PMID 25026277
  1125. Benjamin Ettle et al. (2014). "Intracellular alpha-synuclein affects early maturation of primary oligodendrocyte progenitor cells".PMID 25019582
  1126. R Corpeno et al. (2014). "Time course analysis of mechanical ventilation-induced diaphragm contractile muscle dysfunction in the rat".PMID 25015920
  1127. Rana Baraz et al. (2014). "mTOR inhibition by everolimus in childhood acute lymphoblastic leukemia induces caspase-independent cell death".PMID 25014496
  1128. Sakae Maeda et al. (2014). "Interferon-α acts on the S/G2/M phases to induce apoptosis in the G1 phase of an IFNAR2-expressing hepatocellular carcinoma cell line".PMID 25012666
  1129. Bo Lin et al. (2014). "Human pluripotent stem cells have a novel mismatch repair-dependent damage response".PMID 25012654
  1130. Spencer U McKinstry et al. (2014). "Huntingtin is required for normal excitatory synapse development in cortical and striatal circuits".PMID 25009276
  1131. Wen Yang et al. (2014). "Mesencephalic astrocyte-derived neurotrophic factor prevents neuron loss via inhibiting ischemia-induced apoptosis".PMID 25001514
  1132. P Owens et al. (2015). "Inhibition of BMP signaling suppresses metastasis in mammary cancer".PMID 24998846
  1133. Krista L Sider et al. (2014). "Evaluation of a porcine model of early aortic valve sclerosis".PMID 24998316
  1134. Courtney Bricker-Anthony et al. (2014). "Molecular changes and vision loss in a mouse model of closed-globe blast trauma".PMID 24994864
  1135. Stephen Sojka et al. (2014). "Congenital heart disease protein 5 associates with CASZ1 to maintain myocardial tissue integrity".PMID 24993940
  1136. Peng Zhang et al. (2014). "Three puncture sites used for in utero electroporation show no significantly different negative impacts during gene transfer into the embryonic mouse brain".PMID 24993303
  1137. Katherine R Sadleir et al. (2014). "Genetic inhibition of phosphorylation of the translation initiation factor eIF2α does not block Aβ-dependent elevation of BACE1 and APP levels or reduce amyloid pathology in a mouse model of Alzheimer's disease".PMID 24992504
  1138. J Yan et al. (2014). "Usp9x- and Noxa-mediated Mcl-1 downregulation contributes to pemetrexed-induced apoptosis in human non-small-cell lung cancer cells".PMID 24991768
  1139. R A Charan et al. (2014). "Inhibition of apoptotic Bax translocation to the mitochondria is a central function of parkin".PMID 24991765
  1140. C Aligny et al. (2014). "Ketamine alters cortical integration of GABAergic interneurons and induces long-term sex-dependent impairments in transgenic Gad67-GFP mice".PMID 24991763
  1141. Christian Hagel et al. (2015). "Upregulation of Shiga toxin receptor CD77/Gb3 and interleukin-1β expression in the brain of EHEC patients with hemolytic uremic syndrome and neurologic symptoms".PMID 24989888
  1142. Tugce B Balci et al. (2014). "A transgenic zebrafish model expressing KIT-D816V recapitulates features of aggressive systemic mastocytosis".PMID 24989799
  1143. Georgios Chondrogiannis et al. (2014). "Cytokine effects on cell viability and death of prostate carcinoma cells".PMID 24982891
  1144. H Ehlken et al. (2014). "Death receptor-independent FADD signalling triggers hepatitis and hepatocellular carcinoma in mice with liver parenchymal cell-specific NEMO knockout".PMID 24971483
  1145. Hye Min Jeon et al. (2014). "Crosstalk between glioma-initiating cells and endothelial cells drives tumor progression".PMID 24962027
  1146. Hans Georg König et al. (2014). "The BCL-2 family protein Bid is critical for pro-inflammatory signaling in astrocytes".PMID 24956542
  1147. V Sudhakar Reddy et al. (2014). "Expression and induction of small heat shock proteins in rat heart under chronic hyperglycemic conditions".PMID 24950024
  1148. Monika E Dolega et al. (2014). "Facile bench-top fabrication of enclosed circular microchannels provides 3D confined structure for growth of prostate epithelial cells".PMID 24945245
  1149. Vanja Tepavcevic et al. (2014). "Early netrin-1 expression impairs central nervous system remyelination".PMID 24942777
  1150. Bradley R Kraemer et al. (2014). "A role for the p75 neurotrophin receptor in axonal degeneration and apoptosis induced by oxidative stress".PMID 24939843
  1151. Koji Otani et al. (2014). "Odd-skipped related 1 is a novel tumour suppressor gene and a potential prognostic biomarker in gastric cancer".PMID 24931004
  1152. Jiunn Min Shieh et al. (2014). "An increase in reactive oxygen species by deregulation of ARNT enhances chemotherapeutic drug-induced cancer cell death".PMID 24921657
  1153. Yoko S Kaneko et al. (2015). "Lipopolysaccharide treatment arrests the cell cycle of BV-2 microglial cells in G₁ phase and protects them from UV light-induced apoptosis".PMID 24919883
  1154. Sami Benzina et al. (2015). "Deoxyp